• Abderrahmani A, Chevre JC, Otabe S, Chikri M, Hani EH, Vaxillaire M, Hinokio Y, Horikawa Y, Bell GI, Froguel P. Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes 49: 306-308 (2000). *

• Accatino L, Pizarro M, Solis N, Arrese M, Vollrath V, Ananthanarayanan M, Chianale J, Koenig CS. Differential expression of canalicular membrane Ca2+/Mg(2+)-ecto-ATPase in estrogen-induced and obstructive cholestasis in the rat. J. Lab. Clin. Med. 136: 125-137 (2000). *

• Actis GC. Cyclosporin for steroid-refractory ulcerative colitis. Am. J. Gastroenterol. 95: 830 (2000). *

• Adams PC. Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases? Mol. Genet. Metab. 71: 81-86 (2000). *

• Adams PC. Population screening for haemochromatosis. Gut 46: 301-303 (2000). *

• Adams PC, Bhayana V. Unsaturated iron-binding capacity: a screening test for C282Y hemochromatosis? Clin. Chem. 46: 1870-1871 (2000). *

• Addous A, Mohamed AS, Ismail G, Al-Hashemy A. Post-transplant diabetes mellitus in kidney transplant recipients with special reference to association with HLA antigens. Saudi J. Kidney Dis. Transpl. 11: 559-562 (2000).

• Adorini L. New trends in clinical and experimental immunosuppression - fourth international conference. IDrugs 3: 496-498 (2000).

• Aebi C, Theiler F, Aebischer CC, Schoeni MH. Autoantibodies directed against bactericidal/permeability-increasing protein in patients with cystic fibrosis: association with microbial respiratory tract colonization. Pediatr. Infect. Dis. J. 19: 207-212 (2000).

• Afessa B, Kubilis PS. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am. J. Gastroenterol. 95: 484-489 (2000). *

• Afzal MA, Armitage E, Ghosh S, Williams LC, Minor PD. Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease. J. Med. Virol. 62: 377-382 (2000). *

• Afzal MA, Minor PD, Schild GC. Clinical safety issues of measles, mumps and rubella vaccines. Bull. World Health Organ. 78: 199-204 (2000).

• Agace WW, Roberts AI, Wu L, Greineder C, Ebert EC, Parker CM. Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. Eur. J. Immunol. 30: 819-826 (2000). *

• Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31: 49-53 (2000). *

• Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, Bassendine MF. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J. Hepatol. 32: 538-541 (2000). *

• Agarwal S, Joyner KA Jr, Swaim MW. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am. J. Gastroenterol. 95: 3218-3224 (2000). *

• Aghdassi E, Allard JP. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic. Biol. Med. 28: 880-886 (2000).

• Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, Reed MW, Afonina IA, Rabinovitch PS, Stevens AC, Feng Z, Bronner MP. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am. J. Pathol. 157: 737-745 (2000). *

• Agrawal S, Gupta A, Yachha SK, Muller-Myhsok B, Mehrotra P, Agarwal SS. Association of human leucocyte-DR and DQ antigens in coeliac disease: a family study. J. Gastroenterol. Hepatol. 15: 771-774 (2000). *

• Agundez JAG, Lozano L, Ladero JM, Sastre J, Cerdan FJ, Diaz-Rubio M, Benitez J. N-Acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: risk variability according to tumour site? Scand. J. Gastroenterol. 35: 1087-1091 (2000). *

• Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. J. Hepatobiliary Pancreat. Surg. 7: 426-431 (2000).

• Aitola P, Mattila J, Matikainen M. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma. Int. J. Colorectal Dis. 15: 167-171 (2000). *

• Ajuebor MN, Singh A, Wallace JL. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G238-G244 (2000). *

• Akagi S, Hiyama E, Imamura Y, Takesue Y, Matsuura Y, Yokoyama T. Interleukin-10 expression in intestine of Crohn disease. Int. J. Mol. Med. 5: 389-395 (2000).

• Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K, Bowden DW. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 10: 851-858 (2000).

• Akira S. Toll-like receptors: lessons from knockout mice. Biochem. Soc. Trans. 28: 551-556 (2000). *

• Akira S, Hoshino K, Kaisho T. The role of Toll-like receptors and MyD88 in innate immune responses. J. Endotoxin Res. 6: 383-387 (2000). *

• Akiyama TE, Ward JM, Gonzalez FJ. Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alterations in fatty acid homeostasis in HNF1alpha-deficient mice. J. Biol. Chem. 275: 27117-27122 (2000). *

• Akiyama Y, Tanaka M, Takeishi M, Adachi D, Mimori A, Suzuki T. Clinical, serological and genetic study in patients with CREST syndrome. Intern. Med. 39: 451-456 (2000). *

• al-Abdulla NA, Schulick RD, Regan F. Hypereosinophilic sclerosing cholangitis: findings using half-Fourier magnetic resonance imaging. Hepatogastroenterology 47: 359-361 (2000).

• Al-Ansari AS, Ollier WE, Villarreal J, Ordi J, Teh LS, Hajeer AH. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. Tissue Antigens 55: 97-99 (2000). *

• Al-Asiri R, Al-Shahed M, Wali S. Histiocytosis X and Caroli's disease. Saudi Med. J. 21: 306-307 (2000).

• Al-Eidan FA, McElnay JC, Scott MG, Kearney MP. Clostridium difficile-associated diarrhoea in hospitalised patients. J. Clin. Pharm. Ther. 25: 101-109 (2000).

• Alam I, Bass NM, Bacchetti P, Gee L, Rockey DC. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Am. J. Gastroenterol. 95: 199-203 (2000). *

• Alavi K, Schwartz MZ, Palazzo JP, Prasad R. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. J. Pediatr. Surg. 35: 847-851 (2000).

• Albanesi C, Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol. 115: 81-87 (2000). *

• Albanopoulos K, Armakolas A, Konstadoulakis MM, Leandros E, Tsiobanou E, Katsaragakis S, Alexiou D, Androulakis G. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer. Am. J. Gastroenterol. 95: 1056-1061 (2000). *

• Aldersley MA, Hamlin PJ, Jones PF, Markham AF, Robinson PA, Howdle PD. No polymorphism in the tissue transglutaminase gene detected in coeliac disease patients. Scand. J. Gastroenterol. 35: 61-63 (2000). *

• Alfonso C, Karlsson L. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18: 113-142 (2000). *

• Alic M. Inflammatory bowel diseases are diseases of higher socioeconomic status: dogma or reality? Am. J. Gastroenterol. 95: 3332-3333 (2000). *

• Alic M. Crohn's disease epidemiology at the turn of the century-solving the puzzle. Am. J. Gastroenterol. 95: 321-323 (2000). *

• Alic M. Epidemiology supports oral contraceptives as a risk factor in Crohn's disease. Gut 46: 140 (2000). *

• Allez M, Modigliani R. Clinical features of inflammatory bowel disease. Curr. Opin. Gastroenterol. 16: 329-336 (2000).

• Allgayer H, Tillmann T, Hombach A, Kruis W, Pohl C. Aminosalicylates and aspirin for colonic cancer: from anti-inflammatory to antineoplastic drugs? Z. Gastroenterol. 38: 963-970 (2000).

• Almallah YZ, El-Tahir A, Heys SD, Richardson S, Eremin O. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur. J. Clin. Invest. 30: 58-65 (2000). *

• Almallah YZ, Ewen SW, El-Tahir A, Mowat NA, Brunt PW, Sinclair TS, Heys SD, Eremin O. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J. Clin. Immunol. 20: 68-76 (2000). *

• Almasio PL, Floreani A, Chiaramonte M, Provenzano G, Battezzati P, Crosignani A, Podda M, Todros L, Rosina F, Saccoccio G, Manenti F, Ballardini G, Bianchi FP, Scheuer PJ, Davies SE, Craxi A. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis. Aliment. Pharmacol. Ther. 14: 1645-1652 (2000). *

• Alper CA, Marcus-Bagley D, Awdeh Z, Kruskall MS, Eisenbarth GS, Brink SJ, Katz AJ, Stein R, Bing DH, Yunis EJ, Schur PH. Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype. Tissue Antigens 56: 207-216 (2000). *

• Altschuler EL. Mycophenolate mofetil, Crohn's disease, measles? Am. J. Gastroenterol. 95: 550-551 (2000). *

• Altschuler EL. Is JC polyoma virus the cause of ulcerative colitis and multiple sclerosis? Med. Hypotheses 55: 335-336 (2000).

• Alvarez I, Lopez de Castro JA. HLA-B27 and immunogenetics of spondyloarthropathies. Curr. Opin. Rheumatol. 12: 248-253 (2000).

• Alvarez R, Checa M, Brun S, Vinas O, Mampel T, Iglesias R, Giralt M, Villarroya F. Both retinoic-acid-receptor- and retinoid-X-receptor-dependent signalling pathways mediate the induction of the brown-adipose-tissue-uncoupling-protein-1 gene by retinoids. Biochem. J. 345: 91-97 (2000). *

• Alvaro D, Benedetti A, Marucci L, Delle Monache M, Monterubbianesi R, Di Cosimo E, Perego L, Macarri G, Glaser S, Le Sage G, Alpini G. The function of alkaline phosphatase in the liver: regulation of intrahepatic biliary epithelium secretory activities in the rat. Hepatology 32: 174-184 (2000). *

• Alvaro D, Gigliozzi A, Attili AF. Regulation and deregulation of cholangiocyte proliferation. J. Hepatol. 33: 333-340 (2000). *

• Alwitry A. Vitamin A deficiency in coeliac disease. Br. J. Ophthalmol. 84: 1079-1080 (2000). *

• Ameen N, Alexis J, Salas P. Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract. Histochem. Cell Biol. 114: 69-75 (2000). *

• Ameen NA, Salas PJ. Microvillus inclusion disease: a genetic defect affecting apical membrane protein traffic in intestinal epithelium. Traffic 1: 76-83 (2000). *

• Amemiya T. The eye and nutrition Jpn. J. Ophthalmol. 44: 320 (2000).

• Anderson HA, Hiltbold EM, Roche PA. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1: 156-162 (2000). *

• Anderson JC, Gonzalez JD, Messina CR, Pollack BJ. Factors that predict incomplete colonoscopy: thinner is not always better. Am. J. Gastroenterol. 95: 2784-2787 (2000). *

• Anderson KV. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12: 13-19 (2000).

• Anderson ML, Pasha TM, Leighton JA. Endoscopic perforation of the colon: lessons from a 10-year study. Am. J. Gastroenterol. 95: 3418-3422 (2000). *

• Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 6: 337-342 (2000). *

• Andersson EC, Svendsen P, Svejgaard A, Holmdahl R, Fugger L. A molecule basis for the HLA association in rheumatoid arthritis. Rev. Immunogenet. 2: 81-87 (2000).

• Andres PG, Beck PL, Mizoguchi E, Mizoguchi A, Bhan AK, Dawson T, Kuziel WA, Maeda N, MacDermott RP, Podolsky DK, Reinecker HC. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 164: 6303-6312 (2000). *

• Andus T, Gross V. Etiology and pathophysiology of inflammatory bowel disease - environmental factors. Hepatogastroenterology 47: 29-43 (2000).

• Angulo P, Batts KP, Jorgensen RA, LaRusso NA, Lindor KD. Oral budesonide in the treatment of primary sclerosing cholangitis. Am. J. Gastroenterol. 95: 2333-2337 (2000). *

• Angulo P, Dickson ER. The timing of liver transplantation in primary biliary cirrhosis. Best Pract. Res. Clin. Gastroenterol. 14: 657-668 (2000). *

• Angulo P, Jorgensen RA, Keach JC, Dickson ER, Smith C, Lindor KD. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 31: 318-323 (2000). *

• Angulo P, Lindor KD. Primary sclerosing cholangitis: emerging new promising therapies. J. Clin. Gastroenterol. 31: 271-273 (2000).

• Angulo P, Lindor KD. Medical treatment for primary sclerosing cholangitis: risk versus benefit. Hepatology 32: 871-872 (2000). *

• Angulo P, Patel T, Jorgensen RA, Therneau TM, Lindor KD. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 32: 897-900 (2000). *

• Angulo P, Pearce DH, Johnson CD, Henry JJ, LaRusso NF, Petersen BT, Lindor KD. Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. J. Hepatol. 33: 520-527 (2000). *

• Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, Lindor KD. Serum autoantibodies in patients with primary sclerosing cholangitis. J. Hepatol. 32: 182-187 (2000). *

• Annibale B, Capurso G, Martino G, Grossi C, Delle Fave G. Iron deficiency anaemia and Helicobacter pylori infection. Int. J. Antimicrob. Agents 16: 515-519 (2000). *

• Anthony A, Pounder RE, Dhillon AP, Wakefield AJ. Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat. Aliment. Pharmacol. Ther. 14: 241-245 (2000). *

• Anthony A, Sim R, Guillaume JL, Strosberg AD, Dhillon AP, Pounder RE, Wakefield AJ. Beta(beta)3-adrenergic receptors in human pancreatic islet and duodenal somatostatin neuroendocrine cells. Aliment. Pharmacol. Ther. 14: 579-585 (2000). *

• Aoki A, Kenmochi H, Hagiwara E, Ohno S, Ueda A, Tsuji T, Ideguchi H, Misumi M, Minamizawa K, Okudera K, Inoue Y, Ishigatsubo Y. Pulmonary hypertension in a patient with primary Sjogren's syndrome, Hashimoto's disease, and primary biliary cirrhosis. Nihon Rinsho Meneki Gakkai Kaishi 23: 462-469 (2000).

• Appelmelk BJ, Monteiro MA, Martin SL, Moran AP, Vandenbroucke-Grauls CM. Why Helicobacter pylori has Lewis antigens. Trends Microbiol. 8: 565-570 (2000). *

• Arad G, Levy R, Hillman D, Kaempfer R. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat. Med. 6: 414-421 (2000). *

• Araki Y, Fujiyama Y, Andoh A, Koyama S, Kanauchi O, Bamba T. The dietary combination of germinated barley foodstuff plus Clostridium butyricum suppresses the dextran sulfate sodium-induced experimental colitis in rats. Scand. J. Gastroenterol. 35: 1060-1067 (2000). *

• Araki Y, Tsujikawa T, Andoh A, Sasaki M, Fujiyama Y, Bamba T. Therapeutic effects of an oral adsorbent on acute dextran sulphate sodium-induced colitis and its recovery phase in rats, especially effects of elimination of bile acids in gut lumen. Dig. Liver Dis. 32: 691-698 (2000).

• Arcos-Burgos M, Palacio LG, Mora O, Sanchez JL, Jimenez M, Jimenez I. Molecular genetic aspects of the susceptibility to develop idiopathic epilepsy. Rev. Neurol. 30: 173-177 (2000).

• Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J. Intern. Med. 247: 63-70 (2000). *

• Arduino C, Gaia E. Genetics of chronic pancreatitis. Biomed. Pharmacother. 54: 394-399 (2000).

• Arechalde A, Saurat JH. Management of psoriasis: the position of retinoid drugs. BioDrugs 13: 327-333 (2000).

• Arentz-Hansen EH, McAdam SN, Molberg O, Kristiansen C, Sollid LM. Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease. Gut 46: 46-51 (2000). *

• Arentz-Hansen H, Korner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, McAdam SN. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191: 603-612 (2000). *

• Armstrong AM, Campbell GR, Gannon C, Kirk SJ, Gardiner KR. Oral administration of inducible nitric oxide synthase inhibitors reduces nitric oxide synthesis but has no effect on the severity of experimental colitis. Scand. J. Gastroenterol. 35: 832-838 (2000). *

• Arnett FC. Genetic studies of human lupus in families. Int. Rev. Immunol. 19: 297-317 (2000).

• Arnott ID, Kingstone K, Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand. J. Gastroenterol. 35: 1163-1169 (2000). *

• Arnott ID, Shand A, Ghosh S. Administration of infliximab in Crohn's disease does not deplete complement components C3 and C4. Am. J. Gastroenterol. 95: 3326-3327 (2000). *

• Aronoff JS, Korelitz BI, Sohn N, Ky A, Rajapakse R, Weinstein MA, Cohen FS. Anorectal Crohn's disease: surgical and medical management. BioDrugs 13: 95-105 (2000).

• Arseneau KO, Pizarro TT, Cominelli F. Discovering the cause of inflammatory bowel disease: lessons from animal models. Curr. Opin. Gastroenterol. 16: 310-317 (2000).

• Arthur MJ. Fibrogenesis. II. Metalloproteinases and their inhibitors in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G245-G249 (2000). *

• Artis D, Humphreys NE, Potten CS, Wagner N, Muller W, McDermott JR, Grencis RK, Else KJ. Beta7 integrin-deficient mice: delayed leukocyte recruitment and attenuated protective immunity in the small intestine during enteric helminth infection. Eur. J. Immunol. 30: 1656-1664 (2000). *

• Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18: 309-345 (2000). *

• Asseman C, Fowler S, Powrie F. Control of experimental inflammatory bowel disease by regulatory T cells. Am. J. Respir. Crit. Care Med. 162: S185-S189 (2000). *

• Asumalahti K, Laitinen T, Itkonen-Vatjus R, Lokki ML, Suomela S, Snellman E, Saarialho-Kere U, Kere J. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum. Mol. Genet. 9: 1533-1542 (2000). *

• Atkinson EM. American society of gene therapy - third annual meeting. IDrugs 3: 1009-1011 (2000).

• Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6: 583-588 (2000). *

• Aukrust P, Muller F, Ueland T, Svardal AM, Berge RK, Froland SS. Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses. Eur. J. Clin. Invest. 30: 252-259 (2000). *

• Auletta M, Oliviero U, Iasiuolo L, Scherillo G, Antoniello S. Pulmonary hypertension associated with liver cirrhosis: an echocardiographic study. Angiology 51: 1013-1020 (2000).

• Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, Megraud F. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89: 1431-1439 (2000). *

• Avila MA, Berasain C, Torres L, Martin-Duce A, Corrales FJ, Yang H, Prieto J, Lu SC, Caballeria J, Rodes J, Mato JM. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 33: 907-914 (2000). *

• Awadallah S, Hamad M. The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent. Cytobios. 101: 145-150 (2000).

• Babcock TA, Carlin JM. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine 12: 588-594 (2000).

• Baert FJ, Rutgeerts PJ. Medical therapies for ulcerative colitis and Crohn's disease. Curr. Gastroenterol. Rep. 2: 446-450 (2000).

• Baier LJ, Permana PA, Traurig M, Dobberfuhl A, Wiedrich C, Sutherland J, Thuillez P, Luczy-Bachman G, Hara M, Horikawa Y, Hinokio Y, Hanson RL, Bogardus C. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians. Diabetes Care 23: 302-304 (2000). *

• Baillie J, Kozarek RA. A little girl with pancreatitis. Endoscopy 32: 72-75 (2000).

• Baiqiu W, Songbin F, Guiyin Z, Pu L. Study of the relationship between psoriasis and the polymorphic site C677T of methylenetetrahydrofolate reductase. Chin. Med. Sci. J. 15: 119-120 (2000).

• Baker SJ, Jacob E, Bowden GH. Crohn disease arthropathy: antigens in synovial fluid share epitopes with strains of two species of Viridans streptococci. Scand. J. Gastroenterol. 35: 287-292 (2000). *

• Bakker D, Willemsen PT, van Zijderveld FG. Paratuberculosis recognized as a problem at last: a review. Vet. Q. 22: 200-204 (2000).

• Baldas V, Tommasini A, Trevisiol C, Berti I, Fasano A, Sblattero D, Bradbury A, Marzari R, Barillari G, Ventura A, Not T. Development of a novel rapid non-invasive screening test for coeliac disease. Gut 47: 628-631 (2000). *

• Baldini V, Casella G, Perego D, Morcelli E, Fraterrigo RT. Hypocalcemic tetany due to coeliac disease. May this symptoms disappear? Minerva Gastroenterol. Dietol. 46: 99-104 (2000).

• Baldry C, Backman SB, Metrakos P, Tchervenkov J, Barkun J, Moore A. Liver transplantation in a Jehovah's Witness with ankylosing spondylitis. Can. J. Anaesth. 47: 642-646 (2000).

• Ballatori N, Rebbeor JF, Connolly GC, Seward DJ, Lenth BE, Henson JH, Sundaram P, Boyer JL. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G57-G63 (2000). *

• Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MJ. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 46: 694-700 (2000). *

• Ballot E, Homberg JC, Johanet C. Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. J. Hepatol. 33: 208-215 (2000). *

• Bamberger CM, Schulte HM. Molecular mechanisms of dissociative glucocorticoid activity. Eur. J. Clin. Invest. 30 Suppl. 3: 6-9 (2000).

• Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10: 475-480 (2000).

• Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10: 375-380 (2000).

• Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J. Clin. Endocrinol. Metab. 85: 4639-4643 (2000). *

• Ban Y, Taniyama M, Tozaki T, Tomita M, Ban Y. Estrogen receptor alpha dinucleotide repeat polymorphism in Japanese patients with autoimmune thyroid diseases. BMC Med. Genet. 1: 1 (2000). *

• Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K. Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am. J. Gastroenterol. 95: 3452-3457 (2000). *

• Bar Meir M, Hadas-Halperin I, Fisher D, Rosenmann E, Brautbar C, Branski D, Faber J, Wilschanski M. Neonatal sclerosing cholangitis associated with autoimmune phenomena. J. Pediatr. Gastroenterol. Nutr. 30: 332-334 (2000). *

• Barbara G, Xing Z, Hogaboam CM, Gauldie J, Collins SM. Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 46: 344-349 (2000). *

• Barbesino G, Chiovato L. The genetics of Hashimoto's disease. Endocrinol. Metab. Clin. North Am. 29: 357-374 (2000).

• Barbieri D. Inflammatory bowel diseases. J. Pediatr. (Rio. J.) 76: S173-S180 (2000). *

• Barcellos LF, Schito AM, Rimmler JB, Vittinghoff E, Shih A, Lincoln R, Callier S, Elkins MK, Goodkin DE, Haines JL, Pericak-Vance MA, Hauser SL, Oksenberg JR. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics 51: 281-288 (2000).

• Bargon J, Rickmann J, Jacobi V, Straub R, Arnemann J, Wagner TO. Cystic fibrosis - initial diagnosis in a 39-year-old patient. Med. Klin. (Munich) 95: 697-700 (2000).

• Barille S, Collette M, Thabard W, Bleunven C, Bataille R, Amiot M. Soluble IL-6R alpha upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells. Cytokine 12: 1426-1429 (2000).

• Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu. Rev. Med. 51: 511-523 (2000). *

• Bartoli R, Fernandez-Banares F, Navarro E, Castella E, Mane J, Alvarez M, Pastor C, Cabre E, Gassull MA. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 46: 191-199 (2000). *

• Barton A, Myerscough A, John S, Gonzalez-Gay M, Ollier W, Worthington J. A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis. Rheumatology (Oxford) 39: 63-66 (2000). *

• Barton CC, Ganey PE, Roth RA. Lipopolysaccharide augments aflatoxin B(1)-induced liver injury through neutrophil-dependent and -independent mechanisms. Toxicol. Sci. 58: 208-215 (2000). *

• Barton CC, Hill DA, Yee SB, Barton EX, Ganey PE, Roth RA. Bacterial lipopolysaccharide exposure augments aflatoxin B(1)-induced liver injury. Toxicol. Sci. 55: 444-452 (2000). *

• Barua AB, Olson JA. beta-Carotene is converted primarily to retinoids in rats in vivo. J. Nutr. 130: 1996-2001 (2000). *

• Baruch Y. The liver: a large endocrine gland. J. Hepatol. 32: 505-507 (2000). *

• Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am. J. Gastroenterol. 95: 2936-2939 (2000). *

• Bastien MC, Leblond F, Pichette V, Villeneuve JP. Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis. Can. J. Physiol. Pharmacol. 78: 912-919 (2000).

• Bateson MC. Advances in gastroenterology and hepatology. Postgrad. Med. J. 76: 328-332 (2000). *

• Batheja N, Suriawinata A, Saxena R, Ionescu G, Schwartz M, Thung SN. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. Mod. Pathol. 13: 1265-1268 (2000). *

• Bathgate AJ, Pravica V, Perrey C, Hayes PC, Hutchinson IV. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur. J. Gastroenterol. Hepatol. 12: 1329-1333 (2000).

• Beck S, Trowsdale J. The human major histocompatability complex: lessons from the DNA sequence. Annu. Rev. Genomics Hum. Genet. 1: 117-137 (2000). *

• Becker D. Enhanced imaging diagnosis of liver carcinomas. Technical progress is not a substitute for clinical knowledge. MMW Fortschr. Med. 142: 38-40 (2000).

• Becquemont L, Camus M, Kriaa F, Barbu V, Charpentier B, Jaillon P. Low levels of lymphocyte MDR1 gene expression during early renal transplantation in patients treated with tacrolimus. Fundam. Clin. Pharmacol. 14: 225-229 (2000).

• Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. The acute phase response is associated with retinoid X receptor repression in rodent liver. J. Biol. Chem. 275: 16390-16399 (2000). *

• Belaiche J, Louis E. Treatment of Crohn disease in adults with tumor necrosis factor-alpha (TNF-alpha) antibodies. Rev. Med. Liege. 55: 827-832 (2000).

• Bell CJ, Elliott EJ, Wallace JL, Redmond DM, Payne J, Li Z, O'Loughlin EV. Do eicosanoids cause colonic dysfunction in experimental E coli O157:H7 (EHEC) infection? Gut 46: 806-812 (2000). *

• Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, Try K, Thomassen Y, Haug E, Raha-Chowdhury R, Thorsby E. The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand. J. Gastroenterol. 35: 1301-1307 (2000). *

• Bellamy R. Evidence of gene-environment interaction in development of tuberculosis. Lancet 355: 588-589 (2000). *

• Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani G, Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am. J. Clin. Nutr. 71: 339S-342S (2000). *

• Ben Rhouma K, Tebourbi O, Sakly M. Acute hepatotoxicity of DDT: effect on glucocorticoid receptors and serum transcortin. Indian J. Exp. Biol. 38: 452-456 (2000).

• Bendjelloul F, Maly P, Mandys V, Jirkovska M, Prokesova L, Tuckova L, Tlaskalova-Hogenova H. Intercellular adhesion molecule-1 (ICAM-1) deficiency protects mice against severe forms of experimentally induced colitis. Clin. Exp. Immunol. 119: 57-63 (2000). *

• Benhamou JP. Primary sclerosing cholangitis. Rev. Prat. 50: 2146-2149 (2000).

• Bennett CL, Yoshioka R, Kiyosawa H, Barker DF, Fain PR, Shigeoka AO, Chance PF. X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3. Am. J. Hum. Genet. 66: 461-468 (2000). *

• Beno I, Klvanova J, Magalova T, Brtkova A. Blood levels of natural antioxidants in gastric and colorectal precancerous lesions and cancers in Slovakia. Neoplasma 47: 37-40 (2000).

• Benyon RC, Iredale JP. Is liver fibrosis reversible? Gut 46: 443-446 (2000). *

• Benz C, Angermuller S, Otto G, Sauer P, Stremmel W, Stiehl A. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur. J. Clin. Invest. 30: 203-209 (2000).

• Berasain C, Betes M, Panizo A, Ruiz J, Herrero JI, Civeira MP, Prieto J. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 47: 429-435 (2000). *

• Berg L, Ronnelid J, Sanjeevi CB, Lampa J, Klareskog L. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Arthritis Res. 2: 75-84 (2000). *

• Berg PA, Klein R. Diagnosis of autoimmune hepatitis. Med. Klin. 95: 178-180 (2000).

• Bergasa NV, Mehlman JK, Jones EA. Pruritus and fatigue in primary biliary cirrhosis. Baillieres Best Pract. Res. Clin. Gastroenterol. 14: 643-655 (2000).

• Bergen AA, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H, Swart J, Kool M, van Soest S, Baas F, ten Brink JB, de Jong PT. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat. Genet. 25: 228-231 (2000). *

• Berger MY, van der Velden JJ, Lijmer JG, de Kort H, Prins A, Bohnen AM. Abdominal symptoms: do they predict gallstones? A systematic review. Scand. J. Gastroenterol. 35: 70-76 (2000). *

• Bergholdt R, Larsen ZM, Andersen NA, Johannesen J, Kristiansen OP, Mandrup-Poulsen T, Nerup J, Pociot F; Danish Study Group of IDDM in Childhood; Danish IDDM Epidemiology and Genetics Group. Characterization of new polymorphisms in the 5' UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level. Genes Immun. 1: 495-500 (2000). *

• Bergogne-Berezin E. Treatment and prevention of antibiotic associated diarrhea. Int. J. Antimicrob. Agents 16: 521-526 (2000). *

• Bergquist A, Tribukait B, Glaumann H, Broome U. Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? J. Hepatol. 33: 873-877 (2000). *

• Berkane N, Cocheton JJ, Brehier D, Merviel P, Wolf C, Lefevre G, Uzan S. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases. Acta Obstet. Gynecol. Scand. 79: 941-946 (2000).

• Bernstein CN. Neoplastic and other complications of inflammatory bowel disease. Curr. Gastroenterol. Rep. 2: 451-459 (2000).

• Bernstein CN, Blanchard JF. Viruses and inflammatory bowel disease: is there evidence for a causal association? Inflamm. Bowel Dis. 6: 34-39 (2000). *

• Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann. Intern. Med. 133: 795-799 (2000). *

• Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am. J. Gastroenterol. 95: 677-683 (2000). *

• Berrettini WH. Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia. Biol. Psychiatry 47: 245-251 (2000).

• Berrettini WH. Genetics of psychiatric disease. Annu. Rev. Med. 51: 465-479 (2000). *

• Berstad AE, Brandtzaeg P. Does reduced microbial exposure contribute to increased prevalence of allergy? Tidsskr. Nor. Laegeforen. 120: 915-919 (2000).

• Bethune CA, Spickett GP. Common variable immunodeficiency: an update on therapeutic approaches. BioDrugs 13: 243-253 (2000).

• Beutler B. Endotoxin, Toll-like receptor 4, and the afferent limb of innate immunity. Curr. Opin. Microbiol. 3: 23-28 (2000).

• Bhan AK, Mizoguchi E, Smith RN, Mizoguchi A. Spontaneous chronic colitis in TCR alpha-mutant mice; an experimental model of human ulcerative colitis. Int. Rev. Immunol. 19: 123-138 (2000).

• Bharucha AE, Jorgensen R, Lichtman SN, LaRusso NF, Lindor KD. A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis. Am. J. Gastroenterol. 95: 2338-2342 (2000). *

• Bhatia E, Durie P, Zielenski J, Lam D, Sikora SS, Choudhuri G, Tsui LC. Mutations in the cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis. Am. J. Gastroenterol. 95: 3658-3659 (2000). *

• Bhavnani M, Lloyd D, Bhattacharyya A, Marples J, Elton P, Worwood M. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase. Gut 46: 707-710 (2000). *

• Bhidayasiri R, Katz JA, Sokos DR. Correction of mesalazine-induced neutropenia with high-dose G-CSF. Am. J. Gastroenterol. 95: 3321-3322 (2000). *

• Bhura-Bandali FN, Suh M, Man SF, Clandinin MT. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J. Nutr. 130: 2870-2875 (2000). *

• Biagi F, Lorenzini P, Corazza GR. Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease, and enteropathy-associated T-cell. Scand. J. Gastroenterol. 35: 785-790 (2000). *

• Biagi F, Parnell ND, Ellis HJ, Ciclitira PJ. Endomysial antibody production is not related to histological damage after in vitro gluten challenge. Eur. J. Gastroenterol. Hepatol. 12: 57-60 (2000).

• Bianchi FB, Muratori L. Primary and secondary autoimmunity in hepatology. Ann. Ital. Med. Int. 15: 56-62 (2000).

• Biancone L, Vernia P, Agostini D, Ferrieri A, Pallone F. Effect of rifaximin on intestinal bacterial overgrowth in Crohn's disease as assessed by the H2-glucose breath test. Curr. Med. Res. Opin. 16: 14-20 (2000).

• Bickston SJ. When to eat dirt. Inflamm. Bowel Dis. 6: 333 (2000). *

• Bildozola M, Kravetz D, Argonz J, Romero G, Suarez A, Jmelnitzky A, Fainberg M, Fassio E, Berreta J, Romero G, Landeira G, Martinez H, Bosco A, Guevara M, Valero J, Chopita N, Berenstein G, Terg R. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial. Scand. J. Gastroenterol. 35: 419-425 (2000). *

• Billoni N, Buan B, Gautier B, Collin C, Gaillard O, Mahe YF, Bernard BA. Expression of peroxisome proliferator activated receptors (PPARs) in human hair follicles and PPAR alpha involvement in hair growth. Acta Derm. Venereol. 80: 329-334 (2000).

• Bilzer M, Gerbes AL. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J. Hepatol. 32: 508-515 (2000). *

• Bingham SJ, Snowden JA, Emery P. Autologous blood stem cell transplantation as therapy for autoimmune diseases. Ann. Med. 32: 615-521 (2000).

• Biola A, Pallardy M. Mode of action of glucocorticoids. Presse. Med. 29: 215-223 (2000).

• Biondi ML, Turri O, Leviti S, Seminati R, Cecchini F, Bernini M, Ghilardi G, Guagnellini E. MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin. Chem. 46: 2023-2024 (2000). *

• Bird JE, Giancarli MR, Kurihara T, Kowala MC, Valentine MT, Gitlitz PH, Pandya DG, French MH, Durham SK. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice. Kidney Int. 57: 129-136 (2000). *

• Birgisson H, Steingrimsson O, Guethnason T. Kingella kingae ostemyelitis and septic arthritis in paediatric patients. Six cases from the Department of Pediatrics, National University Hospital of Iceland. Laeknabladid. 86: 516-519 (2000).

• Birketvedt GS, Berg KJ, Fausa O, Florholmen J. Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis. Inflamm. Bowel Dis. 6: 275-279 (2000). *

• Birnbaum RA, O'Marcaigh A, Wardak Z, Zhang YY, Dranoff G, Jacks T, Clapp DW, Shannon KM. Nf1 and Gmcsf interact in myeloid leukemogenesis. Mol. Cell 5: 189-195 (2000). *

• Bishop-Bailey D. Peroxisome proliferator-activated receptors in the cardiovascular system. Br. J. Pharmacol. 129: 823-834 (2000). *

• Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR, Brasitus TA. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Cancer Res. 60: 4602-4609 (2000). *

• Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Bottinger EP. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 14: 187-197 (2000). *

• Bjornsson ES, Kilander AF, Olsson RG. Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis - a study of bile cultures from ERCP. Hepatogastroenterology 47: 1504-1508 (2000).

• Bjoro K, Hockerstedt K, Ericzon BG, Friman S, Hjortrup A, Keiding S, Schrumpf E, Duraj F, Olausson M, Makisalo H, Bergan A, Kirkegaard P. Liver transplantation in patients over 60 years of age. Transpl. Int. 13 Suppl. 1: S165-S170 (2000).

• Bjorses P, Halonen M, Palvimo JJ, Kolmer M, Aaltonen J, Ellonen P, Perheentupa J, Ulmanen I, Peltonen L. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am. J. Hum. Genet. 66: 378-392 (2000). *

• Blanchard RK, Cousins RJ. Regulation of intestinal gene expression by dietary zinc: induction of uroguanylin mRNA by zinc deficiency. J. Nutr. 130: 1393S-1398S (2000). *

• Blankenhorn EP, Butterfield RJ, Rigby R, Cort L, Giambrone D, McDermott P, McEntee K, Solowski N, Meeker ND, Zachary JF, Doerge RW, Teuscher C. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints. J. Immunol. 164: 3420-3425 (2000). *

• Blomberg B, Jarnerot G. Clinical evaluation and management of acute severe colitis. Inflamm. Bowel Dis. 6: 214-227 (2000). *

• Blomberg J. Newly discovered human retroviruses. Association with disease is still undetermined. Lakartidningen 97: 3597-3599, 3602-3603 (2000).

• Blum A, Miller H. The major histocompatibility complex and inflammation. South. Med. J. 93: 169-172 (2000).

• Boberg KM, Schrumpf E, Bergquist A, Broome U, Pares A, Remotti H, Schjolberg A, Spurkland A, Clausen OP. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development. J. Hepatol. 32: 374-380 (2000). *

• Bodanszky H, Arato A, Szonyi L. Helicobacter infection in children. Orv. Hetil. 141: 777-782 (2000).

• Bode MK, Karttunen TJ, Makela J, Risteli L, Risteli J. Type I and III collagens in human colon cancer and diverticulosis. Scand. J. Gastroenterol. 35: 747-752 (2000). *

• Boedeker EC. Crohn's mucosa harbors adherent-invasive E. coli. Inflamm. Bowel Dis. 6: 155 (2000). *

• Bohlander SK. Fusion genes in leukemia: an emerging network. Cytogenet. Cell Genet. 91: 52-56 (2000).

• Bois-Joyeux B, Chauvet C, Nacer-Cherif H, Bergeret W, Mazure N, Giguere V, Laudet V, Danan JL. Modulation of the far-upstream enhancer of the rat alpha-fetoprotein gene by members of the ROR alpha, Rev-erb alpha, and Rev-erb beta groups of monomeric orphan nuclear receptors. DNA Cell Biol. 19: 589-599 (2000).

• Boismenu R, Chen Y. Insights from mouse models of colitis. J. Leukoc. Biol. 67: 267-278 (2000). *

• Boitier E, Beaune P. Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update. Clin. Rev. Allergy Immunol. 18: 215-239 (2000).

• Bolla JM, De E, Dorez A, Pages JM. Purification, characterization and sequence analysis of Omp50,a new porin isolated from Campylobacter jejuni. Biochem. J. 352: 637-643 (2000). *

• Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R. Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome. J. Rheumatol. 27: 2397-2405 (2000).

• Bombieri C, Giorgi S, Carles S, de Cid R, Belpinati F, Tandoi C, Pallares-Ruiz N, Lazaro C, Ciminelli BM, Romey MC, Casals T, Pompei F, Gandini G, Claustres M, Estivill X, Pignatti PF, Modiano G. A new approach for identifying non-pathogenic mutations. An analysis of the cystic fibrosis transmembrane regulator gene in normal individuals. Hum. Genet. 106: 172-178 (2000). *

• Bombieri C, Luisetti M, Belpinati F, Zuliani E, Beretta A, Baccheschi J, Casali L, Pignatti PF. Increased frequency of CFTR gene mutations in sarcoidosis: a case/control association study. Eur. J. Hum. Genet. 8: 717-720 (2000). *

• Bonapace ES, Maurer AH, Davidoff S, Krevsky B, Fisher RS, Parkman HP. Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am. J. Gastroenterol. 95: 2838-2847 (2000). *

• Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am. J. Gastroenterol. 95: 3053-3063 (2000). *

• Bonet ML, Oliver J, Pico C, Felipe F, Ribot J, Cinti S, Palou A. Opposite effects of feeding a vitamin A-deficient diet and retinoic acid treatment on brown adipose tissue uncoupling protein 1 (UCP1), UCP2 and leptin expression. J. Endocrinol. 166: 511-517 (2000). *

• Bonilla S, Redonnet A, Noel-Suberville C, Pallet V, Garcin H, Higueret P. High-fat diets affect the expression of nuclear retinoic acid receptor in rat liver. Br. J. Nutr. 83: 665-671 (2000). *

• Bonin A, Khan NA. Regulation of calcium signalling by docosahexaenoic acid in human T-cells. Implication of CRAC channels. J. Lipid Res. 41: 277-284 (2000). *

• Bonkovsky HL, Lambrecht RW. Iron-induced liver injury. Clin. Liver Dis. 4: 409-429, vi-vii (2000).

• Bonner GF, Petras RE, Cheong DM, Grewal ID, Breno S, Ruderman WB. Short- and long-term follow-up of treatment for lymphocytic and collagenous colitis. Inflamm. Bowel Dis. 6: 85-91 (2000). *

• Bonner GF, Walczak M, Kitchen L, Bayona M. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease. Am. J. Gastroenterol. 95: 1946-1948 (2000). *

• Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum. 43: 2025-2033 (2000). *

• Borenstein SH, Graham J, Zhang XL, Chamberlain JW. CD8+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens. J. Immunol. 165: 2341-2353 (2000). *

• Borgaonkar M, MacIntosh D, Fardy J, Simms L. Anti-tuberculous therapy for maintaining remission of Crohn's disease. Cochrane Database Syst. Rev. 2: CD000299 (2000). *

• Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut 47: 444-454 (2000). *

• Borgaonkar MR, MacIntosh DG, Fardy JM. A meta-analysis of antimycobacterial therapy for Crohn's disease. Am. J. Gastroenterol. 95: 725-729 (2000). *

• Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92: 1295-1302 (2000). *

• Borst P, Zelcer N, van Helvoort A. ABC transporters in lipid transport. Biochim. Biophys. Acta 1486: 128-144 (2000). *

• Botha JF, Spearman CW, Millar AJ, Michell L, Gordon P, Lopez T, Butt A, Thomas J, McCulloch M, James M, Kirsch RE, Terblanche J, Kahn D. Ten years of liver transplantation at Groote Schuur Hospital. S. Afr. Med. J. 90: 880-883 (2000).

• Bottini N, Gloria-Bottini F, Lucarini N, Ronchetti PG, Fontana L. Inflammatory bowel disease: are there gender differences in the genetics of signal transduction? A preliminary study of cytosolic low molecular weight protein tyrosine phosphatase. Dis. Markers 16: 163-166 (2000).

• Bottino C, Biassoni R, Millo R, Moretta L, Moretta A. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering. Hum. Immunol. 61: 1-6 (2000).

• Bouchard G, Tuchweber B, Yousef IM. Bile salt independent flow during bile salt-induced choleresis and cholestasis in the rat: role of biliary thiol secretion. Liver 20: 27-37 (2000).

• Boudjelal M, Wang Z, Voorhees JJ, Fisher GJ. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res. 60: 2247-2252 (2000). *

• Bougacha-Elleuch N, Tamouza R, Bellassouad M, Jouida J, Abid M, Maalej A, Makni H, Ayadi H. Analysis of heat shock protein polymorphisms in a large family with autoimmune thyroid diseases. Arch. Inst. Pasteur Tunis. 77: 23-24 (2000).

• Boulton-Jones JR, Pritchard K, Mahmoud AA. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy. Aliment. Pharmacol. Ther. 14: 1561-1565 (2000). *

• Bourgain C, Genin E, Quesneville H, Clerget-Darpoux F. Search for multifactorial disease susceptibility genes in founder populations. Ann. Hum. Genet. 64: 255-265 (2000). *

• Bove KE. Liver disease caused by disorders of bile acid synthesis. Clin. Liver Dis. 4: 831-848 (2000).

• Bove KE, Daugherty CC, Tyson W, Mierau G, Heubi JE, Balistreri WF, Setchell KD. Bile acid synthetic defects and liver disease. Pediatr. Dev. Pathol. 3: 1-16 (2000). *

• Bowie JD. What is the upper limit of normal for the common bile duct on ultrasound: how much do you want it to be? Am. J. Gastroenterol. 95: 897-900 (2000). *

• Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543 (2000). *

• Boyle MP. Unique presentations and chronic complications in adult cystic fibrosis: do they teach us anything about CFTR? Respir. Res. 1: 133-135 (2000). *

• Boyne MS, Dye KR. Crohn's colitis and idiopathic thrombocytopenic purpura. Postgrad. Med. J. 76: 299-300 (2000). *

• Bramlett KS, Yao S, Burris TP. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids. Mol. Genet. Metab. 71: 609-615 (2000). *

• Brandhagen DJ, Fairbanks VF, Baldus WP, Smith CI, Kruckeberg KE, Schaid DJ, Thibodeau SN. Prevalence and clinical significance of HFE gene mutations in patients with iron overload. Am. J. Gastroenterol. 95: 2910-2914 (2000). *

• Brandhagen DJ, Gross JB Jr, Poterucha JJ, Germer JJ, Czaja AJ, Smith CI, Ribeiro AC, Guerrero RB, Therneau TM, Schiff E, Gordon FD, Wiesner RH, Persing DH. Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C. Am. J. Gastroenterol. 95: 2056-2060 (2000). *

• Brannigan AE, O'Connell PR, Hurley H, O'Neill A, Brady HR, Fitzpatrick JM, Watson RW. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 13: 361-366 (2000).

• Brant SR. Evaluation of IBD candidate genes and the case of NRAMP2. Inflamm. Bowel Dis. 6: 99-102 (2000). *

• Brant SR, Panhuysen CI, Bailey-Wilson JE, Rohal PM, Lee S, Mann J, Ravenhill G, Kirschner BS, Hanauer SB, Cho JH, Bayless TM. Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity. Gastroenterology 119: 1483-1490 (2000). *

• Brar HS, Surawicz CM. Pseudomembranous colitis: an update. Can. J. Gastroenterol. 14: 51-56 (2000). *

• Brazzelli V, Quaglini M, Martinetti M, Nolli G, Salvaneschi L, Cuccia M, Borroni G. A peculiar sequence motif in the alpha-1-domain of the HLA-C molecule in psoriasis. Dermatology 200: 99-103 (2000).

• Breban M, Falgarone G, Blanchard H, Dernis-Labous E, Lamarque D. Animal models of the spondyloarthropathies. Curr. Rheumatol. Rep. 2: 282-287 (2000).

• Breen EM, Ashley SW. Laparoscopic surgery for Crohn's disease? - a conditional yes. Inflamm. Bowel Dis. 6: 43-45 (2000). *

• Bregenholt S. Cells and cytokines in the pathogenesis of inflammatory bowel disease: new insights from mouse T cell transfer models. Exp. Clin. Immunogenet. 17: 115-129 (2000).

• Breinholt V, Lauridsen ST, Daneshvar B, Jakobsen J. Dose-response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett. 154: 201-210 (2000). *

• Brignola C, Belloli C, Ardizzone S, Astegiano M, Cottone M, Trallori G. The relationship between heritability and smoking habits in Crohn's disease. Italian Cooperative Study Group. Am. J. Gastroenterol. 95: 3171-3175 (2000). *

• Briskey EN, Pamies RJ. Colorectal cancer: update on recent advances and their impact on screening protocols. J. Natl. Med. Assoc. 92: 222-230 (2000).

• Bristol IJ, Farmer MA, Cong Y, Zheng XX, Strom TB, Elson CO, Sundberg JP, Leiter EH. Heritable susceptibility for colitis in mice induced by IL-10 deficiency. Inflamm. Bowel Dis. 6: 290-302 (2000). *

• Britto MR, Thomas LA, Balaratnam N, Griffiths AP, Duane PD. Hepatocellular carcinoma arising in non-cirrhotic liver in genetic haemochromatosis. Scand. J. Gastroenterol. 35: 889-893 (2000). *

• Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DA. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 123: 1102-1111 (2000). *

• Brock JH, Mulero V. Cellular and molecular aspects of iron and immune function. Proc. Nutr. Soc. 59: 537-540 (2000). *

• Brodsky RA, Petri M, Jones RJ. Hematopoietic stem cell transplantation for systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 26: 377-387, viii (2000).

• Bronsveld I, Mekus F, Bijman J, Ballmann M, Greipel J, Hundrieser J, Halley DJ, Laabs U, Busche R, De Jonge HR, Tummler B, Veeze HJ. Residual chloride secretion in intestinal tissue of deltaF508 homozygous twins and siblings with cystic fibrosis. The European CF Twin and Sibling Study Consortium. Gastroenterology 119: 32-40 (2000). *

• Brooks AG, Boyington JC, Sun PD. Natural killer cell recognition of HLA class I molecules. Rev. Immunogenet. 2: 433-448 (2000).

• Broome U. Treatment of primary biliary cirrhosis. The effect of ursodeoxycholic acid is questioned now. Lakartidningen 97: 2585-2587 (2000).

• Brousseau ME, Schaefer EJ, Dupuis J, Eustace B, Van Eerdewegh P, Goldkamp AL, Thurston LM, FitzGerald MG, Yasek-McKenna D, O'Neill G, Eberhart GP, Weiffenbach B, Ordovas JM, Freeman MW, Brown RH Jr, Gu JZ. Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds. J. Lipid Res. 41: 433-441 (2000). *

• Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev. 22: 283-297 (2000). *

• Brown WA, Farmer KC, Skinner SA, Malcontenti-Wilson C, Misajon A, O'Brien PE. 5-Aminosalicyclic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer. Dig. Dis. Sci. 45: 1578-1584 (2000). *

• Bruce BB, Blass MA, Blumberg HM, Lennox JL, del Rio C, Horsburgh CR Jr. Risk of Cryptosporidium parvum transmission between hospital roommates. Clin. Infect. Dis. 31: 947-950 (2000). *

• Bruck R, Hershkoviz R, Lider O, Shirin H, Aeed H, Halpern Z. Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury. Isr. Med. Assoc. J. 2: S74-S80 (2000). *

• Bruinsma KA, Taren DL. Dieting, essential fatty acid intake, and depression. Nutr. Rev. 58: 98-108 (2000).

• Brunetti E, Bruno R, Marangio A, Crippa FG, Filice C, Caturelli E. Is second biopsy helpful in the diagnosis of hepatocellular carcinoma with a first negative biopsy? Am. J. Gastroenterol. 95: 3688-3689 (2000). *

• Brunkhorst R, Eberhardt OK, Haubitz M, Brunkhorst FM. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med. 26 Suppl. 2: S199-S201 (2000).

• Budhu AS, Noy N. On the role of the carboxyl-terminal helix of RXR in the interactions of the receptor with ligand. Biochemistry 39: 4090-4095 (2000). *

• Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7: 273-282 (2000).

• Bueno L. Neuroimmune alterations of ENS functioning. Gut 47 Suppl. 4: iv63-iv65 (2000). *

• Bueno MR, Daneri A, Armendariz-Borunda J. Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity. J. Hepatol. 33: 915-925 (2000). *

• Buisine MP, Devisme L, Degand P, Dieu MC, Gosselin B, Copin MC, Aubert JP, Porchet N. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas. J. Histochem. Cytochem. 48: 1667-1676 (2000). *

• Bulois P, Tremaine WJ, Maunoury V, Gambiez L, Hafraoui S, Leteurtre L, Cortot A, Sandborn WJ, Colombel JF, Desreumaux P. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm. Bowel Dis. 6: 157-164 (2000). *

• Bulow E, Gullberg U, Olsson I. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein. J. Leukoc. Biol. 68: 669-678 (2000). *

• Burden AD. Identifying a gene for psoriasis on chromosome 6 (Psors1). Br. J. Dermatol. 143: 238-241 (2000).

• Burke A, Lawson JA, Meagher EA, Rokach J, FitzGerald GA. Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acid. J. Biol. Chem. 275: 2499-2504 (2000). *

• Burt RK, Marmont A, Schroeder J, Rosa R, Traynor AE. Intense immune suppression for systemic lupus - the role of hematopoietic stem cells. J. Clin. Immunol. 20: 31-37 (2000). *

• Burt RW. Colon cancer screening. Gastroenterology 119: 837-853 (2000). *

• Bus PJ, Verspaget HW, Lamers CB, Griffioen G. Chemoprevention of colorectal cancer by non-steroidal anti-inflammatory drugs. Scand. J. Gastroenterol. Suppl. 232: 101-104 (2000).

• Butterworth RF. Complications of cirrhosis III. Hepatic encephalopathy. J. Hepatol. 32: S171-S180 (2000).

• Buttgereit F. Mechanisms and clinical relevance of nongenomic glucocorticoid actions. Z. Rheumatol. 59 Suppl. 2: S119-S123 (2000).

• Caballeria L, Pares A. Primary sclerosing cholangitis. Gastroenterol. Hepatol. 23: 10-13 (2000).

• Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin. Exp. Immunol. 121: 480-483 (2000). *

• Cahill P, Nason MW Jr, Ambrose C, Yao TY, Thomas P, Egan ME. Identification of the cystic fibrosis transmembrane conductance regulator domains that are important for interactions with ROMK2. J. Biol. Chem. 275: 16697-16701 (2000). *

• Calafat J, Janssen H, Knol EF, Malm J, Egesten A. The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation. APMIS 108: 201-208 (2000).

• Calamia KT, Scolapio JS, Viggiano TR. Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis. Clin. Exp. Rheumatol. 18: 605-608 (2000).

• Calvo B, Castano L, Marcus-Bagley D, Fici DA, Awdeh Z, Alper CA. The [HLA-B18, F1C30, DR3] conserved extended haplotype carries a susceptibility gene for IgD deficiency. J. Clin. Immunol. 20: 216-220 (2000). *

• Campos M, Jouzdani E, Sempoux C, Buts JP, Reding R, Otte JB, Sokal EM. Sclerosing cholangitis associated to cryptosporidiosis in liver-transplanted children. Eur. J. Pediatr. 159: 113-115 (2000).

• Cancino-Diaz M, Ayala-Narvaez H, Burgos-Vargas R, Selene Reyes-Lopez A, Tovar-Castillo L, Dominguez-Lopez L, Granados Arreola J, Jimenez-Zamudio L, Garcia-Latorre E. Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects. Microb. Pathog. 28: 211-220 (2000). *

• Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med. 223: 230-233 (2000). *

• Cantorna MT, Humpal-Winter J, DeLuca HF. In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). Arch. Biochem. Biophys. 377: 135-138 (2000). *

• Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130: 2648-252 (2000). *

• Cantz T, Nies AT, Brom M, Hofmann AF, Keppler D. MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G522-G531 (2000). *

• Capristo E, Addolorato G, Mingrone G, Scarfone A, Greco AV, Gasbarrini G. Low-serum high-density lipoprotein-cholesterol concentration as a sign of celiac disease. Am. J. Gastroenterol. 95: 3331-3332 (2000). *

• Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am. J. Gastroenterol. 95: 1495-1502 (2000). *

• Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin Res. 6: 205-214 (2000). *

• Cardenas A, Bataller R, Arroyo V. Mechanisms of ascites formation. Clin. Liver Dis. 4: 447-465 (2000).

• Cardenas A, Uriz J, Gines P, Arroyo V. Hepatorenal syndrome. Liver Transpl. 6: S63-S71 (2000).

• Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68: 7010-7017 (2000). *

• Carithers RL Jr. Liver transplantation. American Association for the Study of Liver Diseases. Liver Transpl. 6: 122-135 (2000). *

• Carpenter GH, Proctor GB, Pankhurst CL, O'Donohue J, Scott D, Hunnable MP. Sialochemical markers of salivary gland involvement with Sjogren's syndrome secondary to rheumatoid arthritis and primary biliary cirrhosis. J. Oral. Pathol. Med. 29: 452-459 (2000).

• Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am. J. Gastroenterol. 95: 878-896 (2000). *

• Carty E, De Brabander M, Feakins RM, Rampton DS. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper. Gut 46: 487-492 (2000). *

• Carty E, MacEy M, Rampton DS. Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment. Pharmacol. Ther. 14: 1169-1179 (2000). *

• Caruso C, Candore G, Colonna Romano G, Lio D, Bonafe M, Valensin S, Franceschi C. HLA, aging, and longevity: a critical reappraisal. Hum. Immunol. 61: 942-949 (2000).

• Casati J, Toner BB, de Rooy EC, Drossman DA, Maunder RG. Concerns of patients with inflammatory bowel disease: a review of emerging themes. Dig. Dis. Sci. 45: 26-31 (2000). *

• Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Impact of surgery for Crohn's disease on health-related quality of life. Am. J. Gastroenterol. 95: 177-182 (2000). *

• Casini A. Alcohol-induced fatty liver and inflammation: where do Kupffer cells act? J. Hepatol. 32: 1026-1030 (2000). *

• Castellano Tortajada G, Sanchez Pobre P. Autoimmune cholangitis. Gastroenterol. Hepatol. 23 Suppl. 1: 14-23 (2000).

• Castera L, Boige V, Rocher L, Duclos-Vallee JC, Fabre M, Buffet C. Complete regression of hepatocellular carcinoma under tamoxifen. Am. J. Gastroenterol. 95: 827-829 (2000). *

• Cataldo F, Lio D, Marino V, Picarelli A, Ventura A, Corazza GR. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut 47: 366-369 (2000). *

• Catassi C, Fanciulli G, D'Appello AR, El Asmar R, Rondina C, Fabiani E, Bearzi I, Coppa GV. Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease. Scand. J. Gastroenterol. 35: 732-736 (2000). *

• Cathomas G, Renner EL. Liver transplantation and tumors: risk and chance. Schweiz. Med. Wochenschr. 130: 963-968 (2000).

• Cattan D, Notarnicola C, Molinari N, Touitou I. Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. Lancet 355: 378-379 (2000). *

• Cattral MS, Lilly LB, Levy GA. Immunosuppression in liver transplantation. Semin. Liver Dis. 20: 523-531 (2000). *

• Cawkwell L, Sutherland F, Murgatroyd H, Jarvis P, Gray S, Cross D, Shepherd N, Day D, Quirke P. Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut 46: 367-369 (2000). *

• Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12: 721-727 (2000). *

• Ceryak S, Bouscarel B, Malavolti M, Robins SJ, Caslow KL, Fromm H. Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters. Atherosclerosis 153: 59-67 (2000).

• Cha JY, Kim H, Kim KS, Hur MW, Ahn Y. Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene. Cooperative role of hepatocyte nuclear factors 1alpha and 3beta. J. Biol. Chem. 275: 18358-18365 (2000). *

• Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 31: 7-11 (2000). *

• Chamberlin W, Hulten K, Graham DY. Antibiotics as primary therapy for Crohn's disease. Drugs Today (Barc.) 36: 667-678 (2000).

• Chang L, Munakata J, Mayer EA, Schmulson MJ, Johnson TD, Bernstein CN, Saba L, Naliboff B, Anton PA, Matin K. Perceptual responses in patients with inflammatory and functional bowel disease. Gut 47: 497-505 (2000). *

• Chapman C, Morgan LM, Murphy MC. Maternal and early dietary fatty acid intake: changes in lipid metabolism and liver enzymes in adult rats. J. Nutr. 130: 146-151 (2000). *

• Chauveau D, Fakhouri F, Grunfeld JP. Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J. Am. Soc. Nephrol. 11: 1767-1775 (2000). *

• Chawla A, Kahn E, Yunis EJ, Daum F. Rapidly progressive cholestasis: an unusual reaction to amoxicillin/clavulanic acid therapy in a child. J. Pediatr. 136: 121-123 (2000). *

• Chawla A, Saez E, Evans RM. "Don't know much bile-ology". Cell 103: 1-4 (2000). *

• Chazouilleres O. Diagnosis of primary sclerosing cholangitis-autoimmune hepatitis overlap syndrome: to score or not to score? J. Hepatol. 33: 661-663 (2000). *

• Chen H, Howald WN, Juchau MR. Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug Metab. Dispos. 28: 315-322 (2000). *

• Chen JM, Ferec C. Molecular basis of hereditary pancreatitis. Eur. J. Hum. Genet. 8: 473-479 (2000). *

• Chen JM, Mercier B, Audrezet MP, Ferec C. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J. Med. Genet. 37: 67-69 (2000). *

• Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J. Clin. Endocrinol. Metab. 85: 1545-1549 (2000). *

• Chen SJ, Rader DJ, Tazelaar J, Kawashiri M, Gao G, Wilson JM. Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Mol. Ther. 2: 256-261 (2000).

• Chen YM, Chen LY, Wong FH, Lee CM, Chang TJ, Yang-Feng TL. Genomic structure, expression, and chromosomal localization of the human glycine N-methyltransferase gene. Genomics 66: 43-47 (2000). *

• Chen ZY, Istfan NW. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot. Essent. Fatty Acids 63: 301-308 (2000). *

• Cheng K, Ashby D, Smyth R. Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst. Rev. 2: CD000222 (2000). *

• Cheng L, Zhang SZ, Xiao CY, Hou YP, Li L, Luo HC, Jiang HY, Zuo WQ. The A5.1 allele of the major histocompatibility complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese. Br. J. Dermatol. 143: 324-329 (2000).

• Chernajovsky Y, Dreja H, Daly G, Annenkov A, Gould D, Adams G, Croxford JL, Baker D, Podhajcer OL, Mageed RA. Immuno- and genetic therapy in autoimmune diseases. Genes Immun. 1: 295-307 (2000). *

• Chiang JY, Kimmel R, Weinberger C, Stroup D. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J. Biol. Chem. 275: 10918-10924 (2000). *

• Chiba M, Kono M, Hoshina S, Komatsu M, Kitagawa Y, Iizuka M, Watanabe S. Presence of bacterial 16S ribosomal RNA gene segments in human intestinal lymph follicles. Scand. J. Gastroenterol. 35: 824-831 (2000). *

• Chicharro M, Guarner L, Vilaseca J, Planas M, Malagelada J. Does cyclosporin A worsen liver function in patients with inflammatory bowel disease and total parenteral nutrition? Rev. Esp. Enferm. Dig. 92: 68-77 (2000).

• Chikano S, Sawada K, Shimoyama T, Kashiwamura SI, Sugihara A, Sekikawa K, Terada N, Nakanishi K, Okamura H. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut 47: 779-786 (2000). *

• Chikazawa H, Nishiya K, Matsumori A, Hashimoto K. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases. J. Clin. Immunol. 20: 279-286 (2000). *

• Chin EY, Dangler CA, Fox JG, Schauer DB. Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor alphabeta mutant mice. Comp. Med. 50: 586-594 (2000). *

• Chinet T, Fajac I, Ferec C, Garcia Carmona T, Nguyen-Khoa T. Diagnosis of cystic fibrosis in adults. Rev. Mal. Respir. 17: 739-748 (2000).

• Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 49: 497-505 (2000). *

• Chirdo FG, Rumbo M, Carabajal P, Mavromatopulos E, Castagnino N, Anon MC, Fossati CA. Determination of anti-omega-gliadin antibodies in serologic tests for coeliac disease. Scand. J. Gastroenterol. 35: 508-516 (2000). *

• Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI, Nosikov VV. Complex association analysis of Graves disease using a set of polymorphic markers. Mol. Genet. Metab. 70: 214-218 (2000). *

• Chitturi S, Farrell GC. Drug-induced liver disease. Curr. Treat. Options Gastroenterol. 3: 457-462 (2000).

• Cho J. Linkage of inflammatory bowel disease to human chromosome 6p. Inflamm. Bowel Dis. 6: 259-261 (2000). *

• Cho J. Update on inflammatory bowel disease genetics. Curr. Gastroenterol. Rep. 2: 434-439 (2000).

• Cho JH, Nicolae DL, Ramos R, Fields CT, Rabenau K, Corradino S, Brant SR, Espinosa R, LeBeau M, Hanauer SB, Bodzin J, Bonen DK. Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum. Mol. Genet. 9: 1425-1432 (2000). *

• Choi HB, Han H, Youn JI, Kim TY, Kim TG. MICA 5.1 allele is a susceptibility marker for psoriasis in the Korean population. Tissue Antigens 56: 548-550 (2000). *

• Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 43: 405-413 (2000). *

• Choi HK, Waxman DJ. Pulsatility of growth hormone (GH) signalling in liver cells: role of the JAK-STAT5b pathway in GH action. Growth Horm. IGF Res. 10 Suppl. B: S1-S8 (2000).

• Chowers Y, Sela BA, Holland R, Fidder H, Simoni FB, Bar-Meir S. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am. J. Gastroenterol. 95: 3498-3502 (2000). *

• Christadoss P, Poussin M, Deng C. Animal models of myasthenia gravis. Clin. Immunol. 94: 75-87 (2000). *

• Christensson M, Pettersson E, Sundqvist KG, Christensson B. T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy. Clin. Nephrol. 54: 435-442 (2000).

• Chu CY, Yang CY, Huang SF, Lu SC, Wang LF. Lichen planus with xanthomatous change in a patient with primary biliary cirrhosis. Br. J. Dermatol. 142: 377-378 (2000). *

• Chung DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 119: 854-865 (2000). *

• Chung JP. Primary or secondary sclerosing cholangitis? Endoscopy 32: 664-665 (2000).

• Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, Kim TS. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J. Biol. Chem. 275: 32681-32687 (2000). *

• Chutkan R, Sternthal M, Janowitz HD. A family with collagenous colitis, ulcerative colitis, and Crohn's disease. Am. J. Gastroenterol. 95: 3640-3641 (2000). *

• Cirera I. Recurrence of chronic cholestatic liver diseases following liver transplantation. Gastroenterol. Hepatol. 23: 77-80 (2000).

• Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ. An alternative interpretation of nanobacteria-induced biomineralization. Proc. Natl. Acad. Sci. U.S.A. 97: 11511-11515 (2000). *

• Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J. Immunol. 164: 1364-1371 (2000). *

• Clemente MG, Musu MP, Frau F, Brusco G, Sole G, Corazza GR, De Virgiliis S. Immune reaction against the cytoskeleton in coeliac disease. Gut 47: 520-526 (2000). *

• Clot F, Babron MC. Genetics of celiac disease. Mol. Genet. Metab. 71: 76-80 (2000). *

• Coakley G, Brooks D, Iqbal M, Kondeatis E, Vaughan R, Loughran TP Jr, Panayi GS, Lanchbury JS. Major histocompatility complex haplotypic associations in Felty's syndrome and large granular lymphocyte syndrome are secondary to allelic association with HLA-DRB1 *0401. Rheumatology (Oxford) 39: 393-398 (2000). *

• Cohavy O, Bruckner D, Gordon LK, Misra R, Wei B, Eggena ME, Targan SR, Braun J. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect. Immun. 68: 1542-1548 (2000). *

• Cohen RD. The cost of Crohn's disease: drugs or surgery? BioDrugs 14: 331-344 (2000).

• Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. The cost of hospitalization in Crohn's disease. Am. J. Gastroenterol. 95: 524-530 (2000). *

• Cohen RD, Tsang JF, Hanauer SB. Infliximab in Crohn's disease: first anniversary clinical experience. Am. J. Gastroenterol. 95: 3469-3477 (2000). *

• Cohn JA, Bornstein JD, Jowell PS. Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis. Med. Clin. North Am. 84: 621-631, ix (2000).

• Collins BH, Pirsch JD, Becker YT, Hanaway MJ, Van der Werf WJ, D'Alessandro AM, Knechtle SJ, Odorico JS, Leverson G, Musat A, Armbrust M, Becker BN, Sollinger HW, Kalayoglu M. Long-term results of liver transplantation in older patients 60 years of age and older. Transplantation 70: 780-783 (2000).

• Collins MT, Lisby G, Moser C, Chicks D, Christensen S, Reichelderfer M, Hoiby N, Harms BA, Thomsen OO, Skibsted U, Binder V. Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls. J. Clin. Microbiol. 38: 4373-4381 (2000). *

• Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J. Parenter. Enteral Nutr. 24: 345-350 (2000).

• Colombo C, Okolicsanyi L, Strazzabosco M. Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications. Dig. Liver Dis. 32: 152-159 (2000).

• Comay D, Cauch-Dudek K, Hemphill D, Diamandis E, Wanless I, Heathcote EJ. Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis? Dig. Dis. Sci. 45: 2018-2021 (2000). *

• Cong Y, Weaver CT, Lazenby A, Elson CO. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12. J. Immunol. 165: 2173-2182 (2000). *

• Connor WE. Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71: 171S-175S (2000). *

• Conron M, Beynon HL. Churg-Strauss syndrome. Thorax 55: 870-877 (2000). *

• Cook LS. A causal role for Mycobacterium avium subspecies paratuberculosis in Crohn's disease? Can. J. Gastroenterol. 14: 479-480 (2000).

• Cook WS, Yeldandi AV, Rao MS, Hashimoto T, Reddy JK. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha. Biochem. Biophys. Res. Commun. 278: 250-257 (2000). *

• Cookson WO, Moffatt MF. Genetics of asthma and allergic disease. Hum. Mol. Genet. 9: 2359-2364 (2000). *

• Cooper AJ, Wang J, Pasternack R, Fuchsbauer HL, Sheu RK, Blass JP. Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases. Dev. Neurosci. 22: 404-417 (2000).

• Cooper T, Savige J, Nassis L, Paspaliaris B, Neeson P, Neil J, Knight KR, Daskalakis M, Doery JC. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin. Rheumatol. Int. 19: 129-136 (2000). *

• Coppin H, Ribouchon MT, Bausero P, Pessac B, Fontaine B, Semana G, Clanet M, Roth MP; French Multiple Sclerosis Genetics Group. No evidence for transmission disequilibrium between a new marker at the myelin basic protein locus and multiple sclerosis in French patients. Genes Immun. 1: 478-482 (2000). *

• Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 47: 589-594 (2000). *

• Corpechot C, Barbu V, Chazouilleres O, Poupon R. Fetal microchimerism in primary biliary cirrhosis. J. Hepatol. 33: 696-700 (2000). *

• Corpechot C, Carrat F, Bonnand AM, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology 32: 1196-1199 (2000). *

• Corper AL, Stratmann T, Apostolopoulos V, Scott CA, Garcia KC, Kang AS, Wilson IA, Teyton L. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288: 505-511 (2000). *

• Corradini SG, Elisei W, Giovannelli L, Ripani C, Della Guardia P, Corsi A, Cantafora A, Capocaccia L, Ziparo V, Stipa V, Chirletti P, Caronna R, Lomanto D, Attili AF. Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology 118: 912-920 (2000). *

• Corrigan G, Stevens PE. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Aliment. Pharmacol. Ther. 14: 1-6 (2000). *

• Corton JC, Anderson SP, Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40: 491-518 (2000). *

• Corton JC, Lapinskas PJ, Gonzalez FJ. Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutat. Res. 448: 139-151 (2000).

• Costa M, Rodriguez-Sanchez JL, Czaja AJ, Gelpi C. Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis. Clin. Exp. Immunol. 121: 364-374 (2000). *

• Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275: 28240-28245 (2000). *

• Cotellessa M, Minicucci L, Diana MC, Prigione F, Di Febbraro L, Gagliardini R, Manca A, Battistini F, Taccetti G, Magazzu G, Padoan R, Pizzamiglio G, Raia V, Iapichino L, Cardella F, Grinzich G, Lucidi V, Tuccio G, Bignamini E, Salvatore D, Lorini R. Phenotype/genotype correlation and cystic fibrosis related diabetes mellitus (Italian Multicenter Study). J. Pediatr. Endocrinol. Metab. 13: 1087-1093 (2000).

• Cotrim HP, Parana R, Braga E, Lyra L. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Am. J. Gastroenterol. 95: 3018-3019 (2000). *

• Cottliar A, Fundia A, Boerr L, Sambuelli A, Negreira S, Gil A, Gomez JC, Chopita N, Bernedo A, Slavutsky I. High frequencies of telomeric associations, chromosome aberrations, and sister chromatid exchanges in ulcerative colitis. Am. J. Gastroenterol. 95: 2301-2307 (2000). *

• Courtois G, Israel A. NF-kappa B defects in humans: the NEMO/incontinentia pigmenti connection. Sci. STKE 58: PE1 (2000). *

• Creighton JE, Lyall R, Wilson DI, Curtis A, Charnley RM. Mutations of the cationic trypsinogen gene in patients with hereditary pancreatitis. Br. J. Surg. 87: 170-175 (2000).

• Crinnion WJ. Environmental medicine, part 4: pesticides - biologically persistent and ubiquitous toxins. Altern. Med. Rev. 5: 432-447 (2000). *

• Crinnion WJ. Environmental medicine, part 1: the human burden of environmental toxins and their common health effects. Altern. Med. Rev. 5: 52-63 (2000). *

• Crinnion WJ. Environmental medicine, part 2: health effects of and protection from ubiquitous airborne solvent exposure. Altern. Med. Rev. 5: 133-143 (2000). *

• Crinnion WJ. Environmental medicine, part 3: long-term effects of chronic low-dose mercury exposure. Altern. Med. Rev. 5: 209-223 (2000). *

• Criswell LA, Amos CI. Update on genetic risk factors for systemic lupus erythematosus and rheumatoid arthritis. Curr. Opin. Rheumatol. 12: 85-90 (2000).

• Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. 1932. Mt. Sinai J. Med. 67: 263-268 (2000).

• Crosas B, Allali-Hassani A, Martinez SE, Martras S, Persson B, Jornvall H, Pares X, Farres J. Molecular basis for differential substrate specificity in class IV alcohol dehydrogenases: a conserved function in retinoid metabolism but not in ethanol oxidation. J. Biol. Chem. 275: 25180-25187 (2000). *

• Crosdale DJ, Ollier WE, Thomson W, Dyer PA, Jensenious J, Johnson RW, Poulton KV. Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur. J. Immunogenet. 27: 111-117 (2000). *

• Crowther SD, Rees PJ. Current treatment of asthma - focus on leukotrienes. Expert Opin. Pharmacother. 1: 1021-1040 (2000).

• Cruz-Correa M, Giardiello FM, Bayless TM. Atypical forms of inflammatory bowel disease: microscopic colitis and pouchitis. Curr. Opin. Gastroenterol. 16: 343-348 (2000).

• Cuffari C, Hunt S, Bayless TM. Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy. Aliment. Pharmacol. Ther. 14: 1009-1014 (2000). *

• Cunliffe RN, Mahida YR. Antimicrobial peptides in innate intestinal host defence. Gut 47: 16-17 (2000). *

• Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 16: 262-270 (2000).

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 31: 1231-1238 (2000). *

• Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol. Rev. 174: 250-259 (2000). *

• Czaja AJ, Lindor KD. Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. Gastroenterology 119: 1312-1316 (2000). *

• Czaja AJ, Manns MP, McFarlane IG, Hoofnagle JH. Autoimmune hepatitis: the investigational and clinical challenges. Hepatology 31: 1194-1200 (2000). *

• Czaja AJ, Sievers C, Zein NN. Nature and behavior of serum cytokines in type 1 autoimmune hepatitis. Dig. Dis. Sci. 45: 1028-1035 (2000). *

• Czekaj P. Phenobarbital-induced expression of cytochrome P450 genes. Acta Biochim. Pol. 47: 1093-1105 (2000). *

• D'Alfonso S, Nistico L, Bocchio D, Bomprezzi R, Marrosu MG, Murru MR, Lai M, Massacesi L, Ballerini C, Repice A, Salvetti M, Montesperelli C, Ristori G, Trojano M, Liguori M, Gambi D, Quattrone A, Tosi R, Momigliano-Richiardi P. An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population. J. Neurovirol. 6 Suppl. 2: S18-S22 (2000).

• D'Alfonso S, Rampi M, Bocchio D, Colombo G, Scorza-Smeraldi R, Momigliano-Richardi P. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum. 43: 120-128 (2000). *

• D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thromb. Haemost. 83: 563-570 (2000). *

• D'Arienzo A, Manguso F, Astarita C, D'Armiento FP, Scarpa R, Gargano D, Scaglione G, Vicinanza G, Bennato R, Mazzacca G. Allergy and mucosal eosinophil infiltrate in ulcerative colitis. Scand. J. Gastroenterol. 35: 624-631 (2000). *

• D'Haens G. Medical management of major internal fistulae in Crohn's disease. Inflamm. Bowel Dis. 6: 244-245 (2000). *

• Dafnis G, Blomqvist P, Pahlman L, Ekbom A. The introduction and development of colonoscopy within a defined population in Sweden. Scand. J. Gastroenterol. 35: 765-771 (2000). *

• Daig R, Rogler G, Aschenbrenner E, Vogl D, Falk W, Gross V, Scholmerich J, Andus T. Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut 46: 350-358 (2000). *

• Dalwadi H, Bo W, Braun J. Defining new pathogens and nonculturable infectious agents associated with inflammatory bowel disease. Curr. Opin. Gastroenterol. 16: 56-59 (2000).

• Daly BM, Shuster S. Antipruritic action of thalidomide. Acta Derm. Venereol. 80: 24-25 (2000).

• Dantas W. Primary sclerosing cholangitis. Rev. Gastroenterol. Peru 20: 270-284 (2000).

• Das P, Abraham R, David C. HLA transgenic mice as models of human autoimmune diseases. Rev. Immunogenet. 2: 105-114 (2000).

• Date M, Matsuzaki K, Matsushita M, Tahashi Y, Furukawa F, Inoue K. Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury. Gut 46: 719-724 (2000). *

• Davidson BK, Haslock I. Osteomalacia secondary to renal tubular acidosis masquerading as primary biliary cirrhosis. Rheumatology (Oxford) 39: 1428-1429 (2000). *

• Davis JM, Alderson NL, Welsh RS. Serotonin and central nervous system fatigue: nutritional considerations. Am. J. Clin. Nutr. 72: 573S-578S (2000). *

• Dawson KP, Frossard PM. A hypothesis regarding the origin and spread of the cystic fibrosis mutation deltaF508. QJM 93: 313-315 (2000). *

• Dawson KP, Frossard PM. Cystic fibrosis in the Middle East: the historical perspective. Ann. Saudi Med. 20: 20-23 (2000).

• De Benedetti F, Ravelli A. Juvenile idiopathic arthritis: will etanercept be an improvement over current therapies? BioDrugs 14: 93-98 (2000).

• De BK, Sen S, Biswas PK, Sengupta D, Biswas J, Santra A, Hazra B, Maity AK. Propranolol in primary and secondary prophylaxis of variceal bleeding among cirrhotics in India: a hemodynamic evaluation. Am. J. Gastroenterol. 95: 2023-2028 (2000). *

• De Block CE, Van Campenhout CM, De Leeuw IH, Keenoy BM, Martin M, Van Hoof V, Van Gaal LF. Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes. Diabetes Care 23: 1384-1388 (2000).

• De Bona M, Ponton P, Ermani M, Iemmolo RM, Feltrin A, Boccagni P, Gerunda G, Naccarato R, Rupolo G, Burra P. The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. J. Hepatol. 33: 609-615 (2000). *

• De Bosscher K, Vanden Berghe W, Haegeman G. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J. Neuroimmunol. 109: 16-22 (2000).

• de Carmo Silva R, Kater CE, Dib SA, Laureti S, Forini F, Cosentino A, Falorni A. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III. Eur. J. Endocrinol. 142: 187-194 (2000). *

• De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am. J. Clin. Nutr. 71: 213S-223S (2000). *

• de Groen PC. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen? Hepatology 31: 247-248 (2000). *

• De Groote D, Ducatelle R, Haesebrouck F. Helicobacters of possible zoonotic origin: a review. Acta Gastroenterol. Belg. 63: 380-387 (2000).

• de la Concha EG, Fernandez-Arquero M, Conejero L, Lazaro F, Mendoza JL, Sevilla MC, Diaz-Rubio M, Ruiz de Leon A. Presence of a protective allele for achalasia on the central region of the major histocompatibility complex. Tissue Antigens 56: 149-153 (2000). *

• de la Concha EG, Fernandez-Arquero M, Lopez-Nava G, Martin E, Allcock RJ, Conejero L, Paredes JG, Diaz-Rubio M. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 119: 1491-1495 (2000). *

• De la Concha EG, Fernandez-Arquero M, Vigil P, Lazaro F, Ferreira A, Garcia-Rodriguez MC, Fontan G. Tumor necrosis factor genomic polymorphism in Spanish IgA deficiency patients. Tissue Antigens 55: 359-363 (2000). *

• de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, Polanco I, Fernandez C, Figueredo MA. Celiac disease and TNF promoter polymorphisms. Hum. Immunol. 61: 513-517 (2000).

• de la Mata M, Montero JL, Fraga E, Delgado M, Costan G, Padillo J, Diaz C, Rufian S, Lopez-Cillero P, Solorzano G, Pera C, Mino G. Indications and results of liver transplantation in cholestatic diseases. Gastroenterol. Hepatol. 23: 39-42 (2000).

• de Larranaga GF, Harris N, Pierangeli SS, Alonso BS, Schroder T, Fainboim H. Low prevalence of autoimmune antiphospholipid antibodies in hepatic diseases. Medicina (B. Aires) 60: 919-922 (2000).

• de Pablo MA, Alvarez de Cienfuegos G. Modulatory effects of dietary lipids on immune system functions. Immunol. Cell Biol. 78: 31-39 (2000). *

• De Santis A, Famularo G, De Simone C. Probiotics for the hemodynamic alterations of patients with liver cirrhosis. Am. J. Gastroenterol. 95: 323-324 (2000). *

• de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290: 2140-2144 (2000). *

• de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J. Rheumatol. 27: 2860-2865 (2000).

• De Vree JM, Ottenhoff R, Bosma PJ, Smith AJ, Aten J, Oude Elferink RP. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119: 1720-1730 (2000). *

• De Vreede I, Steers JL, Burch PA, Rosen CB, Gunderson LL, Haddock MG, Burgart L, Gores GJ. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl. 6: 309-316 (2000). *

• Debat Zoguereh D, Ruiz JM. Immunosuppression and vaccinations. Sante 10: 211-219 (2000).

• Decensi A, Costa A. Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer. Eur. J. Cancer 36: 694-709 (2000). *

• DeCicco KL, Ross AC. All-trans-retinoic acid and polyriboinosinoic:polyribocytidylic acid cooperate to elevate anti-tetanus immunoglobulin G and immunoglobulin M responses in vitamin A-deficient lewis rats and Balb/c mice. Proc. Nutr. Soc. 59: 519-529 (2000). *

• DeCicco KL, Zolfaghari R, Li N, Ross AC. Retinoic acid and polyriboinosinic acid act synergistically to enhance the antibody response to tetanus toxoid during vitamin A deficiency: possible involvement of interleukin-2 receptor-beta, signal transducer and activator of transcription-1 … J. Infect. Dis. 182 Suppl. 1: S29-S36 (2000). *

• del Castillo-Olivares A, Gil G. Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alpha-hydroxylase transcription. Nucleic Acids Res. 28: 3587-3593 (2000). *

• Delco F, Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis. Gut 46: 500-506 (2000). *

• Delerive P, Furman C, Teissier E, Fruchart J, Duriez P, Staels B. Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner. FEBS Lett. 471: 34-38 (2000). *

• Delerive P, Gervois P, Fruchart JC, Staels B. Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J. Biol. Chem. 275: 36703-36707 (2000). *

• DeLuca JG, Doebber TW, Kelly LJ, Kemp RK, Molon-Noblot S, Sahoo SP, Ventre J, Wu MS, Peters JM, Gonzalez FJ, Moller DE. Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice. Mol. Pharmacol. 58: 470-476 (2000). *

• Delves PJ, Roitt IM. The immune system. First of two parts. N. Engl. J. Med. 343: 37-49 (2000). *

• Delves PJ, Roitt IM. The immune system. Second of two parts. N. Engl. J. Med. 343: 108-117 (2000). *

• Denk H, Stumptner C, Zatloukal K. Mallory bodies revisited. J. Hepatol. 32: 689-702 (2000). *

• Denson LA, Auld KL, Schiek DS, McClure MH, Mangelsdorf DJ, Karpen SJ. Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J. Biol. Chem. 275: 8835-8843 (2000). *

• Denson LA, McClure MH, Bogue CW, Karpen SJ, Jacobs HC. HNF3beta and GATA-4 transactivate the liver-enriched homeobox gene, Hex. Gene 246: 311-320 (2000). *

• Deol HS, Tuch BE. Effect of interleukin-10 on human anti-porcine xenogeneic cellular response in vitro. Transplantation 69: 112-119 (2000).

• Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr. Rev. 21: 363-392 (2000). *

• Desjeux JF. The molecular and genetic base of congenital transport defects. Gut 46: 585-587 (2000). *

• Desmarquest P, Feldmann D, Tamalat A, Boule M, Fauroux B, Tournier G, Clement A. Genotype analysis and phenotypic manifestations of children with intermediate sweat chloride test results. Chest 118: 1591-1597 (2000). *

• Desreumaux P. Specific targeting of IL-6 signalling pathway: a new way to treat IBD? Gut 47: 465-466 (2000). *

• Devaux Y, Grosjean S, Seguin C, David C, Dousset B, Zannad F, Meistelman C, De Talance N, Mertes PM, Ungureanu-Longrois D. Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo. Am. J. Physiol. Endocrinol. Metab. 279: E1045-E1053 (2000). *

• Dhawan A, Mieli-Vergani G. Mycophenolate mofetil - a new treatment for autoimmune hepatitis? J. Hepatol. 33: 480-481 (2000). *

• Di Sebastiano P, di Mola FF, Di Febbo C, Baccante G, Porreca E, Innocenti P, Friess H, Buchler MW. Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis. Gut 47: 423-428 (2000). *

• Di Toro R, Campana G, Murari G, Spampinato S. Effects of specific bile acids on c-fos messenger RNA levels in human colon carcinoma Caco-2 cells. Eur. J. Pharm. Sci. 11: 291-298 (2000). *

• Diaz GJ. Basolateral and canalicular transport of xenobiotics in the hepatocyte: a review. Cytotechnology 34: 225-235 (2000). *

• Dichi I, Frenhane P, Dichi JB, Correa CR, Angeleli AY, Bicudo MH, Rodrigues MA, Victoria CR, Burini RC. Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis. Nutrition 16: 87-90 (2000).

• Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand. J. Gastroenterol. 35: 181-183 (2000). *

• Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol. Genomics 4: 1-11 (2000). *

• Dieleman LA, Arends A, Tonkonogy SL, Goerres MS, Craft DW, Grenther W, Sellon RK, Balish E, Sartor RB. Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect. Immun. 68: 5107-5113 (2000). *

• Dijstelbloem HM, Bijl M, Fijnheer R, Scheepers RH, Oost WW, Jansen MD, Sluiter WJ, Limburg PC, Derksen RH, van de Winkel JG, Kallenberg CG. Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum. 43: 2793-2800 (2000). *

• Dinter H. Phosphodiesterase type 4 inhibitors: potential in the treatment of multiple sclerosis? BioDrugs 13: 87-94 (2000).

• Dipple KM, McCabe ER. Modifier genes convert "simple" Mendelian disorders to complex traits. Mol. Genet. Metab. 71: 43-50 (2000). *

• Disdier B, Marchetti MN, Bun H, Placidi M, Durand A. Kinetics of plasma and tissue distribution of 9-cis-retinoic acid in rat. Skin Pharmacol. Appl. Skin Physiol. 13: 9-16 (2000).

• Distante S, Berg JP, Lande K, Haug E, Bell H. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 47: 575-579 (2000). *

• Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, Weaver J, Nelson-Piercy C, de Swiet M, Warnes G, Elias E, Higgins CF, Johnston DG, McCarthy MI, Williamson C. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum. Mol. Genet. 9: 1209-1217 (2000). *

• Djukanovic R. The role of co-stimulation in airway inflammation. Clin. Exp. Allergy 30 Suppl. 1: 46-50 (2000).

• Dodge JA. Fibrosing colonopathy. Gut 46: 152-153 (2000). *

• Doetze A, Satoguina J, Burchard G, Rau T, Loliger C, Fleischer B, Hoerauf A. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int. Immunol. 12: 623-630 (2000). *

• Dohi T, Fujihashi K, Kiyono H, Elson CO, McGhee JR. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis. Gastroenterology 119: 724-733 (2000). *

• Dohmen K, Miyamoto Y, Irie K, Takeshita T, Ishibashi H. Manifestation of cutaneous polyarteritis nodosa during interferon therapy for chronic hepatitis C associated with primary biliary cirrhosis. J. Gastroenterol. 35: 789-793 (2000). *

• Domschke W, Klein R, Terracciano LM, Jung P, Kirchner T, Berg PA, Bianchi L. Sequential occurrence of primary sclerosing cholangitis and autoimmune hepatitis type III in a patient with ulcerative colitis: a follow up study over 14 years. Liver 20: 340-345 (2000). *

• Donaldson PT, Norris S, Constantini PK, Bernal W, Harrison P, Williams R. The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance. J. Hepatol. 32: 882-886 (2000). *

• Dong C, Flavell RA. Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis Res. 2: 179-188 (2000). *

• Donnenberg MS, Collins MT, Benitez RM, Mackowiak PA. The sound that failed. Am. J. Med. 108: 475-480 (2000). *

• Donner H, Tonjes RR, Bontrop RE, Kurth R, Usadel KH, Badenhoop K. MHC diversity in Caucasians, investigated using highly heterogeneous noncoding sequence motifs at the DQB1 locus including a retroviral long terminal repeat element, and its comparison to nonhuman primate homologues. Immunogenetics 51: 898-904 (2000).

• Dork T, Macek M Jr, Mekus F, Tummler B, Tzountzouris J, Casals T, Krebsova A, Koudova M, Sakmaryova I, Macek M Sr, Vavrova V, Zemkova D, Ginter E, Petrova NV, Ivaschenko T, Baranov V, Witt M, Pogorzelski A, Bal J, Zekanowsky C, Wagner K, et al. Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum. Genet. 106: 259-268 (2000). *

• Dorman J, Steenkiste A, O'Leary L, McCarthy B, Lorenzen T, Foley T. Type 1 diabetes in offspring of parents with type 1 diabetes: the tip of an autoimmune iceberg? Pediatr. Diabetes 1: 17-22 (2000).

• Doyle DF, Mangelsdorf DJ, Corey DR. Modifying ligand specificity of gene regulatory proteins. Curr. Opin. Chem. Biol. 4: 60-63 (2000). *

• Dragnev KH, Rigas JR, Dmitrovsky E. The retinoids and cancer prevention mechanisms. Oncologist 5: 361-368 (2000). *

• Dranoff JA, Nathanson MH. It's swell to have ATP in the liver. J. Hepatol. 33: 323-325 (2000). *

• Dreja H, Annenkov A, Chernajovsky Y. Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis. Arthritis Rheum. 43: 1698-1709 (2000). *

• Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am. J. Gastroenterol. 95: 699-704 (2000). *

• Driessen CA, Winkens HJ, Hoffmann K, Kuhlmann LD, Janssen BP, Van Vugt AH, Van Hooser JP, Wieringa BE, Deutman AF, Palczewski K, Ruether K, Janssen JJ. Disruption of the 11-cis-retinol dehydrogenase gene leads to accumulation of cis-retinols and cis-retinyl esters. Mol. Cell. Biol. 20: 4275-4287 (2000). *

• Droge W, Breitkreutz R. Glutathione and immune function. Proc. Nutr. Soc. 59: 595-600 (2000). *

• Drossman DA, Leserman J, Li Z, Keefe F, Hu YJ, Toomey TC. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom. Med. 62: 309-317 (2000). *

• Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, Jia H, Bangdiwala SI. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am. J. Gastroenterol. 95: 999-1007 (2000). *

• Drossman DA, Whitehead WE, Toner BB, Diamant N, Hu YJ, Bangdiwala SI, Jia H. What determines severity among patients with painful functional bowel disorders? Am. J. Gastroenterol. 95: 974-980 (2000). *

• Du C, Sriram S. Induction of interleukin-12/p40 by superantigens in macrophages is mediated by activation of nuclear factor-kappaB. Cell. Immunol. 199: 50-57 (2000). *

• Du MX, Sotero-Esteva WD, Taylor MW. Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma. J. Interferon Cytokine Res. 20: 133-142 (2000).

• Duane WC, Hartich LA, Bartman AE, Ho SB. Diminished gene expression of ileal apical sodium bile acid transporter explains impaired absorption of bile acid in patients with hypertriglyceridemia. J. Lipid Res. 41: 1384-1389 (2000). *

• Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Theoret Y, Seidman EG. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 118: 705-713 (2000). *

• Dubinsky MC, Seidman EG. Diagnostic markers of inflammatory bowel disease. Curr. Opin. Gastroenterol. 16: 337-342 (2000).

• Dubuquoy L, Bourdon C, Peuchmaur M, Leibowitz MD, Nutten S, Colombel JF, Auwerx J, Desreumaux P. Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease. Gastroenterol. Clin. Biol. 24: 719-724 (2000).

• Duchini A, Hendry RM, Redfield DC, Pockros PJ. Influenza infection in patients before and after liver transplantation. Liver Transpl. 6: 531-542 (2000). *

• Duchini A, McHutchison JG, Pockros PJ. LKM-positive autoimmune hepatitis in the western United States: a case series. Am. J. Gastroenterol. 95: 3238-3241 (2000). *

• Duchini A, Younossi ZM, Saven A, Bordin GM, Knowles HJ, Pockros PJ. An open-label pilot trial of cladibrine (2-cholordeoxyadenosine) in patients with primary sclerosing cholangitis. J. Clin. Gastroenterol. 31: 292-296 (2000).

• Duclos-Vallee JC, Johanet C, Bach JF, Yamamoto AM. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis. J. Hepatol. 33: 163-166 (2000). *

• Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am. J. Hum. Genet. 66: 1857-1862 (2000). *

• Duflo F, Allaouchiche B, Chassard D. Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex. Scand. J. Infect. Dis. 32: 581 (2000).

• Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin. Chem. 46: 2050-2068 (2000). *

• Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin. Chem. 46: 2027-2049 (2000). *

• Dumonceau JM, Cremer M, Auroux J, Delhaye M, Deviere J. A comparison of Ultraflex Diamond stents and Wallstents for palliation of distal malignant biliary strictures. Am. J. Gastroenterol. 95: 670-676 (2000). *

• Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun. 1: 488-494 (2000). *

• Dunn TB, Kumins NH, Raofi V, Holman DM, Mihalov M, Blanchard J, Law WR, Rastellini C, Benedetti E. Multiple intrasplenic hepatocyte transplantations in the dalmatian dog. Surgery 127: 193-199 (2000). *

• Durand F, Belghiti J, Vilgrain V, Valla D. Vanishing graft syndrome after auxiliary liver transplantation. J. Hepatol. 33: 513 (2000). *

• Durie PR. Pancreatic aspects of cystic fibrosis and other inherited causes of pancreatic dysfunction. Med. Clin. North Am. 84: 609-620, ix (2000).

• Durr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, Fattinger K. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther. 68: 598-604 (2000). *

• Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment. Pharmacol. Ther. 14: 145-153 (2000). *

• Eaden JA, Mayberry JF. Colorectal cancer complicating ulcerative colitis: a review. Am. J. Gastroenterol. 95: 2710-2719 (2000). *

• Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest. Endosc. 51: 123-128 (2000). *

• Eckhoff DE, Baron TH, Blackard WG, Morgan DE, Crowe R, Sellers M, McGuire B, Contreras JL, Bynon JS. Role of ERCP in asymptomatic orthotopic liver transplant patients with abnormal liver enzymes. Am. J. Gastroenterol. 95: 141-144 (2000). *

• Edwards JC, Bowness P, Archer JR. Jekyll and Hyde: the transformation of HLA-B27. Immunol. Today 21: 256-260 (2000).

• Egan LJ, Tremaine WJ, Mays DC, Lipsky JJ, Sandborn WJ. Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease. Inflamm. Bowel Dis. 6: 286-289 (2000). *

• Egea PF, Mitschler A, Rochel N, Ruff M, Chambon P, Moras D. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J. 19: 2592-2601 (2000). *

• Eggena M, Cohavy O, Parseghian MH, Hamkalo BA, Clemens D, Targan SR, Gordon LK, Braun J. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J. Autoimmun. 14: 83-97 (2000).

• Egger B, Buchler MW, Lakshmanan J, Moore P, Eysselein VE. Mice harboring a defective epidermal growth factor receptor (waved-2) have an increased susceptibility to acute dextran sulfate-induced colitis. Scand. J. Gastroenterol. 35: 1181-1187 (2000). *

• Einarson A, Ho E, Koren G. Can we use metronidazole during pregnancy and breastfeeding? Putting an end to the controversy. Can. Fam. Physician 46: 1053-1054 (2000).

• Ejiri S, Eguchi Y, Kishida A, Kurumi Y, Tani T, Kodama M. Protective effect of OPC-6535, a superoxide anion production inhibitor, on liver grafts subjected to warm ischemia during porcine liver transplantation. Transplant. Proc. 32: 318-321 (2000). *

• Ekstrom GM, Andersson SE. Plasma exudation, hyperaemia, and epithelial permeability in rats with oxazolone-induced colitis: modulatory effects of budesonide. Scand. J. Gastroenterol. 35: 190-197 (2000). *

• Eland IA, Sturkenboom MJ, Wilson JH, Stricker BH. Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand. J. Gastroenterol. 35: 1110-1116 (2000). *

• Elekima OT, Mills CO, Ahmad A, Skinner GR, Ramsden DB, Bown J, Young TW, Elias E. Reduced hepatic content of dehydroepiandrosterone sulphotransferase in chronic liver diseases. Liver 20: 45-50 (2000). *

• Elewaut D, Kronenberg M. Molecular biology of NK T cell specificity and development. Semin. Immunol. 12: 561-568 (2000). *

• Elkayam O, Oumanski M, Yaron M, Caspi D. Watermelon stomach following and preceding systemic sclerosis. Semin. Arthritis Rheum. 30: 127-131 (2000). *

• Elliott DE, Urban JF JR, Argo CK, Weinstock JV. Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J. 14: 1848-1855 (2000). *

• Ellis HJ, Ciclitira PJ. The mouth - an accessible region for gluten challenge. Clin. Exp. Immunol. 120: 10-11 (2000). *

• Eloranta ML, Heiskanen J, Hiltunen M, Helisalmi S, Mannermaa A, Heinonen S. Apolipoprotein E alleles in women with intrahepatic cholestasis of pregnancy. Scand. J. Gastroenterol. 35: 966-968 (2000). *

• Elson CO. Commensal bacteria as targets in Crohn's disease. Gastroenterology 119: 254-257 (2000). *

• Elson CO, Cong Y, Sundberg J. The C3H/HeJBir mouse model: a high susceptibility phenotype for colitis. Int. Rev. Immunol. 19: 63-75 (2000).

• Encinas JA, Kuchroo VK. Mapping and identification of autoimmunity genes. Curr. Opin. Immunol. 12: 691-697 (2000).

• Enerback C, Enlund F, Inerot A, Samuelsson L, Wahlstrom J, Swanbeck G, Martinsson T. S gene (Corneodesmosin) diversity and its relationship to psoriasis; high content of cSNP in the HLA-linked S gene. J. Invest. Dermatol. 114: 1158-1163 (2000). *

• Enerback C, Nilsson S, Enlund F, Inerot A, Samuelsson L, Wahlstrom J, Swanbeck G, Martinsson T. Stronger association with HLA-Cw6 than with corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients. Arch. Dermatol. Res. 292: 525-530 (2000). *

• Enns RA. Expandable biliary stents: more questions than answers. Am. J. Gastroenterol. 95: 575-577 (2000). *

• Erickson JM, Mawson AR. Possible role of endogenous retinoid (vitamin A) toxicity in the pathophysiology of primary biliary cirrhosis. J. Theor. Biol. 206: 47-54 (2000). *

• Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J. Nutr. 130: 403S-409S (2000). *

• Escher P, Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat. Res. 448: 121-138 (2000).

• Eskdale J, Turestkaya RL, Armstrong C, Kuprash DV, Nedospasov SA, Gallagher G. A polymorphic microsatellite marker in the human p55 TNF receptor, CD120a. Genes Immun. 1: 228-230 (2000). *

• Esteves MI, Schrenzel MD, Marini RP, Taylor NS, Xu S, Hagen S, Feng Y, Shen Z, Fox JG. Helicobacter pylori gastritis in cats with long-term natural infection as a model of human disease. Am. J. Pathol. 156: 709-721 (2000). *

• Etkind P, Du J, Khan A, Pillitteri J, Wiernik PH. Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin. Cancer Res. 6: 1273-1278 (2000). *

• Ettinger RA, Liu AW, Nepom GT, Kwok WW. Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus. J. Immunol. 165: 3232-3238 (2000). *

• Ettorre GM, Pescatori M, Panis Y, Nemeth J, Crescenzi A, Valleur P. Mucosal changes in ileal pouches after restorative proctocolectomy for ulcerative and Crohn's colitis. Dis. Colon Rectum 43: 1743-1748 (2000).

• EUROPEAN COMMISSION, DIRECTORATE-GENERAL HEALTH & CONSUMER PROTECTION, Directorate B - Scientific Health Opinions, Unit B3 - Management of scientific committees II. Possible links between Crohn’s disease and Paratuberculosis (http://europa.eu.int/comm/food/fs/sc/scah/out38_en.pdf). Report of the Scientific Committee on Animal Health and Animal Welfare Adopted 21 March 2000 (2000). *

• Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol. Clin. North Am. 29: 559-578 (2000).

• Everson GT. Increasing incidence and pretransplantation screening of hepatocellular carcinoma. Liver Transpl. 6 (6 Suppl. 2): S2-S10 (2000). *

• Evgenikos NL, Bartolo DC, Hamer-Hodges DW, Ghosh S. Luminal neutrophil migration in ileoanal pouches studied by whole gut lavage. Eur. J. Gastroenterol. Hepatol. 12: 553-557 (2000).

• Eysselein VE. Reduction of stress - a new therapeutic goal in the treatment of inflammatory bowel disease? Inflamm. Bowel Dis. 6: 153-154 (2000). *

• Ezure T, Sakamoto T, Tsuji H, Lunz JG 3rd, Murase N, Fung JJ, Demetris AJ. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am. J. Pathol. 156: 1627-1639 (2000). *

• Fagerstam JP, Whiss PA, Strom M, Andersson RG. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease. Inflamm. Res. 49: 466-472 (2000). *

• Faller G, Kirchner T. Role of antigastric autoantibodies in chronic Helicobacter pylori infection. Microsc. Res. Tech. 48: 321-326 (2000). *

• Faller M, Gasser B, Massard G, Pauli G, Quoix E. Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn's disease. Respiration 67: 459-463 (2000). *

• Fanning PA, Jonsson JR, Clouston AD, Edwards-Smith C, Balderson GA, Macdonald GA, Crawford DH, Kerlin P, Powell LW, Powell EE. Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J. Hepatol. 33: 690-695 (2000). *

• Fargion S, Mattioli M, Fracanzani AL, Fiorelli G. Iron and liver diseases. Can. J. Gastroenterol. 14 Suppl. D: 89D-92D (2000).

• Fargion S, Valenti L, Fracanzani AL, Sampietro M, Cappellini MD, Scaccabarozzi A, Soligo D, Mariani C, Fiorelli G. Hereditary hemochromatosis in a patient with congenital dyserythropoietic anemia. Blood 96: 3653-3655 (2000). *

• Farmer M, Petras RE, Hunt LE, Janosky JE, Galandiuk S. The importance of diagnostic accuracy in colonic inflammatory bowel disease. Am. J. Gastroenterol. 95: 3184-3188 (2000). *

• Farmer PK, He X, Schmitz ML, Rubin J, Nanes MS. Inhibitory effect of NF-kappaB on 1,25-dihydroxyvitamin D(3) and retinoid X receptor function. Am. J. Physiol. Endocrinol. Metab. 279: E213-E220 (2000). *

• Farrell H, Degli-Esposti M, Densley E, Cretney E, Smyth M, Davis-Poynter N. Cytomegalovirus MHC class I homologues and natural killer cells: an overview. Microbes Infect. 2: 521-532 (2000). *

• Farrell RJ, Murphy A, Long A, Donnelly S, Cherikuri A, O'Toole D, Mahmud N, Keeling PW, Weir DG, Kelleher D. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118: 279-288 (2000). *

• Farrell RJ, Shah SA, Lodhavia PJ, Alsahli M, Falchuk KR, Michetti P, Peppercorn MA. Clinical experience with infliximab therapy in 100 patients with Crohn's disease. Am. J. Gastroenterol. 95: 3490-3497 (2000). *

• Farstad IN, Carlsen H, Morton HC, Brandtzaeg P. Immunoglobulin A cell distribution in the human small intestine: phenotypic and functional characteristics. Immunology 101: 354-363 (2000). *

• Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355: 1518-1519 (2000). *

• Fattinger K, Cattori V, Hagenbuch B, Meier PJ, Stieger B. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2. Hepatology 32: 82-86 (2000). *

• Faust TW. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation. Semin. Liver Dis. 20: 481-495 (2000). *

• Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N. Engl. J. Med. 342: 1627-1632 (2000). *

• Feagan BG, Vreeland MG, Larson LR, Bala MV. Annual cost of care for Crohn's disease: a payor perspective. Am. J. Gastroenterol. 95: 1955-1960 (2000). *

• Fedorak RN, Gangl A, Elson CO, Rutgeerts P, Schreiber S, Wild G, Hanauer SB, Kilian A, Cohard M, LeBeaut A, Feagan B. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology 119: 1473-1482 (2000). *

• Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP, Gleim G. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am. J. Gastroenterol. 95: 1949-1954 (2000). *

• Felix H, Holzmann D. Function and ultrastructure of cilia in primary ciliary dyskinesia. Schweiz. Med. Wochenschr. 130: 699-704 (2000).

• Fernandes NF, Martin RR, Schenker S. Trazodone-induced hepatotoxicity: a case report with comments on drug-induced hepatotoxicity. Am. J. Gastroenterol. 95: 532-535 (2000). *

• Fernandez ED, Flohe S, Siemers F, Nau M, Ackermann M, Ruwe M, Schade FU. Endotoxin tolerance protects against local hepatic ischemia/reperfusion injury in the rat. J. Endotoxin Res. 6: 321-328 (2000). *

• Ferrell L. Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems. Mod. Pathol. 13: 679-704 (2000). *

• Fife MS, Fisher SA, John S, Worthington J, Shah CJ, Ollier WE, Panayi GS, Lewis CM, Lanchbury JS. Multipoint linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region. Arthritis Rheum. 43: 1673-1678 (2000). *

• Fine KD, Do K, Schulte K, Ogunji F, Guerra R, Osowski L, McCormack J. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am. J. Gastroenterol. 95: 1974-1982 (2000). *

• Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin. Thromb. Hemost. 26: 219-225 (2000).

• Fiorillo MT, Maragno M, Butler R, Dupuis ML, Sorrentino R. CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J. Clin. Invest. 106: 47-53 (2000). *

• Fisher NC. Gastric antral vascular ectasia and its relation with portal hypertension. Gut 46: 441-442 (2000). *

• Fitzgerald KA, O'Neill LA. The role of the interleukin-1/Toll-like receptor superfamily in inflammation and host defence. Microbes Infect. 2: 933-943 (2000). *

• Flavell DM, Pineda Torra I, Jamshidi Y, Evans D, Diamond JR, Elkeles RS, Bujac SR, Miller G, Talmud PJ, Staels B, Humphries SE. Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects. Diabetologia 43: 673-680 (2000). *

• Flisiak R, Wiercinska-Drapalo A, Prokopowicz D. Antibodies against M2-antigen in differential diagnosis of primary biliary cirrhosis. Pol. Merkuriusz. Lek. 8: 373-375 (2000).

• Floreani A, Baragiotta A, Martines D, Naccarato R, D'odorico A. Plasma antioxidant levels in chronic cholestatic liver diseases. Aliment. Pharmacol. Ther. 14: 353-358 (2000). *

• Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55: 140-148 (2000). *

• Foley PJ, Mullighan CG, McGrath DS, Pantelidis P, Marshall S, Lympany PA, Welsh KI, du Bois RM. Mannose-binding lectin promoter and structural gene variants in sarcoidosis. Eur. J. Clin. Invest. 30: 549-552 (2000). *

• Folwaczny C, Loeschke K, Schnettler D, Jager G, Wiebecke B, Hoelscher M, Sauer T, Konig A, Endres SP, Fricke H. Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection. Clin. Immunol. 95: 197-202 (2000). *

• Fong DG, Angulo P, Burgart LJ, Lindor KD. Cetirizine-induced cholestasis. J. Clin. Gastroenterol. 31: 250-253 (2000).

• Fong DG, Lindor KD. Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy. Am. J. Gastroenterol. 95: 1861-1862 (2000). *

• Fong DG, Nehra V, Lindor KD, Buchman AL. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 32: 3-10 (2000). *

• Fong KY. The genetics of spondyloarthropathies. Ann. Acad. Med. Singapore 29: 370-375 (2000).

• Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18: 245-273 (2000). *

• Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl. Acad. Sci. U.S.A. 97: 12717-12722 (2000). *

• Forabosco P, Collins A, Latiano A, Annese V, Clementi M, Andriulli A, Fortina P, Devoto M, Morton NE. Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis. On behalf of the GISC. Eur. J. Hum. Genet. 8: 846-852 (2000). *

• Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann. Clin. Lab. Sci. 30: 3-21 (2000).

• Fox RJ, Rostami AM. Anti-interleukin-12 antibody: potential role in preventing relapses of multiple sclerosis. BioDrugs 13: 233-241 (2000).

• Fracanzani AL, Borzio M, Roncalli M, Derenzini M, Trere D, Mattioli M, Taioli E, Fiorelli G, Fargion S. Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis? Am. J. Gastroenterol. 95: 2940-2945 (2000). *

• Fracchia M, Secreto P, Tabone M, Zaffino C, Pera A, Galatola G. Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination. Eur. J. Gastroenterol. Hepatol. 12: 463-468 (2000).

• Fraile A, Collado MD, Mataran L, Martin J, Nieto A. TAP1 and TAP2 polymorphism in Spanish patients with ankylosing spondylitis. Exp. Clin. Immunogenet. 17: 199-204 (2000).

• Fraser J, Arcus V, Kong P, Baker E, Proft T. Superantigens - powerful modifiers of the immune system. Mol. Med. Today 6: 125-132 (2000).

• Freedman SD, Blanco P, Shea JC, Alvarez JG. Mechanisms to explain pancreatic dysfunction in cystic fibrosis. Med. Clin. North Am. 84: 657-664, x (2000).

• Freedman SD, Shea JC, Blanco PG, Alvarez JG. Fatty acids in cystic fibrosis. Curr. Opin. Pulm. Med. 6: 530-532 (2000).

• Freeman HJ. Inflammatory bowel diseases in Indo-Canadians with and without antineutrophil cytoplasmic autoantibodies. Can. J. Gastroenterol. 14: 21-26 (2000). *

• Freeman HJ, Freeman KJ. Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn's disease. Can. J. Gastroenterol. 14: 138-143 (2000). *

• Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann. Clin. Psychiatry 12: 159-165 (2000).

• Freeman RB Jr, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl. 6: 543-552 (2000). *

• Freitas AA, Rocha B. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18: 83-111 (2000). *

• French N, Pettersson S. Microbe-host interactions in the alimentary tract: the gateway to understanding inflammatory bowel disease. Gut 47: 162-163 (2000). *

• Friederich P, Putensen C, Stuber F. Prothrombin gene G20210A mutation and elevated anticardiolipin antibodies in a patient with combined portal-mesenteric vein thrombosis. Intensive Care Med. 26: 1571-1574 (2000).

• Frieri G, Giacomelli R, Pimpo M, Palumbo G, Passacantando A, Pantaleoni G, Caprilli R. Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis. Gut 47: 410-414 (2000). *

• Fromm MF, Kauffmann HM, Fritz P, Burk O, Kroemer HK, Warzok RW, Eichelbaum M, Siegmund W, Schrenk D. The effect of rifampin treatment on intestinal expression of human MRP transporters. Am. J. Pathol. 157: 1575-1580 (2000). *

• Fryer AA, Spiteri MA, Bianco A, Hepple M, Jones PW, Strange RC, Makki R, Tavernier G, Smilie FI, Custovic A, Woodcock AA, Ollier WE, Hajeer AH. The -403 G-->A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun. 1: 509-514 (2000). *

• Fuhr U. Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans. Clin. Pharmacokinet. 38: 493-504 (2000).

• Fukagawa NK, Martin JM, Wurthmann A, Prue AH, Ebenstein D, O'Rourke B. Sex-related differences in methionine metabolism and plasma homocysteine concentrations. Am. J. Clin. Nutr. 72: 22-29 (2000). *

• Fukazawa T, Yamasaki K, Ito H, Kikuchi S, Minohara M, Horiuchi I, Tsukishima E, Sasaki H, Hamada T, Nishimura Y, Tashiro K, Kira J. Both the HLA-DPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens 55: 199-205 (2000). *

• Fukushima N, Ikematsu H, Nakamura M, Matsui M, Shimoda S, Hayashida K, Niho Y, Koike K, Gershwin ME, Ishibashi H. Nucleotide variations amongst V(H) genes of AMA-producing B cell clones in primary biliary cirrhosis. J. Autoimmun. 14: 247-257 (2000). *

• Fulcher AS, Turner MA, Franklin KJ, Shiffman ML, Sterling RK, Luketic VA, Sanyal AJ. Primary sclerosing cholangitis: evaluation with MR cholangiography - a case-control study. Radiology 215: 71-80 (2000). *

• Furuya T, Salstrom JL, McCall-Vining S, Cannon GW, Joe B, Remmers EF, Griffiths MM, Wilder RL. Genetic dissection of a rat model for rheumatoid arthritis: significant gender influences on autosomal modifier loci. Hum. Mol. Genet. 9: 2241-2250 (2000). *

• Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD, Vazquez N, Pestka S, Donnelly RP, Kotenko SV. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun. 1: 442-450 (2000). *

• Galon J, Aksentijevich I, McDermott MF, O'Shea JJ, Kastner DL. TNFRSF1A mutations and autoinflammatory syndromes. Curr. Opin. Immunol. 12: 479-486 (2000).

• Galvan M, Tsuboi S, Fukuda M, Baum LG. Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J. Biol. Chem. 275: 16730-16737 (2000). *

• Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin. Endocrinol. (Oxf.) 52: 565-573 (2000). *

• Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Falorni A, Sanjeevi CB. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 43: 507-514 (2000). *

• Gampe RT Jr, Montana VG, Lambert MH, Miller AB, Bledsoe RK, Milburn MV, Kliewer SA, Willson TM, Xu HE. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 5: 545-555 (2000). *

• Gampe RT Jr, Montana VG, Lambert MH, Wisely GB, Milburn MV, Xu HE. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Genes Dev. 14: 2229-2241 (2000). *

• Gandolfi L, Pratesi R, Cordoba JC, Tauil PL, Gasparin M, Catassi C. Prevalence of celiac disease among blood donors in Brazil. Am. J. Gastroenterol. 95: 689-692 (2000). *

• Gao C, Li Z, Ding J, Wang J, Hu X, Liu T, Xu T, Li H. Study on the relations between HLA-DRB 1 alleles and Helicobacter pylori infection. Zhonghua Liu Xing Bing Xue Za Zhi 21: 417-419 (2000).

• Garcia RF, Garcia CE, McMaster P. Chronic rejection of the liver: the role of immunosuppression. BioDrugs 14: 283-297 (2000).

• Garcia Rodriguez LA, Ruigomez A, Wallander MA, Johansson S, Olbe L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand. J. Gastroenterol. 35: 306-311 (2000). *

• Garcia-Osogobio S, Takahashi T, Gamboa-Dominguez A, Medina H, Arch J, Mass W, Sierra-Madero J, Uscanga L. Toxic pseudomembranous colitis in a patient with ulcerative colitis. Inflamm. Bowel Dis. 6: 188-190 (2000). *

• Garcia-Paredes J, Lopez-Nava G. New forms of hepatobiliary complications in chronic intestinal inflammatory disease. Rev. Esp. Enferm. Dig. 92: 65-67 (2000).

• Garside P, Kennedy MW, Wakelin D, Lawrence CE. Immunopathology of intestinal helminth infection. Parasite Immunol. 22: 605-612 (2000). *

• Gasche C. Anemia in IBD: the overlooked villain. Inflamm. Bowel Dis. 6: 142-150 (2000). *

• Gasche C, Bakos S, Dejaco C, Tillinger W, Zakeri S, Reinisch W. IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J. Clin. Immunol. 20: 362-370 (2000). *

• Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm. Bowel Dis. 6: 8-15 (2000). *

• Gauthier F, Hadchouel M. Congenital disorders of the biliary ducts. Rev. Prat. 50: 2142-2145 (2000).

• Geboes K. Ulcerative colitis and malignancy. Acta Gastroenterol. Belg. 63: 279-283 (2000).

• Geboes K, Riddell R, Ost A, Jensfelt B, Persson T, Lofberg R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47: 404-409 (2000). *

• Geerling BJ, Badart-Smook A, van Deursen C, van Houwelingen AC, Russel MG, Stockbrugger RW, Brummer RJ. Nutritional supplementation with n-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm. Bowel Dis. 6: 77-84 (2000). *

• Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrugger RW, Brummer RJ. Diet as a risk factor for the development of ulcerative colitis. Am. J. Gastroenterol. 95: 1008-1013 (2000). *

• Gelbmann CM. Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease - do we have reliable markers? Inflamm. Bowel Dis. 6: 123-131 (2000). *

• Geluk A, van Meijgaarden KE, Franken KL, Drijfhout JW, D'Souza S, Necker A, Huygen K, Ottenhoff TH. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J. Immunol. 165: 6463-6471 (2000). *

• Gencik M, Meller S, Borgmann S, Fricke H. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int. 58: 2473-2477 (2000). *

• Gencik M, Meller S, Borgmann S, Sitter T, Menezes Saecker AM, Fricke H, Epplen JT. The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides. Clin. Immunol. 94: 9-12 (2000). *

• Genovese E, Maghnie M, Maggiore G, Tinelli C, Lizzoli F, De Giacomo C, Pozza S, Campani R. MR imaging of CNS involvement in children affected by chronic liver disease. AJNR Am. J. Neuroradiol. 21: 845-851 (2000). *

• George J, Shoenfeld Y, Gilburd B, Afek A, Shaish A, Harats D. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ. Res. 86: 1203-1210 (2000). *

• Gerber DA, Green M, Jaffe R, Greenberg D, Mazariegos G, Reyes J. Cryptosporidial infections after solid organ transplantation in children. Pediatr. Transplant. 4: 50-55 (2000).

• Germain DP, Perdu J, Remones V, Jeunemaitre X. Homozygosity for the R1268Q mutation in MRP6, the pseudoxanthoma elasticum gene, is not disease-causing. Biochem. Biophys. Res. Commun. 274: 297-301 (2000). *

• Gerrish K, Gannon M, Shih D, Henderson E, Stoffel M, Wright CV, Stein R. Pancreatic beta cell-specific transcription of the pdx-1 gene. The role of conserved upstream control regions and their hepatic nuclear factor 3beta sites. J. Biol. Chem. 275: 3485-3492 (2000). *

• Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, Coppel RL. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol. Rev. 174: 210-225 (2000). *

• Gershwin ME, Leung PS, Li H, Seldin MF. Primary biliary cirrhosis and autoimmunity: evaluating the genetic risk. Isr. Med. Assoc. J. 2 Suppl: 7-10 (2000).

• Gerson LB, Triadafilopoulos G. Palliative care in inflammatory bowel disease: an evidence-based approach. Inflamm. Bowel Dis. 6: 228-243 (2000). *

• Gervois P, Torra IP, Fruchart JC, Staels B. Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin. Chem. Lab. Med. 38: 3-11 (2000).

• Geubel AP, Sempoux CL. Drug and toxin-induced bile duct disorders. J. Gastroenterol. Hepatol. 15: 1232-1238 (2000). *

• Ghosh S. Linking genotype with phenotype in inflammatory bowel disease - will we ever have reagent standard patients? Dis. Markers 16: 167-171 (2000).

• Ghosh S, Shand A, Ferguson A. Ulcerative colitis. BMJ 320: 1119-1123 (2000). *

• Giannini E, Borro P, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Risso D, Lantieri PB, Antonucci A, Boccato M, Milone S, Testa R. Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis. Int. J. Biol. Markers 15: 226-230 (2000).

• Giannini E, Fasoli A, Botta F, Romagnoli P, Malfatti F, Chiarbonello B, Testa R. Is there a role for multiple quantitative liver function tests? Dig. Liver Dis. 32: 644 (2000).

• Giannini E, Testa R. Is aspartate aminotransferase enough? Am. J. Gastroenterol. 95: 3687-3688 (2000). *

• Gibson J, Wray D, Bagg J. Oral staphylococcal mucositis: a new clinical entity in orofacial granulomatosis and Crohn's disease. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 89: 171-176 (2000).

• Gidlof AC, Zhang W, Gidlof A, Sirsjo A. Synthetic retinoids improve survival in rodent model of endotoxic shock. Eur. J. Surg. 166: 165-169 (2000).

• Gierer IM, Abdala O, Calderon C, Risoli E, Cravero A, Pinchuk L. Meloxican-induced cholestasis. Acta Gastroenterol. Latinoam. 30: 511-514 (2000).

• Gilad J. Antimycobacterial therapy for Crohn's disease. Am. J. Gastroenterol. 95: 2985-2986 (2000). *

• Gilger MA, Gann ME, Opekun AR, Gleason WA Jr. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J. Pediatr. Gastroenterol. Nutr. 31: 136-141 (2000). *

• Gillett HR, Cauch-Dudek K, Jenny E, Heathcote EJ, Freeman HJ. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can. J. Gastroenterol. 14: 672-675 (2000). *

• Gilroy DW, Colville-Nash PR. New insights into the role of COX 2 in inflammation. J. Mol. Med. 78: 121-129 (2000). *

• Gilroy R, Sudan D. Liver and small bowel transplantation: therapeutic alternatives for the treatment of liver disease and intestinal failure. Semin. Liver Dis. 20: 437-450 (2000). *

• Gilroy RK, Lynch SV, Strong RW, Kerlin P, Balderson GA, Stuart KA, Crawford DH. Confirmation of the role of the Mayo Risk Score as a predictor of resource utilization after orthotopic liver transplantation for primary biliary cirrhosis. Liver Transpl. 6: 749-752 (2000). *

• Gines P, Arroyo V. Is there still a need for albumin infusions to treat patients with liver disease? Gut 46: 588-590 (2000). *

• Ginzburg L, Oppenheimer GD. Non-specific granulomata of the intestine (inflammatory tumors and strictures of bowel). 1932. Mt. Sinai J. Med. 67: 246-262 (2000). *

• Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305-309 (2000). *

• Giraud AS. Lessons from genetically engineered animal models. X. Trefoil peptide and EGF receptor/ligand transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G501-G506 (2000). *

• Girodon-Boulandet E, Cazeneuve C, Goossens M. Screening practices for mutations in the CFTR gene ABCC7. Hum. Mutat. 15: 135-149 (2000).

• Giron Moreno RM, Ancochea Bermudez J. The diagnosis of cystic fibrosis in the adult. Arch. Bronconeumol. 36: 3-6 (2000).

• Gislason D, Bjoernsson E, Gislason T. Allergy and intolerance to food in an Icelandic urban population 20-44 years of age. Laeknabladid. 86: 851-857 (2000).

• Glintborg B. Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine. Ugeskr. Laeger. 162: 4553-4554 (2000).

• Gluud CN, Jorgensen T. The Cochrane Hepato-Biliary Group - status after three years. Ugeskr. Laeger. 162: 3017-3019 (2000).

• Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut 46 Suppl. 3-4: IV1-IV5 (2000). *

• Goddard EA, Mouton SC, Westwood AT, Ireland JD, Durra G. Cryptosporidiosis of the gastrointestinal tract associated with sclerosing cholangitis in the absence of documented immunodeficiency: Cryptosporidium parvum and sclerosing cholangitis in an immunocompetent child. J. Pediatr. Gastroenterol. Nutr. 31: 317-320 (2000). *

• Goessling W, Zucker SD. Role of apolipoprotein D in the transport of bilirubin in plasma. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G356-G365 (2000). *

• Gold N, Issenman R, Roberts J, Watt S. Well-adjusted children: an alternate view of children with inflammatory bowel disease and functional gastrointestinal complaints. Inflamm. Bowel Dis. 6: 1-7 (2000). *

• Goldstein NS, Bayati N, Silverman AL, Gordon SC. Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis. Am. J. Clin. Pathol. 114: 591-598 (2000). *

• Goljan A, Puscinska E, Zych D, Zielinski J. Familial sarcoidosis in Poland: analysis of clinical characteristics and environmental aspects. Pneumonol. Alergol. Pol. 68: 510-522 (2000).

• Goll V, Viollon-Abadie C, Nicod L, Richert L. Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines. Hum. Exp. Toxicol. 19: 193-202 (2000).

• Gollapudi S, Kim C, Gupta S. P-glycoprotein (encoded by multidrug resistance genes) is not required for interleukin-2 secretion in mice and humans. Genes Immun. 1: 371-379 (2000). *

• Gomez Lira M, Benetazzo MG, Marzari MG, Bombieri C, Belpinati F, Castellani C, Cavallini GC, Mastella G, Pignatti PF. High frequency of cystic fibrosis transmembrane regulator mutation L997F in patients with recurrent idiopathic pancreatitis and in newborns with hypertrypsinemia. Am. J. Hum. Genet. 66: 2013-2014 (2000). *

• Gonzalez ID, Saeza RS, Rodilla EM, Yges y EL, Toledano FL. Hypersensitivity reactions to chemotherapy drugs. Alergol. Inmunol. Clin. 15: 161-181 (2000). *

• Gonzalez S, Martinez-Borra J, Del Rio JS, Santos-Juanes J, Lopez-Vazquez A, Blanco-Gelaz M, Lopez-Larrea C. The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. J. Invest. Dermatol. 115: 824-828 (2000). *

• Gonzalez-Lara V, Carneros JA, Nunez-Martinez O, Rodriguez C, Escudero M, Alvarez R. The prolonged administration of intravenous immunoglobulins as a treatment for refractory fistulous Crohn's diseases. Gastroenterol. Hepatol. 23: 12-13 (2000).

• Good RA. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases. World J. Surg. 24: 797-810 (2000). *

• Goode T, O'Connell J, Anton P, Wong H, Reeve J, O'Sullivan GC, Collins JK, Shanahan F. Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. Gut 47: 387-396 (2000). *

• Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6: 517-526 (2000). *

• Gordon LK, Eggena M, Targan SR, Braun J. Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies. Clin. Immunol. 94: 42-50 (2000). *

• Gordon MM, Lucie N, Porter D. Acquired C1q deficiency caused by monoclonal paraproteinaemia. Lupus 9: 68-71 (2000).

• Gores GJ. Early detection and treatment of cholangiocarcinoma. Liver Transpl. 6: S30-S34 (2000). *

• Gorriz L, Molino R, Arjona D, Estripeaut D. Sjogren syndrome associated with renal tubular acidosis type I. Rev. Med. Panama 25: 30-33 (2000).

• Gosling J, Dairaghi DJ, Wang Y, Hanley M, Talbot D, Miao Z, Schall TJ. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J. Immunol. 164: 2851-2856 (2000). *

• Gossard AA, Lindor KD. Medical management of chronic cholestatic liver diseases. Can. J. Gastroenterol. 14 Suppl. D: 93D-98D (2000).

• Gotay CC, Dumitriu D. Health food store recommendations for breast cancer patients. Arch. Fam. Med. 9: 692-699 (2000). *

• Gough SC. The genetics of Graves' disease. Endocrinol. Metab. Clin. North Am. 29: 255-266 (2000).

• Gow PJ, Chapman RW. Liver transplantation for primary sclerosing cholangitis. Liver 20: 97-103 (2000). *

• Gow PJ, Chapman RW. Simultaneous occurrence of focal nodular hyperplasia and primary sclerosing cholangitis in a young female. Eur. J. Gastroenterol. Hepatol. 12: 565-567 (2000).

• Goyal V, Tripathi M. Sunflower cataract in Wilson's disease. J. Neurol. Neurosurg. Psychiatry 69: 133 (2000). *

• Gozlan J, Nion I, Chazouilleres O, Chretien Y, Poupon R. Soluble Fas is increased in serum of patients with primary biliary cirrhosis, but is not a useful marker for disease activity. Am. J. Gastroenterol. 95: 3328-3329 (2000). *

• Grace ND. Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know. Am. J. Gastroenterol. 95: 1862-1864 (2000). *

• Graham AM, Dollinger MM, Howie SE, Harrison DJ. Identification of novel alleles at a polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: analysis of allele frequencies in primary biliary cirrhosis. J. Med. Genet. 37: 150-152 (2000). *

• Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L, Kim S, Lazarovici D, Jensen DM, Busuttil RW, Martin P. Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease - the LDQOL 1.0. Am. J. Gastroenterol. 95: 3552-3565 (2000). *

• Granel B, Ravix V, Pedeillier K, Serratrice J, Disdier P, Voelckel MA, Mattei JF, Weiller PJ. A first molecular approach towards CGG repeat expansion in FMR1 gene in systemic lupus erythematosus and in Sjogren's syndrome: a preliminary report. Clin. Rheumatol. 19: 262-264 (2000).

• Granel B, Swiader L, Serratrice J, Disdier P, Weiller PJ. Heat shock proteins or "stress proteins". Rev. Med. Interne. 21: 421-427 (2000).

• Grant SF, Kristjansdottir H, Steinsson K, Blondal T, Yuryev A, Stefansson K, Gulcher JR. Long PCR detection of the C4A null allele in B8-C4AQ0-C4B1-DR3. J. Immunol. Methods 244: 41-47 (2000). *

• Grasemann H, Knauer N, Buscher R, Hubner K, Drazen JM, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am. J. Respir. Crit. Care Med. 162: 2172-2176 (2000). *

• Grasso A, Watkinson AF, Tibballs JM, Burroughs AK. Radiofrequency ablation in the treatment of hepatocellular carcinoma - a clinical viewpoint. J. Hepatol. 33: 667-672 (2000). *

• Graudal NA, Madsen HO, Tarp U, Svejgaard A, Jurik G, Graudal HK, Garred P. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum. 43: 515-521 (2000). *

• Gray M, O'Reilly C, Winpenny J, Argent B. Anion interactions with CFTR and consequences for HCO3- transport in secretory epithelia. J. Korean Med. Sci. 15: S12-S15 (2000). *

• Gray-McGuire C, Moser KL, Gaffney PM, Kelly J, Yu H, Olson JM, Jedrey CM, Jacobs KB, Kimberly RP, Neas BR, Rich SS, Behrens TW, Harley JB. Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. Am. J. Hum. Genet. 67: 1460-1469 (2000). *

• Green JM. The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease. Am. J. Respir. Cell. Mol. Biol. 22: 261-264 (2000). *

• Green JT, Richardson C, Marshall RW, Rhodes J, McKirdy HC, Thomas GA, Williams GT. Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment. Pharmacol. Ther. 14: 1429-1434 (2000). *

• Green RM, Hoda F, Ward KL. Molecular cloning and characterization of the murine bile salt export pump. Gene 241: 117-123 (2000). *

• Greener M. Fatty acid imbalance might lead to novel treatments for CF. Mol. Med. Today 6: 47-48 (2000).

• Griffin JM, Blossom SJ, Jackson SK, Gilbert KM, Pumford NR. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 46: 123-137 (2000).

• Griffin JM, Gilbert KM, Lamps LW, Pumford NR. CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol. Sci. 57: 345-352 (2000). *

• Griffin JM, Gilbert KM, Pumford NR. Inhibition of CYP2E1 reverses CD4+ T-cell alterations in trichloroethylene-treated MRL+/+ mice. Toxicol. Sci. 54: 384-389 (2000). *

• Griga T, Tromm A, Muller KM, May B. Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases. Eur. J. Gastroenterol. Hepatol. 12: 559-564 (2000).

• Grip O, Svensson PJ, Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand. J. Gastroenterol. 35: 619-623 (2000). *

• Grubic Z, Zunec R, Cecuk-Jelicic E, Kerhin-Brkljacic V, Kastelan A. Polymorphism of HLA-A, -B, -DRB1, -DQA1 and -DQB1 haplotypes in a Croatian population. Eur. J. Immunogenet. 27: 47-51 (2000). *

• Gruenheid S, Gros P. Genetic susceptibility to intracellular infections: Nramp1, macrophage function and divalent cations transport. Curr. Opin. Microbiol. 3: 43-48 (2000).

• Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N. Engl. J. Med. 342: 69-77 (2000). *

• Guassora AD, Kruuse C, Thomsen OO, Binder V. Quality of life study in a regional group of patients with Crohn disease. A structured interview study. Scand. J. Gastroenterol. 35: 1068-1074 (2000). *

• Guha C, Chowdhury NR, Chowdhury JR. Recombinant adenoassociated virus in cancer gene therapy. J. Hepatol. 32: 1031-1034 (2000). *

• Gullberg E, Leonard M, Karlsson J, Hopkins AM, Brayden D, Baird AW, Artursson P. Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem. Biophys. Res. Commun. 279: 808-813 (2000). *

• Gulwani-Akolkar B, Akolkar PN, Lin XY, Heresbach D, Manji R, Katz S, Yang SY, Silver J. HLA class II alleles associated with susceptibility and resistance to Crohn's disease in the Jewish population. Inflamm. Bowel Dis. 6: 71-76 (2000). *

• Gunton JE, Stiel J, Clifton-Bligh P, Wilmshurst E, McElduff A. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur. J. Endocrinol. 142: 587 (2000).

• Gupta A, Chandy G, Chacko A. Hepatobiliary and pancreatic: recurrent right upper quadrant pain. J. Gastroenterol. Hepatol. 15: 211-214 (2000). *

• Gupta RA, Tan J, Krause WF, Geraci MW, Willson TM, Dey SK, DuBois RN. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 97: 13275-13280 (2000). *

• Gupta S, Todd Stravitz R, Pandak WM, Muller M, Reno Vlahcevic Z, Hylemon PB. Regulation of multidrug resistance 2 P-glycoprotein expression by bile salts in rats and in primary cultures of rat hepatocytes. Hepatology 32: 341-347 (2000). *

• Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN, Provenzano C, Browne PO, Rajanayagam O, Burris TP, Schwabe JW, Lazar MA, Chatterjee VK. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J. Biol. Chem. 275: 5754-5759 (2000). *

• Gyomorey K, Rozmahel R, Bear CE. Amelioration of intestinal disease severity in cystic fibrosis mice is associated with improved chloride secretory capacity. Pediatr. Res. 48: 731-734 (2000). *

• Haas L, McClain C, Varilek G. Complementary and alternative medicine and gastrointestinal diseases. Curr. Opin. Gastroenterol. 16: 188-196 (2000).

• Haechler S, Van den Ingh TS, Rogivue C, Ehrensperger F, Welle M. Congenital hepatic fibrosis and cystic bile duct formation in Swiss Freiberger horses. Vet. Pathol. 37: 669-671 (2000). *

• Haider MA, Bret PM. The role of magnetic resonance cholangiography in primary sclerosing cholangitis. J. Hepatol. 33: 659-660 (2000). *

• Hajeer AH, Dababneh A, Makki RF, Thomson W, Poulton K, Gonzalez-Gay MA, Garcia-Porrua C, Mattey DL, Ollier WE. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 55: 319-325 (2000). *

• Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: clinical and biological implications. Microsc. Res. Tech. 50: 216-228 (2000). *

• Hake SB, Masternak K, Kammerbauer C, Janzen C, Reith W, Steimle V. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol. Cell. Biol. 20: 7716-7725 (2000). *

• Hall MA, Ahmadi KR, Norman P, Snieder H, MacGregor AJ, Vaughan RW, Spector TD, Lanchbury JS. Genetic influence on peripheral blood T lymphocyte levels. Genes Immun. 1: 423-427 (2000). *

• Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D, Kaklamani E, Moutsopoulos H, Loughran TP Jr, Ollier WE, Panayi GS, Lanchbury JS. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun. 1: 219-224 (2000). *

• Hall RP 3rd, Owen S, Smith A, Keough M, Bagheri B, Church P, Streilein R. TCR Vbeta expression in the small bowel of patients with dermatitis herpetiformis and gluten sensitive enteropathy. Limited expression in dermatitis herpetiformis and treated asymptomatic gluten sensitive enteropathy. Exp. Dermatol. 9: 275-282 (2000).

• Hall RP 3rd, Smith AD, Streilein RD. Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy. Dig. Dis. Sci. 45: 2036-2043 (2000). *

• Hallberg K, Reims A, Strandvik B. Electrogenic ion transport in duodenum, an aid in cystic fibrosis diagnosis. Scand. J. Gastroenterol. 35: 1106-1109 (2000). *

• Haller D, Bode C, Hammes WP, Pfeifer AM, Schiffrin EJ, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47: 79-87 (2000). *

• Halmos B, Szalay F, Cserniczky T, Nemesanszky E, Lakatos P, Barlage S, Schmitz G, Romics L, Csaszar A. Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population. Dig. Dis. Sci. 45: 1091-1095 (2000). *

• Halvorsen B, Staff AC, Ligaarden S, Prydz K, Kolset SO. Lithocholic acid and sulphated lithocholic acid differ in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line CaCo-2. Biochem. J. 349: 189-193 (2000). *

• Hamaguchi K, Kimura A, Seki N, Higuchi T, Yasunaga S, Takahashi M, Sasazuki T, Kusuda Y, Okeda T, Itoh K, Sakata T. Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens 55: 10-16 (2000). *

• Hamamoto Y, Tateno H, Ishida T, Muto M. Lack of association between promoter polymorphism of the tumor necrosis factor-alpha gene and psoriatic arthritis in Japanese patients. J. Invest. Dermatol. 115: 1162-1164 (2000). *

• Hamburg SM, Piers DA, van den Berg AP, Slooff MJ, Haagsma EB. Bone mineral density in the long term after liver transplantation. Osteoporos. Int. 11: 600-606 (2000). *

• Hampe J, Heymann K, Kruis W, Raedler A, Folsch UR, Schreiber S. Anticipation in inflammatory bowel disease: a phenomenon caused by an accumulation of confounders. Am. J. Med. Genet. 92: 178-183 (2000). *

• Hampe J, Wienker T, Nurnberg P, Schreiber S. Mapping genes for polygenic disorders: considerations for study design in the complex trait of inflammatory bowel disease. Hum. Hered. 50: 91-101 (2000). *

• Han SW, Gregory W, Nylander D, Tanner A, Trewby P, Barton R, Welfare M. The SIBDQ: further validation in ulcerative colitis patients. Am. J. Gastroenterol. 95: 145-151 (2000). *

• Han SY, Choung SY, Paik IS, Kang HJ, Choi YH, Kim SJ, Lee MO. Activation of NF-kappaB determines the sensitivity of human colon cancer cells to TNFalpha-induced apoptosis. Biol. Pharm. Bull. 23: 420-426 (2000).

• Hanauer SB. Medical therapy for ulcerative colitis. Curr. Opin. Gastroenterol. 16: 324-328 (2000).

• Handschin C, Podvinec M, Meyer UA. CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. U.S.A. 97: 10769-10774 (2000). *

• Hanna MK, Kudsk KA. Nutritional and pharmacological enhancement of gut-associated lymphoid tissue. Can. J. Gastroenterol. 14 Suppl. D: 145D-151D (2000).

• Hanslik T, Vaillant JN, Audrain L, Jubault V, Prinseau J, Baglin A, Flahault A. Systemic lupus erythematosus and risk of hepatitis B vaccination: from level of evidence to prescription. Rev. Med. Interne. 21: 785-790 (2000).

• Harada M, Sakisaka S, Kawaguchi T, Kimura R, Taniguchi E, Koga H, Hanada S, Baba S, Furuta K, Kumashiro R, Sugiyama T, Sata M. Copper does not alter the intracellular distribution of ATP7B, a copper-transporting ATPase. Biochem. Biophys. Res. Commun. 275: 871-876 (2000). *

• Harada M, Sakisaka S, Terada K, Kimura R, Kawaguchi T, Koga H, Taniguchi E, Sasatomi K, Miura N, Suganuma T, Fujita H, Furuta K, Tanikawa K, Sugiyama T, Sata M. Role of ATP7B in biliary copper excretion in a human hepatoma cell line and normal rat hepatocytes. Gastroenterology 118: 921-928 (2000). *

• Harant H, Spinner D, Reddy GS, Lindley IJ. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor. J. Cell. Biochem. 78: 112-120 (2000). *

• Hardy RG, Meltzer SJ, Jankowski JA. ABC of colorectal cancer. Molecular basis for risk factors. BMJ 321: 886-889 (2000). *

• Harish S, Ashok MS, Khanam T, Rangarajan PN. Serine 27, a human retinoid X receptor alpha residue, phosphorylated by protein kinase A is essential for cyclicAMP-mediated downregulation of RXRalpha function. Biochem. Biophys. Res. Commun. 279: 853-857 (2000). *

• Harper L, Savage CO. Pathogenesis of ANCA-associated systemic vasculitis. J. Pathol. 190: 349-359 (2000). *

• Harris JM, McIntosh EM, Muscat GE. Expression and cytoplasmic localisation of deoxyuridine triphosphate pyrophosphatase encoded by a human endogenous retrovirus. Arch. Virol. 145: 353-363 (2000). *

• Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am. J. Gastroenterol. 95: 2029-2034 (2000). *

• Harty JT, Tvinnereim AR, White DW. CD8+ T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18: 275-308 (2000). *

• Hasegawa Y, Ohi M, Fujisaku A. Autoimmune cholangitis (AIC) associated with myositis in monozygotic twins. Ryumachi 40: 898-903 (2000).

• Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J. Biol. Chem. 275: 28918-28928 (2000). *

• Haslam N, Mayberry JF, Hawthorne AB, Newcombe RG, Holmes GK, Probert CS. Measles, month of birth, and Crohn's disease. Gut 47: 801-803 (2000). *

• Hassard PV, Vasiliauskas EA, Kam LY, Targan SR, Abreu MT. Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease. Inflamm. Bowel Dis. 6: 16-20 (2000). *

• Hausegger KA, Kugler C. Treatment of malignant and benign biliary obstructions with metal stents. Rofo. 172: 315-322 (2000).

• Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J. Hepatol. 32: 1035-1038 (2000). *

• Haussinger D, Schmitt M, Weiergraber O, Kubitz R. Short-term regulation of canalicular transport. Semin. Liver Dis. 20: 307-321 (2000).

• Hawkey CJ, Snowden JA, Lobo A, Beglinger C, Tyndall A. Stem cell transplantation for inflammatory bowel disease: practical and ethical issues. Gut 46: 869-872 (2000). *

• Hayday A, Viney JL. The ins and outs of body surface immunology. Science 290: 97-100 (2000). *

• Haydon GH, Neuberger J. PBC: an infectious disease? Gut 47: 586-588 (2000). *

• Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc. Nutr. Soc. 59: 531-535 (2000). *

• Hazama H, Omagari K, Masuda J, Kinoshita H, Ohba K, Sakimura K, Matsuo I, Isomoto H, Murase K, Murata I, Kohno S. Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis. J. Clin. Lab. Anal. 14: 208-213 (2000). *

• He YW. The role of orphan nuclear receptor in thymocyte differentiation and lymphoid organ development. Immunol. Res. 22: 71-82 (2000).

• He YW, Beers C, Deftos ML, Ojala EW, Forbush KA, Bevan MJ. Down-regulation of the orphan nuclear receptor ROR gamma t is essential for T lymphocyte maturation. J. Immunol. 164: 5668-5674 (2000). *

• Heath PK, Athwal D, Jones S. Reader response: antitumor necrosis factor therapy. Inflamm. Bowel Dis. 6: 70 (2000).

• Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31: 1005-1013 (2000). *

• Heathcote J. Update on primary biliary cirrhosis. Can. J. Gastroenterol. 14: 43-48 (2000). *

• Hedley ML. Gene therapy of chronic inflammatory disease. Adv. Drug Deliv. Rev. 44: 195-207 (2000).

• Heininger K. A unifying hypothesis of Alzheimer's disease. III. Risk factors. Hum. Psychopharmacol. 15: 1-70 (2000).

• Heino M, Peterson P, Sillanpaa N, Guerin S, Wu L, Anderson G, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Jenkinson EJ, Naquet P, Krohn KJ. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur. J. Immunol. 30: 1884-1893 (2000). *

• Heinzmann A, Plesnar C, Kuehr J, Forster J, Deichmann KA. Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy. Eur. J. Immunogenet. 27: 57-61 (2000). *

• Heiskanen I, Luostarinen T, Jarvinen HJ. Impact of screening examinations on survival in familial adenomatous polyposis. Scand. J. Gastroenterol. 35: 1284-1287 (2000). *

• Hellier MD, Morris AI. ERCP training - time for change. Gut 47: 459-460 (2000). *

• Hellmich B, Csernok E, Trabandt A, Gross WL, Ernst M. Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro. Clin. Exp. Immunol. 120: 392-398 (2000). *

• Helm JF, Russo MW, Biddle AK, Simpson KN, Ransohoff DF, Sandler RS. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Am. J. Gastroenterol. 95: 3250-3258 (2000). *

• Helmberger H, Hellerhoff K, Rull T, Rosch T. Chronic infections of the biliary system. Radiologe 40: 530-536 (2000).

• Helper DJ. PSC in UC: is it or is it not a risk factor for the development of neoplasia? Inflamm. Bowel Dis. 6: 61-62 (2000). *

• Hemauer A, Gigler A, Searle K, Beckenlehner K, Raab U, Broliden K, Wolf H, Enders G, Modrow S. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women. J. Med. Virol. 60: 48-55 (2000).

• Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745 (2000). *

• Hendrickx AG, Makori N, Peterson P. Nonhuman primates: their role in assessing developmental effects of immunomodulatory agents. Hum. Exp. Toxicol. 19: 219-225 (2000).

• Heneghan MA, Feeley KM, Stevens FM, Little MP, McCarthy CF. Precipitation of iron overload and hereditary hemochromatosis after successful treatment of celiac disease. Am. J. Gastroenterol. 95: 298-300 (2000). *

• Hennig BJ, Parkhill JM, Chapple IL, Heasman PA, Taylor JJ. Dinucleotide repeat polymorphism in the interleukin-10 gene promoter (IL-10.G) and genetic susceptibility to early-onset periodontal disease. Genes Immun. 1: 402-404 (2000). *

• Herbst F, Ciclitira PJ, Talbot IC, Nicholls RJ. Early changes of ileoanal pouch mucosa in patients with ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 12: 899-905 (2000).

• Hermon-Taylor J. Mycobacterium avium subspecies paratuberculosis in the causation of Crohn's disease. World J. Gastroenterol. 6: 630-632 (2000). *

• Hermon-Taylor J, Bull TJ, Sheridan JM, Cheng J, Stellakis ML, Sumar N. Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can. J. Gastroenterol. 14: 521-539 (2000). *

• Herr AS, Wochnik GM, Rosenhagen MC, Holsboer F, Rein T. Rifampicin is not an activator of glucocorticoid receptor. Mol. Pharmacol. 57: 732-737 (2000). *

• Herr M, Dudbridge F, Zavattari P, Cucca F, Guja C, March R, Campbell RD, Barnett AH, Bain SC, Todd JA, Koeleman BP. Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. Hum. Mol. Genet. 9: 1291-1301 (2000). *

• Herrmann DN, Blaivas M, Wald JJ, Feldman EL. Granulomatous myositis, primary biliary cirrhosis, pancytopenia, and thymoma. Muscle Nerve 23: 1133-1136 (2000). *

• Hervonen K, Karell K, Holopainen P, Collin P, Partanen J, Reunala T. Concordance of dermatitis herpetiformis and celiac disease in monozygous twins. J. Invest. Dermatol. 115: 990-993 (2000). *

• Hess C, Sadallah S, Schifferli JA. Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils. Blood 96: 2822-2827 (2000). *

• Heufelder AE. Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev. Endocr. Metab. Disord. 1: 87-95 (2000).

• Heuschkel RB. New immunologic treatments for inflammatory bowel disease. Curr. Opin. Gastroenterol. 16: 565-570 (2000).

• Heuschkel RB, MacDonald TT, Monteleone G, Bajaj-Elliott M, Smith JA, Pender SL. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut 47: 57-62 (2000). *

• Heyen JR, Ye S, Finck BN, Johnson RW. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 77: 138-147 (2000).

• Heyman M. Effect of lactic acid bacteria on diarrheal diseases. J. Am. Coll. Nutr. 19: 137S-146S (2000). *

• Hidi R, Riches V, Al-Ali M, Cruikshank WW, Center DM, Holgate ST, Djukanovic R. Role of B7-CD28/CTLA-4 costimulation and NF-kappa B in allergen-induced T cell chemotaxis by IL-16 and RANTES. J. Immunol. 164: 412-418 (2000). *

• Hill I, Fasano A, Schwartz R, Counts D, Glock M, Horvath K. The prevalence of celiac disease in at-risk groups of children in the United States. J. Pediatr. 136: 86-90 (2000).

• Hilsden RJ, Hodgins DC, Timmer A, Sutherland LR. Helping patients with Crohn's disease quit smoking. Am. J. Gastroenterol. 95: 352-358 (2000). *

• Hinojosa J, Bau I, Martinez B, Garcia Armengol J, Roig JV, Ferrando J, Moles JR, Gomez AB, Lledo S. Morphological, histochemical and immunochemical characteristics of the terminal ileum of patients with ulcerative colitis. Relationship with the development of pouchitis. Gastroenterol. Hepatol. 23: 263-268 (2000).

• Hinokio Y, Horikawa Y, Furuta H, Cox NJ, Iwasaki N, Honda M, Ogata M, Iwamoto Y, Bell GI. Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes 49: 302-305 (2000). *

• Hinz B, Brune K. New insights into physiological and pathophysiological functions of cyclo-oxygenase-2. Curr. Opin. Anaesthesiol. 13: 585-590 (2000).

• Hiramatsu K, Harada K, Tsuneyama K, Sasaki M, Fujita S, Hashimoto T, Kaneko S, Kobayashi K, Nakanuma Y. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J. Hepatol. 33: 9-18 (2000). *

• Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J. Biol. Chem. 275: 2905-2910 (2000). *

• Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, Jones ML, Caughey RC, Brown R, Millikin PD, Darras FS. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int. 57: 2360-2374 (2000). *

• Hochholzer P, Lipford GB, Wagner H, Pfeffer K, Heeg K. Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect. Immun. 68: 3502-3508 (2000). *

• Hocqueloux L, Gervais A. Cholangiocarcinoma and AIDS-related sclerosing cholangitis. Ann. Intern. Med. 132: 1006-1007 (2000). *

• Hoffenberg EJ, Bao F, Eisenbarth GS, Uhlhorn C, Haas JE, Sokol RJ, Rewers M. Transglutaminase antibodies in children with a genetic risk for celiac disease. J. Pediatr. 137: 356-360 (2000). *

• Hoffmann JC, Zeitz M. Treatment of Crohn's disease. Hepatogastroenterology 47: 90-100 (2000).

• Hoffmann P, Reinshagen M, Zeeh JM, Lakshmanan J, Wu VS, Goebell H, Gerken G, Eysselein VE. Increased expression of epidermal growth factor-receptor in an experimental model of colitis in rats. Scand. J. Gastroenterol. 35: 1174-1180 (2000). *

• Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. U.S.A. 97: 3473-3478 (2000). *

• Hohler T, Leininger S, Kohler HH, Schirmacher P, Galle PR. Heterozygosity for the hemochromatosis gene in liver diseases - prevalence and effects on liver histology. Liver 20: 482-486 (2000).

• Hollis BW. Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin. Chem. 46: 1657-1661 (2000). *

• Holt PG. Parasites, atopy, and the hygiene hypothesis: resolution of a paradox? Lancet 356: 1699-1701 (2000). *

• Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, Muller A, deWaal Malefyt R, Deng G, Orozco R, Ruzicka T, Lehmann P, Lebecque S, Caux C, Zlotnik A. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164: 6621-6632 (2000). *

• Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347: 321-337 (2000). *

• Horigome H, Nomura T, Saso K, Joh T, Ohara H, Akita S, Sobue S, Mizuno Y, Kato Y, Itoh M. Coexistence of primary biliary cirrhosis and myasthenia gravis: a case study. Hepatogastroenterology 47: 125-127 (2000).

• Horiuchi T, Tsukamoto H, Morita C, Sawabe T, Harashima S, Nakashima H, Miyahara H, Hashimura C, Kondo M. Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun. 1: 464-466 (2000). *

• Hormi K, Cadiot G, Kermorgant S, Dessirier V, Le Romancer M, Lewin MJ, Mignon M, Lehy T. Transforming growth factor-alpha and epidermal growth factor receptor in colonic mucosa in active and inactive inflammatory bowel disease. Growth Factors 18: 79-91 (2000).

• Horrobin DF. Essential fatty acid metabolism and its modification in atopic eczema. Am. J. Clin. Nutr. 71: 367S-372S (2000). *

• Horvat-Karajz K, Csepregi A, Nemesanszky E, Tulassay Z, Selmeci L, Szalay F. Activity of neutral endopeptidase in serum of patients with primary biliary cirrhosis. Orv. Hetil. 141: 963-965 (2000).

• Howard TD, Meyers DA, Bleecker ER. Mapping susceptibility genes for asthma and allergy. J. Allergy Clin. Immunol. 105: S477-S481 (2000).

• Howard WR, Pospisil JA, Njolito E, Noonan DJ. Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor. Toxicol. Appl. Pharmacol. 163: 195-202 (2000). *

• Howel D, Fischbacher CM, Bhopal RS, Gray J, Metcalf JV, James OF. An exploratory population-based case-control study of primary biliary cirrhosis. Hepatology 31: 1055-1060 (2000). *

• Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun. 1: 515-520 (2000). *

• Huang D, Giscombe R, Zhou Y, Lefvert AK. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis. J. Rheumatol. 27: 397-401 (2000).

• Huang HC, Chu CJ, Lee FY, Chang FY, Wang SS, Lin HC, Hou MC, Chan CC, Wu SL, Chen CT, Lee SD. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension. Scand. J. Gastroenterol. 35: 1308-1313 (2000). *

• Huang L, Koziel MJ. Immunology of hepatitis C virus infection. Curr. Opin. Gastroenterol. 16: 558-564 (2000).

• Huang L, Smit JW, Meijer DK, Vore M. Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats. Hepatology 32: 66-72 (2000). *

• Huard B. Expression of inhibitory receptors for MHC class I molecules on T cells. Crit. Rev. Immunol. 20: 471-476 (2000).

• Hubacek JA, Stuber F, Frohlich D, Book M, Wetegrove S, Rothe G, Schmitz G. The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun. 1: 405-407 (2000). *

• Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am. J. Gastroenterol. 95: 760-767 (2000). *

• Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, van Hul W, Whyte MP, Nakatsuka K, Hovy L, Anderson DM. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat. Genet. 24: 45-48 (2000). *

• Hughes M, Hayward CP, Warkentin TE, Horsewood P, Chorneyko KA, Kelton JG. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 96: 188-194 (2000). *

• Hui AC, Wong SM. Deafness and liver disease in a 57-year-old man: a medical history of Beethoven. Hong Kong Med. J. 6: 433-438 (2000). *

• Hull PR, Demkiw-Bartel C. Isotretinoin use in acne: prospective evaluation of adverse events. J. Cutan. Med. Surg. 4: 66-70 (2000).

• Hulten K, Almashhrawi A, El-Zaatari FA, Graham DY. Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria. Dig. Dis. Sci. 45: 445-456 (2000). *

• Hunt LE, Eichenberger MR, Petras R, Galandiuk S. Use of a microsatellite marker in predicting dysplasia in ulcerative colitis. Arch. Surg. 135: 582-585 (2000). *

• Hunt MC, Yang YZ, Eggertsen G, Carneheim CM, Gafvels M, Einarsson C, Alexson SE. The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis. J. Biol. Chem. 275: 28947-28953 (2000). *

• Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. 85: 4650-4656 (2000). *

• Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JA, Welsh KI. Cytokine gene polymorphisms in autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 85: 1984-1988 (2000). *

• Hunter SF, Hafler DA. Ubiquitous pathogens: links between infection and autoimmunity in MS? Neurology 55: 164-165 (2000).

• Huss JM, Kasper CB. Two-stage glucocorticoid induction of CYP3A23 through both the glucocorticoid and pregnane X receptors. Mol. Pharmacol. 58: 48-57 (2000). *

• Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 60: 3333-3337 (2000). *

• Hustache-Mathieu L, Brousse A, Lohse A, Michel F, Toussirot E, Dupond JL, Wendling D. Infectious osteoarthritis due to Propionibacterium acnes. Two new cases. Rev. Med. Interne. 21: 547-549 (2000).

• Hwang D. Fatty acids and immune responses - a new perspective in searching for clues to mechanism. Annu. Rev. Nutr. 20: 431-456 (2000). *

• Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164: 3596-3599 (2000). *

• Hyams JS, Markowitz J, Wyllie R. Use of infliximab in the treatment of Crohn's disease in children and adolescents. J. Pediatr. 137: 192-196 (2000). *

• Igaz P, Horvath A, Horvath B, Szalai C, Pallinger E, Rajnavolgyi E, Toth S, Rose-John S, Falus A. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production. Immunol. Lett. 71: 143-148 (2000).

• Iivonen MK, Mattila JJ, Nordback IH, Matikainen MJ. Long-term follow-up of patients with jejunal pouch reconstruction after total gastrectomy. A randomized prospective study. Scand. J. Gastroenterol. 35: 679-685 (2000). *

• Iizuka M, Chiba M, Yukawa M, Nakagomi T, Fukushima T, Watanabe S, Nakagomi O. Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease. Gut 46: 163-169 (2000). *

• Ikehata A, Sakuma T. Gastric duplication cyst with markedly elevated concentration of carbohydrate antigen 19-9. Am. J. Gastroenterol. 95: 842-843 (2000). *

• Ikehata A, Tomichi N. CD44v6 expression in granuloma of Crohn's disease. Am. J. Gastroenterol. 95: 3325-3326 (2000). *

• Ikonomopoulos JA, Gorgoulis VG, Kastrinakis NG, Zacharatos PV, Kokotas SN, Evangelou K, Kotsinas AG, Tsakris AG, Manolis EN, Kittas CN. Sensitive differential detection of genetically related mycobacterial pathogens in archival material. Am. J. Clin. Pathol. 114: 940-950 (2000). *

• Ilan Y, Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rabbani E, Engelhardt D, Chowdhury NR, Chowdhury JR, Goldin E. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am. J. Gastroenterol. 95: 966-973 (2000). *

• Imae M, Inoue Y, Fu Z, Kato H, Noguchi T. Gene expression of the three members of hepatocyte nuclear factor-3 is differentially regulated by nutritional and hormonal factors. J. Endocrinol. 167: R1-R5 (2000). *

• Imai K, Sato M, Kojima N, Miura M, Sato T, Sugiyama T, Enomoto K, Senoo H. Storage of lipid droplets in and production of extracellular matrix by hepatic stellate cells (vitamin A-storing cells) in Long-Evans cinnamon-like colored (LEC) rats. Anat. Rec. 258: 338-348 (2000).

• Imamura H, Momose T, Kitabayashi H, Takahashi W, Yazaki Y, Takenaka H, Isobe M, Sekiguchi M, Kubo K. Pulmonary hypertension as a result of asymptomatic portosystemic shunt. Jpn. Circ. J. 64: 471-473 (2000).

• Inada H, Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Umemura T, Tanaka E, Kiyosawa K. T cell repertoire in the liver of patients with primary biliary cirrhosis. Hum. Immunol. 61: 675-683 (2000).

• Inan MS, Tolmacheva V, Wang QS, Rosenberg DW, Giardina C. Transcription factor NF-kappaB participates in regulation of epithelial cell turnover in the colon. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G1282-G1291 (2000). *

• Indaram AV, Visvalingam V, Locke M, Bank S. Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease. Am. J. Gastroenterol. 95: 1221-1225 (2000). *

• Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165: 6107-6115 (2000). *

• Ingen-Housz S, Venutolo E, Pinquier L, Cavelier-Balloy B, Dubertret L, Flageul B. Erythema annulare centrifugum and relapsing polychondritis. Ann. Dermatol. Venereol. 127: 735-739 (2000).

• Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiatt K, New S, Hood A, Shannon K, Williams DA, Clapp DW. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J. Exp. Med. 191: 181-188 (2000). *

• Ings S. Diet therapy - a forgotten art? Paediatr. Nurs. 12: 14-17 (2000).

• Ingvarsson T. Prevalence and inheritance of hip osteoarthritis in Iceland. Acta Orthop. Scand. Suppl. 298: 1-46 (2000).

• Inohara N, Koseki T, Lin J, del Peso L, Lucas PC, Chen FF, Ogura Y, Nunez G. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275: 27823-27831 (2000). *

• Inoue Y, Fujisawa M, Shoji M, Hashizume S, Katakura Y, Shirahata S. Enhanced antibody production of human-human hybridomas by retinoic acid. Cytotechnology 33: 83-88 (2000). *

• Invernizzi P, De Andreis C, Sirchia SM, Battezzati PM, Zuin M, Rossella F, Perego F, Bignotto M, Simoni G, Podda M. Blood fetal microchimerism in primary biliary cirrhosis. Clin. Exp. Immunol. 122: 418-422 (2000). *

• Ip WK, Lau YL, Chan SY, Mok CC, Chan D, Tong KK, Lau CS. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum. 43: 1679-1687 (2000). *

• Iqbal A, Huraib S, Tanimu D. Successful late conversion to mycophenolate mofetil and prednisone immunosuppression therapy in a renal transplant recipient. Saudi J. Kidney Dis. Transpl. 11: 197-200 (2000).

• Irvine EJ, Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Nilsson LG, Persson T. Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. Inflamm. Bowel Dis. 6: 181-187 (2000). *

• Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 119: 1740-1744 (2000). *

• Ishaq M, Fan M, Natarajan V. Accumulation of RXR alpha during activation of cycling human T lymphocytes: modulation of RXRE transactivation function by mitogen-activated protein kinase pathways. J. Immunol. 165: 4217-4225 (2000). *

• Ishida H, Yamashita C, Kuruta Y, Yoshida Y, Noshiro M. Insulin is a dominant suppressor of sterol 12 alpha-hydroxylase P450 (CYP8B) expression in rat liver: possible role of insulin in circadian rhythm of CYP8B. J. Biochem. 127: 57-64 (2000).

• Ishii T, Suzuki Y, Ando N, Matsuo N, Ogata T. Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 85: 2922-2926 (2000). *

• Ishikawa A, Nishida H, Baba T, Mitamura K. Evaluation of balloon-occluded hepatic venography with carbon dioxide for portography and correlation between retrograde portogram and liver function in patients with liver cirrhosis. Hepatol. Res. 18: 239-251 (2000).

• Ito H, Imada T, Rino Y, Kondo J. A case of segmental primary sclerosing cholangitis. Hepatogastroenterology 47: 128-131 (2000).

• Itoh S, Matsuzaki Y, Kimura T, Ikegami T, Shoda J, Fujiwara M, Tanaka N. Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction. J. Gastroenterol. Hepatol. 15: 443-451 (2000). *

• Iwata M, Harada K, Hiramatsu K, Tsuneyama K, Kaneko S, Kobayashi K, Nakanuma Y. Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis. Liver 20: 129-135 (2000).

• Iwata M, Harada K, Kono N, Kaneko S, Kobayashi K, Nakanuma Y. Expression of Bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis. Hum. Pathol. 31: 179-184 (2000).

• Jabri B, de Serre NP, Cellier C, Evans K, Gache C, Carvalho C, Mougenot JF, Allez M, Jian R, Desreumaux P, Colombel JF, Matuchansky C, Cugnenc H, Lopez-Botet M, Vivier E, Moretta A, Roberts AI, Ebert EC, Guy-Grand D, Brousse N, Schmitz J, Cerf-Bensussan N. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 118: 867-879 (2000). *

• Jacquemin E. Progressive familial intrahepatic cholestasis. Genetic basis and treatment. Clin. Liver Dis. 4: 753-763 (2000).

• Jagodzinski PP, Lecybyl R, Ignacak M, Juszczyk J, Trzeciak WH. Distribution of 32 alelle of the CCR5 gene in the population of Poland. J. Hum. Genet. 45: 271-274 (2000).

• Jalan R, Hayes PC. Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut 46: 527-533 (2000). *

• Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 46 Suppl. 3-4: III1-III15 (2000). *

• James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 71: 343S-348S (2000). *

• Jameson S. Coeliac disease, insulin-like growth factor, bone mineral density, and zinc. Scand. J. Gastroenterol. 35: 894-896 (2000). *

• Janatuinen EK, Kemppainen TA, Pikkarainen PH, Holm KH, Kosma VM, Uusitupa MI, Maki M, Julkunen RJ. Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut 46: 327-331 (2000). *

• Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N. Engl. J. Med. 342: 1960-1968 (2000). *

• Jansen PL. Foreword: from classic bile physiology to cloned transporters. Semin. Liver Dis. 20: 245-250 (2000).

• Jansen PL. The pathophysiology of cholestasis with special reference to primary biliary cirrhosis. Baillieres Best Pract. Res. Clin. Gastroenterol. 14: 571-583 (2000).

• Jansen PL, Muller M. The molecular genetics of familial intrahepatic cholestasis. Gut 47: 1-5 (2000). *

• Jansen PL, Muller M. Genetic cholestasis: lessons from the molecular physiology of bile formation. Can. J. Gastroenterol. 14: 233-238 (2000). *

• Jansen PL, Muller M, Kuipers F. Bile formation and cholestasis. Ned. Tijdschr. Geneeskd. 144: 2384-2391 (2000).

• Jaroszewicz J, Flisiak R. Primary biliary cirrhosis. Pol. Merkuriusz. Lek. 8: 369-372 (2000).

• Jassar P, Jaramillo M, Nunez DA. Base of tongue varices associated with portal hypertension. Postgrad. Med. J. 76: 576-577 (2000). *

• Javitt NB. Biologic role(s) of the 25(R),26-hydroxycholesterol metabolic pathway. Biochim. Biophys. Acta 1529: 136-141 (2000). *

• Jeffrey GP, Adams PC. Pitfalls in the genetic diagnosis of hereditary hemochromatosis. Genet. Test. 4: 143-146 (2000).

• Jelaska A, Korn JH. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum. 43: 2230-2239 (2000). *

• Jelinkova L, Tuckova L, Sanchez D, Krupickova S, Pozler O, Nevoral J, Kotalova R, Tlaskalova-Hogenova H. Increased levels of circulating ICAM-1, E-selectin, and IL-2 receptors in celiac disease. Dig. Dis. Sci. 45: 398-402 (2000). *

• Jenkins DJ, Kendall CW. Resistant starches. Curr. Opin. Gastroenterol. 16: 178-183 (2000).

• Jensen WA, Jois JA, Murphy P, De Giorgio J, Brown B, Rowley MJ, Mackay IR. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis. Clin. Chem. Lab. Med. 38: 753-758 (2000).

• Jeon YJ, Han SH, Lee YW, Lee M, Yang KH, Kim HM. Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation. Immunopharmacology 48: 173-183 (2000).

• Jeshion WC, Larsen KL, Jawad AF, Piccoli DA, Verma R, Maller ES, Baldassano RN. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children. J. Clin. Gastroenterol. 30: 294-298 (2000).

• Jimenez-Saenz M, Arguelles-Arias F, Herrerias-Gutierrez JM, Duran-Quintana JA. Acute cholestatic hepatitis in a child treated with famotidine. Am. J. Gastroenterol. 95: 3665-3666 (2000). *

• Jirapongsananuruk O, Melamed I, Leung DY. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J. Allergy Clin. Immunol. 106: 981-985 (2000). *

• Jobin C, Sartor RB. NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases. Inflamm. Bowel Dis. 6: 206-213 (2000). *

• Johanet C, Andre C, Sibilia J, Baquey A, Oksman F, San Marco M, Humbel RL, Taillefer MF, Chretien P, Escande A, Cohen J, Chevailler A, Monier JC, Goetz J. Clinical significance of antiribosomal antibodies. Study Group on Autoimmunity (GEAI). Rev. Med. Interne. 21: 510-516 (2000).

• Johannesen J, Pociot F, Kristiansen OP, Karlsen AE, Nerup J; DIEGG and DSGD Danish IDDM Epidemiology and Genetics Group, Danish Study Group of Diabetis in Childhood. No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population. Genes Immun. 1: 362-366 (2000). *

• Johansen FE, Braathen R, Brandtzaeg P. Role of J chain in secretory immunoglobulin formation. Scand. J. Immunol. 52: 240-248 (2000). *

• Johansson C, Castillejo-Lopez C, Johanneson B, Svenungsson E, Gunnarsson I, Frostegard J, Sturfelt G, Truedsson L, Lofstrom B, Alcocer-Varela J, Lundberg I, Gyllensten UB, Alarcon-Segovia D, Alarcon-Riquelme ME. Association analysis with microsatellite and SNP markers does not support the involvement of BCL-2 in systemic lupus erythematosus in Mexican and Swedish patients and their families. Genes Immun. 1: 380-385 (2000). *

• Johnson P, Bruix J. Hepatocellular carcinoma and the art of prognostication. J. Hepatol. 33: 1006-1008 (2000). *

• Johnson SR, Koehler A, Pennington LK, Hanto DW. Long-term results of surgical repair of bile duct injuries following laparoscopic cholecystectomy. Surgery 128: 668-677 (2000). *

• Johnston SD, Smye M, Watson RG, McMillan SA, Trimble ER, Love AH. Lactulose-mannitol intestinal permeability test: a useful screening test for adult coeliac disease. Ann. Clin. Biochem. 37: 512-519 (2000).

• Jois J, Omagari K, Rowley MJ, Anderson J, Mackay IR. Enzyme inhibitory antibody to pyruvate dehydrogenase: diagnostic utility in primary biliary cirrhosis. Ann. Clin. Biochem. 37: 67-73 (2000).

• Jojic N. Pharmacotherapy of inflammatory bowel disease. Acta Chir. Iugosl. 47: 51-55 (2000).

• Jonas E, Slezak P, Miller N. Imaging-based dynamic liver testing - a computerized simulation. Hepatogastroenterology 47: 967-972 (2000).

• Jones AM, Gaspar HB. Immunogenetics: changing the face of immunodeficiency. J. Clin. Pathol. 53: 60-65 (2000). *

• Jones DE. Autoantigens in primary biliary cirrhosis. J. Clin. Pathol. 53: 813-821 (2000). *

• Jones DE. Fetal microchimerism: an aetiological factor in primary biliary cirrhosis? J. Hepatol. 33: 834-837 (2000). *

• Jones DE, Palmer JM, Kirby JA, De Cruz DJ, McCaughan GW, Sedgwick JD, Yeaman SJ, Burt AD, Bassendine MF. Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy. Liver 20: 351-356 (2000).

• Jones EA. Pathogenesis of hepatic encephalopathy. Clin. Liver Dis. 4: 467-485 (2000).

• Jones EA, Bergasa NV. Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis. Can. J. Gastroenterol. 14: 33-40 (2000). *

• Jones EA, Dekker LR. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis. Gastroenterology 118: 431-432 (2000). *

• Jones G, Crotty M, Brooks P. Interventions for psoriatic arthritis. Cochrane Database Syst. Rev. 3: CD000212 (2000). *

• Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NC, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, Moore JT. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol. 14: 27-39 (2000). *

• Jordanides N, Eskdale J, Stuart R, Gallagher G. Allele associations reveal four prominent haplotypes at the human interleukin-6 (IL-6) locus. Genes Immun. 1: 451-455 (2000). *

• Jovanovic DV, Martel-Pelletier J, Di Battista JA, Mineau F, Jolicoeur FC, Benderdour M, Pelletier JP. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum. 43: 1134-1144 (2000). *

• Jung SA, Chung YH, Park NH, Lee SS, Kim JA, Yang SH, Song IH, Lee YS, Suh DJ, Moon IH. Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allylalcohol. Scand. J. Gastroenterol. 35: 969-975 (2000). *

• Jurcic Z, Brkljacic-Surkalovic L, Grubic Z, Zunec R, Vezmar V, Kastelan A. Gluten enteropathy in Croatian children is primarily associated with the HLA-DR3-DQ2 haplotype. Lijec. Vjesn. 122: 259-263 (2000).

• Jurutka PW, Remus LS, Whitfield GK, Galligan MA, Haussler CA, Haussler MR. Biochemical evidence for a 170-kilodalton, AF-2-dependent vitamin D receptor/retinoid X receptor coactivator that is highly expressed in osteoblasts. Biochem. Biophys. Res. Commun. 267: 813-819 (2000). *

• Juvonen PO, Alhava EM, Takala JA. Gut permeability in patients with acute pancreatitis. Scand. J. Gastroenterol. 35: 1314-1318 (2000). *

• Kaczur V, Takacs M, Szalai C, Falus A, Nagy Z, Berencsi G, Balazs C. Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. Eur. J. Immunogenet. 27: 17-23 (2000).

• Kader HA, Wenner WJ Jr, Telega GW, Maller ES, Baldassano RN. Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease. J. Clin. Gastroenterol. 30: 409-413 (2000).

• Kaisho T, Akira S. Critical roles of Toll-like receptors in host defense. Crit. Rev. Immunol. 20: 393-405 (2000).

• Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192: 921-930 (2000). *

• Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J. Invest. Dermatol. 114: 1180-1183 (2000). *

• Kam LY, Targan SR. TNF-alpha antagonists for the treatment of Crohn's disease. Expert Opin. Pharmacother. 1: 615-622 (2000).

• Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y, Gabazza EC, Adachi Y. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J. Gastroenterol. 35: 659-664 (2000). *

• Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin. Endocrinol. (Oxf.) 52: 759-764 (2000). *

• Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 11: 459-466 (2000).

• Kanazawa A, Platt JL. Prospects for xenotransplantation of the liver. Semin. Liver Dis. 20: 511-522 (2000).

• Kane SV. What's good for the goose should be good for the gander - 6-MP use in fathers with inflammatory bowel disease. Am. J. Gastroenterol. 95: 581-582 (2000). *

• Kaneko H, Fukao T, Inoue R, Kasahara K, Matsui E, Kondo N. Long-term study of a female hyper-IgM immunodeficiency. Exp. Clin. Immunogenet. 17: 173-178 (2000).

• Kang BY, Chung SW, Kim SH, Kang SN, Choe YK, Kim TS. Retinoid-mediated inhibition of interleukin-12 production in mouse macrophages suppresses Th1 cytokine profile in CD4(+) T cells. Br. J. Pharmacol. 130: 581-586 (2000). *

• Kansu A, Kalayci AG, Altuntas B, Doganci T, Girgin N. Autoimmune hepatitis in children: a report of ten cases. Turk. J. Med. Sci. 30: 55-61 (2000). *

• Kapsoritakis AN, Potamianos SP, Sfiridaki AI, Koukourakis MI, Koutroubakis IE, Roussomoustakaki MI, Manousos ON, Kouroumalis EA. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease. Am. J. Gastroenterol. 95: 3478-3481 (2000). *

• Karagezian KG, Nazaretian EE, Zavgorodniaia AM, Ovnanian KO. Immune disorders in periodic disease. Klin. Med. (Mosk.) 78: 24-25 (2000).

• Karandikar NJ, Eagar TN, Vanderlugt CL, Bluestone JA, Miller SD. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 109: 173-180 (2000).

• Karasu Z, Gurakar A, Kerwin B, Hulagu S, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Van Thiel DH, Wright H. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig. Dis. Sci. 45: 1971-1976 (2000). *

• Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur. J. Radiol. 35: 154-167 (2000).

• Karlsson KA. The human gastric colonizer Helicobacter pylori: a challenge for host-parasite glycobiology. Glycobiology 10: 761-771 (2000). *

• Karolyi Z, Eros N, Ujszaszy L, Nagy G. Cutaneous and mucosal manifestations of inflammatory bowel diseases. Orv. Hetil. 141: 1391-1395 (2000).

• Kassam A, Winrow CJ, Fernandez-Rachubinski F, Capone JP, Rachubinski RA. The peroxisome proliferator response element of the gene encoding the peroxisomal beta-oxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptor beta/9-cis-retinoic acid receptor-mediated … J. Biol. Chem. 275: 4345-4350 (2000). *

• Kasvosve I, Gomo ZA, Mvundura E, Moyo VM, Saungweme T, Khumalo H, Gordeuk VR, Boelaert JR, Delanghe JR, De Bacquer D, Gangaidzo IT. Haptoglobin polymorphism and mortality in patients with tuberculosis. Int. J. Tuberc. Lung Dis. 4: 771-775 (2000).

• Katagiri Y, Takeda K, Yu ZX, Ferrans VJ, Ozato K, Guroff G. Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat. Cell Biol. 2: 435-440 (2000). *

• Katayama Y, Kohriyama K, Kirizuka K, Nishizaki H, Fujii H, Tanji Y. Sjogren's syndrome complicated with autoimmune hepatitis and antiphospholipid antibody syndrome. Intern. Med. 39: 73-76 (2000). *

• Kato H, Tsuchiya N, Tokunaga K. Single nucleotide polymorphisms in the coding regions of human CXC-chemokine receptors CXCR1, CXCR2 and CXCR3. Genes Immun. 1: 330-337 (2000). *

• Kato S. Molecular mechanism of transcriptional control by nuclear vitamin receptors. Br. J. Nutr. 84 Suppl. 2: S229-S233 (2000).

• Kato S. Nuclear steroid hormone receptors as possible target molecule for endocrine disruptant. Nippon Rinsho 58: 1535-1543 (2000).

• Katsuta T, Lim C, Shimoda K, Shibuta K, Mitra P, Banner BF, Mori M, Barnard GF. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease. Am. J. Gastroenterol. 95: 3157-3164 (2000). *

• Katz JA. Thalidomide for Crohn's disease: high dose, low dose, or "no doze" at all? Inflamm. Bowel Dis. 6: 152-153 (2000). *

• Katz Y, Nadiv O, Rapoport MJ, Loos M. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts. Clin. Exp. Immunol. 120: 22-29 (2000). *

• Kaukinen K, Turjanmaa K, Maki M, Partanen J, Venalainen R, Reunala T, Collin P. Intolerance to cereals is not specific for coeliac disease. Scand. J. Gastroenterol. 35: 942-946 (2000). *

• Kaushik SP, Kaye G, Clarke AC. Autoimmune hepatobiliary disease in trisomy 21. J. Clin. Gastroenterol. 30: 330-332 (2000).

• Kavak A, Baykal C, Ozarmagan G, Akar U. HLA in alopecia areata. Int. J. Dermatol. 39: 589-592 (2000).

• Kawabata Y, Ikegami H, Kawaguchi Y, Fujisawa T, Hotta M, Ueda H, Shintani M, Nojima K, Ono M, Nishino M, Taniguchi H, Noso S, Yamada K, Babaya N, Ogihara T. Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. Hum. Immunol. 61: 624-629 (2000).

• Kawachi S, Morise Z, Jennings SR, Conner E, Cockrell A, Laroux FS, Chervenak RP, Wolcott M, van der Heyde H, Gray L, Feng L, Granger DN, Specian RA, Grisham MB. Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells. Inflamm. Bowel Dis. 6: 171-180 (2000). *

• Kawada T, Kamei Y, Fujita A, Hida Y, Takahashi N, Sugimoto E, Fushiki T. Carotenoids and retinoids as suppressors on adipocyte differentiation via nuclear receptors. Biofactors 13: 103-109 (2000).

• Kawaguchi T, Sakisaka S, Mitsuyama K, Harada M, Koga H, Taniguchi E, Sasatomi K, Kimura R, Ueno T, Sawada N, Mori M, Sata M. Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis. Hepatology 31: 1285-1295 (2000). *

• Kawai H, Aoyagi Y, Nomoto M, Takizawa H, Suzuki Y, Hama A, Suda T, Takahashi T, Asakura H. Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis. Dig. Dis. Sci. 45: 680-684 (2000). *

• Kawamata H, Kumazaki T, Kanazawa H, Takahashi S, Tajima H, Hayashi H. Transjugular intrahepatic portosystemic shunt in a patient with cavernomatous portal vein occlusion. Cardiovasc. Intervent. Radiol. 23: 145-149 (2000).

• Kawamura K, Kobayashi Y, Kageyama F, Kawasaki T, Nagasawa M, Toyokuni S, Uchida K, Nakamura H. Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis. Am. J. Gastroenterol. 95: 3596-3601 (2000). *

• Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K. Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun. 1: 351-357 (2000). *

• Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig. Dis. Sci. 45: 723-729 (2000). *

• Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J. Hepatol. 33: 537-542 (2000). *

• Keates AC, Castagliuolo I, Cruickshank WW, Qiu B, Arseneau KO, Brazer W, Kelly CP. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice. Gastroenterology 119: 972-982 (2000). *

• Kedzierska A, Turowski G. HLA class I haplotypes in families of children with coeliac disease. Med. Sci. Monit. 6: 336-341 (2000).

• Keicho N, Ohashi J, Tamiya G, Nakata K, Taguchi Y, Azuma A, Ohishi N, Emi M, Park MH, Inoko H, Tokunaga K, Kudoh S. Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis. Am. J. Hum. Genet. 66: 501-507 (2000). *

• Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, Tage-Jensen U, Dahlerup JF. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Ugeskr. Laeger. 162: 782-785 (2000).

• Keim V, Teich N, Mossner J. Trypsinogen mutations in hereditary pancreatitis: which nomenclature is convenient? Gut 46: 873 (2000). *

• Keith Hanna M, Zarzaur BL Jr, Fukatsu K, Chance DeWitt R, Renegar KB, Sherrell C, Wu Y, Kudsk KA. Individual neuropeptides regulate gut-associated lymphoid tissue integrity, intestinal immunoglobulin A levels, and respiratory antibacterial immunity. JPEN J. Parenter. Enteral Nutr. 24: 261-268 (2000).

• Keller JM, Collet P, Bianchi A, Huin C, Bouillaud-Kremarik P, Becuwe P, Schohn H, Domenjoud L, Dauca M. Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease. Int. J. Dev. Biol. 44: 429-442 (2000). *

• Kemp EH, Ridgway JN, Smith KA, Watson PF, Weetman AP. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease. Clin. Endocrinol. (Oxf.) 53: 291-299 (2000). *

• Kennedy RJ, Hoper M, Deodhar K, Kirk SJ, Gardiner KR. Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand. J. Gastroenterol. 35: 1266-1271 (2000). *

• Kennon B, Connell JM. ACE gene polymorphism and diabetic complications: is there a connection? BioDrugs 14: 73-81 (2000).

• Keppler D, Konig J. Hepatic secretion of conjugated drugs and endogenous substances. Semin. Liver Dis. 20: 265-272 (2000).

• Kerr MA. Function of immunoglobulin A in immunity. Gut 47: 751-752 (2000). *

• Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 405: 421-424 (2000). *

• Kersten S, Mandard S, Tan NS, Escher P, Metzger D, Chambon P, Gonzalez FJ, Desvergne B, Wahli W. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275: 28488-28493 (2000). *

• Kersten S, Wahli W. Peroxisome proliferator activated receptor agonists. EXS 89: 141-151 (2000).

• Kessel D, Caruso JA, Reiners JJ Jr. Potentiation of photodynamic therapy by ursodeoxycholic acid. Cancer Res. 60: 6985-6988 (2000). *

• Khalkhali-Ellis Z, Moore TL, Hendrix MJ. Could hormones make a difference in the treatment of juvenile rheumatoid arthritis? BioDrugs 13: 77-86 (2000).

• Khani-Hanjani A, Lacaille D, Hoar D, Chalmers A, Horsman D, Anderson M, Balshaw R, Keown PA. Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 356: 820-825 (2000). *

• Khanlou H, Sass D, Rothstein K, Manzarbeitia C, Reich D, Jacobson L, Fleischer D, Munoz SJ. Idiopathic adulthood ductopenia: case report and review of the literature. Arch. Intern. Med. 160: 1033-1036 (2000). *

• Khoo BP, Leow YH. A review of inpatients with adverse drug reactions to allopurinol. Singapore Med. J. 41: 156-160 (2000). *

• Kielar ML, Jeyarajah DR, Penfield JG, Lu CY. Docosahexaenoic acid decreases IRF-1 mRNA and thus inhibits activation of both the IRF-E and NFkappa d response elements of the iNOS promoter. Transplantation 69: 2131-2137 (2000).

• Kilinc MO, Ninis VN, Tolun A, Estivill X, Casals T, Savov A, Dagli E, Karakoc F, Demirkol M, Huner G, Ozkinay F, Demir E, Seculi JL, Pena J, Bousono C, Ferrer-Calvete J, Calvo C, Glover G, Kremenski I. Genotype-phenotype correlation in three homozygotes for the cystic fibrosis mutation 2183AA-->G shows a severe phenotype. J. Med. Genet. 37: 307-309 (2000). *

• Kim KM, Kim YM, Park M, Park K, Chang HK, Park TK, Chung HH, Kang CY. A broad-spectrum caspase inhibitor blocks concanavalin A-induced hepatitis in mice. Clin. Immunol. 97: 221-233 (2000). *

• Kim MH, Seong MC, Kwak NH, Yoo JS, Huh W, Kim TG, Han H. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am. J. Ophthalmol. 129: 173-177 (2000). *

• Kim WR. Quality of life instruments for liver transplant recipients: too many choices? Liver Transpl. 6: 784-785 (2000). *

• Kim WR, Dickson ER. Timing of liver transplantation. Semin. Liver Dis. 20: 451-464 (2000). *

• Kim WR, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP, Wiesner RH. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl. 6: 453-458 (2000). *

• Kim WR, Lindor KD, Locke GR 3rd, Therneau TM, Homburger HA, Batts KP, Yawn BP, Petz JL, Melton LJ 3rd, Dickson ER. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 119: 1631-1636 (2000). *

• Kim WR, Lindor KD, Malinchoc M, Petz JL, Jorgensen R, Dickson ER. Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. Hepatology 32: 924-929 (2000). *

• Kim WR, Ludwig J, Lindor KD. Variant forms of cholestatic diseases involving small bile ducts in adults. Am. J. Gastroenterol. 95: 1130-1138 (2000). *

• Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, LaRusso NF, Lindor KD, Dickson ER. A revised natural history model for primary sclerosing cholangitis. Mayo Clin. Proc. 75: 688-694 (2000). *

• Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA, Dickson ER. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl. 6: 489-494 (2000). *

• Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 46: 725-731 (2000). *

• Kimmings AN, van Deventer SJ, Rauws EAJ, Huibregtse K, Gouma DJ. Systemic inflammatory response in acute cholangitis and after subsequent treatment. Eur. J. Surg. 166: 700-705 (2000).

• Kimura K, Hunter SF, Thollander MS, Loftus EV Jr, Melton LJ 3rd, O'Brien PC, Rodriguez M, Phillips SF. Concurrence of inflammatory bowel disease and multiple sclerosis. Mayo Clin. Proc. 75: 802-806 (2000). *

• Kimura M, Tatsumi KI, Tada H, Ikemoto M, Fukuda Y, Kaneko A, Kato M, Hidaka Y, Amino N. Enzyme immunoassay for autoantibodies to human liver-type arginase and its clinical application. Clin. Chem. 46: 112-117 (2000). *

• Kimura S, Okabayashi Y, Inushima K, Yutsudo Y, Kasuga M. Polymorphism of cystic fibrosis gene in Japanese patients with chronic pancreatitis. Dig. Dis. Sci. 45: 2007-2012 (2000). *

• King AL, Ciclitira PJ. Celiac disease: strongly heritable, oligogenic, but genetically complex. Mol. Genet. Metab. 71: 70-75 (2000). *

• King AL, Ciclitira PJ. Celiac disease. Curr. Opin. Gastroenterol. 16: 102-106 (2000).

• King AL, Yiannakou JY, Brett PM, Curtis D, Morris MA, Dearlove AM, Rhodes M, Rosen-Bronson S, Mathew C, Ellis HJ, Ciclitira PJ. A genome-wide family-based linkage study of coeliac disease. Ann. Hum. Genet. 64: 479-490 (2000). *

• Kini D, Aggarwal R, Saraswat VA, Naik SR. Symptomatic chronic calcific pancreatitis in a patient with idiopathic ulcerative colitis and sclerosing cholangitis. Indian J. Gastroenterol. 19: 29-30 (2000).

• Kinnman N, Lindblad A, Housset C, Buentke E, Scheynius A, Strandvik B, Hultcrantz R. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis. Hepatology 32: 334-340 (2000). *

• Kintscher U, Goetze S, Wakino S, Kim S, Nagpal S, Chandraratna RA, Graf K, Fleck E, Hsueh WA, Law RE. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. Eur. J. Pharmacol. 401: 259-270 (2000). *

• Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118: 1001-1011 (2000). *

• Kipp H, Arias IM. Newly synthesized canalicular ABC transporters are directly targeted from the Golgi to the hepatocyte apical domain in rat liver. J. Biol. Chem. 275: 15917-15925 (2000). *

• Kipp H, Arias IM. Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters. Semin. Liver Dis. 20: 339-351 (2000).

• Kirby CP, Freeman JK, Ford WD, Davidson GP, Furness ME. Malrotation with recurrent volvulus presenting with cholestasis, pruritus, and pancreatitis. Pediatr. Surg. Int. 16: 130-131 (2000).

• Kishimoto S, Haruma K, Tari A, Sakurai K, Nakano M, Nakagawa Y. Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats. Dig. Dis. Sci. 45: 1608-1616 (2000). *

• Kitauchi S, Nishi S, Nishioka S. Intestinal Behcet's disease: epidemiology, pathophysiology and potential of mesalazine. BioDrugs 13: 409-413 (2000).

• Kivivuori SM, Pelkonen P, Ylijoki H, Verronen P, Siimes MA. Elevated serum transferrin receptor concentration in children with juvenile chronic arthritis as evidence of iron deficiency. Rheumatology (Oxford) 39: 193-197 (2000). *

• Klapproth JM, Greenwald BD. Dysplastic polyps in chronic colitis: is colectomy needed? Inflamm. Bowel Dis. 6: 262-263 (2000). *

• Klein J, Sato A. The HLA system. Second of two parts. N. Engl. J. Med. 343: 782-786 (2000). *

• Klein J, Sato A. The HLA system. First of two parts. N. Engl. J. Med. 343: 702-709 (2000). *

• Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Runte M, Epplen JT. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis 21: 3578-3582 (2000). *

• Kleizen B, Braakman I, de Jonge HR. Regulated trafficking of the CFTR chloride channel. Eur. J. Cell Biol. 79: 544-556 (2000).

• Klomp LW, Bull LN, Knisely AS, van Der Doelen MA, Juijn JA, Berger R, Forget S, Nielsen IM, Eiberg H, Houwen RH. A missense mutation in FIC1 is associated with Greenland familial cholestasis. Hepatology 32: 1337-1341 (2000). *

• Klucken J, Buchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G, Kapinsky M, Diederich W, Drobnik W, Dean M, Allikmets R, Schmitz G. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc. Natl. Acad. Sci. U.S.A. 97: 817-822 (2000). *

• Knisely AS. Progressive familial intrahepatic cholestasis: a personal perspective. Pediatr. Dev. Pathol. 3: 113-125 (2000).

• Kobata T, Azuma M, Yagita H, Okumura K. Role of costimulatory molecules in autoimmunity. Rev. Immunogenet. 2: 74-80 (2000).

• Kobayashi A, Kasano M, Maeda T, Hori S, Motojima K, Suzuki M, Fujiwara T, Takahashi E, Yabe T, Tanaka K, Kasahara M, Yamaguchi Y, Maeda M. A half-type ABC transporter TAPL is highly conserved between rodent and man, and the human gene is not responsive to interferon-gamma in contrast to TAP1 and TAP2. J. Biochem. 128: 711-718 (2000).

• Koeleman BP, Herr MH, Zavattari P, Dudbridge F, March R, Campbell D, Barnett AH, Bain SC, Mulargia AP, Loddo M, Amos W, Cucca F, Todd JA. Conditional ETDT analysis of the human leukocyte antigen region in type 1 diabetes. Ann. Hum. Genet. 64: 215-221 (2000).

• Kogan J, Ilan I. Combined liver damage from primary biliary cirrhosis, primary sclerosing cholangitis, liver allograft rejection and graft-versus-host disease. Harefuah. 138: 38-41 (2000).

• Kohn LD, Napolitano G, Singer DS, Molteni M, Scorza R, Shimojo N, Kohno Y, Mozes E, Nakazato M, Ulianich L, Chung HK, Matoba H, Saunier B, Suzuki K, Schuppert F, Saji M. Graves' disease: a host defense mechanism gone awry. Int. Rev. Immunol. 19: 633-664 (2000).

• Kokotsakis JN, Lambidis CD, Lioulias AG, Skouteli ET, Bastounis EA, Livesay JJ. Celiac artery compression syndrome. Cardiovasc. Surg. 8: 219-222 (2000).

• Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum. 43: 2481-2487 (2000). *

• Kolios G, Wright KL, Linehan JD, Robertson DA, Westwick J. Interleukin-13 inhibits nitric oxide production in human colonic mucosa. Hepatogastroenterology 47: 714-717 (2000).

• Komatsu K, Shimosegawa T, Kikuchi S, Uchi M, Maruhama Y, Kisara N, Ueno Y, Toyota T. Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis. Intern. Med. 39: 1049-1053 (2000). *

• Kondo H. CREST syndrome; a changing clinical significance. Intern. Med. 39: 437 (2000). *

• Kong YC, David CS. New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models. Int. Rev. Immunol. 19: 573-585 (2000).

• Konig J, Cui Y, Nies AT, Keppler D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J. Biol. Chem. 275: 23161-23168 (2000). *

• Konig J, Cui Y, Nies AT, Keppler D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G156-G164 (2000). *

• Konno M, Muraoka S, Takahashi M, Imai T. Iron-deficiency anemia associated with Helicobacter pylori gastritis. J. Pediatr. Gastroenterol. Nutr. 31: 52-56 (2000). *

• Koop I, Ilchmann R, Izzi L, Adragna A, Koop H, Barthelmes H. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am. J. Gastroenterol. 95: 2009-2014 (2000). *

• Kopf E, Plassat JL, Vivat V, de The H, Chambon P, Rochette-Egly C. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J. Biol. Chem. 275: 33280-33288 (2000). *

• Korelitz BI. The role of liquid diet in the management of small bowel Crohn's disease. Inflamm. Bowel Dis. 6: 66-67 (2000). *

• Korzenik JR. Infliximab for fistulas: a hole in one? Inflamm. Bowel Dis. 6: 62-63 (2000). *

• Korzenik JR, Dieckgraefe BK. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig. Dis. Sci. 45: 1121-1129 (2000). *

• Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun. 1: 185-190 (2000). *

• Koss K, Satsangi J, Welsh KI, Jewell DP. Is interleukin-6 important in inflammatory bowel disease? Genes Immun. 1: 207-212 (2000). *

• Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J. Immunol. 165: 6606-6611 (2000). *

• Koutroubakis IE, Dilaveraki E, Vlachonikolis IG, Vardas E, Vrentzos G, Ganotakis E, Mouzas IA, Gravanis A, Emmanouel D, Kouroumalis EA. Hyperhomocysteinemia in Greek patients with inflammatory bowel disease. Dig. Dis. Sci. 45: 2347-2351 (2000). *

• Koutroubakis IE, Sfiridaki A, Mouzas IA, Maladaki A, Kapsoritakis A, Roussomoustakaki M, Kouroumalis EA, Manousos ON. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am. J. Gastroenterol. 95: 190-194 (2000). *

• Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am. J. Gastroenterol. 95: 171-176 (2000). *

• Kowdley KV. Ursodeoxycholic acid therapy in hepatobiliary disease. Am. J. Med. 108: 481-486 (2000). *

• Kozak T, Becvar R, Havrdova E, Pitha J, Gregora E, Pytlik R, Maaloufova J, Kobylka P, Vodvarkova S. Hematopoietic stem cell transplantation in autoimmune diseases in rheumatology practice. Cas. Lek. Cesk. 139: 329-333 (2000).

• Kozoni V, Tsioulias G, Shiff S, Rigas B. The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen. Carcinogenesis 21: 999-1005 (2000). *

• Krahenbuhl S, Brass EP, Hoppel CL. Decreased carnitine biosynthesis in rats with secondary biliary cirrhosis. Hepatology 31: 1217-1223 (2000). *

• Kramer G, Klingler HC, Steiner GE. Role of bacteria in the development of kidney stones. Curr. Opin. Urol. 10: 35-38 (2000). *

• Krappmann D, Hatada EN, Tegethoff S, Li J, Klippel A, Giese K, Baeuerle PA, Scheidereit C. The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component. J. Biol. Chem. 275: 29779-29787 (2000). *

• Krause W, DuBois RN. Eicosanoids and the large intestine. Prostaglandins Other Lipid Mediat. 61: 145-161 (2000).

• Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Etherton TD. Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 71: 179S-188S (2000). *

• Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun. 1: 170-184 (2000). *

• Kristiansen OP, Nolsoe RL, Holst H, Reker S, Larsen ZM, Johannesen J, Nerup J, Pociot F, Mandrup-Poulsen T; Danish Study Group of IDDM in Childhood. The intercellular adhesion molecule-1 K469E polymorphism in type 1 diabetes. Immunogenetics 52: 107-111 (2000). *

• Kroeger KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 12: 110-119 (2000).

• Kronborg O. Screening for early colorectal cancer. World J. Surg. 24: 1069-1074 (2000). *

• Kronenberg M, Cheroutre H. Do mucosal T cells prevent intestinal inflammation? Gastroenterology 118: 974-977 (2000). *

• Kruis W. Cholangitis in ulcerative colitis - a risk factor for colonic malignancy? Int. J. Colorectal Dis. 15: 172 (2000). *

• Kubicka S, Manns MP. Gallbladder and bile duct carcinoma. Internist (Berl.) 41: 841-847 (2000).

• Kucharzik T, Lugering N, Rautenberg K, Lugering A, Schmidt MA, Stoll R, Domschke W. Role of M cells in intestinal barrier function. Ann. N. Y. Acad. Sci. 915: 171-183 (2000). *

• Kugathasan S, Werlin SL, Martinez A, Rivera MT, Heikenen JB, Binion DG. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Am. J. Gastroenterol. 95: 3189-3194 (2000). *

• Kugelmas M. Preliminary observation: oral zinc sulfate replacement is effective in treating muscle cramps in cirrhotic patients. J. Am. Coll. Nutr. 19: 13-15 (2000). *

• Kuhns MS, Epshteyn V, Sobel RA, Allison JP. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells. Proc. Natl. Acad. Sci. U.S.A. 97: 12711-12716 (2000). *

• Kukreja A, Maclaren NK. Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes. Cell. Mol. Life Sci. 57: 534-541 (2000). *

• Kullak-Ublick GA, Beuers U, Paumgartner G. Hepatobiliary transport. J. Hepatol. 32: S3-S18 (2000).

• Kullak-Ublick GA, Meier PJ. Mechanisms of cholestasis. Clin. Liver Dis. 4: 357-385 (2000).

• Kullak-Ublick GA, Stieger B, Hagenbuch B, Meier PJ. Hepatic transport of bile salts. Semin. Liver Dis. 20: 273-292 (2000). *

• Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clin. Proc. 75: 733-739 (2000). *

• Kumar R, Lumsden A, Ciclitira PJ, Ellis HJ, Laurie GW. Human genome search in celiac disease using gliadin cDNA as probe. J. Mol. Biol. 300: 1155-1167 (2000). *

• Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, Ebert EC, Vierra MA, Goodman SB, Genovese MC, Wardlaw AJ, Greenberg HB, Parker CM, Butcher EC, Andrew DP, Agace WW. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192: 761-768 (2000). *

• Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, Takabayashi K, Iwamoto I. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 43: 2455-2463 (2000). *

• Kurebayashi S, Ueda E, Sakaue M, Patel DD, Medvedev A, Zhang F, Jetten AM. Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc. Natl. Acad. Sci. U.S.A. 97: 10132-10137 (2000). *

• Kurihara T, Niimi A, Maeda A, Shigemoto M, Yamashita K. Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid. Am. J. Gastroenterol. 95: 2990-2992 (2000). *

• Kusuda Y, Hamaguchi K, Mori T, Shin R, Seike M, Sakata T. Novel mutations of the ATP7B gene in Japanese patients with Wilson disease. J. Hum. Genet. 45: 86-91 (2000).

• Kuwana M, Kaburaki J, Pandey JP, Murata M, Kawakami Y, Inoko H, Ikeda Y. HLA class II alleles in Japanese patients with immune thrombocytopenic purpura. Associations with anti-platelet glycoprotein autoantibodies and responses to splenectomy. Tissue Antigens 56: 337-343 (2000).

• Kuwana T, Sato Y, Saka M, Kondo Y, Miyata M, Obara K, Nishimaki T, Kasukawa R. Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis. J. Gastroenterol. 35: 682-689 (2000). *

• Labori KJ, Bjornbeth BA, Hvattum E, Lyberg T, Raeder MG. Intravenous bilirubin, dibromosulfophthalein, and bromosulfophthalein infusions uncouple biliary phospholipid and cholesterol secretion from bile acid secretion by inhibiting hepatic phosphoglycoprotein-3 activity in pigs. Scand. J. Gastroenterol. 35: 873-882 (2000). *

• Lacki JK. Management of the patient with severe refractory rheumatoid arthritis: are the newer treatment options worth considering? BioDrugs 13: 425-435 (2000).

• Lader AS, Prat AG, Jackson GR Jr, Chervinsky KL, Lapey A, Kinane TB, Cantiello HF. Increased circulating levels of plasma ATP in cystic fibrosis patients. Clin. Physiol. 20: 348-353 (2000).

• Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, Edwards PA. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J. Biol. Chem. 275: 10638-10647 (2000). *

• Lafon M. Viral superantigens. Rev. Med. Interne. 21: 713-716 (2000).

• Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6: 1229-1234 (2000). *

• Lahteenoja H, Maki M, Viander M, Raiha I, Vilja P, Rantala I, Toivanen A, Syrjanen S. Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease. Am. J. Gastroenterol. 95: 2880-2887 (2000). *

• Lahteenoja H, Maki M, Viander M, Toivanen A, Syrjanen S. Local challenge of oral mucosa with gliadin in patients with coeliac disease. Clin. Exp. Immunol. 120: 38-45 (2000). *

• Lahteenoja H, Toivanen A, Viander M, Raiha I, Rantala I, Syrjanen S, Maki M. Increase in T-cell subsets of oral mucosa: a late immune response in patients with treated coeliac disease? Scand. J. Immunol. 52: 602-608 (2000). *

• Lai HC, Kosorok MR, Laxova A, Davis LA, FitzSimmon SC, Farrell PM. Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics 105: 53-61 (2000). *

• Laivoranta-Nyman S, Mottonen T, Luukkainen R, Hakala M, Yli-Kerttula U, Hannonen P, Tuokko J, Toivanen A, Ilonen J. Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis. Ann. Rheum. Dis. 59: 173-177 (2000). *

• Lakatos L. Immunology of inflammatory bowel diseases. Acta Physiol. Hung. 87: 355-372 (2000).

• Lakatos PL, Firneisz G, Borcsiczky D, Zalatnai A, Selmeci L, Szalay F. Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis. Eur. J. Clin. Invest. 30: 793-797 (2000).

• Lambert NC, Evans PC, Hashizumi TL, Maloney S, Gooley T, Furst DE, Nelson JL. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J. Immunol. 164: 5545-5548 (2000). *

• Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J. Hepatol. 33: 1012-1021 (2000). *

• Lampen A, Meyer S, Arnhold T, Nau H. Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes. J. Pharmacol. Exp. Ther. 295: 979-985 (2000). *

• Langdahl BL, Gravholt CH, Brixen K, Eriksen EF. Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fractures. Eur. J. Clin. Invest. 30: 608-617 (2000). *

• Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1 receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J. Bone Miner. Res. 15: 402-414 (2000).

• Langevitz P, Livneh A, Bank I, Pras M. Benefits and risks of minocycline in rheumatoid arthritis. Drug Saf. 22: 405-414 (2000).

• Langlois MR, Martin ME, Boelaert JR, Beaumont C, Taes YE, De Buyzere ML, Bernard DR, Neels HM, Delanghe JR. The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clin. Chem. 46: 1619-1625 (2000). *

• Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study. Arch. Intern. Med. 160: 961-964 (2000). *

• Langmann T, Porsch-Ozcurumez M, Unkelbach U, Klucken J, Schmitz G. Genomic organization and characterization of the promoter of the human ATP-binding cassette transporter-G1 (ABCG1) gene. Biochim. Biophys. Acta 1494: 175-180 (2000). *

• Lanier LL. Turning on natural killer cells. J. Exp. Med. 191: 1259-1262 (2000). *

• Lanzini A, Lanzarotto F. Review article: the 'mechanical pumps' and the enterohepatic circulation of bile acids - defects in coeliac disease. Aliment. Pharmacol. Ther. 14 Suppl. 2: 58-61 (2000).

• Lapinski TW, Prokopowicz D, Lapinska L, Kuryliszyn-Moskal A, Puzanowska B. The joint changes and presence of HLA-B27 antigen in patients with ulcerative colitis. Pol. Merkur. Lekarski. 8: 392-394 (2000).

• Larsen F, Oturai A, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Sawcer S, Fugger L, Sorensen PS, Svejgaard A. Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q. Genes Immun. 1: 456-459 (2000). *

• Latruffe N, Cherkaoui Malki M, Nicolas-Frances V, Clemencet MC, Jannin B, Berlot JP. Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases. Biochem. Pharmacol. 60: 1027-1032 (2000). *

• Laub R, Dorsch M, Meyer D, Ermann J, Hedrich HJ, Emmrich F. A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses. J. Immunol. Methods 246: 37-50 (2000). *

• Laufer J, Oren R, Goldberg I, Horwitz A, Kopolovic J, Chowers Y, Passwell JH. Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease. Clin. Exp. Immunol. 120: 30-37 (2000). *

• Lawrenson RA, Seaman HE, Sundstrom A, Williams TJ, Farmer RD. Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data. Drug Saf. 23: 333-349 (2000).

• Lawson CM. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell. Mol. Life Sci. 57: 552-560 (2000). *

• Lazarczyk DA, Duffy MC. Erythromycin-induced primary biliary cirrhosis. Dig. Dis. Sci. 45: 1115-1118 (2000). *

• Lazaridis KN, Lindor KD. Management of primary biliary cirrhosis: from diagnosis to end-stage disease. Curr. Gastroenterol. Rep. 2: 94-98 (2000).

• Lazaridis KN, Tietz P, Wu T, Kip S, Dawson PA, LaRusso NF. Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport properties. Proc. Natl. Acad. Sci. U.S.A. 97: 11092-11097 (2000). *

• Lazennec G, Canaple L, Saugy D, Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 14: 1962-1975 (2000). *

• Le May C, Pineau T, Bigot K, Kohl C, Girard J, Pegorier JP. Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression. FEBS Lett. 475: 163-166 (2000). *

• Lebensztejn DM. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children. Med. Sci. Monit. 6: 632-636 (2000). *

• Lecanda J, Urtasun R, Medina JF. Molecular cloning and genomic organization of the mouse AE2 anion exchanger gene. Biochem. Biophys. Res. Commun. 276: 117-124 (2000). *

• Lecoindre P, Chevallier M, Peyrol S, Boude M, Ferrero RL, Labigne A. Gastric Helicobacters in cats. J. Feline Med. Surg. 2: 19-27 (2000).

• Lecureur V, Courtois A, Payen L, Verhnet L, Guillouzo A, Fardel O. Expression and regulation of hepatic drug and bile acid transporters. Toxicology 153: 203-219 (2000). *

• Lee H, Barrett TA. Oral tolerance therapy in an experimental model of colitis. Am. J. Gastroenterol. 95: 861 (2000). *

• Lee HY, Suh YA, Robinson MJ, Clifford JL, Hong WK, Woodgett JR, Cobb MH, Mangelsdorf DJ, Kurie JM. Stress pathway activation induces phosphorylation of retinoid X receptor. J. Biol. Chem. 275: 32193-32199 (2000). *

• Lee J, Boyer JL. Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin. Liver Dis. 20: 373-384 (2000). *

• Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, Boyer JL. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 118: 163-172 (2000). *

• Lee SH, Kim HJ, Yang SK, Kim WH, Joo YS, Dong SH, Kim BH, Lee JI, Chang YW, Chang R. Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea. J. Gastroenterol. Hepatol. 15: 512-518 (2000). *

• Lee SK, Lee B, Lee JW. Mutations in retinoid X receptor that impair heterodimerization with specific nuclear hormone receptor. J. Biol. Chem. 275: 33522-33526 (2000). *

• Lee WC, Hwang KP, King YT, Chen HC, Chiou SS, Yang RC, Huang TY. Late diagnosis of Kawasaki disease is associated with haptoglobin phenotype. Eur. J. Clin. Invest. 30: 379-382 (2000).

• Lee WM. Assessing causality in drug-induced liver injury. J. Hepatol. 33: 1003-1005 (2000). *

• Lee YA, Ruschendorf F, Windemuth C, Schmitt-Egenolf M, Stadelmann A, Nurnberg G, Stander M, Wienker TF, Reis A, Traupe H. Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am. J. Hum. Genet. 67: 1020-1024 (2000). *

• Lee YJ, Huang FY, Lo FS, Wang WC, Hsu CH, Kao HA, Yang TY, Chang JG. Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children. Clin. Endocrinol. (Oxf.) 52: 153-157 (2000). *

• Lee YK, Dell H, Dowhan DH, Hadzopoulou-Cladaras M, Moore DD. The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol. Cell Biol. 20: 187-195 (2000). *

• Leibovitch I, Amital H, Levy Y, Langevitz P, Shoenfeld Y. Isotretinoin-induced adult onset Still's disease. Clin. Exp. Rheumatol. 18: 616-618 (2000).

• Leiper K, Morris AI, Rhodes JM. Open label trial of oral clarithromycin in active Crohn's disease. Aliment. Pharmacol. Ther. 14: 801-806 (2000). *

• Lemann M, Zenjari T, Bouhnik Y, Cosnes J, Mesnard B, Rambaud JC, Modigliani R, Cortot A, Colombel JF. Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am. J. Gastroenterol. 95: 1730-1734 (2000). *

• Lenarczyk A, Helsloot J, Farmer K, Peters L, Sturgess A, Kirkham B. Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls. Clin. Exp. Immunol. 122: 41-48 (2000). *

• Lentsch AB, Ward PA. Regulation of inflammatory vascular damage. J. Pathol. 190: 343-348 (2000). *

• Leon-Trueba H, Del Pozzo JA, Bolio-Galvis A. Pancreatic pseudocyst, Torulopsis glabrata primary infection. Report of a case. Rev. Gastroenterol. Mex. 65: 129-131 (2000).

• Lesage S, Zouali H, Colombel JF, Belaiche J, Cezard JP, Tysk C, Almer S, Gassull M, Binder V, Chamaillard M, Le Gall I, Thomas G, Hugot JP. Genetic analyses of chromosome 12 loci in Crohn's disease. Gut 47: 787-791 (2000). *

• Lesavre P, Noel LH. Causes and mechanisms of vasculitides. Rev. Prat. 50: 255-260 (2000).

• Leslie KK, Reznikov L, Simon FR, Fennessey PV, Reyes H, Ribalta J. Estrogens in intrahepatic cholestasis of pregnancy. Obstet. Gynecol. 95: 372-376 (2000).

• Leuschner M. UDCA, PBC, and biochemistry, what does normal mean? Gut 47: 595-596 (2000). *

• Leuschner M, Dietrich CF, You T, Seidl C, Raedle J, Herrmann G, Ackermann H, Leuschner U. Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment. Gut 46: 121-126 (2000). *

• Leuschner U. Cholestatic hepatopathy: primary biliary cirrhosis. Schweiz. Rundsch. Med. Prax. 89: 1043-1048 (2000).

• Levine AD. Apoptosis: implications for inflammatory bowel disease. Inflamm. Bowel Dis. 6: 191-205 (2000). *

• Levine AD, Fiocchi C. Immunology of inflammatory bowel disease. Curr. Opin. Gastroenterol. 16: 306-309 (2000).

• Levy O. A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein. Antimicrob. Agents Chemother. 44: 2925-2931 (2000). *

• Levy O, Sisson RB, Kenyon J, Eichenwald E, Macone AB, Goldmann D. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of Gram-negative bacteria tested in neonatal cord blood … Infect. Immun. 68: 5120-5125 (2000). *

• Lewis C, Book L, Black J, Sawitzke A, Cannon-Albright L, Zone J, Neuhausen S. Celiac disease and human leukocyte antigen genotype: accuracy of diagnosis in self-diagnosed individuals, dosage effect, and sibling risk. J. Pediatr. Gastroenterol. Nutr. 31: 22-27 (2000). *

• Lewis JH. Drug-induced liver disease. Med. Clin. North Am. 84: 1275-1311, x (2000).

• Li CP, Tong MJ, Hwang SJ, Luo JC, Co RL, Tsay SH, Chang FY, Lee SD. Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid. J. Gastroenterol. Hepatol. 15: 95-98 (2000). *

• Li L, Chen M, Huang DY, Nishioka M. Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I. J. Gastroenterol. Hepatol. 15: 1176-1182 (2000). *

• Li M, Indra AK, Warot X, Brocard J, Messaddeq N, Kato S, Metzger D, Chambon P. Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature 407: 633-636 (2000). *

• Li SD, Lue W, Mobarhan S, Nadir A, Van Thiel DH, Hagerty A. Nutrition support for individuals with liver failure. Nutr. Rev. 58: 242-247 (2000).

• Li X, Commane M, Nie H, Hua X, Chatterjee-Kishore M, Wald D, Haag M, Stark GR. Act1, an NF-kappa B-activating protein. Proc. Natl. Acad. Sci. U.S.A. 97: 10489-10493 (2000). *

• Li Y, Li H, Martin R, Mariuzza RA. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J. Mol. Biol. 304: 177-188 (2000). *

• Li-Hawkins J, Lund EG, Bronson AD, Russell DW. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. J. Biol. Chem. 275: 16543-16549 (2000). *

• Li-Hawkins J, Lund EG, Turley SD, Russell DW. Disruption of the oxysterol 7alpha-hydroxylase gene in mice. J. Biol. Chem. 275: 16536-16542 (2000). *

• Liang B, Mamula MJ. Molecular mimicry and the role of B lymphocytes in the processing of autoantigens. Cell. Mol. Life Sci. 57: 561-568 (2000). *

• Liblau R, Gautam AM. HLA, molecular mimicry and multiple sclerosis. Rev. Immunogenet. 2: 95-104 (2000).

• Lichtenstein GR. Chemokines and cytokines in inflammatory bowel disease and their application to disease treatment. Curr. Opin. Gastroenterol. 16: 83-88 (2000).

• Lichtenstein GR. Treatment of fistulizing Crohn's disease. Gastroenterology 119: 1132-1147 (2000). *

• Liden H, Norrby J, Friman S, Olausson M. Liver transplantation for primary sclerosing cholangitis - a single-center experience. Transpl. Int. 13: 162-164 (2000).

• Liden J, Rafter I, Truss M, Gustafsson JA, Okret S. Glucocorticoid effects on NF-kappaB binding in the transcription of the ICAM-1 gene. Biochem. Biophys. Res. Commun. 273: 1008-1014 (2000). *

• Lieber CS. Alcohol and the liver: metabolism of alcohol and its role in hepatic and extrahepatic diseases. Mt. Sinai J. Med. 67: 84-94 (2000). *

• Lievin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser JR, Servin AL. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47: 646-652 (2000). *

• Lillemoe KD. Surgical treatment of biliary tract infections. Am. Surg. 66: 138-144 (2000).

• Lillemoe KD, Melton GB, Cameron JL, Pitt HA, Campbell KA, Talamini MA, Sauter PA, Coleman J, Yeo CJ. Postoperative bile duct strictures: management and outcome in the 1990s. Ann. Surg. 232: 430-441 (2000). *

• Limaye V, Lester S, Downie-Doyle S, Pile K, Bardy P, Gordon TP, Rischmueller M. Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjogren's syndrome. J. Rheumatol. 27: 2945-2946 (2000).

• Limburg PJ, Ahlquist DA, Sandborn WJ, Mahoney DW, Devens ME, Harrington JJ, Zinsmeister AR. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am. J. Gastroenterol. 95: 2831-2837 (2000). *

• Linares Rodriguez A. Medical treatment of chronic cholestasis: ursodeoxycholic acid. Gastroenterol. Hepatol. 23: 24-38 (2000).

• Lindberg E, Lindquist B, Holmquist L, Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J. Pediatr. Gastroenterol. Nutr. 30: 259-264 (2000). *

• Linden A, Hoshino H, Laan M. Airway neutrophils and interleukin-17. Eur. Respir. J. 15: 973-977 (2000). *

• Lindgren S, Nilsson S, Nassberger L, Verbaan H, Wieslander J. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK) J. Gastroenterol. Hepatol. 15: 437-442 (2000). *

• Lindor KD. UDCA, PBC and biochemistry: what does normal mean? Gut 46: 8 (2000). *

• Lindor KD, Jorgensen RA, Tiegs RD, Khosla S, Dickson ER. Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. J. Hepatol. 33: 878-882 (2000). *

• Lindor KD, Poupon R, Poupon R, Heathcote EJ, Therneau T. Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 355: 657-658 (2000). *

• Lindqvist AK, Steinsson K, Johanneson B, Kristjansdottir H, Arnasson A, Grondal G, Jonasson I, Magnusson V, Sturfelt G, Truedsson L, Svenungsson E, Lundberg I, Terwilliger JD, Gyllensten UB, Alarcon-Riquelme ME. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J. Autoimmun. 14: 169-178 (2000).

• Linsdell P. Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel currents by arachidonic acid. Can. J. Physiol. Pharmacol. 78: 490-499 (2000).

• Lippman SM, Lotan R. Advances in the development of retinoids as chemopreventive agents. J. Nutr. 130: 479S-482S (2000). *

• Liscovitch M, Lavie Y. Multidrug resistance: a role for cholesterol efflux pathways? Trends Biochem. Sci. 25: 530-534 (2000). *

• Littlewood JM, Wolfe SP. Control of malabsorption in cystic fibrosis. Paediatr. Drugs 2: 205-222 (2000).

• Litzman J, Sevcikova I, Stikarovska D, Pikulova Z, Pazdirkova A, Lokaj J. IgA deficiency in Czech healthy individuals and selected patient groups. Int. Arch. Allergy Immunol. 123: 177-180 (2000).

• Liu C, Gelius E, Liu G, Steiner H, Dziarski R. Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth. J. Biol. Chem. 275: 24490-24499 (2000). *

• Liu H, Sidiropoulos P, Song G, Pagliari LJ, Birrer MJ, Stein B, Anrather J, Pope RM. TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta. J. Immunol. 164: 4277-4285 (2000). *

• Liu YL, Sennitt MV, Hislop DC, Crombie DL, Heyman RA, Cawthorne MA. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats. Int. J. Obes. Relat. Metab. Disord. 24: 997-1004 (2000).

• Liu YY, Nguyen C, Peleg S. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor. Mol. Endocrinol. 14: 1776-1787 (2000). *

• Liu Z, Geboes K, Colpaert S, D'Haens GR, Rutgeerts P, Ceuppens JL. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J. Immunol. 164: 3608-3615 (2000). *

• Liverani E, Silveri NG, Gasbarrini G, Mingrone G. Intestinal permeability increases with the severity of abdominal trauma: a comparison between gas liquid chromatographic and enzymatic method. Hepatogastroenterology 47: 1037-1041 (2000).

• Lizarralde E, Martinez P, Ibanez T, Gutierrez A. Primary hepatic lymphoma and primary biliary cirrhosis. Am. J. Gastroenterol. 95: 562-563 (2000). *

• Ljubuncic P, Tanne Z, Bomzon A. Ursodeoxycholic acid suppresses extent of lipid peroxidation in diseased liver in experimental cholestatic liver disease. Dig. Dis. Sci. 45: 1921-1928 (2000). *

• Ljubuncic P, Tanne Z, Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 47: 710-716 (2000). *

• Ljungdahl M, Lundholm M, Katouli M, Rasmussen I, Engstrand L, Haglund U. Bacterial translocation in experimental shock is dependent on the strains in the intestinal flora. Scand. J. Gastroenterol. 35: 389-397 (2000). *

• Locht H, Skogh T, Wiik A. Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis. Ann. Rheum. Dis. 59: 898-903 (2000). *

• Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 46: 336-343 (2000). *

• Loftus EV Jr, Tremaine WJ, Habermann TM, Harmsen WS, Zinsmeister AR, Sandborn WJ. Risk of lymphoma in inflammatory bowel disease. Am. J. Gastroenterol. 95: 2308-2312 (2000). *

• Logan RF, Skelly MM. Smoking and hepato-biliary disease. Eur. J. Gastroenterol. Hepatol. 12: 863-867 (2000).

• Lohi H, Kujala M, Kerkela E, Saarialho-Kere U, Kestila M, Kere J. Mapping of five new putative anion transporter genes in human and characterization of SLC26A6, a candidate gene for pancreatic anion exchanger. Genomics 70: 102-112 (2000). *

• Lohiniemi S, Maki M, Kaukinen K, Laippala P, Collin P. Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch-based gluten-free diets. Scand. J. Gastroenterol. 35: 947-949 (2000). *

• Loll PJ, Axelsen PH. The structural biology of molecular recognition by vancomycin. Annu. Rev. Biophys. Biomol. Struct. 29: 265-289 (2000). *

• Lombard CB. What is the role of food in preventing depression and improving mood, performance and cognitive function? Med. J. Aust. 173: S104-S105 (2000).

• Lombardi G, Annese V, Piepoli A, Bovio P, Latiano A, Napolitano G, Perri F, Conoscitore P, Andriulli A. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature. Dis. Colon Rectum 43: 999-1007 (2000).

• Look MP, Riezler R, Reichel C, Brensing KA, Rockstroh JK, Stabler SP, Spengler U, Berthold HK, Sauerbruch T. Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase? Scand. J. Gastroenterol. 35: 866-872 (2000). *

• Lopez I, Buchman AL. Metabolic bone disease in IBD. Curr. Gastroenterol. Rep. 2: 317-322 (2000).

• Lopez-Botet M, Bellon T, Llano M, Navarro F, Garcia P, de Miguel M. Paired inhibitory and triggering NK cell receptors for HLA class I molecules. Hum. Immunol. 61: 7-17 (2000).

• Lopez-Brea M, Selgas R. Nanobacteria as a cause of renal diseases and vascular calcifying pathology in renal patients ("endovascular lithiasis"). Enferm. Infecc. Microbiol. Clin. 18: 491-492 (2000).

• Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68: 6398-6401 (2000). *

• Lotem Y, Barak A, Mussaffi H, Shohat M, Wilschanski M, Sivan Y, Blau H. Reaching the diagnosis of cystic fibrosis - the limits of the spectrum. Isr. Med. Assoc. J. 2: 94-98 (2000). *

• Loudianos G, Gitlin JD. Wilson's disease. Semin. Liver Dis. 20: 353-364 (2000). *

• Loudianos G, Lovicu M, Solinas P, Kanavakis E, Tzetis M, Manolaki N, Panagiotakaki E, Karpathios T, Cao A. Delineation of the spectrum of Wilson disease mutations in the Greek population and the identification of six novel mutations. Genet. Test. 4: 399-402 (2000).

• Loudig O, Babichuk C, White J, Abu-Abed S, Mueller C, Petkovich M. Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. Mol. Endocrinol. 14: 1483-1497 (2000). *

• Louis E, Peeters M, Franchimont D, Seidel L, Fontaine F, Demolin G, Croes F, Dupont P, Davin L, Omri S, Rutgeerts P, Belaiche J. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin. Exp. Immunol. 119: 64-68 (2000). *

• Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, Boniver J, Belaiche J, Malaise M. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin. Exp. Immunol. 120: 241-246 (2000). *

• Louis-Plence P, Kerlan-Candon S, Morel J, Combe B, Clot J, Pinet V, Eliaou JF. The down-regulation of HLA-DM gene expression in rheumatoid arthritis is not related to their promoter polymorphism. J. Immunol. 165: 4861-4869 (2000). *

• Lozano A, Vildosola H, Takano J, Vargas G, Uribe R, Moreno C. Clinical and immunological profile in 22 patients with primary biliary cirrhosis. Rev. Gastroenterol. Peru. 20: 14-24 (2000).

• Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6: 507-515 (2000). *

• Lubberts E, Joosten LA, Chabaud M, van Den Bersselaar L, Oppers B, Coenen-De Roo CJ, Richards CD, Miossec P, van Den Berg WB. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J. Clin. Invest. 105: 1697-1710 (2000). *

• Luceri C, Guglielmi F, De Filippo C, Caderni G, Mini E, Biggeri A, Napoli C, Tonelli F, Cianchi F, Dolara P. Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas. Scand. J. Gastroenterol. 35: 637-641 (2000). *

• Ludewig B, Zinkernagel RM, Hengartner H. Transgenic animal models for virus-induced autoimmune diseases. Exp. Physiol. 85: 653-659 (2000). *

• Ludwig D, Stange EF. Treatment of ulcerative colitis. Hepatogastroenterology 47: 83-89 (2000).

• Ludwig J. The pathology of primary biliary cirrhosis and autoimmune cholangitis. Best Pract. Res. Clin. Gastroenterol. 14: 601-613 (2000).

• Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat. Med. 6: 1183-1186 (2000). *

• Luster MI, Simeonova PP, Gallucci RM, Matheson JM, Yucesoy B. Immunotoxicology: role of inflammation in chemical-induced hepatotoxicity. Int. J. Immunopharmacol. 22: 1143-1147 (2000).

• Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M, Zarrilli R, Imeneo M, Pallone F. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 165: 5332-5337 (2000). *

• Lyons PA, Armitage N, Argentina F, Denny P, Hill NJ, Lord CJ, Wilusz MB, Peterson LB, Wicker LS, Todd JA. Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res. 10: 446-453 (2000). *

• M'Koma AE, Lindquist K, Liljeqvist L. A study of plasma immunoglobulins profile in connection with restorative proctocolectomy. Int. J. Surg. Investig. 2: 125-131 (2000).

• Ma TY, Tran D, Hoa N, Nguyen D, Merryfield M, Tarnawski A. Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc. Res. Tech. 51: 156-168 (2000).

• Ma X, Sun J, Papasavvas E, Riemann H, Robertson S, Marshall J, Bailer RT, Moore A, Donnelly RP, Trinchieri G, Montaner LJ. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J. Immunol. 164: 1722-1729 (2000). *

• Maalej A, Hadj Kacem H, Bellassoued M, Abid M, Makni H, Ayadi H. Polymorphisms of HLA DQB1 CAR1/CAR2 and TNFalpha IR2/IR4 microsatellite markers in patients affected with Graves disease. Clin. Immunol. 96: 91-93 (2000). *

• Maayan S, Zhang L, Shinar E, Ho J, He T, Manni N, Kostrikis LG, Neumann AU. Evidence for recent selection of the CCR5-delta 32 deletion from differences in its frequency between Ashkenazi and Sephardi Jews. Genes Immun. 1: 358-361 (2000). *

• Mabee CL, Thiele DL. Mechanisms of autoimmune liver disease. Clin. Liver Dis. 4: 431-45, vii (2000).

• Macchioni P, Boiardi L, Casali B, Nicoli D, Farnetti E, Salvarani C. Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 18: 553-558 (2000).

• MacDermott RP. Progress in understanding the mechanisms of action of 5-aminosalicylic acid. Am. J. Gastroenterol. 95: 3343-3345 (2000). *

• MacDonald TT, Monteleone G, Pender SL. Recent developments in the immunology of inflammatory bowel disease. Scand. J. Immunol. 51: 2-9 (2000). *

• MacDonald TT, Pettersson S. Bacterial regulation of intestinal immune responses. Inflamm. Bowel Dis. 6: 116-122 (2000). *

• MacHulla HK, Schonermarck U, Schaaf A, Muller LP, Kloss C, Kruger J, Kunze G, Schonermarck G, Langner J. HLA-A, B, Cw and DRB1, DRB3/4/5, DQB1, DPB1 frequencies in German immunoglobulin A-deficient individuals. Scand. J. Immunol. 52: 207-211 (2000). *

• Mack DR. Probiotics for ulcerative colitis therapy. Am. J. Gastroenterol. 95: 1 (2000). *

• Mackay IR. Autoimmunity and primary biliary cirrhosis. Baillieres Best Pract. Res. Clin. Gastroenterol. 14: 519-533 (2000).

• Mackay IR, Whittingham S, Fida S, Myers M, Ikuno N, Gershwin ME, Rowley MJ. The peculiar autoimmunity of primary biliary cirrhosis. Immunol. Rev. 174: 226-237 (2000). *

• Macken E, Drijkoningen M, Van Aken E, Van Steenbergen W. Brush cytology of ductal strictures during ERCP. Acta Gastroenterol. Belg. 63: 254-259 (2000).

• Mackenzie PI, Miners JO, McKinnon RA. Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance. Clin. Chem. Lab. Med. 38: 889-892 (2000).

• Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288: 2222-2226 (2000). *

• Madsen JR. Chronic inflammatory bowel disease - pathogenic concepts and therapeutic perspectives. Ugeskr. Laeger. 162: 1361-1366 (2000).

• Madsen KL, Doyle JS, Tavernini MM, Jewell LD, Rennie RP, Fedorak RN. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 118: 1094-1105 (2000). *

• Magee EA, Richardson CJ, Hughes R, Cummings JH. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am. J. Clin. Nutr. 72: 1488-1494 (2000). *

• Maggi LB Jr, Sadeghi H, Weigand C, Scarim AL, Heitmeier MR, Corbett JA. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes 49: 346-355 (2000). *

• Magid MS, Emre S, Norton KI, Ivanov K, Schneider BL. A 7-month-old male infant with extra- and intrahepatic biliary cysts. Semin. Liver Dis. 20: 385-390 (2000).

• Magnusson V, Lindqvist AK, Castillejo-Lopez C, Kristjansdottir H, Steinsson K, Grondal G, Sturfelt G, Truedsson L, Svenungsson E, Lundberg I, Gunnarsson I, Bolstad AI, Haga HJ, Jonsson R, Klareskog L, Alcocer-Varela J, Alarcon-Segovia D, et al. Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. Genomics 70: 307-314 (2000). *

• Mahadeva R, Lomas DA. Secondary genetic factors in cystic fibrosis lung disease. Thorax 55: 446 (2000). *

• Mahadeva R, Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur. Respir. J. 15: 41-48 (2000). *

• Mahadevan U, Tremaine WJ, Johnson T, Pike MG, Mays DC, Lipsky JJ, Sandborn WJ. Intravenous azathioprine in severe ulcerative colitis: a pilot study. Am. J. Gastroenterol. 95: 3463-3468 (2000). *

• Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm. Bowel Dis. 6: 21-33 (2000). *

• Maidment ID. Are fish oils an effective therapy in mental illness - an analysis of the data. Acta Psychiatr. Scand. 102: 3-11 (2000).

• Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119: 996-1006 (2000). *

• Majumdar R, Al Jumah M, Al Rajeh S, Fraser M, Al Zaben A, Awada A, Al Traif I, Paterson M. A novel deletion mutation within the carboxyl terminus of the copper-transporting ATPase gene causes Wilson disease. J. Neurol. Sci. 179: 140-143 (2000). *

• Makki RF, al Sharif F, Gonzalez-Gay MA, Garcia-Porrua C, Ollier WE, Hajeer AH. RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Clin. Exp. Rheumatol. 18: 391-393 (2000).

• Maksymowych WP, Tao S, Vaile J, Suarez-Almazor M, Ramos-Remus C, Russell AS. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis. J. Rheumatol. 27: 183-189 (2000).

• Malamud A, Wilson KT. Treatment of gastrointestinal infections. Curr. Opin. Gastroenterol. 16: 51-55 (2000).

• Maliarik MJ, Chen KM, Sheffer RG, Rybicki BA, Major ML, Popovich J Jr, Iannuzzi MC. The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am. J. Respir. Cell Mol. Biol. 22: 672-675 (2000). *

• Mallolas J, Esteve M, Rius E, Cabre E, Gassull MA. Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis. Gut 47: 74-78 (2000). *

• Mallon E. Retroviruses and psoriasis. Curr. Opin. Infect. Dis. 13: 103-107 (2000).

• Malmgaard L, Paludan SR, Mogensen SC, Ellermann-Eriksen S. Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-kappaB. J. Gen. Virol. 81: 3011-3020 (2000). *

• Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, Giachelli CM. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. J. Biol. Chem. 275: 20959-20962 (2000). *

• Mandal A, Mayberry J. How common is celiac disease in South America? Am. J. Gastroenterol. 95: 579-580 (2000). *

• Mankertz J, Tavalali S, Schmitz H, Mankertz A, Riecken EO, Fromm M, Schulzke JD. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J. Cell Sci. 113: 2085-2090 (2000). *

• Manns MP. Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis. J. Hepatol. 33: 326-328 (2000). *

• Manokas T, Fromkes JJ, Sundaram U. Effect of chronic inflammation on ileal short-chain fatty acid/bicarbonate exchange. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G585-G590 (2000). *

• Manyike PT, Kharasch ED, Kalhorn TF, Slattery JT. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin. Pharmacol. Ther. 67: 275-282 (2000). *

• Mari JY, Guy C, Beyens MN, Ollagnier M. Delayed drug-induced hepatic injury. Evoking the role of amoxicillin-clavulinic acid combination. Therapie 55: 699-704 (2000).

• Markovitz BP. Biomedicine's electronic publishing paradigm shift: copyright policy and PubMed Central. J. Am. Med. Inform. Assoc. 7: 222-229 (2000). *

• Marotta PJ, Graziadei IW, Ghent CN. Muscle cramps: a 'complication' of cirrhosis. Can. J. Gastroenterol. 14 Suppl. D: 21D-25D (2000).

• Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Bonacchi A, Caporale R, Laffi G, Pinzani M, Gentilini P. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 119: 466-478 (2000). *

• Marrapodi M, Chiang JY. Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J. Lipid Res. 41: 514-520 (2000). *

• Marrie RA, Wolfson C, Sturkenboom MC, Gout O, Heinzlef O, Roullet E, Abenhaim L. Multiple sclerosis and antecedent infections: a case-control study. Neurology 54: 2307-2310 (2000).

• Marron MP, Zeidler A, Raffel LJ, Eckenrode SE, Yang JJ, Hopkins DI, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT, Park Y, Bach JF, Rotter JI, Yang MC, She JX. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes 49: 492-499 (2000). *

• Marschall HU, Busch N. CSE (cholesterol-synthesis enzyme) inhibitors in the treatment of hypercholesterolemia in primary biliary cirrhosis. Dtsch. Med. Wochenschr. 125: 100-101 (2000).

• Marshak S, Benshushan E, Shoshkes M, Havin L, Cerasi E, Melloul D. Functional conservation of regulatory elements in the pdx-1 gene: PDX-1 and hepatocyte nuclear factor 3beta transcription factors mediate beta-cell-specific expression. Mol. Cell. Biol. 20: 7583-7590 (2000). *

• Marteau P, Florent C. Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study Group. Am. J. Gastroenterol. 95: 166-170 (2000). *

• Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, Riley J, Finch KL, Stevens JF, Livak KJ, Slotterbeck BD, Slifer SH, Warren LL, Conneally PM, Schmechel DE, Purvis I, Pericak-Vance MA, Roses AD, Vance JM. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am. J. Hum. Genet. 67: 383-394 (2000). *

• Martin G, Poirier H, Hennuyer N, Crombie D, Fruchart JC, Heyman RA, Besnard P, Auwerx J. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target. J. Biol. Chem. 275: 12612-12618 (2000). *

• Martinelli P, Troncone R, Paparo F, Torre P, Trapanese E, Fasano C, Lamberti A, Budillon G, Nardone G, Greco L. Coeliac disease and unfavourable outcome of pregnancy. Gut 46: 332-335 (2000). *

• Martinez A, Fernandez-Arquero M, Pascual-Salcedo D, Conejero L, Alves H, Balsa A, de la Concha EG. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum. 43: 1366-1370 (2000). *

• Martinez-Borra J, Gonzalez S, Lopez-Vazquez A, Gelaz MA, Armas JB, Kanga U, Mehra NK, Lopez-Larrea C. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Hum. Immunol. 61: 131-139 (2000).

• Martins EB, Chapman RW. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 16: 444-449 (2000).

• Marusic A, Grcevic D, Katavic V, Kovacic N, Lukic IK, Kalajzic I, Lorenzo JA. Role of B lymphocytes in new bone formation. Lab. Invest. 80: 1761-1774 (2000).

• Massaad C, Paradon M, Jacques C, Salvat C, Bereziat G, Berenbaum F, Olivier JL. Induction of secreted type IIA phospholipase A2 gene transcription by interleukin-1beta. Role of C/EBP factors. J. Biol. Chem. 275: 22686-22694 (2000). *

• Massei F, Massimetti M, Messina F, Macchia P, Maggiore G. Bartonella henselae and inflammatory bowel disease. Lancet 356: 1245-1246 (2000). *

• Massei F, Messina F, Massimetti M, Macchia P, Maggiore G. Pseudoinfectious mononucleosis: a presentation of Bartonella henselae infection. Arch. Dis. Child. 83: 443-444 (2000). *

• Massie RJ, Wilcken B, Van Asperen P, Dorney S, Gruca M, Wiley V, Gaskin K. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels. J. Pediatr. 137: 214-220 (2000). *

• Masteller EL, Chuang E, Mullen AC, Reiner SL, Thompson CB. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164: 5319-5327 (2000). *

• Masuyama H, Hiramatsu Y, Kunitomi M, Kudo T, MacDonald PN. Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate pregnane X receptor-mediated transcription. Mol. Endocrinol. 14: 421-428 (2000). *

• Mathew JS, Sharma RP. Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line. Int. J. Immunopharmacol. 22: 693-706 (2000).

• Mathurin P, Deng QG, Keshavarzian A, Choudhary S, Holmes EW, Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32: 1008-1017 (2000). *

• Matri S, Karoui S, Filali A. Tobacco and inflammatory bowel disease. Tunis. Med. 78: 693-698 (2000).

• Matsuda H, Fujiyama Y, Andoh A, Ushijima T, Kajinami T, Bamba T. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J. Gastroenterol. Hepatol. 15: 61-68 (2000). *

• Matsui T, Ikeda K, Tsuda S, Yao K, Sou S, Satoh S, Hatakeyama S, Matake H, Sakurai T, Yao T. Long-term outcome of endoscopic balloon dilation in obstructive gastrointestinal Crohn's disease: a prospective long-term study. Diagn. Ther. Endosc. 6: 67-75 (2000).

• Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kitami N, Sato N, Abe H, Aoki Y, Hoshi T, Hashimoto H. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 20: 366-373 (2000).

• Matsunaga Y, Terada T. Mast cell subpopulations in chronic inflammatory hepatobiliary diseases. Liver 20: 152-156 (2000).

• Matsuo I, Ikuno N, Omagari K, Kinoshita H, Oka M, Yamaguchi H, Kohno S, Mackay IR. Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis. J. Gastroenterol. 35: 226-234 (2000).

• Matsushita M, Tsuchiya N, Oka T, Yamane A, Tokunaga K. New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus. Genes Immun. 1: 428-434 (2000). *

• Matsuura T, West GA, Levine AD, Fiocchi C. Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease. Dig. Liver Dis. 32: 484-494 (2000).

• Matsuzaka Y, Makino S, Nakajima K, Tomizawa M, Oka A, Kimura M, Bahram S, Tamiya G, Inoko H. New polymorphic microsatellite markers in the human MHC class II region. Tissue Antigens 56: 492-500 (2000). *

• Mattey DL, Gonzalez-Gay MA, Hajeer AH, Dababneh A, Thomson W, Garcia-Porrua C, Ollier WE. Association between HLA-DRB1*15 and secondary Sjogren's syndrome in patients with rheumatoid arthritis. J. Rheumatol. 27: 2611-2616 (2000).

• Mattey DL, Hajeer AH, Dababneh A, Thomson W, Gonzalez-Gay MA, Garcia-Porrua C, Ollier WE. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum. 43: 1749-1755 (2000). *

• Mattey DL, Hassell AB, Dawes PT, Jones PW, Yengi L, Alldersea J, Strange RC, Fryer AA. Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes. Arthritis Rheum. 43: 859-864 (2000). *

• Matthias A, Ohlson KB, Fredriksson JM, Jacobsson A, Nedergaard J, Cannon B. Thermogenic responses in brown fat cells are fully UCP1-dependent. UCP2 or UCP3 do not substitute for UCP1 in adrenergically or fatty scid-induced thermogenesis. J. Biol. Chem. 275: 25073-25081 (2000). *

• Matzinger D, Degen L, Drewe J, Meuli J, Duebendorfer R, Ruckstuhl N, D'Amato M, Rovati L, Beglinger C. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 46: 688-693 (2000). *

• May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289: 1550-1554 (2000). *

• Mayer EA. Psychological stress and colitis. Gut 46: 595-596 (2000). *

• Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 47: 861-869 (2000). *

• Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 47: 546-552 (2000). *

• Mayer L. Epithelial cell antigen presentation. Curr. Opin. Gastroenterol. 16: 531-535 (2000).

• Mayer L. IBD: immunologic research at The Mount Sinai Hospital. Mt. Sinai J. Med. 67: 208-213 (2000). *

• Mayo I, Arizti P, Pares A, Oliva J, Doforno RA, de Sagarra MR, Rodes J, Castano JG. Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J. Hepatol. 33: 528-536 (2000). *

• Mazariegos GV, Salzedas AA, Zavatsky J, Sindhi R, Parizhskaya M, McGhee W, Jain A, Reyes J. Long term management of liver transplant rejection in children. BioDrugs 14: 31-48 (2000).

• McAdam SN, Sollid LM. Getting to grips with gluten. Gut 47: 743-745 (2000). *

• McAuley DF, Elborn JS. Cystic fibrosis: basic science. Paediatr. Respir. Rev. 1: 93-100 (2000).

• McCafferty DM. Peroxynitrite and inflammatory bowel disease. Gut 46: 436-439 (2000). *

• McDermott MF, Aganna E, Hitman GA, Ogunkolade BW, Booth DR, Hawkins PN. An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1q. Arthritis Rheum. 43: 2034-2040 (2000). *

• McDevitt HO. Discovering the role of the major histocompatibility complex in the immune response. Annu. Rev. Immunol. 18: 1-17 (2000). *

• McDiarmid SV. Liver transplantation. The pediatric challenge. Clin. Liver Dis. 4: 879-927 (2000).

• McDonagh JE, Isenberg DA. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 59: 230-232 (2000). *

• McGrath KM. To stent or not to stent? Am. J. Gastroenterol. 95: 1857-1859 (2000). *

• McKay LI, Cidlowski JA. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol. Endocrinol. 14: 1222-1234 (2000). *

• McLachlan SM, Rapoport B. Autoimmune response to the thyroid in humans: thyroid peroxidase - the common autoantigenic denominator. Int. Rev. Immunol. 19: 587-618 (2000).

• McMurray DN, Jolly CA, Chapkin RS. Effects of dietary n-3 fatty acids on T cell activation and T cell receptor-mediated signaling in a murine model. J. Infect. Dis. 182 Suppl. 1: S103-S107 (2000). *

• McTernan CL, Stewart LC, Mijovic CH, Barnett AH. Assessment of the non-HLA-DR-DQ contribution to IDDM1 in British Caucasian families: analysis of LMP7 polymorphisms. Diabet. Med. 17: 661-666 (2000). *

• McWilliams TJ, Wilsher ML, Kolbe J. Cystic fibrosis diagnosed in adult patients. N. Z. Med. J. 113: 6-8 (2000).

• Medina JF. Pathophysiology of biliary epithelium in primary biliary cirrhosis. Gastroenterol. Hepatol. 23 Suppl. 1: 4-9 (2000).

• Medina JF, Lecanda J, Acin A, Ciesielczyk P, Prieto J. Tissue-specific N-terminal isoforms from overlapping alternate promoters of the human AE2 anion exchanger gene. Biochem. Biophys. Res. Commun. 267: 228-235 (2000). *

• Medzhitov R, Janeway C Jr. Innate immunity. N. Engl. J. Med. 343: 338-344 (2000). *

• Meier PN. ERCP topics. Endoscopic retrograde cholangiopancreatography. Endoscopy 32: 863-873 (2000).

• Mekus F, Ballmann M, Bronsveld I, Bijman J, Veeze H, Tummler B. Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res. 3: 277-293 (2000).

• Mellemkjaer L, Johansen C, Gridley G, Linet MS, Kjaer SK, Olsen JH. Crohn's disease and cancer risk (Denmark). Cancer Causes Control 11: 145-150 (2000). *

• Melter M, Rodeck B, Kardorff R, Hoyer PF, Petersen C, Ballauff A, Brodehl J. Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients. Am. J. Gastroenterol. 95: 3522-3528 (2000). *

• Memoli B, Postiglione L, Cianciaruso B, Bisesti V, Cimmaruta C, Marzano L, Minutolo R, Cuomo V, Guida B, Andreucci M, Rossi G. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. Kidney Int. 58: 417-424 (2000). *

• Memon MI, Memon B, Memon MA. Hepatobiliary manifestations of inflammatory bowel disease. HPB Surg. 11: 363-371 (2000). *

• Menni S, Boccardi D, Brusasco A. Ichthyosis revealing coeliac disease. Eur. J. Dermatol. 10: 398-399 (2000).

• Menzel J, Domschke W. Gastrointestinal miniprobe sonography: the current status. Am. J. Gastroenterol. 95: 605-616 (2000). *

• Menzel J, Poremba C, Dietl KH, Domschke W. Preoperative diagnosis of bile duct strictures - comparison of intraductal ultrasonography with conventional endosonography. Scand. J. Gastroenterol. 35: 77-82 (2000). *

• Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, Gatta A. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 32: 930-934 (2000). *

• Merkel C, Zoli M, Siringo S, van Buuren H, Magalotti D, Angeli P, Sacerdoti D, Bolondi L, Gatta A. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am. J. Gastroenterol. 95: 2915-2920 (2000). *

• Meucci G, Vecchi M, Astegiano M, Beretta L, Cesari P, Dizioli P, Ferraris L, Panelli MR, Prada A, Sostegni R, de Franchis R. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am. J. Gastroenterol. 95: 469-473 (2000). *

• Meyer T, Kneissel M, Mariani J, Fournier B. In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism. Proc. Natl. Acad. Sci. U.S.A. 97: 9197-9202 (2000). *

• Michetti P. Intestinal pathogen or IBD, same T-cell response. Inflamm. Bowel Dis. 6: 63-64 (2000). *

• Michl P, Gulberg V, Bilzer M, Waggershauser T, Reiser M, Gerbes AL. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure. Scand. J. Gastroenterol. 35: 654-658 (2000). *

• Mickle JE, Cutting GR. Genotype-phenotype relationships in cystic fibrosis. Med. Clin. North Am. 84: 597-607 (2000).

• Mickle JE, Milewski MI, Macek M Jr, Cutting GR. Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels. Am. J. Hum. Genet. 66: 1485-1495 (2000). *

• Mighty HE, Atkins D. Pregnancy and inflammatory bowel disease: current management. J. Assoc. Acad. Minor Phys. 11: 38-43 (2000).

• Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr. Opin. Rheumatol. 12: 281-286 (2000).

• Mikula C. Measles vaccination a risk factor for inflammatory bowel disease? Gastroenterol. Nurs. 23: 168-171 (2000).

• Milicic A, Lindheimer F, Laval S, Rudwaleit M, Ackerman H, Wordsworth P, Hohler T, Brown MA. Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis. Genes Immun. 1: 418-422 (2000). *

• Milkiewicz P, Gunson B, Saksena S, Hathaway M, Hubscher SG, Elias E. Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors. Transplantation 70: 477-480 (2000).

• Milkiewicz P, Mendoza A, Cardenas T, Keogh A, Hubscher SG, Elias E. Recurrent autoimmune LKM hepatitis with multiple relapses. Med. Sci. Monit. 6: 586-591 (2000). *

• Milkiewicz P, Saksena S, Cardenas T, Mills CO, Elias E. Plasma elimination of cholyl-lysyl-fluorescein (CLF): a pilot study in patients with liver cirrhosis. Liver 20: 330-334 (2000).

• Milkiewicz P, Saksena S, Hubscher SG, Elias E. Wilson's disease with superimposed autoimmune features: report of two cases and review. J. Gastroenterol. Hepatol. 15: 570-574 (2000). *

• Miller C, Roberts SJ, Ramsburg E, Hayday AC. Gamma delta cells in gut infection, immunopathology, and organogenesis. Springer Semin. Immunopathol. 22: 297-310 (2000).

• Miller NH. Spine update: genetics of familial idiopathic scoliosis. Spine 25: 2416-2418 (2000).

• Min JK, Park KS, Yu WJ, Lee YS, Park SM, Park SH, Cho CS, Kim HY. Systemic mononuclear inflammatory vasculopathy associated with Sjogren's syndrome in a patient with primary biliary cirrhosis. Korean J. Intern. Med. 15: 89-92 (2000).

• Miossec P. Are T cells in rheumatoid synovium aggressors or bystanders? Curr. Opin. Rheumatol. 12: 181-185 (2000).

• Mischoulon D, Fava M. Docosahexanoic acid and omega-3 fatty acids in depression. Psychiatr. Clin. North Am. 23: 785-794 (2000).

• Mitchell SA, Chapman RW. Primary sclerosing cholangitis. Clin. Rev. Allergy Immunol. 18: 185-214 (2000).

• Mitsos LM, Cardon LR, Fortin A, Ryan L, LaCourse R, North RJ, Gros P. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun. 1: 467-477 (2000). *

• Mitsuyama K, Toyonaga A, Sata M. Cytokine-targeted therapeutic approaches for inflammatory bowel disease. Drugs Today (Barc.) 36: 281-293 (2000).

• Miyaguchi S, Ebinuma H, Imaeda H, Nitta Y, Watanabe T, Saito H, Ishii H. A novel treatment for refractory primary biliary cirrhosis? Hepatogastroenterology 47: 1518-1521 (2000).

• Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, Anania FA, Willson TM, Tsukamoto H. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J. Biol. Chem. 275: 35715-35722 (2000). *

• Miyakawa H, Kitazawa E, Fujikawa H, Kikuchi K, Abe K, Kawaguchi N, Kako M. Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOADC-E2) in primary biliary cirrhosis: relationship to titers of immunofluorescent anti-mitochondrial antibody. Hepatol. Res. 18: 1-9 (2000).

• Miyamoto H, Azuma A, Taniguchi Y, Takahashi T, Yoshimura A, Hemmi S, Fukuda Y, Kudoh S. Interstitial pneumonia complicated by Sjogren's syndrome, Hashimoto's disease, rheumatoid arthritis and primary biliary cirrhosis. Intern. Med. 39: 970-975 (2000). *

• Miyazawa M, Tabata N, Fujisawa R, Hashimoto K, Shiwaku H, Takei YA. Roles of endogenous retroviruses and platelets in the development of vascular injury in spontaneous mouse models of autoimmune diseases. Int. J. Cardiol. 75 Suppl. 1: S65-S73 (2000).

• Mizukawa Y, Shiohara T. Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: with emphasis on EB virus, human herpesvirus 6 and hepatitis C virus. J. Dermatol. Sci. 22: 169-180 (2000).

• Mizuki N, Ota M, Yabuki K, Katsuyama Y, Ando H, Palimeris GD, Kaklamani E, Accorinti M, Pivetti-Pezzi P, Ohno S, Inoko H. Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest. Ophthalmol. Vis. Sci. 41: 3702-3708 (2000). *

• Modigliani R. Immunosuppressors for inflammatory bowel disease: how long is long enough? Inflamm. Bowel Dis. 6: 251-257 (2000). *

• Molberg O, McAdam SN, Sollid LM. Role of tissue transglutaminase in celiac disease. J. Pediatr. Gastroenterol. Nutr. 30: 232-240 (2000). *

• Moller P, Wallin H, Dybdahl M, Frentz G, Nexo BA. Psoriasis patients with basal cell carcinoma have more repair-mediated DNA strand-breaks after UVC damage in lymphocytes than psoriasis patients without basal cell carcinoma. Cancer Lett. 151: 187-192 (2000).

• Monaghan KG, Feldman GL, Barbarotto GM, Manji S, Desai TK, Snow K. Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study. Am. J. Med. Genet. 95: 361-365 (2000).

• Monaghan KG, Jackson CE, KuKuruga DL, Feldman GL. Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am. J. Med. Genet. 94: 120-124 (2000).

• Monson J. Surgical management is the preferred option for major internal fistulae. Inflamm. Bowel Dis. 6: 246-248 (2000). *

• Montejo M, Valdivielso A, Suarez MJ, Testillano M, Bustamante J, Gastaca M, Campo M, Errazti G, Perdigo K, Aguirrebengoa K, Gonzalez de Zarate P, Ortiz de Urbina J. Infection after orthotopic liver transplantation: analysis of the first 120 consecutive cases. Rev. Clin. Esp. 200: 245-251 (2000).

• Monteleone G, MacDonald TT. Manipulation of cytokines in the management of patients with inflammatory bowel disease. Ann. Med. 32: 552-560 (2000).

• Montes Santiago J, Gambon Deza F, Garcia Garcia MJ, Gonzalez Vazquez L, Hermo Brion JA, Perez Alvarez R. Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations. An. Med. Interna. 17: 343-346 (2000).

• Montgomery SM, Wakefield AJ, Morris DL, Pounder RE, Murch SH. The initial care of newborn infants and subsequent hay fever. Allergy 55: 916-922 (2000).

• Moore BC, Simmons DL. COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs. Curr. Med. Chem. 7: 1131-1144 (2000).

• Moore JT, Kliewer SA. Use of the nuclear receptor PXR to predict drug interactions. Toxicology 153: 1-10 (2000). *

• Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. U.S.A. 97: 7500-7502 (2000). *

• Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 275: 15122-15127 (2000). *

• Moosig F, Csernok E, Kumanovics G, Gross WL. Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha). Clin. Exp. Immunol. 122: 499-503 (2000). *

• Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G, Wakeland EK. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. U.S.A. 97: 6670-6675 (2000). *

• Morelli J, Wilson FA. Does administration of infliximab increase susceptibility to listeriosis? Am. J. Gastroenterol. 95: 841-842 (2000). *

• Mori A, Kaminuma O, Ogawa K, Nakata A, Egan RW, Akiyama K, Okudaira H. Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors. J. Allergy Clin. Immunol. 106: S58-S64 (2000).

• Morita S, Ueda Y, Eguchi K. Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature. Endocr. J. 47: 467-470 (2000).

• Morris CS, Najarian KE. Transjugular intrahepatic portosystemic shunt for bleeding stomal varices associated with chronic portal vein occlusion: long-term angiographic, hemodynamic, and clinical follow-up. Am. J. Gastroenterol. 95: 2966-2968 (2000). *

• Morris DL, Montgomery SM, Thompson NP, Ebrahim S, Pounder RE, Wakefield AJ. Measles vaccination and inflammatory bowel disease: a national British Cohort Study. Am. J. Gastroenterol. 95: 3507-3512 (2000). *

• Morris MA, Yiannakou JY, King AL, Brett PM, Biagi F, Vaughan R, Curtis D, Ciclitira PJ. Coeliac disease and Down syndrome: associations not due to genetic linkage on chromosome 21. Scand. J. Gastroenterol. 35: 177-180 (2000). *

• Morteau O, Morham SG, Sellon R, Dieleman LA, Langenbach R, Smithies O, Sartor RB. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest. 105: 469-478 (2000). *

• Morton DH, Salen G, Batta AK, Shefer S, Tint GS, Belchis D, Shneider B, Puffenberger E, Bull L, Knisely AS. Abnormal hepatic sinusoidal bile acid transport in an Amish kindred is not linked to FIC1 and is improved by ursodiol. Gastroenterology 119: 188-195 (2000). *

• Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn's disease, pregnancy, and birth weight. Am. J. Gastroenterol. 95: 1021-1026 (2000). *

• Motojima K. PPAR-mediated diverse responses in various tissues of mouse. Cell. Biochem. Biophys. 32: 205-211 (2000).

• Motojima K. Differential effects of PPARalpha activators on induction of ectopic expression of tissue-specific fatty acid binding protein genes in the mouse liver. Int. J. Biochem. Cell. Biol. 32: 1085-1092 (2000). *

• Moum B. Chronic inflammatory bowel disease and pregnancy. Scand. J. Gastroenterol. 35: 673-678 (2000). *

• Moum B. Medical treatment: does it influence the natural course of inflammatory bowel disease? Eur. J. Intern. Med. 11: 197-203 (2000).

• Moustakas AK, van de Wal Y, Routsias J, Kooy YM, van Veelen P, Drijfhout JW, Koning F, Papadopoulos GK. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int. Immunol. 12: 1157-1166 (2000). *

• Mueller AR, Platz KP, Krause P, Kahl A, Rayes N, Glanemann M, Lang M, Wex C, Bechstein WO, Neuhaus P. Perioperative factors influencing patient outcome after liver transplantation. Transpl. Int. 13 Suppl. 1: S158-S161 (2000).

• Mueller S, Boehme MW, Hofmann WJ, Stremmel W. Extrapulmonary sarcoidosis primarily diagnosed in the liver. Scand. J. Gastroenterol. 35: 1003-1008 (2000). *

• Muhlberg T, Herrmann K, Joba W, Kirchberger M, Heberling HJ, Heufelder AE. Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population. J. Clin. Endocrinol. Metab. 85: 2640-2643 (2000). *

• Muller M. Transcriptional control of hepatocanalicular transporter gene expression. Semin. Liver Dis. 20: 323-337 (2000).

• Muller-Rover S, Bulfone-Paus S, Handjiski B, Welker P, Sundberg JP, McKay IA, Botchkarev VA, Paus R. Intercellular adhesion molecule-1 and hair follicle regression. J. Histochem. Cytochem. 48: 557-568 (2000). *

• Mullighan CG, Heatley S, Bardy PG, Lester S, Rischmueller M, Gordon TP. Lack of association between mannose-binding lectin gene polymorphisms and primary Sjogren's syndrome. Arthritis Rheum. 43: 2851-2852 (2000). *

• Mullighan CG, Marshall SE, Welsh KI. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand. J. Immunol. 51: 111-122 (2000). *

• Mullin GE, Galinkin D. Anti-IL12 imposes the death sentence on Th1 cells in TNBS colitis - is there a light at the end of the tunnel for Crohn's disease? Inflamm. Bowel Dis. 6: 261-262 (2000). *

• Muoio DM, Lewin TM, Wiedmer P, Coleman RA. Acyl-CoAs are functionally channeled in liver: potential role of acyl-CoA synthetase. Am. J. Physiol. Endocrinol. Metab. 279: E1366-E1373 (2000). *

• Murakami M, Mizuide M, Kashima K, Kojima A, Tomioka SI, Kohama T, Araki O, Ogiwara T, Mizuma H, Mori M. Identification of monoclonal insulin autoantibodies in insulin autoimmune syndrome associated with HLA-DRB1*0401. Horm. Res. 54: 49-52 (2000).

• Murano M, Maemura K, Hirata I, Toshina K, Nishikawa T, Hamamoto N, Sasaki S, Saitoh O, Katsu K. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin. Exp. Immunol. 120: 51-58 (2000). *

• Muratori L, Parola M, Ripalti A, Robino G, Muratori P, Bellomo G, Carini R, Lenzi M, Landini MP, Albano E, Bianchi FB. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 46: 553-561 (2000). *

• Murphy GJ, Holder JC. PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol. Sci. 21: 469-474 (2000). *

• Murphy JE, Robert C, Kupper TS. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J. Invest. Dermatol. 114: 602-608 (2000). *

• Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18: 451-494 (2000). *

• Muzio M, Polentarutti N, Bosisio D, Manoj Kumar PP, Mantovani A. Toll-like receptor family and signalling pathway. Biochem. Soc. Trans. 28: 563-566 (2000). *

• Myerscough A, John S, Barrett JH, Ollier WE, Worthington J. Linkage of rheumatoid arthritis to insulin-dependent diabetes mellitus loci: evidence supporting a hypothesis for the existence of common autoimmune susceptibility loci. Arthritis Rheum. 43: 2771-2775 (2000). *

• Myung SJ, Kim MH, Shim KN, Kim YS, Kim EO, Kim HJ, Park ET, Yoo KS, Lim BC, Seo DW, Lee SK, Min YI, Kim JY. Detection of Helicobacter pylori DNA in human biliary tree and its association with hepatolithiasis. Dig. Dis. Sci. 45: 1405-1412 (2000). *

• Nadin L, Murray M. Arachidonic acid-mediated cooxidation of all-trans-retinoic acid in microsomal fractions from human liver. Br. J. Pharmacol. 131: 851-857 (2000). *

• Nagata S, McKenzie C, Pender SL, Bajaj-Elliott M, Fairclough PD, Walker-Smith JA, Monteleone G, MacDonald TT. Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J. Immunol. 165: 5315-5321 (2000). *

• Nagino M, Kamiya J, Kanai M, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery 127: 155-260 (2000). *

• Nagler-Anderson C. Tolerance and immunity in the intestinal immune system. Crit. Rev. Immunol. 20: 103-120 (2000).

• Nagpal S, Chandraratna RA. Recent developments in receptor-selective retinoids. Curr. Pharm. Des. 6: 919-931 (2000).

• Nagy Z, Nagy A, Karadi O, Par A, Mozsik G. The high prevalence of the factor V Leiden mutation in central European inflammatory bowel disease patients. Am. J. Gastroenterol. 95: 3013-3014 (2000). *

• Naidoo R, Tarin M, Chetty R. A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age. Am. J. Gastroenterol. 95: 3266-3275 (2000). *

• Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees JJ, Elder JT. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am. J. Hum. Genet. 66: 1833-1844 (2000). *

• Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am. J. Gastroenterol. 95: 2795-2800 (2000). *

• Najafian N, Sayegh MH. CTLA4-Ig: a novel immunosuppressive agent. Expert Opin. Investig. Drugs 9: 2147-2157 (2000).

• Nakai S, Masaki T, Kurokohchi K, Deguchi A, Nishioka M. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study. Am. J. Gastroenterol. 95: 326-327 (2000). *

• Nakajima T, Kamijo Y, Usuda N, Liang Y, Fukushima Y, Kametani K, Gonzalez FJ, Aoyama T. Sex-dependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator-activated receptor alpha (PPARalpha). Carcinogenesis 21: 677-682 (2000). *

• Nakanishi N, Nakamura K, Nakajima K, Suzuki K, Tatara K. Coffee consumption and decreased serum gamma-glutamyltransferase: a study of middle-aged Japanese men. Eur. J. Epidemiol. 16: 419-423 (2000).

• Nakanuma Y, Tsuneyama K, Sasaki M, Harada K. Destruction of bile ducts in primary biliary cirrhosis. Best Pract. Res. Clin. Gastroenterol. 14: 549-570 (2000).

• Nakao F, Ihara K, Ahmed S, Sasaki Y, Kusuhara K, Takabayashi A, Nishima S, Hara T. Lack of association between CD28/CTLA-4 gene polymorphisms and atopic asthma in the Japanese population. Exp. Clin. Immunogenet. 17: 179-184 (2000).

• Nakase H, Okazaki K, Tabata Y, Uose S, Ohana M, Uchida K, Matsushima Y, Kawanami C, Oshima C, Ikada Y, Chiba T. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy. J. Pharmacol. Exp. Ther. 292: 15-21 (2000). *

• Nakayama EE, Wasi C, Ajisawa A, Iwamoto A, Shioda T. A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene. Genes Immun. 1: 293-294 (2000). *

• Naluai AT, Nilsson S, Samuelsson L, Gudjonsdottir AH, Ascher H, Ek J, Hallberg B, Kristiansson B, Martinsson T, Nerman O, Sollid LM, Wahlstrom J. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders. Tissue Antigens 56: 350-355 (2000). *

• Narahara H, Tatsuta M, Iishi H, Baba M, Uedo N, Sakai N, Yano H, Ishiguro S. K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid. Int. J. Cancer 88: 157-161 (2000). *

• Naser SA, Hulten K, Shafran I, Graham DY, El-Zaatari FA. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Vet. Microbiol. 77: 497-504 (2000). *

• Naser SA, Schwartz D, Shafran I. Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am. J. Gastroenterol. 95: 1094-1095 (2000). *

• Nawaz AA, Gregory DH. Colorectal cancer screening challenges health professionals. Am. J. Gastroenterol. 95: 2992-2993 (2000). *

• Neiger R, Simpson KW. Helicobacter infection in dogs and cats: facts and fiction. J. Vet. Intern. Med. 14: 125-133 (2000).

• Nejentsev S, Gombos Z, Laine AP, Veijola R, Knip M, Simell O, Vaarala O, Akerblom HK, Ilonen J. Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 49: 2217-2221 (2000). *

• Nejentsev S, Laine AP, Simell O, Ilonen J. Intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism: no association with type 1 diabetes among Finns. Tissue Antigens 55: 568-570 (2000). *

• Nelissen I, Vandenbroeck K, Fiten P, Hillert J, Olsson T, Marrosu MG, Opdenakker G. Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis. J. Neuroimmunol. 105: 58-63 (2000).

• Nell MJ, Koerten HK, Grote JJ. Bactericidal/permeability-increasing protein prevents mucosal damage in an experimental rat model of chronic otitis media with effusion. Infect. Immun. 68: 2992-2994 (2000). *

• Nemazee D. Receptor selection in B and T lymphocytes. Annu. Rev. Immunol. 18: 19-51 (2000). *

• Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68: 688-693 (2000). *

• Neuberger J. Recurrent primary biliary cirrhosis. Best Pract. Res. Clin. Gastroenterol. 14: 669-680 (2000). *

• Neuberger J. URSO-panacea or placebo? Hepatology 31: 1027-1028 (2000). *

• Neurath MF. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives. Arch. Immunol. Ther. Exp. (Warsz.) 48: 81-84 (2000).

• Neurath MF, Schurmann G. Immunopathogenesis of inflammatory bowel diseases. Chirurg. 71: 30-40 (2000).

• Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an evolving diagnosis. Can. J. Gastroenterol. 14: 321-326 (2000). *

• Neve BP, Fruchart JC, Staels B. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem. Pharmacol. 60: 1245-1250 (2000). *

• Neville KL, Dal Canto MC, Bluestone JA, Miller SD. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease. J. Virol. 74: 8349-8357 (2000). *

• Newsome PN, Beldon I, Moussa Y, Delahooke TE, Poulopoulos G, Hayes PC, Plevris JN. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment. Pharmacol. Ther. 14: 1295-1301 (2000). *

• Newton JL, Jones DE, Metcalf JV, Park JB, Burt AD, Bassendine MF, James OF. Presentation and mortality of primary biliary cirrhosis in older patients. Age Ageing 29: 305-309 (2000). *

• Ng VL, Alonso M, Bezerra JA. Hepatocyte transplantation. Advancing biology and treating children. Clin. Liver Dis. 4: 929-945, vii (2000).

• Ng VL, Ryckman FC, Porta G, Miura IK, de Carvalho E, Servidoni MF, Bezerra JA, Balistreri WF. Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis. J. Pediatr. Gastroenterol. Nutr. 30: 152-156 (2000). *

• Nickoloff BJ, Bonish B, Huang BB, Porcelli SA. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J. Dermatol. Sci. 24: 212-225 (2000).

• Nielsen JN, Larsen TB, Fredholm L, Brandslund I, Munkholm P, Hey H. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with IBD. Gut 47: 456-457 (2000). *

• Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am. J. Gastroenterol. 95: 359-367 (2000). *

• Nietsch HH, Libman BS, Pansze TW, Eicher JN, Reeves JR, Krawitt EL. Minocycline-induced hepatitis. Am. J. Gastroenterol. 95: 2993-2995 (2000). *

• Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J. Neurol. Sci. 177: 65-71 (2000).

• Niizeki H, Naruse T, Hashigucci K, Yokoyama M, Yamasaki Y, Akiya K, Tojo T, Urushibara T, Yamazaki Y, Inoko H, Nishikawa T. Polymorphisms in the TNFA promoter region is not associated with palmoplantar pustulosis. Tissue Antigens 56: 162-165 (2000). *

• Nikolaus S, Folscn U, Schreiber S. Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease. Hepatogastroenterology 47: 71-82 (2000).

• Nikolaus S, Raedler A, Kuhbacker T, Sfikas N, Folsch UR, Schreiber S. Mechanisms in failure of infliximab for Crohn's disease. Lancet 356: 1475-1479 (2000). *

• Nikolovska D, Vasilev P, Mikhova A. Treatment of primary biliary cirrhosis with ursodeoxycholic acid. Vutr. Boles. 32: 25-27 (2000).

• Nilbert M, Fernebro J, Kristoffersson U. Novel germline APC mutations in Swedish patients with familial adenomatous polyposis and Gardner syndrome. Scand. J. Gastroenterol. 35: 1200-1203 (2000). *

• Niles RM. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 16: 1084-1089 (2000). *

• Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J. Clin. Microbiol. 38: 1072-1076 (2000). *

• Nilsson HO, Taneera J, Castedal M, Wadstrom T, Olsson R. Infectious agents and primary biliary cirrhosis. J. Hepatol. 33: 342-343 (2000). *

• Nilsson I, Lindgren S, Eriksson S, Wadstrom T. Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease. Gut 46: 410-414 (2000). *

• Nishimaki K, Kawamura T, Inada H, Yagawa K, Nose Y, Nabeya N, Isshiki G, Tatsumi N, Niihira S. HLA DPB1*0201 gene confers disease susceptibility in Japanese with childhood onset type I diabetes, independent of HLA-DR and DQ genotypes. Diabetes Res. Clin. Pract. 47: 49-55 (2000).

• Nishimura M, Maeda M, Matsuoka M, Mine H, Saji H, Matsui M, Kuroda Y, Kawakami H, Uchiyama T. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum. Immunol. 61: 1262-1269 (2000).

• Nishio A, Coppel R, Ishibashi H, Gershwin ME. The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis. Baillieres Best Pract. Res. Clin. Gastroenterol. 14: 535-547 (2000).

• Nishio A, Keeffe EB, Ishibashi H, Gershwin EM. Diagnosis and treatment of primary biliary cirrhosis. Med. Sci. Monit. 6: 181-193 (2000). *

• Nithiyananthan R, Heward JM, Allahabadia A, Barnett AH, Franklyn JA, Gough SC. A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: no evidence for association. J. Clin. Endocrinol. Metab. 85: 1320-1322 (2000). *

• Niv Y, Abuksis G, Fraser GM. Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements. Am. J. Gastroenterol. 95: 693-698 (2000). *

• Niveloni S, Pedreira S, Sugai E, Vazquez H, Smecuol E, Fiorini A, Cabanne A, Dezi R, Valero J, Kogan Z, Maurino E, Bai JC. The natural history of gluten sensitivity: report of two new celiac disease patients resulting from a long-term follow-up of nonatrophic, first-degree relatives. Am. J. Gastroenterol. 95: 463-468 (2000). *

• Niveloni S, Weksler-Zangen S, Pedreira S, Dezi R, Granot E, Doldan I, Wengrower D, Vazquez H, Smecuol E, Valero J, Kogan Z, Maurino E, Bai JC, Goldin E. Time course of nitric oxide synthase generation after gluten exposure in the rectal mucosa of gluten-sensitive patients. Scand. J. Gastroenterol. 35: 1150-1156 (2000). *

• Nizam R, Ahmed R, DiMarco AT. Initial presentation of ulcerative colitis with acute pancreatitis. Am. J. Gastroenterol. 95: 825-826 (2000). *

• No authors listed. Don't exaggerate the systemic adverse effects of hepatitis B vaccination: the vaccine benefits people at risk. Prescrire. Int. 9: 59-63 (2000).

• No authors listed. 2nd International Meeting on Inflammatory Bowel Diseases. Capri, Italy, June 18-21, 2000. Abstracts. Inflamm. Bowel Dis. 6 Suppl. 1: S1-S33 (2000).

• No authors listed. Quinine and cramp: uncertainty efficacy, major risks. Prescrire. Int. 9: 154-157 (2000).

• Noel LH. Antineutrophil cytoplasm antibodies (ANCA): description and immunopathological role. Ann. Med. Interne (Paris) 151: 178-183 (2000).

• Noone PG, Pue CA, Zhou Z, Friedman KJ, Wakeling EL, Ganeshananthan M, Simon RH, Silverman LM, Knowles MR. Lung disease associated with the IVS8 5T allele of the CFTR gene. Am. J. Respir. Crit. Care Med. 162: 1919-1924 (2000). *

• Nordquist N, Olofsson P, Vingsbo-Lundberg C, Petterson U, Holmdahl R. Complex genetic control in a rat model for rheumatoid arthritis. J. Autoimmun. 15: 425-432 (2000).

• Nores JM, Biacabe B, Bonfils P. Olfactory disorders and general pathology. Analysis and review of the literature. Rev. Med. Interne. 21: 95-104 (2000).

• Norgard B, Fonager K, Sorensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am. J. Gastroenterol. 95: 3165-3170 (2000). *

• Norioka M, Suzuki M, Ryomoto K, Ikebuchi M, Harano Y. Effect of bezafibrate treatment on the altered lipoprotein profiles in hypertriglyceridemic subjects. J. Atheroscler. Thromb. 7: 198-202 (2000).

• Norlin M, Toll A, Bjorkhem I, Wikvall K. 24-Hydroxycholesterol is a substrate for hepatic cholesterol 7alpha-hydroxylase (CYP7A). J. Lipid Res. 41: 1629-1639 (2000). *

• Norment AM, Bogatzki LY, Gantner BN, Bevan MJ. Murine CCR9, a chemokine receptor for thymus-expressed chemokine that is up-regulated following pre-TCR signaling. J. Immunol. 164: 639-648 (2000). *

• O'Brien J. Nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease. Am. J. Gastroenterol. 95: 1859-1861 (2000). *

• O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RN, Mills PR. Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 47: 717-720 (2000). *

• O'Grady JG. Treatment options for other hepatic malignancies. Liver Transpl. 6: S23-S29 (2000). *

• O'Leary JJ, Uhlmann V, Wakefield AJ. Measles virus and autism. Lancet 356: 772 (2000).

• O'Regan A, Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int. J. Exp. Pathol. 81: 373-390 (2000). *

• O'Reilly CM, Winpenny JP, Argent BE, Gray MA. Cystic fibrosis transmembrane conductance regulator currents in guinea pig pancreatic duct cells: inhibition by bicarbonate ions. Gastroenterology 118: 1187-1196 (2000). *

• O'Sullivan M, O'Morain C. Patient knowledge in inflammatory bowel disease. Am. J. Gastroenterol. 95: 2128-2129 (2000). *

• Oaks MK, Hallett KM. Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J. Immunol. 164: 5015-5018 (2000). *

• Oberhoffer M, Rußwurm S, Bredle D, Chatzinicolaou K, Reinhart K. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points. Intensive Care Med. 26: S170-S174 (2000). *

• Obermayer-Pietsch BM, Fruhauf GE, Chararas K, Mikhail-Reinisch S, Renner W, Berghold A, Kenner L, Lackner C. Association of the vitamin D receptor genotype BB with low bone density in hyperthyroidism. J. Bone Miner. Res. 15: 1950-1955 (2000).

• Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune polyglandular syndrome type 1. Clin. Rev. Allergy Immunol. 18: 167-183 (2000).

• Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J. Hepatol. 32: S181-S197 (2000).

• Ockenga J, Stuhrmann M, Ballmann M, Teich N, Keim V, Dork T, Manns MP. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am. J. Gastroenterol. 95: 2061-2067 (2000). *

• Odze RD, Brown CA, Hartmann CJ, Noffsinger AE, Fogt F. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas. Am. J. Surg. Pathol. 24: 1209-1216 (2000).

• Ogawa K, Suzuki H, Hirohashi T, Ishikawa T, Meier PJ, Hirose K, Akizawa T, Yoshioka M, Sugiyama Y. Characterization of inducible nature of MRP3 in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G438-G446 (2000). *

• Ogawa S, Sakaguchi K, Takaki A, Shiraga K, Sawayama T, Mouri H, Miyashita M, Koide N, Tsuji T. Increase in CD95 (Fas/APO-1)-positive CD4+ and CD8+ T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena. J. Gastroenterol. Hepatol. 15: 69-75 (2000). *

• Oh CJ, Das KM, Gottlieb AB. Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions. J. Am. Acad. Dermatol. 42: 829-830 (2000).

• Oh MD, Kim SS, Kim EY, Lee S, Kim N, Park KY, Kim U, Kim T, Kim T, Choe K, Lee JS. The frequency of mutation in CCR5 gene among Koreans. Int. J. STD AIDS 11: 266-267 (2000).

• Ohara T, Kasuga M. Insulin autoimmune syndrome. Ryoikibetsu Shokogun Shirizu 31: 125-128 (2000).

• Ohata M, Yamauchi M, Takeda K, Toda G, Kamimura S, Motomura K, Xiong S, Tsukamoto H. RAR and RXR expression by Kupffer cells. Exp. Mol. Pathol. 68: 13-20 (2000). *

• Ohge H, Takesue Y, Yokoyama T, Hiyama E, Murakami Y, Imamura Y, Shimamoto F, Matsuura Y. Progression of primary biliary cirrhosis after proctocolectomy for ulcerative colitis. J. Gastroenterol. 35: 870-872 (2000). *

• Ohi M, Miki C. Tissue concentration of platelet-derived endothelial cell growth factor in colorectal cancer. Scand. J. Gastroenterol. 35: 413-418 (2000). *

• Ohman L, Franzen L, Rudolph U, Harriman GR, Hultgren Hornquist E. Immune activation in the intestinal mucosa before the onset of colitis in Galphai2-deficient mice. Scand. J. Immunol. 52: 80-90 (2000). *

• Oida T, Suzuki K, Nanno M, Kanamori Y, Saito H, Kubota E, Kato S, Itoh M, Kaminogawa S, Ishikawa H. Role of gut cryptopatches in early extrathymic maturation of intestinal intraepithelial T cells. J. Immunol. 164: 3616-3626 (2000). *

• Oishi K, Fukui H, Ishida N. Rhythmic expression of BMAL1 mRNA is altered in Clock mutant mice: differential regulation in the suprachiasmatic nucleus and peripheral tissues. Biochem. Biophys. Res. Commun. 268: 164-171 (2000). *

• Okada T, Morise T, Takeda Y, Mabuchi H. A new variant deletion of a copper-transporting P-type ATPase gene found in patients with Wilson's disease presenting with fulminant hepatic failure. J. Gastroenterol. 35: 278-283 (2000). *

• Okada T, Shiono Y, Hayashi H, Satoh H, Sawada T, Suzuki A, Takeda Y, Yano M, Michitaka K, Onji M, Mabuchi H. Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Hum. Mutat. 15: 454-462 (2000). *

• Okazaki A, Miyagawa S, Yamashina Y, Kitamura W, Shirai T. Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid. J. Dermatol. 27: 149-156 (2000).

• Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, Matsushima Y, Katamura K, Ohmori K, Chiba T. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118: 573-581 (2000). *

• Olavesen MG, Hampe J, Mirza MM, Saiz R, Lewis CM, Bridger S, Teare D, Easton DF, Herrmann T, Scott G, Hirst J, Sanderson J, Hodgson SV, Lee J, MacPherson A, Schreiber S, Lennard-Jones JE, Curran ME, Mathew CG. Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease. Immunogenetics 51: 1-7 (2000).

• Olden KW, Drossman DA. Psychologic and psychiatric aspects of gastrointestinal disease. Med. Clin. North Am. 84: 1313-1327 (2000).

• Oldenburg B, Fijnheer R, van der Griend R, vanBerge-Henegouwen GP, Koningsberger JC. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am. J. Gastroenterol. 95: 2825-2830 (2000). *

• Olosz F, Malek TR. Three loops of the common gamma chain ectodomain required for the binding of interleukin-2 and interleukin-7. J. Biol. Chem. 275: 30100-30105 (2000). *

• Olsson C, Waldenstrom E, Westermark K, Landegre U, Syvanen AC. Determination of the frequencies of ten allelic variants of the Wilson disease gene (ATP7B), in pooled DNA samples. Eur. J. Hum. Genet. 8: 933-938 (2000). *

• Omagari K, Masuda J, Kato Y, Nakata K, Kanematsu T, Kusumoto Y, Mori I, Furukawa R, Tanioka H, Tajima H, Koga M, Yano M, Kohno S. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group. Intern. Med. 39: 1008-1012 (2000). *

• Ono SJ. Molecular genetics of allergic diseases. Annu. Rev. Immunol. 18: 347-366 (2000). *

• Ono T, Miki C. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma. Am. J. Gastroenterol. 95: 1062-1067 (2000). *

• Onuma EK, Amenta PS, Ramaswamy K, Lin JJ, Das KM. Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5. Clin. Exp. Immunol. 121: 466-471 (2000). *

• Ooi CJ, Lim BL, Cheong WK, Ling AE, Ng HS. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study. Ann. Acad. Med. Singapore 29: 704-707 (2000).

• Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725 (2000). *

• Orchard TR, Satsangi J, Van Heel D, Jewell DP. Genetics of inflammatory bowel disease: a reappraisal. Scand. J. Immunol. 51: 10-17 (2000). *

• Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 118: 274-278 (2000). *

• Oren R, Sikuler E, Wong F, Blendis LM, Halpern Z. The effects of hypothyroidism on liver status of cirrhotic patients. J. Clin. Gastroenterol. 31: 162-163 (2000).

• Orholm M, Binder V, Sorensen TI, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand. J. Gastroenterol. 35: 1075-1081 (2000). *

• Orlando A, D'Antoni A, Camma C, Albanese M, Livraghi T, Torzilli G, Virdone R, Sciarrino E, Simonetti RG, Maringhini A, Pagliaro L, Cottone M. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model. Am. J. Gastroenterol. 95: 2921-2927 (2000). *

• Orlando R, Lirussi F. Are liver cirrhosis and portal hypertension associated with an increased risk of bleeding during laparoscopy? A retrospective analysis of 1,000 consecutive cases. Surg. Laparosc. Endosc. Percutan. Tech. 10: 208-210 (2000).

• Orth T, Neurath M, Schirmacher P, Galle PR, Mayet WJ. A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated bile duct is associated with increased TNF-alpha production and autoantibodies. J. Hepatol. 33: 862-872 (2000). *

• Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst. Rev. 2: CD000951 (2000). *

• Oshima J. Comparative aspects of the Werner syndrome gene. In Vivo 14: 165-172 (2000).

• Ostedgaard LS, Baldursson O, Vermeer DW, Welsh MJ, Robertson AD. A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution. Proc. Natl. Acad. Sci. U.S.A. 97: 5657-5662 (2000). *

• Ota S, Bamba H, Kato A. Colorectal cancer and non-steroidal anti-inflammatory drugs. Acta Pharmacol. Sin. 21: 391-395 (2000).

• Otto JM, Chandrasekeran R, Vermes C, Mikecz K, Finnegan A, Rickert SE, Enders JT, Glant TT. A genome scan using a novel genetic cross identifies new susceptibility loci and traits in a mouse model of rheumatoid arthritis. J. Immunol. 165: 5278-5286 (2000). *

• Oude Elferink RP, Groen AK. Mechanisms of biliary lipid secretion and their role in lipid homeostasis. Semin. Liver Dis. 20: 293-305 (2000). *

• Owings E, Georgeson K. Management of cholestasis in infants with very low birth weight. Semin. Pediatr. Surg. 9: 96-102 (2000).

• Ozaki S. ANCA in inflammatory bowel disease. J. Gastroenterol. 35: 721-723 (2000). *

• Ozaki Y, Nomura S, Nagahama M, Yoshimura C, Kagawa H, Fukuhara S. Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron 85: 86-91 (2000).

• Ozgen A, Cila A. Riedel's thyroiditis in multifocal fibrosclerosis: CT and MR imaging findings. AJNR Am. J. Neuroradiol. 21: 320-321 (2000). *

• Pabst O, Forster R, Lipp M, Engel H, Arnold HH. NKX2.3 is required for MAdCAM-1 expression and homing of lymphocytes in spleen and mucosa-associated lymphoid tissue. EMBO J. 19: 2015-2023 (2000). *

• Padilla PI, Wada A, Yahiro K, Kimura M, Niidome T, Aoyagi H, Kumatori A, Anami M, Hayashi T, Fujisawa J, Saito H, Moss J, Hirayama T. Morphologic differentiation of HL-60 cells is associated with appearance of RPTPbeta and induction of Helicobacter pylori VacA sensitivity. J. Biol. Chem. 275: 15200-15206 (2000). *

• Paik J, Vogel S, Piantedosi R, Sykes A, Blaner WS, Swisshelm K. 9-cis-Retinoids: biosynthesis of 9-cis-retinoic acid. Biochemistry 39: 8073-8084 (2000). *

• Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT. Characterisation of uveitis in patients with psoriatic arthritis. Ann. Rheum. Dis. 59: 67-70 (2000). *

• Pallares-Ruiz N, Carles S, des Georges M, Guittard C, Claustres M, Larrey D, Pageaux G. Is isolated idiopathic pancreatitis associated with CFTR mutations? Gut 46: 141 (2000). *

• Palmer DG, Eads J. Intrahepatic cholestasis of pregnancy: a critical review. J. Perinat. Neonatal. Nurs. 14: 39-51 (2000).

• Palmer JM, Doshi M, Kirby JA, Yeaman SJ, Bassendine MF, Jones DE. Secretory autoantibodies in primary biliary cirrhosis (PBC). Clin. Exp. Immunol. 122: 423-428 (2000). *

• Palmer LJ, Burton PR, James AL, Musk AW, Cookson WO. Familial aggregation and heritability of asthma-associated quantitative traits in a population-based sample of nuclear families. Eur. J. Hum. Genet. 8: 853-860 (2000). *

• Pan DA, Mater MK, Thelen AP, Peters JM, Gonzalez FJ, Jump DB. Evidence against the peroxisome proliferator-activated receptor alpha (PPARalpha) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription. J. Lipid Res. 41: 742-751 (2000). *

• Pan Q, Wendel J, Fluhr R. Divergent evolution of plant NBS-LRR resistance gene homologues in dicot and cereal genomes. J. Mol. Evol. 50: 203-213 (2000). *

• Pang CP, Baum L, Lam DS. Hunting for disease genes in multi-functional diseases. Clin. Chem. Lab. Med. 38: 819-825 (2000).

• Pantelidis P, Jones MG, Welsh KI, Taylor AN, du Bois RM. Identification of four novel interleukin-13 gene polymorphisms. Genes Immun. 1: 341-345 (2000). *

• Panus JF, McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific T helper cell function: differential cytokine expression in primary and memory responses. J. Exp. Med. 192: 1301-1316 (2000). *

• Papa A, De Stefano V, Gasbarrini A, Chiusolo P, Cianci R, Casorelli I, Paciaroni K, Cammarota G, Leone G, Gasbarrini G. Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease. Blood Coagul. Fibrinolysis 11: 499-503 (2000).

• Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD, Andrew DP, Targan SR. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J. Immunol. 165: 5069-5076 (2000). *

• Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51: 289-298 (2000). *

• Papadakis KA, Targan SR. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 119: 1148-1157 (2000). *

• Papadakis KA, Targan SR. The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm. Bowel Dis. 6: 303-313 (2000). *

• Papassavas EC, Spyropoulou-Vlachou M, Papassavas AC, Schipper RF, Doxiadis IN, Stavropoulos-Giokas C. MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data. Hum. Immunol. 61: 615-623 (2000).

• Par A. Gastrointestinal tract as a part of immune defence. Acta Physiol. Hung. 87: 291-304 (2000).

• Pardi DS, Tremaine WJ, Sandborn WJ, Loftus EV Jr, Poland GA, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Early measles virus infection is associated with the development of inflammatory bowel disease. Am. J. Gastroenterol. 95: 1480-1485 (2000). *

• Parente F, Cucino C, Bollani S, Imbesi V, Maconi G, Bonetto S, Vago L, Porro GB. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Am. J. Gastroenterol. 95: 705-711 (2000). *

• Pares A, Caballeria L, Rodes J, Bruguera M, Rodrigo L, Garcia-Plaza A, Berenguer J, Rodriguez-Martinez D, Mercader J, Velicia R. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver. J. Hepatol. 32: 561-566 (2000). *

• Pares A, Rodes J. Treatment of primary biliary cirrhosis. Minerva Gastroenterol. Dietol. 46: 165-174 (2000).

• Park SZ, Nagorney DM, Czaja AJ. Hepatocellular carcinoma in autoimmune hepatitis. Dig. Dis. Sci. 45: 1944-1948 (2000). *

• Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ, Cho BY. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10: 453-459 (2000).

• Park YS, Kim TW, Kim WB, Cho BY. Increased prevalence of autoimmune thyroid disease in patients with type 1 diabetes. Korean J. Intern. Med. 15: 202-210 (2000).

• Parkes M, Barmada MM, Satsangi J, Weeks DE, Jewell DP, Duerr RH. The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am. J. Hum. Genet. 67: 1605-1610 (2000). *

• Parlesak A, Menzl I, Feuchter A, Bode JC, Bode C. Inhibition of retinol oxidation by ethanol in the rat liver and colon. Gut 47: 825-831 (2000). *

• Parrello T, Monteleone G, Cucchiara S, Monteleone I, Sebkova L, Doldo P, Luzza F, Pallone F. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J. Immunol. 165: 7234-7239 (2000). *

• Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, Johnston J, Madden K, Xu W, West J, Schrader S, Burkhead S, Heipel M, Brandt C, Kuijper JL, Kramer J, Conklin D, Presnell SR, Berry J, Shiota F, Bort S, Hambly K, Mudri S, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63 (2000). *

• Pascual M, Nieto A, Mataran L, Balsa A, Pascual-Salcedo D, Martin J. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun. 1: 338-340 (2000). *

• Pascussi JM, Drocourt L, Fabre JM, Maurel P, Vilarem MJ. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol. Pharmacol. 58: 361-372 (2000). *

• Pascussi JM, Gerbal-Chaloin S, Fabre JM, Maurel P, Vilarem MJ. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol. Pharmacol. 58: 1441-1450 (2000). *

• Pascussi JM, Gerbal-Chaloin S, Pichard-Garcia L, Daujat M, Fabre JM, Maurel P, Vilarem MJ. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem. Biophys. Res. Commun. 274: 707-713 (2000). *

• Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am. J. Gastroenterol. 95: 204-207 (2000). *

• Patel DD, Knight BL, Soutar AK, Gibbons GF, Wade DP. The effect of peroxisome-proliferator-activated receptor-alpha on the activity of the cholesterol 7 alpha-hydroxylase gene. Biochem. J. 351: 747-753 (2000). *

• Patel T. Apoptosis in hepatic pathophysiology. Clin. Liver Dis. 4: 295-317 (2000).

• Pathmakanthan S, Hawkey CJ. A lay doctor's guide to the inflammatory process in the gastrointestinal tract. Postgrad. Med. J. 76: 611-617 (2000). *

• Patrignani P. Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer. Toxicol. Lett. 112-113: 493-498 (2000). *

• Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, Risler T, Berger ED, Kuhlmann U, Mettang T. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J. Am. Soc. Nephrol. 11: 514-519 (2000). *

• Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, Fromm MF. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. J. Pharmacol. Exp. Ther. 293: 376-382 (2000). *

• Paulsen JE, Namork E, Steffensen IL, Eide TJ, Alexander J. Identification and quantification of aberrant crypt foci in the colon of Min mice - a murine model of familial adenomatous polyposis. Scand. J. Gastroenterol. 35: 534-539 (2000). *

• Paysant J, Blanque R, Vasse M, Soria C, Soria J, Gardner CR. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes. Cytokine 12: 774-779 (2000).

• Peeters M, Cortot A, Vermeire S, Colombel JF. Familial and sporadic inflammatory bowel disease: different entities? Inflamm. Bowel Dis. 6: 314-320 (2000). *

• Pemberton MN, Sloan P, Thakker NS. Oral lichenoid lesions after hepatitis B vaccination. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 89: 717-719 (2000).

• Penglis PS, Bond C, Humphreys I, McCluskey J, Cleland LG. Genetic susceptibility and the link between cat exposure and rheumatoid arthritis. Semin. Arthritis Rheum. 30: 111-120 (2000). *

• Pera A, Sostegni R, Daperno M, Ercole E, Laudi C, Rocca R, Rigazio C, Astegiano M, Rocca G. Genotype-phenotype relationship in inflammatory bowel disease. Eur. J. Intern. Med. 11: 204-209 (2000).

• Pereira J, Hidalgo P, Ocqueteau M, Blacutt M, Marchesse M, Nien Y, Letelier L, Mezzano D. Glycoprotein Ib/IX complex is the target in rifampicin-induced immune thrombocytopenia. Br. J. Haematol. 110: 907-910 (2000). *

• Perez P, Goicovich E, Alliende C, Aguilera S, Leyton C, Molina C, Pinto R, Romo R, Martinez B, Gonzalez MJ. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum. 43: 2807-2817 (2000). *

• Perez-Aguilar F, Sanchez-Cuenca JM, Carmona E, Berenguer J. Clinical usefulness of antineutrophil cytoplasmic antibodies with special reference to cystic fibrosis. Med. Clin. (Barc.) 114: 238-239 (2000).

• Perniola R, Falorni A, Clemente MG, Forini F, Accogli E, Lobreglio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Eur. J. Endocrinol. 143: 497-503 (2000). *

• Perron H, Perin JP, Rieger F, Alliel PM. Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis? J. Neurovirol. 6 Suppl. 2: S67-S75 (2000).

• Persu A, Devuyst O, Lannoy N, Materne R, Brosnahan G, Gabow PA, Pirson Y, Verellen-Dumoulin C. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 11: 2285-2296 (2000). *

• Peters JM, Rusyn I, Rose ML, Gonzalez FJ, Thurman RG. Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis 21: 823-826 (2000). *

• Petersein J, Reisinger W, Mutze S, Hamm B. Value of negative oral contrast media in MR cholangiopancreatography (MRCP). Rofo. Fortschr. Geb. Rontgenstr. Neuen. Bildgeb. Verfahr. 172: 55-60 (2000).

• Petersen DN, Tkalcevic GT, Mansolf AL, Rivera-Gonzalez R, Brown TA. Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J. Biol. Chem. 275: 36172-36180 (2000). *

• Petersen SV, Thiel S, Jensen L, Vorup-Jensen T, Koch C, Jensenius JC. Control of the classical and the MBL pathway of complement activation. Mol. Immunol. 37: 803-811 (2000). *

• Peterson P, Uibo R, Krohn KJ. Adrenal autoimmunity: results and developments. Trends Endocrinol. Metab. 11: 285-290 (2000). *

• Petronis A, Petroniene R. Epigenetics of inflammatory bowel disease. Gut 47: 302-306 (2000). *

• Petros JG. Crohn's disease update. Curr. Surg. 57: 95-103 (2000).

• Petryshen TL, Kaplan BJ, Liu MF, Field LL. Absence of significant linkage between phonological coding dyslexia and chromosome 6p23-21.3, as determined by use of quantitative-trait methods: confirmation of qualitative analyses. Am. J. Hum. Genet. 66: 708-714 (2000). *

• Pflanz S, Kurth I, Grotzinger J, Heinrich PC, Muller-Newen G. Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation. J. Immunol. 165: 7042-7049 (2000). *

• Pfutzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, Furey WF, Whitcomb DC. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 119: 615-623 (2000). *

• Piazza F, Montagnani M, Russo C, Azzaroli F, Aldini R, Roda E, Roda A. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid. Dig. Liver Dis. 32: 318-328 (2000).

• Picco MF, Bayless TM. Analyzing hospital costs for patients with inflammatory bowel disease. Am. J. Gastroenterol. 95: 577-578 (2000). *

• Picco P, Gattorno M, Marchese N, Vignola S, Sormani MP, Barabino A, Buoncompagni A. Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clin. Exp. Rheumatol. 18: 773-778 (2000).

• Pier GB. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci. U.S.A. 97: 8822-8828 (2000). *

• Pietrangelo A. Iron, friend or foe? "Freedom" makes the difference. J. Hepatol. 32: 862-864 (2000). *

• Pietzak MM, Thomas DW. Pancreatitis in childhood. Pediatr. Rev. 21: 406-412 (2000).

• Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, Lin HC. Identification of a prodromal period in Crohn's disease but not ulcerative colitis. Am. J. Gastroenterol. 95: 3458-3462 (2000). *

• Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am. J. Gastroenterol. 95: 3503-3506 (2000). *

• Pinaire J, Smith JR, Cho WK, Crabb DW. Effects of vitamin A deficiency on rat liver alcohol dehydrogenase expression and alcohol elimination rate in rats. Alcohol Clin. Exp. Res. 24: 1759-1764 (2000). *

• Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur. J. Dermatol. 10: 85-90 (2000).

• Pineau P, Buendia MA. Studies of genetic defects in hepatocellular carcinoma: recent outcomes and new challenges. J. Hepatol. 33: 152-156 (2000). *

• Pitcher MC, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 46: 64-72 (2000). *

• Pitkanen J, Doucas V, Sternsdorf T, Nakajima T, Aratani S, Jensen K, Will H, Vahamurto P, Ollila J, Vihinen M, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Krohn K, Peterson P. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J. Biol. Chem. 275: 16802-16809 (2000). *

• Pizarro TT, Arseneau KO, Cominelli F. Lessons from genetically engineered animal models. XI. Novel mouse models to study pathogenic mechanisms of Crohn's disease. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G665-G669 (2000). *

• Pizurki L, Morris MA, Chanson M, Solomon M, Pavirani A, Bouchardy I, Suter S. Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers. Am. J. Pathol. 156: 1407-1416 (2000). *

• Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol. Biomarkers Prev. 9: 1059-1065 (2000). *

• Plevris JN, Haydon GH, Simpson KJ, Dawkes R, Ludlum CA, Harrison DJ, Hayes PC. Serum hyaluronan - a non-invasive test for diagnosing liver cirrhosis. Eur. J. Gastroenterol. Hepatol. 12: 1121-1127 (2000).

• Plutzky J. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms. Curr. Atheroscler. Rep. 2: 327-335 (2000).

• Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am. J. Gastroenterol. 95: S11-S13 (2000).

• Podolsky DK. Pride and prejudice: inflammatory bowel disease models and drug development. Curr. Opin. Gastroenterol. 16: 295-296 (2000).

• Pohl C, Hombach A, Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 47: 57-70 (2000).

• Pohle T, Menzel J, Domschke W. Minocycline and fulminant hepatic failure necessitating liver transplantation. Am. J. Gastroenterol. 95: 560-561 (2000). *

• Polgar A, Brozik M, Toth S, Holub M, Hegyi K, Kadar A, Hodinka L, Falus A. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis. Med. Sci. Monit. 6: 13-18 (2000). *

• Pometta R, Callea F, Mangano M, Zuccoli E, Conte D. Recurrent cholestasis and hypereosinophilia in a young female. Dig. Liver Dis. 32: 630-633 (2000).

• Pompeia C, Lopes LR, Miyasaka CK, Procopio J, Sannomiya P, Curi R. Effect of fatty acids on leukocyte function. Braz. J. Med. Biol. Res. 33: 1255-1268 (2000). *

• Ponzetto A, Pellicano R, Leone N, Cutufia MA, Turrini F, Grigioni WF, D'Errico A, Mortimer P, Rizzetto M, Silengo L. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med. Hypotheses 54: 275-277 (2000).

• Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32: 689-692 (2000). *

• Porta G. Autoimmune hepatitis. J. Pediatr. (Rio. J.) 76: S181-S186 (2000). *

• Porter SJ, Somogyi AA, White JM. Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosol. Br. J. Clin. Pharmacol. 50: 465-471 (2000). *

• Poulain D, Sendid B, Fajardy I, Danze PM, Colombel JF. Mother to child transmission of anti-S cerevisiae mannan antibodies (ASCA) in non-IBD families. Gut 47: 870-871 (2000). *

• Poupon R, Chazouilleres O, Poupon RE. Chronic cholestatic diseases. J. Hepatol. 32: S129-S140 (2000).

• Poupon R, Poupon RE. Treatment of primary biliary cirrhosis. Best Pract. Res. Clin. Gastroenterol. 14: 615-628 (2000). *

• Poupon RE. Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past - issues for the future. J. Hepatol. 32: 685-688 (2000). *

• Poussier P, Ning T, Chen J, Banerjee D, Julius M. Intestinal inflammation observed in IL-2R/IL-2 mutant mice is associated with impaired intestinal T lymphopoiesis. Gastroenterology 118: 880-81 (2000). *

• Praderio L, Dagna L, Longhi P, Rubin G, Sabbadini MG. Budd-Chiari syndrome in a patient with ulcerative colitis: association with anticardiolipin antibodies. J. Clin. Gastroenterol. 30: 203-204 (2000).

• Prahalad S, Ryan MH, Shear ES, Thompson SD, Giannini EH, Glass DN. Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. Arthritis Rheum. 43: 2335-2338 (2000). *

• Prall RT, LaRusso NF. Biliary tract physiology. Curr. Opin. Gastroenterol. 16: 432-436 (2000).

• Prall RT, Lindor KD, Wiesner RH, LaRusso NF. Current therapies and clinical controversies in the management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 2: 99-103 (2000).

• Praseedom RK, Jalan R, Allan P, McGilchrist A, Roddie H, Madhavan KK. Combined hepatic artery and segmental portal vein occlusion in antiphospholipid syndrome. Dig. Surg. 17: 405-406 (2000).

• Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, Migliorini P. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J. Rheumatol. 27: 109-115 (2000).

• Pratha VS, Hogan DL, Martensson BA, Bernard J, Zhou R, Isenberg JI. Identification of transport abnormalities in duodenal mucosa and duodenal enterocytes from patients with cystic fibrosis. Gastroenterology 118: 1051-1060 (2000). *

• Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N. Engl. J. Med. 342: 1266-1271 (2000). *

• Present DH. How to do without steroids in inflammatory bowel disease. Inflamm. Bowel Dis. 6: 48-57 (2000). *

• Presland RB, Dale BA. Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit. Rev. Oral Biol. Med. 11: 383-408 (2000).

• Price PT, Nelson CM, Clarke SD. Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr. Opin. Lipidol. 11: 3-7 (2000).

• Prince MI, James OF, Holland NP, Jones DE. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J. Hepatol. 32: 368-373 (2000). *

• Prince MI, Jones DE. Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad. Med. J. 76: 199-206 (2000). *

• Prindiville TP, Sheikh RA, Cohen SH, Tang YJ, Cantrell MC, Silva J Jr. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg. Infect. Dis. 6: 171-174 (2000). *

• Pritzker LB, Joshi S, Gowan JJ, Harauz G, Moscarello MA. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 39: 5374-5381 (2000). *

• Pritzker LB, Joshi S, Harauz G, Moscarello MA. Deimination of myelin basic protein. 2. Effect of methylation of MBP on its deimination by peptidylarginine deiminase. Biochemistry 39: 5382-5388 (2000). *

• Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J. Autoimmun. 14: 23-42 (2000).

• Prufer K, Racz A, Lin GC, Barsony J. Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors. J. Biol. Chem. 275: 41114-41123 (2000). *

• Putterman C, Deocharan B, Diamond B. Molecular analysis of the autoantibody response in peptide-induced autoimmunity. J. Immunol. 164: 2542-2549 (2000). *

• Qi C, Zhu Y, Reddy JK. Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell. Biochem. Biophys. 32: 187-204 (2000).

• Qian C, Drozdzik M, Caselmann WH, Prieto J. The potential of gene therapy in the treatment of hepatocellular carcinoma. J. Hepatol. 32: 344-351 (2000). *

• Qiao D, Chen W, Stratagoules ED, Martinez JD. Bile acid-induced activation of activator protein-1 requires both extracellular signal-regulated kinase and protein kinase C signaling. J. Biol. Chem. 275: 15090-15098 (2000). *

• Quack M, Carlberg C. The impact of functional vitamin D(3) receptor conformations on DNA-dependent vitamin D(3) signaling. Mol. Pharmacol. 57: 375-384 (2000). *

• Quack M, Carlberg C. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. J. Mol. Biol. 296: 743-756 (2000). *

• Quadro L, Gamble MV, Vogel S, Lima AA, Piantedosi R, Moore SR, Colantuoni V, Gottesman ME, Guerrant RL, Blaner WS. Retinol and retinol-binding protein: gut integrity and circulating immunoglobulins. J. Infect. Dis. 182 Suppl. 1: S97-S102 (2000). *

• Quattrocchi E, Dallman MJ, Feldmann M. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis. Arthritis Rheum. 43: 1688-1697 (2000). *

• Quaye IK, Ekuban FA, Goka BQ, Adabayeri V, Kurtzhals JA, Gyan B, Ankrah NA, Hviid L, Akanmori BD. Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94: 216-219 (2000).

• Quentin Y, Fichant G. ABCdb: an ABC transporter database. J. Mol. Microbiol. Biotechnol. 2: 501-504 (2000).

• Rabusin M, Andolina M, Maximova N, Lepore L, Parco S, Tuveri G, Jankovic G. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease. Haematologica 85: S81-S85 (2000).

• Racke MK, Ratts RB, Arredondo L, Perrin PJ, Lovett-Racke A. The role of costimulation in autoimmune demyelination. J. Neuroimmunol. 107: 205-215 (2000).

• Radford DJ, Savage CO, Nash GB. Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion. Arthritis Rheum. 43: 1337-1345 (2000). *

• Radice A, Vecchi M, Bianchi MB, Sinico RA. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin. Exp. Rheumatol. 18: 707-712 (2000).

• Raggers RJ, Pomorski T, Holthuis JC, Kalin N, van Meer G. Lipid traffic: the ABC of transbilayer movement. Traffic 1: 226-234 (2000).

• Rago C, Tocce K, Ficarro S, Masters G, Riggs J. Superantigen disruption of CD8+ T and B lymphocyte homeostasis. Immunobiology 202: 508-518 (2000).

• Raia V, Maiuri L, de Ritis G, de Vizia B, Vacca L, Conte R, Auricchio S, Londei M. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr. Res. 47: 344-350 (2000). *

• Raina N, Matsui J, Jeejeebhoy KN. Nutritional and metabolic effects of the endotoxin bacterial lipopolysaccharide in orally and parenterally fed rats. Am. J. Clin. Nutr. 71: 835-843 (2000). *

• Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am. J. Gastroenterol. 95: 684-688 (2000). *

• Ramakrishna B, Eapen CE, Kang G, Kurian G, Chandy GM. Familial intrahepatic cholestatic cirrhosis with positive antimitochondrial antibody: familial primary biliary cirrhosis. J. Clin. Gastroenterol. 30: 255-258 (2000).

• Rasmussen HB, Lucotte G, Clausen J. Endogenous retroviruses and multiple sclerosis. J. Neurovirol. 6 Suppl. 2: S80-S84 (2000).

• Rau R, Herborn G, Zueger S, Fenner H. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years. J. Rheumatol. 27: 2566-2575 (2000).

• Rauramaa R, Vaisanen SB, Luong LA, Schmidt-Trucksass A, Penttila IM, Bouchard C, Toyry J, Humphries SE. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20: 2657-2662 (2000). *

• Rausa FM, Tan Y, Zhou H, Yoo KW, Stolz DB, Watkins SC, Franks RR, Unterman TG, Costa RH. Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol. Cell. Biol. 20: 8264-8282 (2000). *

• Ravnik-Glavac M, Dean M, di Sant'Agnese P, Chernick M, Kozelj M, Krizman I, Glavac D. Evidence that hereditary pancreatitis is genetically heterogeneous disorder. Pflugers Arch. 439: R50-R52 (2000).

• Raya A, Revert-Ros F, Martinez-Martinez P, Navarro S, Rosello E, Vieites B, Granero F, Forteza J, Saus J. Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis. J. Biol. Chem. 275: 40392-40399 (2000). *

• Rebhandl W, Felberbauer FX, Huber WD, Puig S, Paya K, Rauhofer U, Saadi S, Aberle J, Horcher E. Progressive familial intrahepatic cholestasis (Byler disease): current genetics and therapy. Klin. Padiatr. 212: 64-70 (2000).

• Reddy BS. The Fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol. Biomarkers Prev. 9: 239-247 (2000). *

• Reddy BS, Hirose Y, Cohen LA, Simi B, Cooma I, Rao CV. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention. Cancer Res. 60: 4792-4797 (2000). *

• Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res. 60: 293-297 (2000). *

• Reddy BS, Rao CV. Colon cancer: a role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs. Drugs Aging 16: 329-334 (2000).

• Reddy ST, Wadleigh DJ, Herschman HR. Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J. Biol. Chem. 275: 3107-3113 (2000). *

• Reeves AR, Johnson MS, Stine S. Percutaneous diagnosis and treatment of biliary candidiasis. J. Vasc. Interv. Radiol. 11: 107-109 (2000).

• Regueiro MD. Update in medical treatment of Crohn's disease. J. Clin. Gastroenterol. 31: 282-291 (2000).

• Reid AE. Same disease, different impact. Inflamm. Bowel Dis. 6: 330-331 (2000). *

• Reif S, Lavy A, Keter D, Fich A, Eliakim R, Halak A, Broide E, Niv Y, Ron Y, Patz J, Odes S, Villa Y, Gilat T. Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am. J. Gastroenterol. 95: 474-478 (2000). *

• Reinacher-Schick A, Seidensticker F, Petrasch S, Reiser M, Philippou S, Theegarten D, Freitag G, Schmiegel W. Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowel. Endoscopy 32: 245-254 (2000).

• Renes J, de Vries EE, Hooiveld GJ, Krikken I, Jansen PL, Muller M. Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem. J. 350: 555-561 (2000). *

• Renes J, de Vries EG, Jansen PL, Muller M. The (patho)physiological functions of the MRP family. Drug Resist. Updat. 3: 289-302 (2000).

• Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G829-G833 (2000). *

• Renz JF, Busuttil RW. Adult-to-adult living-donor liver transplantation: a critical analysis. Semin. Liver Dis. 20: 411-424 (2000). *

• Renzoni E, Lympany P, Sestini P, Pantelidis P, Wells A, Black C, Welsh K, Bunn C, Knight C, Foley P, du Bois RM. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum. 43: 1633-1640 (2000). *

• Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14: 2819-2830 (2000). *

• Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16: 459-481 (2000). *

• Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529 (2000). *

• Reumaux D, Colombel JF, Masy E, Duclos B, Heresbach D, Belaiche J, Cortot A, Duthilleul P; GETAID, Groupe d'Etude des Affections Inflammatoires du Tube Digestif. Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in ulcerative colitis (UC): no relationship with disease activity. Inflamm. Bowel Dis. 6: 270-274 (2000). *

• Revel-Vilk S, Tamary H, Broide E, Zoldan M, Dinari G, Zahavi I, Yaniv I, Shamir R. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur. J. Pediatr. 159: 585-589 (2000).

• Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am. J. Gastroenterol. 95: 868-877 (2000). *

• Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann. Med. 32: 94-106 (2000).

• Reynoso-Paz S, Coppel RL, Nakanuma Y, Gershwin ME. Primary biliary cirrhosis. Connecting molecular biology to clinical medicine. Clin. Rev. Allergy Immunol. 18: 241-262 (2000).

• Reynoso-Paz S, Leung PS, Van De Water J, Tanaka A, Munoz S, Bass N, Lindor K, Donald PJ, Coppel RL, Ansari AA, Gershwin ME. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Hepatology 31: 24-29 (2000). *

• Riestra S, Fernandez E, Rodrigo L, Garcia S, Ocio G. Prevalence of coeliac disease in the general population of northern Spain. Strategies of serologic screening. Scand. J. Gastroenterol. 35: 398-402 (2000). *

• Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J. Hepatol. 32: 142-153 (2000). *

• Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc. Natl. Acad. Sci. U.S.A. 97: 6001-6006 (2000). *

• Rink L, Gabriel P. Zinc and the immune system. Proc. Nutr. Soc. 59: 541-552 (2000). *

• Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, Green T, Brettin TS, Stone V, Bull SB, Bitton A, Williams CN, Greenberg GR, Cohen Z, Lander ES, Hudson TJ, Siminovitch KA. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet. 66: 1863-1870 (2000). *

• Ritter JK. Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem. Biol. Interact. 129: 171-193 (2000).

• Rivera A, White K, Stohr H, Steiner K, Hemmrich N, Grimm T, Jurklies B, Lorenz B, Scholl HP, Apfelstedt-Sylla E, Weber BH. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am. J. Hum. Genet. 67: 800-813 (2000). *

• Robinson J, Malik A, Parham P, Bodmer JG, Marsh SG. IMGT/HLA database - a sequence database for the human major histocompatibility complex. Tissue Antigens 55: 280-287 (2000). *

• Rocken C, Pross M, Brucks U, Ridwelski K, Roessner A. Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes). Arch. Pathol. Lab. Med. 124: 1704-1706 (2000). *

• Rodrigues CM, Steer CJ. Mitochondrial membrane perturbations in cholestasis. J. Hepatol. 32: 135-141 (2000). *

• Rodrigues CM, Stieers CL, Keene CD, Ma X, Kren BT, Low WC, Steer CJ. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. J. Neurochem. 75: 2368-2379 (2000). *

• Rodrigues ML, Travassos LR, Miranda KR, Franzen AJ, Rozental S, de Souza W, Alviano CS, Barreto-Bergter E. Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect. Immun. 68: 7049-7060 (2000). *

• Roe DL, Lewis RE, Cruse JM. Association of HLA-DQ and -DR alleles with protection from or infection with HIV-1. Exp. Mol. Pathol. 68: 21-28 (2000). *

• Roeder E. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie 55: 711-726 (2000).

• Roediger WE, Babidge WJ. Thiol methyltransferase activity in inflammatory bowel disease. Gut 47: 206-210 (2000). *

• Rogy MA, Beinhauer BG, Reinisch W, Huang L, Pokieser P. Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum. Hum. Gene Ther. 11: 1731-1741 (2000).

• Rojas CV, Martinez JI, Flores I, Hoffman DR, Uauy R. Gene expression analysis in human fetal retinal explants treated with docosahexaenoic acid. Invest. Ophthalmol. Vis. Sci. 44: 3170-3177 (2000). *

• Roland JT. Autoimmune inner ear disease. Curr. Rheumatol. Rep. 2: 171-174 (2000).

• Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J. Nutr. 130: 396S-402S (2000). *

• Rolo AP, Oliveira PJ, Moreno AJ, Palmeira CM. Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy. Toxicol. Sci. 57: 177-185 (2000). *

• Roma MG, Milkiewicz P, Elias E, Coleman R. Control by signaling modulators of the sorting of canalicular transporters in rat hepatocyte couplets: role of the cytoskeleton. Hepatology 32: 1342-1356 (2000). *

• Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85: 9-18 (2000).

• Romagnuolo J, Jewell LD, Kneteman NM, Bain VG. Graft-versus-host disease after liver transplantation complicated by systemic aspergillosis with pancarditis. Can. J. Gastroenterol. 14: 637-640 (2000). *

• Romero MF, Henry D, Nelson S, Harte PJ, Dillon AK, Sciortino CM. Cloning and characterization of a Na+-driven anion exchanger (NDAE1). A new bicarbonate transporter. J. Biol. Chem. 275: 24552-24559 (2000). *

• Romey MC, Pallares-Ruiz N, Mange A, Mettling C, Peytavi R, Demaille J, Claustres M. A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression. J. Biol. Chem. 275: 3561-3567 (2000). *

• Romiti ML, Colognesi C, Cancrini C, Mas A, Berrino M, Salvatori F, Orlandi P, Jansson M, Palomba E, Plebani A, Bertran JM, Hernandez M, de Martino M, Amoroso A, Tovo PA, Rossi P, Espanol T, Scarlatti G. Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection. Mol. Med. 6: 28-36 (2000).

• Roncarolo MG, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12: 676-683 (2000).

• Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 43: 129-134 (2000). *

• Roozendaal C, de Jong MA, van den Berg AP, van Wijk RT, Limburg PC, Kallenberg CG. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. J. Hepatol. 32: 734-741 (2000). *

• Ropponen KM, Kellokoski JK, Lipponen PK, Eskelinen MJ, Alanne L, Alhava EM, Kosma VM. Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis. Scand. J. Gastroenterol. 35: 1204-1211 (2000). *

• Roseau E. Crohn's disease: prevention of relapse with methotrexate or growth hormone. Presse. Med. 29: 1652-1653 (2000).

• Rosella O, Sinclair A, Gibson PR. Polyunsaturated fatty acids reduce non-receptor-mediated transcellular permeation of protein across a model of intestinal epithelium in vitro. J. Gastroenterol. Hepatol. 15: 626-631 (2000). *

• Rosenecker J. Relations between the frequency of the DeltaF 508 mutation and the course of pulmonary disease in cystic fibrosis patients infected with Pseudomonas aeruginosa. Eur. J. Med. Res. 5: 356-359 (2000).

• Rosenfield RL, Deplewski D, Greene ME. Peroxisome proliferator-activated receptors and skin development. Horm. Res. 54: 269-274 (2000).

• Rosenthal P. Digestive disease week 2000. American association for the study of liver diseases. IDrugs 3: 868-871 (2000).

• Rosenthal RL. Effectiveness of altering serum cholesterol levels without drugs. Proc. Bayl. Univ. Med. Cent. 13: 351-355 (2000).

• Rosmorduc O, Poupon R, Nion I, Wendum D, Feder J, Bereziat G, Hermelin B. Differential HFE allele expression in hemochromatosis heterozygotes. Gastroenterology 119: 1075-1086 (2000). *

• Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242 (2000). *

• Rossmann H, Alper SL, Nader M, Wang Z, Gregor M, Seidler U. Three 5'-variant mRNAs of anion exchanger AE2 in stomach and intestine of mouse, rabbit, and rat. Ann. N. Y. Acad. Sci. 915: 81-91 (2000). *

• Rothermund L, Leggewie S, Schwarz A, Thone-Reinecke C, Cho JJ, Bauer C, Paul M, Neumayer HH, Schuppan D, Hocher B. Regulation of the hepatic endothelin system in advanced biliary fibrosis in rats. Clin. Chem. Lab. Med. 38: 507-512 (2000).

• Roudier J. Association of MHC and rheumatoid arthritis. Association of RA with HLA-DR4: the role of repertoire selection. Arthritis Res. 2: 217-220 (2000). *

• Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am. J. Gastroenterol. 95: 2000-2008 (2000). *

• Rowley MJ, Scealy M, Whisstock JC, Jois JA, Wijeyewickrema LC, Mackay IR. Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display. J. Immunol. 164: 3413-3419 (2000). *

• Royston P. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat. Med. 19: 1831-1847 (2000). *

• Rozenkov V. Antineutrophil cytoplasmic cntibodies (ANCA): pathophysiological aspects, investigation opportunities and diagnostic role. THE CANBERRA HOSPITAL, AUSTRALIA: PATHOLOGY NEWSLETTER NUMBER 53 p. 4-11 (2000). *

• Rubio CA. Qualitative and quantitative differences between bile ducts in chronic hepatitis and in primary biliary cirrhosis. J. Clin. Pathol. 53: 765-769 (2000). *

• Rubio CA. A simple method to evaluate the thickness of collagen in collagenous colitis. Scand. J. Gastroenterol. 35: 223-224 (2000). *

• Rubio JP, Speed TP, Bahlo M, Kilpatrick TJ, Foote SJ. The current state of multiple sclerosis genetic research. Ann. Acad. Med. Singapore 29: 322-330 (2000).

• Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, Potter J, Elia AJ, Mak TW. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14: 854-862 (2000). *

• Rudwaleit M, Braun J, Sieper J. Treatment of reactive arthritis: a practical guide. BioDrugs 13: 21-28 (2000).

• Rujescu D, Giegling I, Dahmen N, Szegedi A, Anghelescu I, Gietl A, Schafer M, Muller-Siecheneder F, Bondy B, Moller HJ. Association study of suicidal behavior and affective disorders with a genetic polymorphism in ABCG1, a positional candidate on chromosome 21q22.3. Neuropsychobiology 42 Suppl. 1: 22-25 (2000).

• Rumalla A, Petersen BT. Diagnosis and therapy of biliary tract malignancy. Semin. Gastrointest. Dis. 11: 168-173 (2000).

• Rumi G, Szabo I, Vincze A, Matus Z, Toth G, Mozsik G. Decrease of serum carotenoids in Crohn's disease. J. Physiol. Paris 94: 159-161 (2000).

• Runge D, Kohler C, Kostrubsky VE, Jager D, Lehmann T, Runge DM, May U, Stolz DB, Strom SC, Fleig WE, Michalopoulos GK. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes. Biochem. Biophys. Res. Commun. 273: 333-341 (2000). *

• Ruoslahti E, Rajotte D. An address system in the vasculature of normal tissues and tumors. Annu. Rev. Immunol. 18: 813-827 (2000). *

• Russell RM. The vitamin A spectrum: from deficiency to toxicity. Am. J. Clin. Nutr. 71: 878-884 (2000). *

• Russo K, Hoch S, Dima C, Varga J, Teodorescu M. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. J. Rheumatol. 27: 142-148 (2000).

• Rust C, Rau H, Gerbes AL, Pape GR, Haller M, Kramling H, Schildberg FW, Paumgartner G, Beuers U. Liver transplantation in primary biliary cirrhosis: risk assessment and 11-year follow-up. Digestion 62: 38-43 (2000).

• Rust C, Sauter GH, Oswald M, Buttner J, Kullak-Ublick GA, Paumgartner G, Beuers U. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man. Eur. J. Clin. Invest. 30: 135-139 (2000).

• Rutgeerts P. Infliximab is the drug we have been waiting for in Crohn's disease. Inflamm. Bowel Dis. 6: 132-136 (2000). *

• Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology 119: 243-251 (2000). *

• Saarinen S, Olerup O, Broome U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 95: 3195-3199 (2000). *

• Saez J, Martinez J, Garcia C, Grino P, Perez-Mateo M. Idiopathic pancreatitis associated with ulcerative colitis. Am. J. Gastroenterol. 95: 3004-3005 (2000). *

• Saify ZS, Hassan S, Arif M, Ahmad F, Chishti KA, Siddiqui S. A comparative study of omega-3-fatty acids obtained from marine fish and bezafibrate alone and in combination as hypolipidemic agents. Pak. J. Pharm. Sci. 13: 1-11 (2000).

• Sakai Y, Demay MB. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. Endocrinology 141: 2043-2049 (2000). *

• Sakamaki S, Takayanagi N, Yoshizaki N, Hayashi S, Takayama T, Kato J, Kogawa K, Yamauchi N, Takemoto N, Nobuoka A, Ayabe T, Kohgo Y, Niitsu Y. Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells. Gut 47: 236-241 (2000). *

• Sakisaka S, Koga H, Sasatomi K, Ohishi M, Kawaguchi T, Harada M, Taniguchi E, Uchimura Y, Ueno T, Sata M, Tanikawa K. Ursodeoxycholic acid reduces expression of heat shock proteins in primary biliary cirrhosis. Liver 20: 78-87 (2000). *

• Sakoguchi T, Nishizaki T, Suehiro T, Nomoto K, Hashimoto K, Ohta R, Minagawa R, Hiroshige S, Terashi T, Ninomiya M, Nagata S, Shiotani S, Shimada M, Sugimachi K. Living donor liver transplantation in Kyushu University. Fukuoka Igaku Zasshi 91: 198-202 (2000).

• Sakuma T, Takai M, Endo Y, Kuroiwa M, Ohara A, Jarukamjorn K, Honma R, Nemoto N. A novel female-specific member of the CYP3A gene subfamily in the mouse liver. Arch. Biochem. Biophys. 377: 153-162 (2000). *

• Salamat N, Saleem M, Ahmed T. Lupus coagulant and anticardiolipin antibodies in patients with recurrent fetal loss: a case control study. Ann. Saudi Med. 20: 450-453 (2000).

• Saleh MN, Gutheil J, Moore M, Bunch PW, Butler J, Kunkel L, Grillo-Lopez AJ, LoBuglio AF. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. Semin. Oncol. 27: S99-S103 (2000).

• Salky B. Is laparoscopic surgery for most, a few, or no patients with Crohn's disease? Inflamm. Bowel Dis. 6: 40-42 (2000). *

• Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, Farnetti E, Brini M, Portioli I. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J. Rheumatol. 27: 1215-1221 (2000).

• Salvi SS. Liver disease and pulmonary hypertension. Gut 47: 595 (2000). *

• Salzmann J, Lightman S. The potential of newer immunomodulating drugs in the treatment of uveitis: a review. BioDrugs 13: 397-408 (2000).

• Sanchez-Mete L, Attili AF. Cholelithiasis: genetic hypothesis. Minerva Gastroenterol. Dietol. 46: 45-55 (2000).

• Sandborn W, McLeod R, Jewell D. Pharmacotherapy for inducing and maintaining remission in pouchitis. Cochrane Database Syst. Rev. 2: CD001176 (2000). *

• Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst. Rev. 2: CD000545 (2000). *

• Sandborn WJ. Therapy for Crohn disease. Curr. Opin. Gastroenterol. 16: 318-323 (2000).

• Sandborn WJ. Steroid-dependent Crohn's disease. Can. J. Gastroenterol. 14 Suppl. C: 17C-22C (2000).

• Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen ML, Nelson MN, Wexler HM. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child. Neurol. 15: 429-435 (2000).

• Sands BE. Therapy of inflammatory bowel disease. Gastroenterology 118: S68-S82 (2000).

• Sandstad O, Osnes T, Urdal P, Skar V, Osnes M. Brown pigment stones in the common bile duct: reduced bilirubinate diconjugate in bile. Scand. J. Gastroenterol. 35: 198-203 (2000). *

• Sane SP, Bhatt AD. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management. J. Assoc. Physicians India 48: 999-1003 (2000).

• Sanjabi S, Hoffmann A, Liou HC, Baltimore D, Smale ST. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. U.S.A. 97: 12705-12710 (2000). *

• Sanjeevi CB, Miller EN, Dabadghao P, Rumba I, Shtauvere A, Denisova A, Clayton D, Blackwell JM. Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum. 43: 1397-1404 (2000). *

• Santos PS, Oliveira L, Moraes MF, Da Graca JP, Monteiro E, Abecasis P, De Oliveira LN. Granulomatous uveitis, CREST syndrome, and primary biliary cirrhosis. Br. J. Ophthalmol. 84: 548-549 (2000). *

• Sapey T, Mendler MH, Guyader D, Morio O, Corbinais S, Deugnier Y, Brissot P. Respective value of alkaline phosphatase, gamma-glutamyl transpeptidase and 5' nucleotidase serum activity in the diagnosis of cholestasis: a prospective study of 80 patients. J. Clin. Gastroenterol. 30: 259-263 (2000).

• Sapone A, Peters JM, Sakai S, Tomita S, Papiha SS, Dai R, Friedman FK, Gonzalez FJ. The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants. Pharmacogenetics 10: 321-333 (2000).

• Sartor RB. New therapeutic approaches to Crohn's disease. N. Engl. J. Med. 342: 1664-1666 (2000).

• Saruhan-Direskeneli G, Uyar FA, Bas F, Gunoz H, Bundak R, Saka N, Darendeliler F. HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey. Hum. Immunol. 61: 296-302 (2000).

• Sarvetnick N. Etiology of autoimmunity. Immunol. Res. 21: 357-362 (2000).

• Sasaki K, Tsutsumi A, Wakamiya N, Ohtani K, Suzuki Y, Watanabe Y, Nakayama N, Koike T. Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand. J. Gastroenterol. 35: 960-965 (2000). *

• Sasaki M, Ansari A, Pumford N, van de Water J, Leung PS, Humphries KM, Szweda LI, Nakanuma Y, Roche TE, Coppel RL, Bach JF, Gershwin ME. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic. J. Autoimmun. 15: 51-60 (2000). *

• Sasaki M, Ansari AA, Nakanuma Y, Coppel RL, Keeffe EB, Gershwin ME. The immunopathology of primary biliary cirrhosis: thoughts for the millennium. Arch. Immunol. Ther. Exp. (Warsz.) 48: 1-10 (2000). *

• Sasaki M, Nakamura S, Ohyama Y, Shinohara M, Ezaki I, Hara H, Kadena T, Kishihara K, Yamamoto K, Nomoto K, Shirasuna K. Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjogren's syndrome. J. Immunol. 164: 2823-2831 (2000). *

• Sasaki T, Kanke Y, Nagahashi M, Toyokawa M, Matsuda M, Shimizu J, Misawa Y, Takita T. Dietary docosahexaenoic acid can alter the surface expression of CD4 and CD8 on T cells in peripheral blood. J. Agric. Food Chem. 48: 1047-1049 (2000). *

• Sato M, Watanabe Y, Tokui K, Kawachi K, Sugata S, Ikezoe J. CT-guided treatment of ultrasonically invisible hepatocellular carcinoma. Am. J. Gastroenterol. 95: 2102-2106 (2000). *

• Saubermann LJ. pANCA - is this your final answer? Inflamm. Bowel Dis. 6: 332-333 (2000). *

• Saubermann LJ, Beck P, De Jong YP, Pitman RS, Ryan MS, Kim HS, Exley M, Snapper S, Balk SP, Hagen SJ, Kanauchi O, Motoki K, Sakai T, Terhorst C, Koezuka Y, Podolsky DK, Blumberg RS. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119: 119-128 (2000). *

• Sauer P, Stiehl A, Fitscher BA, Riedel HD, Benz C, Kloters-Plachky P, Stengelin S, Stremmel W, Kramer W. Downregulation of ileal bile acid absorption in bile-duct-ligated rats. J. Hepatol. 33: 2-8 (2000). *

• Saurin JC, Joly-Pharaboz MO, Pernas P, Henry L, Ponchon T, Madjar JJ. Detection of Ki-ras gene point mutations in bile specimens for the differential diagnosis of malignant and benign biliary strictures. Gut 47: 357-361 (2000). *

• Savarino V, Sulli A, Zentilin P, Raffaella Mele M, Cutolo M. No evidence of an association between Helicobacter pylori infection and Raynaud phenomenon. Scand. J. Gastroenterol. 35: 1251-1254 (2000). *

• Savas U, Wester MR, Griffin KJ, Johnson EF. Rabbit pregnane X receptor is activated by rifampicin. Drug Metab. Dispos. 28: 529-537 (2000). *

• Sawada-Hase N, Kiyohara T, Miyagawa J, Ueyama H, Nishibayashi H, Murayama Y, Kashihara T, Nakahara M, Miyazaki Y, Kanayama S, Nezu R, Shinomura Y, Matsuzawa Y. An increased number of CD40-high monocytes in patients with Crohn's disease. Am. J. Gastroenterol. 95: 1516-1523 (2000). *

• Scarpace PJ, Matheny M, Moore RL, Kumar MV. Modulation of uncoupling protein 2 and uncoupling protein 3: regulation by denervation, leptin and retinoic acid treatment. J. Endocrinol. 164: 331-337 (2000). *

• Schafer DF, Sorrell MF. Together we stand: liver units in the new millennium. Semin. Liver Dis. 20: 409-410 (2000).

• Schaffner F. The history of liver disease at The Mount Sinai Hospital. Mt. Sinai J. Med. 67: 76-83 (2000). *

• Scharek L, Hartmann L, Heinevetter L, Blaut M. Bifidobacterium adolescentis modulates the specific immune response to another human gut bacterium, Bacteroides thetaiotaomicron, in gnotobiotic rats. Immunobiology 202: 429-441 (2000).

• Scheper HJ, Brand HS. Oral aspects of Crohn's disease. Ned. Tijdschr. Tandheelkd. 107: 413-416 (2000).

• Schiano TD, Bodian C, Schwartz ME, Glajchen N, Min AD. Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. Transplantation 69: 545-550 (2000).

• Schiedermaier P, Hansen S, Asdonk D, Brensing K, Sauerbruch T. Effects of ursodeoxycholic acid on splanchnic and systemic hemodynamics. A double-blind, cross-over, placebo-controlled study in healthy volunteers. Digestion 61: 107-112 (2000).

• Schiller LR. Diarrhea. Med. Clin. North Am. 84: 1259-1274, x (2000).

• Schilling F, KesslerS. SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases. Z. Rheumatol. 59: 1-28 (2000).

• Schjerven H, Brandtzaeg P, Johansen FE. Mechanism of IL-4-mediated up-regulation of the polymeric Ig receptor: role of STAT6 in cell type-specific delayed transcriptional response. J. Immunol. 165: 3898-3906 (2000). *

• Schlottman K, Wachs FP, Krieg RC, Kullmann F, Scholmerich J, Rogler G. Characterization of bile salt-induced apoptosis in colon cancer cell lines. Cancer Res. 60: 4270-4276 (2000). *

• Schmidt PT, Hartmann B, Bregenholt S, Hoist JJ, Claesson MH. Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+ T cells. Scand. J. Gastroenterol. 35: 522-527 (2000). *

• Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israel A, Rajewsky K, Pasparakis M. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell 5: 981-992 (2000). *

• Schmitz G, Kaminski WE, Orso E. ABC transporters in cellular lipid trafficking. Curr. Opin. Lipidol. 11: 493-501 (2000).

• Scholl PR. Periodic fever syndromes. Curr. Opin. Pediatr. 12: 563-566 (2000).

• Schoonjans K, Brendel C, Mangelsdorf D, Auwerx J. Sterols and gene expression: control of affluence. Biochim. Biophys. Acta 1529: 114-125 (2000). *

• Schottelius A, Wedel S, Weltrich R, Rohde W, Buttgereit F, Schreiber S, Lochs H. Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. Am. J. Gastroenterol. 95: 1994-1999 (2000). *

• Schreiber S. Genetics of inflammatory bowel disease: a puzzle with contradictions? Gut 47: 746-747 (2000). *

• Schreiber S. Inflammatory bowel disease: immunologic concepts. Hepatogastroenterology 47: 15-28 (2000).

• Schreiber S. Animal models: are they useful for the investigation of gastrointestinal disease? Int. J. Colorectal Dis. 15: 126 (2000). *

• Schreiber S, Fedorak RN, Nielsen OH, Wild G, Williams CN, Nikolaus S, Jacyna M, Lashner BA, Gangl A, Rutgeerts P, Isaacs K, van Deventer SJ, Koningsberger JC, Cohard M, LeBeaut A, Hanauer SB. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology 119: 1461-1472 (2000). *

• Schreiber S, Hampe J. Genomics and inflammatory bowel disease. Curr. Opin. Gastroenterol. 16: 297-305 (2000).

• Schreiber S, Hampe J, Eickhoff H, Lehrach H. Functional genomics in gastroenterology. Gut 47: 601-607 (2000). *

• Schriml LM, Dean M. Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. Genomics 64: 24-31 (2000). *

• Schroeder HW Jr. Genetics of IgA deficiency and common variable immunodeficiency. Clin. Rev. Allergy Immunol. 19: 127-140 (2000). *

• Schrumpf E, Boberg KM. Primary sclerosing cholangitis: challenges of a new millenium. Dig. Liver Dis. 32: 753-755 (2000).

• Schulte CM, Dignass AU, Goebell H, Roher HD, Schulte KM. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 119: 909-920 (2000). *

• Schultz H, Csernok E, Nikkari S, Toivanen P, Toivanen A, Gross WL. BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI molecule. Scand. J. Rheumatol. 29: 226-231 (2000). *

• Schultz H, Csernok E, Schuster A, Schmitz TS, Ernst M, Gross WL. Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding … Pediatr. Allergy Immunol. 11: 64-70 (2000). *

• Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, Shan B. Role of LXRs in control of lipogenesis. Genes Dev. 14: 2831-2838 (2000). *

• Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, Tiegs G. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am. J. Pathol. 157: 1671-1683 (2000). *

• Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 119: 234-242 (2000). *

• Schuppan D, Hahn EG. MMPs in the gut: inflammation hits the matrix. Gut 47: 12-14 (2000). *

• Schurmann G, Ochman S, Neurath MF. Colonic carcinoma associated with ulcerative colitis. Risk factors, molecular pathogenesis and surveillance. Dtsch. Med. Wochenschr. 125: 1045-1050 (2000).

• Schurmann M, Lympany PA, Reichel P, Muller-Myhsok B, Wurm K, Schlaak M, Muller-Quernheim J, du Bois RM, Schwinger E. Familial sarcoidosis is linked to the major histocompatibility complex region. Am. J. Respir. Crit. Care Med. 162: 861-864 (2000). *

• Schwamborn K, Weil R, Courtois G, Whiteside ST, Israel A. Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-kappa B-independent pathway. J. Biol. Chem. 275: 22780-22789 (2000). *

• Schwandner R, Yamaguchi K, Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J. Exp. Med. 191: 1233-1240 (2000). *

• Schwartz D, Shafran I, Romero C, Piromalli C, Biggerstaff J, Naser N, Chamberlin W, Naser SA. Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients. Clin. Microbiol. Infect. 6: 303-307 (2000).

• Schwarz M, Wright AC, Davis DL, Nazer H, Bjorkhem I, Russell DW. The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis. J. Clin. Invest. 106: 1175-1184 (2000). *

• Scolapio JS, Raimondo M, Lankisch M. Nutritional support in pancreatitis. Scand. J. Gastroenterol. 35: 1010-1015 (2000). *

• Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 46 Suppl. 1: i1-i8 (2000). *

• Seelig A, Blatter XL, Wohnsland F. Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. Int. J. Clin. Pharmacol. Ther. 38: 111-121 (2000).

• Seewaldt S, Thomas HE, Ejrnaes M, Christen U, Wolfe T, Rodrigo E, Coon B, Michelsen B, Kay TW, von Herrath MG. Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 49: 1801-1909 (2000). *

• Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottiere HM, Galmiche JP. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47: 397-403 (2000). *

• Seibold F. Indications for preoperative ERCP. Swiss Surg. 6: 216-219 (2000).

• Seibold F, Egger B, Goke B. New knowledge on the pathogenesis of chronic inflammatory bowel diseases: what have we learned from colitis animal models? Schweiz. Med. Wochenschr. 130: 749-755 (2000).

• Seidman EG. Recent advances in the diagnosis and treatment of pediatric inflammatory bowel disease. Curr. Gastroenterol. Rep. 2: 248-252 (2000).

• Seitz HK. Alcohol and retinoid metabolism. Gut 47: 748-750 (2000). *

• Selby W. Pathogenesis and therapeutic aspects of Crohn's disease. Vet. Microbiol. 77: 505-511 (2000). *

• Sellebjerg F, Jensen J, Madsen HO, Svejgaard A. HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis. Tissue Antigens 55: 312-318 (2000). *

• Sellebjerg F, Madsen HO, Jensen CV, Jensen J, Garred P. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J. Neuroimmunol. 102: 98-106 (2000).

• Semrad CE. Bone mass and gastrointestinal disease. Ann. N. Y. Acad. Sci. 904: 564-570 (2000).

• Sentongo TA, Stettler N, Christian A, Han PD, Stallings VA, Baldassano RN. Growth after intestinal resection for Crohn's disease in children, adolescents, and young adults. Inflamm. Bowel Dis. 6: 265-269 (2000). *

• Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192: 1197-1204 (2000). *

• Shaheen NJ, Crosby MA, O'Malley MS, Murray SC, Sandler RS, Galanko JA, Ransohoff DF, Klenzak JS. The practices and attitudes of primary care nurse practitioners and physician assistants with respect to colorectal cancer screening. Am. J. Gastroenterol. 95: 3259-3265 (2000). *

• Shakhov AN, Rubtsov AV, Lyakhov IG, Tumanov AV, Nedospasov SA. SPLASH (PLA2IID), a novel member of phospholipase A2 family, is associated with lymphotoxin deficiency. Genes Immun. 1: 191-199 (2000). *

• Shamim EA, Miller FW. Familial autoimmunity and the idiopathic inflammatory myopathies. Curr. Rheumatol. Rep. 2: 201-211 (2000).

• Shanahan F. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for). Inflamm. Bowel Dis. 6: 137-139 (2000). *

• Shanahan F. Immunological and genetic links in Crohn's disease. Gut 46: 6-7 (2000). *

• Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm. Bowel Dis. 6: 107-115 (2000). *

• Shanahan F, Nally K, O'Sullivan GC. Turning on T-cell death and turning off Crohn's disease. Gastroenterology 119: 1166-1168 (2000). *

• Shangraw RE, Jahoor F. Lipolysis and lipid oxidation in cirrhosis and after liver transplantation. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G967-G973 (2000). *

• Shao JS, Engle M, Xie Q, Schmidt RE, Narisawa S, Millan JL, Alpers DH. Effect of tissue non-specific alkaline phosphatase in maintenance of structure of murine colon and stomach. Microsc. Res. Tech. 51: 121-128 (2000). *

• Sharma VK, Corder FA, Fancher J, Howden CW. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test. Am. J. Gastroenterol. 95: 3629-3632 (2000). *

• Sharma VK, Vasudeva R, Howden CW. Changes in colorectal cancer over a 15-year period in a single United States city. Am. J. Gastroenterol. 95: 3615-3619 (2000). *

• Sheikh RA, Prindiville TP, Yenamandra S, Munn RJ, Ruebner BH. Microsporidial AIDS cholangiopathy due to Encephalitozoon intestinalis: case report and review. Am. J. Gastroenterol. 95: 2364-2371 (2000). *

• Shemesh E, Lurie S, Stuber ML, Emre S, Patel Y, Vohra P, Aromando M, Shneider BL. A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics 105: e29 (2000). *

• Shen X, Hong F, Nguyen VA, Gao B. IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3. FEBS Lett. 480: 132-136 (2000). *

• Sherlock S. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis. Clin. Liver Dis. 4: 97-113 (2000).

• Shetty K, Wu GY, Wu CH. Gene therapy of hepatic diseases: prospects for the new millennium. Gut 46: 136-139 (2000). *

• Shevach EM. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18: 423-449 (2000). *

• Sheweita SA. Drug-metabolizing enzymes: mechanisms and functions. Curr. Drug Metab. 1: 107-132 (2000).

• Shi Y, Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, Barber MC, Wang W, Wathen K, Hodge V, Fisher CL, Olsen H, Ruben SM, Knyazev I, Cho YH, Kao V, Wilkinson KA, Carrell JA, Ebner R. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J. Biol. Chem. 275: 19167-19176 (2000). *

• Shibata T, Takeuchi S, Yokota S, Kakimoto K, Yonemori F, Wakitani K. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br. J. Pharmacol. 130: 495-504 (2000). *

• Shibue T, Tsuchiya N, Komata T, Matsushita M, Shiota M, Ohashi J, Wakui M, Matsuta K, Tokunaga K. Tumor necrosis factor alpha 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis. Arthritis Rheum. 43: 753-757 (2000). *

• Shields JW. The functional evolution of GALT: a review. Lymphology 33: 47-57 (2000).

• Shigematsu H, Shimoda S, Nakamura M, Matsushita S, Nishimura Y, Sakamoto N, Ichiki Y, Niho Y, Gershwin ME, Ishibashi H. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens. Hepatology 32: 901-909 (2000). *

• Shikuwa S, Omagari K, Mizuta Y, Murase K, Osabe M, Yoshimura M, Ohfukuji M, Takehara Y, Isomoto H, Ito M, Shimokawa I, Kohno S. Primary biliary cirrhosis associated with idiopathic retroperitoneal fibrosis. J. Gastroenterol. 35: 646-648 (2000). *

• Shimada M, Hasegawa H, Gion T, Utsunomiya T, Shirabe K, Takenaka K, Otsuka T, Maehara Y, Sugimachi K. The role of telomerase activity in hepatocellular carcinoma. Am. J. Gastroenterol. 95: 748-752 (2000). *

• Shimoda S, Nakamura M, Shigematsu H, Tanimoto H, Gushima T, Gershwin ME, Ishibashi H. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 31: 1212-1216 (2000). *

• Shimonishi T, Sasaki M, Nakanuma Y. Precancerous lesions of intrahepatic cholangiocarcinoma. J. Hepatobiliary Pancreat. Surg. 7: 542-550 (2000).

• Shiozawa S, Cummins JM, Fox PC. Opening the flood gates: interferon-alpha treatment for Sjogren's syndrome. BioDrugs 13: 305-311 (2000).

• Shirazi T, Longman RJ, Corfield AP, Probert CS. Mucins and inflammatory bowel disease. Postgrad. Med. J. 76: 473-478 (2000). *

• Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? J. Autoimmun. 14: 1-10 (2000). *

• Shull GE, Miller ML, Schultheis PJ. Lessons from genetically engineered animal models. VIII. Absorption and secretion of ions in the gastrointestinal tract. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G185-G190 (2000). *

• Siew LF, Basit AW, Newton JM. The potential of organic-based amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems. AAPS PharmSciTech. 1: E22 (2000).

• Siewert E, Bort R, Kluge R, Heinrich PC, Castell J, Jover R. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 32: 49-55 (2000). *

• Sigrist S, Bedoucha M, Boelsterli UA. Down-regulation by troglitazone of hepatic tumor necrosis factor-alpha and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes. Biochem. Pharmacol. 60: 67-75 (2000). *

• Silva EM, Fernandes MI, Galvao LC, Sawamura R, Donadi EA. Human leukocyte antigen class II alleles in white Brazilian patients with celiac disease. J. Pediatr. Gastroenterol. Nutr. 31: 391-394 (2000). *

• Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284: 1247-1255 (2000). *

• Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J. Surg. 24: 851-856 (2000). *

• Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 47: 211-214 (2000). *

• Simopoulos AP. Human requirement for n-3 polyunsaturated fatty acids. Poult. Sci. 79: 961-970 (2000). *

• Simpson KW, Strauss-Ayali D, Scanziani E, Straubinger RK, McDonough PL, Straubinger AF, Chang YF, Domeneghini C, Arebi N, Calam J. Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats. Infect. Immun. 68: 779-790 (2000). *

• Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102: 731-744 (2000). *

• Sinclair AJ, Murphy KJ, Li D. Marine lipids: overview "news insights and lipid composition of Lyprinol". Allerg. Immunol. (Paris) 32: 261-271 (2000).

• Sinclair CJ, Chi KD, Subramanian V, Ward KL, Green RM. Functional expression of a high affinity mammalian hepatic choline/organic cation transporter. J. Lipid Res. 41: 1841-1848 (2000). *

• Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degre M, Rollag H. Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection. Scand. J. Immunol. 51: 354-360 (2000). *

• Singal DP, Li J, Zhu Y, Zhang G. NRAMP1 gene polymorphisms in patients with rheumatoid arthritis. Tissue Antigens 55: 44-47 (2000). *

• Sinski E. Resistance to intestinal opportunistic infections using Cryptosporidium sp. as an example. Wiad. Parazytol. 46: 29-40 (2000).

• Sir O, Fazal N, Choudhry MA, Gamelli RL, Sayeed MM. Neutrophil depletion prevents intestinal mucosal permeability alterations in burn-injured rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278: R1224-R1231 (2000). *

• Sladek R, Giguere V. Orphan nuclear receptors: an emerging family of metabolic regulators. Adv. Pharmacol. 47: 23-87 (2000).

• Slatkin M, Rannala B. Estimating allele age. Annu. Rev. Genomics Hum. Genet. 1: 225-249 (2000). *

• Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA, McKinley MJ. A preliminary study of growth hormone therapy for Crohn's disease. N. Engl. J. Med. 342: 1633-1637 (2000).

• Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, Israel A, Heiss NS, Klauck SM, Kioschis P, Wiemann S, Poustka A, Esposito T, Bardaro T, Gianfrancesco F, Ciccodicola A, D'Urso M, Woffendin H, Jakins T, Donnai D, Stewart H, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405: 466-472 (2000). *

• Smale S, Tibble J, Bjarnason I. Small intestinal permeability. Curr. Opin. Gastroenterol. 16: 134-139 (2000).

• Smith AJ, van Helvoort A, van Meer G, Szabo K, Welker E, Szakacs G, Varadi A, Sarkadi B, Borst P. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J. Biol. Chem. 275: 23530-23539 (2000). *

• Smith ML, Hawcroft G, Hull MA. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur. J. Cancer 36: 664-674 (2000). *

• Smyth RL, Croft NM, O'Hea U, Marshall TG, Ferguson A. Intestinal inflammation in cystic fibrosis. Arch. Dis. Child. 82: 394-399 (2000). *

• Socha P, Nowicka G, Jankowska I, Rujner J, Pawlowska J, Socha J. Apolipoprotein E polymorphism in Alagille syndrome and progressive familial intrahepatic cholestasis. Dig. Dis. Sci. 45: 675-679 (2000). *

• Soderbergh A, Rorsman F, Halonen M, Ekwall O, Bjorses P, Kampe O, Husebye ES. Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease. J. Clin. Endocrinol. Metab. 85: 460-463 (2000). *

• Soleimani M, Ulrich CD 2nd. How cystic fibrosis affects pancreatic ductal bicarbonate secretion. Med. Clin. North Am. 84: 641-655, x (2000).

• Sollid LM. Molecular basis of celiac disease. Annu. Rev. Immunol. 18: 53-81 (2000). *

• Song C, Hiipakka RA, Liao S. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 65: 423-427 (2000).

• Song J, Sohn KJ, Medline A, Ash C, Gallinger S, Kim YI. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res. 60: 3191-3199 (2000). *

• Sonnante AM, Correale M, Linsalata M, Di Leo A, Guerra V. Circulating levels of matrix metalloproteinase-9 in patients with colorectal cancer. Scand. J. Gastroenterol. 35: 671-672 (2000). *

• Sonnenberg A, Gavin MW. Timing of surgery for enterovesical fistula in Crohn's disease: decision analysis using a time-dependent compartment model. Inflamm. Bowel Dis. 6: 280-285 (2000). *

• Sorbi D, McGill DB, Thistle JL, Therneau TM, Henry J, Lindor KD. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am. J. Gastroenterol. 95: 3206-3210 (2000). *

• Sorda J, Findor J. Methotrexate therapy in primary biliary cirrhosis. Acta Gastroenterol. Latinoam. 30: 221-225 (2000).

• Soriano JB, de Cid R, Estivill X, Anto JM, Sunyer J, Otero D, Roca J, Rodriguez-Roisin R, Morell F, Rodrigo MJ, Ercilla G, Beaty TH, Lazaro C. Association study of proposed candidate genes/regions in a population of Spanish asthmatics. Eur. J. Epidemiol. 16: 745-750 (2000). *

• Sorice M, Pittoni V, Griggi T, Losardo A, Leri O, Magno MS, Misasi R, Valesini G. Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin. Exp. Immunol. 120: 301-306 (2000). *

• Spalinger J. Cystic fibrosis: current therapy. Diagnosis and treatment of hepatobiliary diseases. Schweiz. Med. Wochenschr. Suppl. 122: 17S-21S (2000).

• Sparsa A, Loustaud-Ratti V, Mousset-Hovaere M, De Vencay P, Le Brun V, Liozon E, Soria P, Bedane C, Bouyssou-Gauthier ML, Boulinguez S, Bonnetblanc JM, Vidal E. Drug-induced hypersensitivity syndrome in internal medicine: diagnostic and therapeutic traps. Eight observations. Rev. Med. Interne 21: 1052-1059 (2000).

• Specks U. What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA. Arthritis Res. 2: 263-267 (2000). *

• Sperber AD, Drossman DA. Chronic functional abdominal pain (CFAP). Curr. Treat. Options Gastroenterol. 3: 315-328 (2000).

• Spieker T, Herbst H. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. Am. J. Pathol. 157: 51-57 (2000). *

• Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis 21: 525-530 (2000). *

• Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evrovski J, Peltekova VD, Heathcote EJ. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 118: 145-151 (2000). *

• Stabel JR. Johne's disease and milk: do consumers need to worry? J. Dairy Sci. 83: 1659-1663 (2000). *

• Stahle-Backdahl M, Maim J, Veress B, Benoni C, Bruce K, Egesten A. Increased presence of eosinophilic granulocytes expressing transforming growth factor-beta1 in collagenous colitis. Scand. J. Gastroenterol. 35: 742-746 (2000). *

• Stallmach A, Chan CC, Ecker KW, Feifel G, Herbst H, Schuppan D, Zeitz M. Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 47: 415-422 (2000). *

• Stammers M, Rowen L, Rhodes D, Trowsdale J, Beck S. BTL-II: a polymorphic locus with homology to the butyrophilin gene family, located at the border of the major histocompatibility complex class II and class III regions in human and mouse. Immunogenetics 51: 373-382 (2000). *

• Starzl TE, Murase N, Demetris A, Trucco M, Fung J. The mystique of hepatic tolerogenicity. Semin. Liver Dis. 20: 497-510 (2000).

• Staykova ND, Geneva-Popova MG, Troev DD, Kuzmanova SI, Alimanska SA, Murdzheva MA. Immune profile and thyroid function in patients with rheumatoid arthritis. Folia Med. (Plovdiv.) 42: 30-33 (2000).

• Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J. Immunol. Methods 241: 33-42 (2000). *

• Stein RB, Hanauer SB. Comparative tolerability of treatments for inflammatory bowel disease. Drug Saf. 23: 429-448 (2000).

• Stein RB, Lichtenstein GR. Complications after ileal pouch-anal anastomosis. Semin. Gastrointest. Dis. 11: 2-9 (2000).

• Steinhart H. Maintenance therapy in Crohn's disease. Can. J. Gastroenterol. 14 Suppl. C: 23C-28C (2000).

• Sterling CR. Cryptosporidiosis: the treatment dilemma. J. Med. Microbiol. 49: 207-208 (2000). *

• Stern MA, Fendrick AM, McDonnell WM, Gunaratnam N, Moseley R, Chey WD. A randomized, controlled trial to assess a novel colorectal cancer screening strategy: the conversion strategy ... Am. J. Gastroenterol. 95: 2074-2079 (2000). *

• Stevceva L, Abimiku AG, Franchini G. Targeting the mucosa: genetically engineered vaccines and mucosal immune responses. Genes Immun. 1: 308-315 (2000). *

• Stevceva L, Pavli P, Husband A, Matthaei KI, Young IG, Doe WF. Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient mice. Genes Immun. 1: 213-218 (2000). *

• Stickel F, Seitz HK. The efficacy and safety of comfrey. Public Health Nutr. 3: 501-508 (2000).

• Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118: 422-430 (2000). *

• Stiehl A, Benz C, Sauer P. Primary sclerosing cholangitis. Can. J. Gastroenterol. 14: 311-315 (2000). *

• Stiehl A, Benz C, Sauer P. Therapy of primary sclerosing cholangitis. Schweiz. Rundsch. Med. Prax. 89: 975-977 (2000).

• Stokkers PC, Huibregtse K Jr, Leegwater AC, Reitsma PH, Tytgat GN, van Deventer SJ. Analysis of a positional candidate gene for inflammatory bowel disease: NRAMP2. Inflamm. Bowel Dis. 6: 92-98 (2000). *

• Stone M, Inman RD. Recent developments in the therapy of spondyloarthropathies. Curr. Rheumatol. Rep. 2: 279-281 (2000).

• Stotland PK, Radzioch D, Stevenson MM. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Pediatr. Pulmonol. 30: 413-424 (2000).

• Stotzer PO, Kilander AF. Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion 61: 165-171 (2000).

• Strain AJ, Crosby HA. Hepatic stem cells. Gut 46: 743-745 (2000). *

• Strassburg CP, Manns MP. Jaundice, genes and promoters. J. Hepatol. 33: 476-479 (2000). *

• Strassburg CP, Manns MP. Autoimmune tests in primary biliary cirrhosis. Best Pract. Res. Clin. Gastroenterol. 14: 585-599 (2000). *

• Strassburg CP, Obermayer-Straub P, Manns MP. Autoimmunity in liver diseases. Clin. Rev. Allergy Immunol. 18: 127-139 (2000).

• Straus WL, Eisen GM, Sandler RS, Murray SC, Sessions JT. Crohn's disease: does race matter? The Mid-Atlantic Crohn's Disease Study Group. Am. J. Gastroenterol. 95: 479-483 (2000). *

• Strazzabosco M, Spirli C, Okolicsanyi L. Pathophysiology of the intrahepatic biliary epithelium. J. Gastroenterol. Hepatol. 15: 244-253 (2000). *

• Streetz KL, Luedde T, Manns MP, Trautwein C. Interleukin 6 and liver regeneration. Gut 47: 309-312 (2000). *

• Stricker T, Braegger CP. Images in clinical medicine. Oral manifestations of Crohn's disease. N. Engl. J. Med. 342: 1644 (2000). *

• Struben VM, Hespenheide EE, Caldwell SH. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am. J. Med. 108: 9-13 (2000). *

• Struk B, Cai L, Zach S, Ji W, Chung J, Lumsden A, Stumm M, Huber M, Schaen L, Kim CA, Goldsmith LA, Viljoen D, Figuera LE, Fuchs W, Munier F, Ramesar R, Hohl D, Richards R, Neldner KH, Lindpaintner K. Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum. J. Mol. Med. 78: 282-286 (2000). *

• Strul H, Arber N. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins. Isr. Med. Assoc. J. 2: 695-702 (2000). *

• Struyf F, Thoelen I, Charlier N, Keyaerts E, Van der Donck I, Wuu J, Van Ranst M. Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium. Hum. Hered. 50: 304-307 (2000). *

• Struys EA, Jansen EE, de Meer K, Jakobs C. Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry. Clin. Chem. 46: 1650-1656 (2000). *

• Stuart KA, Fletcher LM, Clouston AD, Lynch SV, Purdie DM, Kerlin P, Crawford DH. Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation. Hepatology 32: 1200-1207 (2000). *

• Sturm A, Schulte C, Schatton R, Becker A, Cario E, Goebell H, Dignass AU. Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 12: 445-450 (2000).

• Su B, Sun G, Lu D, Xiao J, Hu F, Chakraborty R, Deka R, Jin L. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations. Eur. J. Hum. Genet. 8: 975-979 (2000). *

• Su CG, Stein RB, Lewis JD, Lichtenstein GR. Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits? Dig. Liver Dis. 32: 518-531 (2000).

• Sukegawa Y, Kamiya S, Yagita A, Sugamata M, Atomi Y. Induction of autoimmune colitis by Yersinia enterocolitica 60-kilodalton heat-shock protein. Scand. J. Gastroenterol. 35: 1188-1193 (2000). *

• Sukhai M, Yong A, Kalitsky J, Piquette-Miller M. Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b genes. Mol. Cell. Biol. Res. Commun. 4: 248-256 (2000). *

• Sullivan KE, Piliero LM, Goldman D, Petri MA. A TNFR2 3' flanking region polymorphism in systemic lupus erythematosus. Genes Immun. 1: 225-227 (2000). *

• Sun S, Zhang X, Tough D, Sprent J. Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons. Springer Semin. Immunopathol. 22: 77-84 (2000).

• Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, Brenner-Morton S, Mebius RE, Littman DR. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 288: 2369-2373 (2000). *

• Sund NJ, Ang SL, Sackett SD, Shen W, Daigle N, Magnuson MA, Kaestner KH. Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte. Mol. Cell. Biol. 20: 5175-5183 (2000). *

• Sung LA, Gao KM, Yee LJ, Temm-Grove CJ, Helfman DM, Lin JJ, Mehrpouryan M. Tropomyosin isoform 5b is expressed in human erythrocytes: implications of tropomodulin-TM5 or tropomodulin-TM5b complexes in the protofilament and hexagonal organization of membrane skeletons. Blood 95: 1473-1480 (2000). *

• Sutherland LR. Prevention of relapse of Crohn's disease. Inflamm. Bowel Dis. 6: 321-328 (2000). *

• Sutton CL, Kim J, Yamane A, Dalwadi H, Wei B, Landers C, Targan SR, Braun J. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 119: 23-31 (2000). *

• Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 46: 58-63 (2000). *

• Suzuki A, Sugimura K, Ohtsuka K, Hasegawa K, Suzuki K, Ishizuka K, Mochizuki T, Honma T, Narisawa R, Asakura H. Fas/Fas ligand expression and characteristics of primed CD45RO+ T cells in the inflamed mucosa of ulcerative colitis. Scand. J. Gastroenterol. 35: 1278-1283 (2000). *

• Suzuki H, Sugiyama Y. Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liver. Semin. Liver Dis. 20: 251-263 (2000).

• Suzuki S, Sakamoto S, Mitamura T, Sassa S, Kudo H, Yamashita Y. Preventive effects of sulphasalazine on colorectal carcinogenesis in mice with ulcerative colitis. In Vivo 14: 463-466 (2000).

• Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, Fort M, Kang H, Gufwoli E. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164: 5375-5382 (2000). *

• Svebak S, Sondenaa K, Hausken T, Soreide O, Hammar A, Berstad A. The significance of personality in pain from gallbladder stones. Scand. J. Gastroenterol. 35: 759-764 (2000). *

• Swartz-Basile DA, Rubin DC, Levin MS. Vitamin A status modulates intestinal adaptation after partial small bowel resection. JPEN J. Parenter. Enteral Nutr. 24: 81-88 (2000).

• Tacikowski T, Milewski B, Dzieniszewski J, Nowicka G, Walewska-Zielecka B. Comparative analysis of plasma lipoprotein components assessed by ultracentrifugation in primary biliary cirrhosis and chronic hepatitis. Med. Sci. Monit. 6: 325-329 (2000). *

• Tafazoli F, Taylor J, McFarland EG, Gianfelice D, Lepanto L, Reinhold C. New imaging techniques for the evaluation of gastrointestinal diseases. Can. J. Gastroenterol. 14 Suppl. D: 163D-180D (2000).

• Tai HL. Technology evaluation: Valspodar, Novartis AG. Curr. Opin. Mol. Ther. 2: 459-467 (2000).

• Takada I, Yu RT, Xu HE, Lambert MH, Montana VG, Kliewer SA, Evans RM, Umesono K. Alteration of a single amino acid in peroxisome proliferator-activated receptor-alpha (PPAR alpha) generates a PPAR delta phenotype. Mol. Endocrinol. 14: 733-740 (2000). *

• Takagi I, Shibamoto Y, Toda G. Primary sclerosing cholangitis (PSC). Ryoikibetsu Shokogun Shirizu 31: 226-229 (2000).

• Takahashi K, Fukushima K, Sasaki I, Ogawa H, Sato S, Naito H, Funayama Y, Matsuno S, Nagura H. Identification of cells responding to vasoactive intestinal peptide by measuring intracellular cyclic adenosine monophosphate in human colonic mucosa. Scand. J. Gastroenterol. 35: 737-741 (2000). *

• Takara M, Komiya I, Kinjo Y, Tomoyose T, Yamashiro S, Akamine H, Masuda M, Takasu N. Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. Diabetes Care 23: 975-978 (2000). *

• Takase S, Suruga K, Goda T. Regulation of vitamin A metabolism-related gene expression. Br. J. Nutr. 84 Suppl. 2: S217-S221 (2000).

• Takatori M, Iwabuchi S, Hayashi T, Takahashi Y, Suzuki M, Iino S, Maeyama S, Uchikoshi T. Congenital hepatic fibrosis with fatal cholestatic liver damage. Intern. Med. 39: 930-935 (2000). *

• Takeshita A, Ozawa Y, Chin WW. Nuclear receptor coactivators facilitate vitamin D receptor homodimer action on direct repeat hormone response elements. Endocrinology 141: 1281-1284 (2000). *

• Takeshita F, Klinman DM. CpG ODN-mediated regulation of IL-12 p40 transcription. Eur. J. Immunol. 30: 1967-1976 (2000). *

• Takeuchi F, Nabeta H, Fussel M, Conrad K, Frank KH. Association of the TNFa13 microsatellite with systemic sclerosis in Japanese patients. Ann. Rheum. Dis. 59: 293-296 (2000). *

• Takeyama K, Kodera Y, Suzawa M, Kato S. Peroxisome proliferator-activated receptor (PPAR) - structure, function, tissue distribution, gene expression. Nippon Rinsho 58: 357-363 (2000).

• Talwalkar JA, LaRusso NF, Lindor KD. Defining the relationship between autoimmune disease and primary sclerosing cholangitis. Am. J. Gastroenterol. 95: 3024-3026 (2000). *

• Talwalkar JA, Seaberg E, Kim WR, Wiesner RH. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group. Liver Transpl. 6: 753-758 (2000). *

• Talwar A, Edwards D, Moran BJ. Hepatic abscesses as the primary presentation of Crohn's disease. J. R. Army Med. Corps. 146: 37-38 (2000).

• Tamai H, Kato S, Horie Y, Ohki E, Yokoyama H, Ishii H. Effect of acute ethanol administration on the intestinal absorption of endotoxin in rats. Alcohol Clin. Exp. Res. 24: 390-394 (2000). *

• Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, Tsuji A. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun. 273: 251-260 (2000). *

• Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J. Biol. Chem. 275: 40064-40072 (2000). *

• Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagne F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes. Arthritis Res. 2: 154-164 (2000). *

• Tanaka A, Lindor K, Ansari A, Gershwin ME. Fetal microchimerisms in the mother: immunologic implications. Liver Transpl. 6: 138-143 (2000). *

• Tanaka A, Nalbandian G, Leung PS, Benson GD, Munoz S, Findor JA, Branch AD, Coppel RL, Ansari AA, Gershwin ME. Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine. Hepatology 32: 910-915 (2000). *

• Tanaka M, Saito H, Fukuda S, Sasaki Y, Munakata A, Kudo H. Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity. Scand. J. Gastroenterol. 35: 281-286 (2000). *

• Tanaka S, Iwai M, Harada Y, Morikawa T, Muramatsu A, Mori T, Okanoue T, Kashima K, Maruyama-Tabata H, Hirai H, Satoh E, Imanishi J, Mazda O. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter. Cancer Gene Ther. 7: 1241-1250 (2000).

• Tanaka Y, Naitoh M, Yoshiura K, Ookubo K, Uegaki S, Matsumoto K, Sawabe M, Esaki Y, Kino K, Tsuru M, Fukazawa T, Takubo K. Hepatocellular carcinoma arising in an elderly male with primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 12: 239-241 (2000).

• Taneja V, David CS. Autoimmunity versus tolerance: analysis using transgenic mice. Hum. Immunol. 61: 1383-1389 (2000).

• Tang W, Yi C, Kalitsky J, Piquette-Miller M. Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. Mol. Cell. Biol. Res. Commun. 4: 90-97 (2000).

• Tarlton JF, Whiting CV, Tunmore D, Bregenholt S, Reimann J, Claesson MH, Bland PW. The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis. Am. J. Pathol. 157: 1927-1935 (2000). *

• Tarnacka B, Gromadzka G, Rodo M, Mierzejewski P, Czloonkowska A. Frequency of His1069Gln and Gly1267Lys mutations in Polish Wilson's disease population. Eur. J. Neurol. 7: 495-498 (2000). *

• Tasev V, Nikolaeva E, Bulanov D, Gaidarski R. Caustic sclerosing cholangitis following injection of anthelmintics into rat bile duct. An experimental study. Khirurgiia (Sofiia) 56: 35-38 (2000).

• Tay GK, Hui J, Gaudieri S, Schmitt-Egenolf M, Martinez OP, Leelayuwat C, Williamson JF, Eiermann TH, Dawkins RL. PERB11 (MIC): a polymorphic MHC gene is expressed in skin and single nucleotide polymorphisms are associated with psoriasis. Clin. Exp. Immunol. 119: 553-558 (2000). *

• Te HS, Schiano TD, Das S, Kuan SF, DasGupta K, Conjeevaram HS, Baker AL. Donor liver uridine diphosphate (UDP)-glucuronosyltransferase-1A1 deficiency causing Gilbert's syndrome in liver transplant recipients. Transplantation 69: 1882-1886 (2000).

• Te HS, Schiano TD, Kuan SF, Hanauer SB, Conjeevaram HS, Baker AL. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Am. J. Gastroenterol. 95: 3150-3156 (2000). *

• Teefy AM, Martin JE, Kovacs MJ. Warfarin resistance due to sulfasalazine. Ann. Pharmacother. 34: 1265-1268 (2000).

• Teich N, Hoffmeister A, Keim V. Nomenclature of trypsinogen mutations in hereditary pancreatitis. Hum. Mutat. 15: 197-198 (2000). *

• Teich N, Ockenga J, Hoffmeister A, Manns M, Mossner J, Keim V. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology 119: 461-465 (2000). *

• Tenno T, Botling J, Oberg F, Jossan S, Nilsson K, Siegbahn A. The role of RAR and RXR activation in retinoid-induced tissue factor suppression. Leukemia 14: 1105-1111 (2000). *

• Terada T, Ueyama J, Ukita Y, Ohta T. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma. Liver 20: 450-457 (2000).

• Teraki Y, Hotta T, Shiohara T. Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis. Br. J. Dermatol. 143: 373-378 (2000). *

• Teramoto S, Ishii T, Ouchi Y. The mechanism of hypoxemia in liver disease with pulmonary hypertension. Chest 117: 614-615 (2000). *

• Teraoka Y, Naruse TK, Oka A, Matsuzawa Y, Shiina T, Iizuka M, Iwashita K, Ozawa A, Inoko H. Genetic polymorphisms in the cell growth regulated gene, SC1 telomeric of the HLA-C gene and lack of association of psoriasis vulgaris. Tissue Antigens 55: 206-211 (2000).

• Terjung B, Spengler U, Sauerbruch T, Worman HJ. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 119: 310-322 (2000). *

• Terracciano LM, Patzina RA, Lehmann FS, Tornillo L, Cathomas G, Mhawech P, Vecchione R, Bianchi L. A spectrum of histopathologic findings in autoimmune liver disease. Am. J. Clin. Pathol. 114: 705-711 (2000). *

• Terry SF, Davidson ME. Empowering the public to be informed consumers of genetic technologies and services. Community Genet. 3: 148-150 (2000).

• Thacher SM, Vasudevan J, Chandraratna RA. Therapeutic applications for ligands of retinoid receptors. Curr. Pharm. Des. 6: 25-58 (2000).

• Theise ND, Nimmakayalu M, Gardner R, Illei PB, Morgan G, Teperman L, Henegariu O, Krause DS. Liver from bone marrow in humans. Hepatology 32: 11-16 (2000). *

• Theodoulou FL. Plant ABC transporters. Biochim. Biophys. Acta 1465: 79-103 (2000). *

• Thiele K, Riemann D, Navarrete Santos A, Langner J, Kehlen A. Cell-cell contact of human T cells with fibroblasts changes lymphocytic mRNA expression: increased mRNA expression of interleukin-17 and interleukin-17 receptor. Eur. Cytokine Netw. 11: 53-58 (2000).

• Thomas GA, Rhodes J, Green JT, Richardson C. Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad. Med. J. 76: 273-279 (2000). *

• Thomas SR, Kharitonov SA, Scott SF, Hodson ME, Barnes PJ. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 117: 1085-1089 (2000). *

• Thompson NP, Montgomery SM, Wadsworth ME, Pounder RE, Wakefield AJ. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur. J. Gastroenterol. Hepatol. 12: 25-30 (2000).

• Thompson R, Jansen PL. Genetic defects in hepatocanalicular transport. Semin. Liver Dis. 20: 365-372 (2000).

• Thorn M, Raab Y, Larsson A, Gerdin B, Hallgren R. Intestinal mucosal secretion of basic fibroblast growth factor in patients with ulcerative colitis. Scand. J. Gastroenterol. 35: 408-412 (2000). *

• Thurman RG. Sex-related liver injury due to alcohol involves activation of Kupffer cells by endotoxin. Can. J. Gastroenterol. 14 Suppl. D: 129D-135D (2000).

• Tiainen J, Matikainen M. Long-term clinical outcome and anemia after restorative proctocolectomy for ulcerative colitis. Scand. J. Gastroenterol. 35: 1170-1173 (2000). *

• Tian E, Sawyer JR, Largaespada DA, Jenkins NA, Copeland NG, Shaughnessy JD Jr. Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene 19: 2098-2109 (2000). *

• Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 47: 506-513 (2000). *

• Tietze MK, Wuestefeld T, Paul Y, Zender L, Trautwein C, Manns MP, Kubicka S. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas. Cancer Gene Ther. 7: 1315-1323 (2000).

• Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343: 1467-1476 (2000). *

• Ting PP, Demetriou AA. Clinical experience with artificial liver support systems. Can. J. Gastroenterol. 14 Suppl. D: 79D-84D (2000).

• Tishon A, LaFace DM, Lewicki H, van Binnendijk RS, Osterhaus A, Oldstone MB. Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection. Virology 275: 286-293 (2000). *

• Tjandra K, Sharkey KA, Swain MG. Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis. Hepatology 31: 280-290 (2000). *

• Tobin KA, Steineger HH, Alberti S, Spydevold O, Auwerx J, Gustafsson JA, Nebb HI. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha. Mol. Endocrinol. 14: 741-752 (2000). *

• Toda G. Revised criteria for diagnosis of autoimmune hepatitis. Intern. Med. 39: 999-1000 (2000). *

• Toda K, Yasuda I, Nishigaki Y, Enya M, Yamada T, Nagura K, Sugihara J, Wakahara T, Tomita E, Moriwaki H. Inflammatory pseudotumor of the liver with primary sclerosing cholangitis. J. Gastroenterol. 35: 304-309 (2000). *

• Tojimbara T, Fuchinoue S, Nakajima I, Kimikawa M, Kitajima K, Ishida H, Koyama I, Utsumi K, Sannomiya A, Tsuji K, Tanaka K, Takasaki K, Agishi T. Factors affecting survival after living-related liver transplantation. Transpl. Int. 13 Suppl. 1: S136-S139 (2000).

• Tomar BS. Infantile cholestasis - advances in its understanding: new concepts. Acta Paediatr. Taiwan 41: 6-12 (2000).

• Tomobe YI, Morizawa K, Tsuchida M, Hibino H, Nakano Y, Tanaka Y. Dietary docosahexaenoic acid suppresses inflammation and immunoresponses in contact hypersensitivity reaction in mice. Lipids 35: 61-69 (2000).

• Tonacchera M, Pinchera A. Thyrotropin receptor polymorphisms and thyroid diseases. J. Clin. Endocrinol. Metab. 85: 2637-2639 (2000). *

• Tong BJ, Tan J, Tajeda L, Das SK, Chapman JA, DuBois RN, Dey SK. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia 2: 483-490 (2000).

• Torma H, Karlsson T, Michaelsson G, Rollman O, Vahlquist A. Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin. Acta Derm. Venereol. 80: 4-9 (2000).

• Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL. Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch. Dermatol. 136: 1487-1494 (2000). *

• Torra IP, Tsibulsky V, Delaunay F, Saladin R, Laudet V, Fruchart JC, Kosykh V, Staels B. Circadian and glucocorticoid regulation of Rev-erbalpha expression in liver. Endocrinology 141: 3799-3806 (2000). *

• Tortorella C, Sacco R, Orlando P, Salerno MT, Schiraldi O, Antonaci S. sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. Immunopharmacol. Immunotoxicol. 22: 19-33 (2000).

• Toshina K, Hirata I, Maemura K, Sasaki S, Murano M, Nitta M, Yamauchi H, Nishikawa T, Hamamoto N, Katsu K. Enprostil, a prostaglandin-E(2) analogue, inhibits interleukin-8 production of human colonic epithelial cell lines. Scand. J. Immunol. 52: 570-575 (2000). *

• Toussirot E, Lohse A, Wendling D, Mougin C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum. 43: 2139-2140 (2000). *

• Toussirot E, Sauvageot C, Chabod J, Ferrand C, Tiberghien P, Wendling D. The association of HLA-DM genes with rheumatoid arthritis in Eastern France. Hum. Immunol. 61: 303-308 (2000).

• Toussirot E, Wendling D, Tiberghien P, Luka J, Roudier J. Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann. Rheum. Dis. 59: 533-538 (2000). *

• Trachtenberg EA, Yang H, Hayes E, Vinson M, Lin C, Targan SR, Tyan D, Erlich H, Rotter JI. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish Caucasian populations. Hum. Immunol. 61: 326-333 (2000).

• Trauner M, Boyer JL. Cholestatic syndromes. Curr. Opin. Gastroenterol. 16: 239-250 (2000).

• Trauner M, Fickert P, Stauber RE. Hepatocellular bile salt transport: lessons from cholestasis. Can. J. Gastroenterol. 14 Suppl. D: 99D-104D (2000).

• Trautwein C, Possienke M, Schlitt HJ, Boker KH, Horn R, Raab R, Manns MP, Brabant G. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am. J. Gastroenterol. 95: 2343-2351 (2000). *

• Traynor AE, Schroeder J, Rosa RM, Cheng D, Stefka J, Mujais S, Baker S, Burt RK. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 356: 701-707 (2000). *

• Treiber G. Mycophenolate mofetil for therapy-resistant interstitial lung disease associated with ulcerative colitis. Am. J. Gastroenterol. 95: 3674-3675 (2000). *

• Triantafillidis JK, Cheracakis P, Hereti IA, Argyros N, Karra E. Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment. Am. J. Gastroenterol. 95: 3334-3336 (2000). *

• Triantafillidis JK, Emmanouilidis A, Manousos O, Nicolakis D, Kogevinas M. Clinical patterns of Crohn's disease in Greece: a follow-up study of 155 cases. Digestion 61: 121-128 (2000).

• Triantafillidis JK, Emmanouilidis A, Nicolakis D, Ifantis T, Cheracakis P, Merikas EG. Crohn's disease in the elderly: clinical features and long-term outcome of 19 Greek patients. Dig. Liver Dis. 32: 498-503 (2000).

• Trim JE, Samra SK, Arthur MJ, Wright MC, McAulay M, Beri R, Mann DA. Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. J. Biol. Chem. 275: 6657-6663 (2000). *

• Tritto G, Iaccarino V, De Martino S, D'Agostino L. A case of sclerosing cholangitis managed by a percutaneous approach. J. Clin. Gastroenterol. 30: 205-209 (2000).

• Trotter JF. Selection of donors and recipients for living donor liver transplantation. Liver Transpl. 6: S52-S58 (2000). *

• Trotter JF. Expanding the donor pool for liver transplantation. Curr. Gastroenterol. Rep. 2: 46-54 (2000).

• Trotter JF, Bak TE, Wachs ME, Everson GT, Kam I. Combined liver-pancreas transplantation in a patient with primary sclerosing cholangitis and insulin-dependent diabetes mellitus. Transplantation 70: 1469-1471 (2000).

• Trotter JF, Wachs M, Trouillot T, Steinberg T, Bak T, Everson GT, Kam I. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl. 6: 290-295 (2000).

• Truninger K. Risk groups for pancreatic and bile duct carcinomas. Schweiz. Rundsch. Med. Prax. 89: 1299-1304 (2000).

• Tse WY, Abadeh S, Jefferis R, Savage CO, Adu D. Neutrophil FcgammaRIIIb allelic polymorphism in anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis. Clin. Exp. Immunol. 119: 574-577 (2000). *

• Tsianos EV. Risk of cancer in inflammatory bowel disease (IBD). Eur. J. Intern. Med. 11: 75-78 (2000).

• Tsuchiya N, Komata T, Matsushita M, Ohashi J, Tokunaga K. New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus. Genes Immun. 1: 501-503 (2000). *

• Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawanaka H, Tomikawa M, Tanoue K, Sugimachi K. Endoscopic ligation of oesophageal varices compared with injection sclerotherapy in primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 12: 1111-1115 (2000).

• Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawanaka H, Tomikawa M, Tanoue K, Sugimachi K. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model. Scand. J. Gastroenterol. 35: 1097-1105 (2000). *

• Tsujikawa T, Urabe M, Bamba H, Andoh A, Sasaki M, Koyama S, Fujiyama Y, Bamba T. Haemorrhagic cerebral sinus thrombosis associated with ulcerative colitis: a case report of successful treatment by anticoagulant therapy. J. Gastroenterol. Hepatol. 15: 688-692 (2000). *

• Tsukada M, Schroder M, Roos TC, Chandraratna RA, Reichert U, Merk HF, Orfanos CE, Zouboulis CC. 13-cis Retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J. Invest. Dermatol. 115: 321-327 (2000). *

• Tsuneyama K, Saito K, Ruebner BH, Konishi I, Nakanuma Y, Gershwin ME. Immunological similarities between primary sclerosing cholangitis and chronic sclerosing sialadenitis: report of the overlapping of these two autoimmune diseases. Dig. Dis. Sci. 45: 366-372 (2000). *

• Tsutsui H, Matsui K, Okamura H, Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol. Rev. 174: 192-209 (2000). *

• Tu H, Okamoto AY, Shan B. FXR, a bile acid receptor and biological sensor. Trends Cardiovasc. Med. 10: 30-35 (2000).

• Tuckova L, Flegelova Z, Tlaskalova-Hogenova H, Zidek Z. Activation of macrophages by food antigens: enhancing effect of gluten on nitric oxide and cytokine production. J. Leukoc. Biol. 67: 312-318 (2000). *

• Turcu A, Leveque L, Bielefeld P, Besancenot JF, Hillon P. Adult celiac disease and hemochromatosis. Am. J. Gastroenterol. 95: 3661-3662 (2000). *

• Turner MW, Hamvas RM. Mannose-binding lectin: structure, function, genetics and disease associations. Rev. Immunogenet. 2: 305-322 (2000).

• Tutuncu NB, Erbas T, Bayraktar M, Gedik O. Multifocal idiopathic fibrosclerosis manifesting with Riedel's thyroiditis. Endocr. Pract. 6: 447-449 (2000).

• Tyndall A, Gratwohl A. Immune ablation and stem-cell therapy in autoimmune disease. Clinical experience. Arthritis Res. 2: 276-280 (2000). *

• Uauy R, Mena P, Rojas C. Essential fatty acids in early life: structural and functional role. Proc. Nutr. Soc. 59: 3-15 (2000). *

• Uchida K, Okazaki K, Konishi Y, Ohana M, Takakuwa H, Hajiro K, Chiba T. Clinical analysis of autoimmune-related pancreatitis. Am. J. Gastroenterol. 95: 2788-2794 (2000). *

• Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, Kwiatkowski D. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol. Cell. Biol. 20: 9113-9119 (2000). *

• Uddenfeldt P, Danielsson A. Primary biliary cirrhosis: survival of a cohort followed for 10 years. J. Intern. Med. 248: 292-298 (2000). *

• Ullman TA. Markov Polo: finding the costs of Crohn's in an Olmstead County pool. Inflamm. Bowel Dis. 6: 64-65 (2000). *

• Ulrich CD 2nd. Bicarbonate secretion and CFTR: continuing the paradigm shift. Gastroenterology 118: 1258-1261 (2000). *

• Ulven SM, Gundersen TE, Weedon MS, Landaas VO, Sakhi AK, Fromm SH, Geronimo BA, Moskaug JO, Blomhoff R. Identification of endogenous retinoids, enzymes, binding proteins, and receptors during early postimplantation development in mouse: important role of retinal dehydrogenase type 2 in synthesis of all-trans-retinoic acid. Dev. Biol. 220: 379-391 (2000). *

• Umar S, Scott J, Sellin JH, Dubinsky WP, Morris AP. Murine colonic mucosa hyperproliferation. I. Elevated CFTR expression and enhanced cAMP-dependent Cl(-) secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G753-G764 (2000). *

• Umesaki Y, Setoyama H. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect. 2: 1343-1351 (2000). *

• Underdahl JP, Florakis GJ, Braunstein RE, Johnson DA, Cheung P, Briggs J, Meisler DM. Propionibacterium acnes as a cause of visually significant corneal ulcers. Cornea 19: 451-454 (2000).

• Ung KA, Gillberg R, Kilander A, Abrahamsson H. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 46: 170-175 (2000). *

• Uni Z, Zaiger G, Gal-Garber O, Pines M, Rozenboim I, Reifen R. Vitamin A deficiency interferes with proliferation and maturation of cells in the chicken small intestine. Br. Poult. Sci. 41: 410-415 (2000).

• Urbanski SJ, Fogt F. Dysplasia in chronic ulcerative colitis: a molecular approach to its differential diagnosis. Int. J. Surg. Pathol. 8: 11-16 (2000). *

• Urbatsch IL, Gimi K, Wilke-Mounts S, Senior AE. Investigation of the role of glutamine-471 and glutamine-1114 in the two catalytic sites of P-glycoprotein. Biochemistry 39: 11921-11927 (2000). *

• Urbatsch IL, Julien M, Carrier I, Rousseau ME, Cayrol R, Gros P. Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein. Biochemistry 39: 14138-14149 (2000). *

• Uriz J, Gines P, Cardenas A, Sort P, Jimenez W, Salmeron JM, Bataller R, Mas A, Navasa M, Arroyo V, Rodes J. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J. Hepatol. 33: 43-48 (2000). *

• Urizar NL, Dowhan DH, Moore DD. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J. Biol. Chem. 275: 39313-39317 (2000). *

• Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N, Dagalp K. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 95: 3584-3589 (2000). *

• Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH, Carr D, Hurel SJ, James RA, Kelly WF, Kemp EH, Young ET, Weetman AP, Kendall-Taylor P, Pearce SH. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 85: 688-691 (2000). *

• Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, Kendall-Taylor P, Pearce SH. Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am. J. Hum. Genet. 66: 1710-1714 (2000). *

• Vainer B, Nielsen OH. Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin. Exp. Immunol. 121: 242-247 (2000). *

• Vainer B, Nielsen OH, Hendel J, Horn T, Kirman I. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine 12: 1531-1536 (2000).

• Vaishnavi C, Bhasin DK, Singh K. Fecal lactoferrin assay as a cost-effective tool for intestinal inflammation. Am. J. Gastroenterol. 95: 3002-3003 (2000). *

• Valdimarsson T, Toss G, Lofman O, Strom M. Three years' follow-up of bone density in adult coeliac disease: significance of secondary hyperparathyroidism. Scand. J. Gastroenterol. 35: 274-280 (2000). *

• Valenzuela-Castano A, Garcia-Lopez A, Perez-Vilches D, Rodriguez-Perez R, Gonzalez-Escribano MF, Nunez-Roldan A. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study. J. Rheumatol. 27: 571-574 (2000).

• Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, Masini A, De Castro S, Merli M. Modification of cardiac function in cirrhotic patients with and without ascites. Am. J. Gastroenterol. 95: 3200-3205 (2000). *

• Vales-Gomez M, Reyburn H, Strominger J. Molecular analyses of the interactions between human NK receptors and their HLA ligands. Hum. Immunol. 61: 28-38 (2000).

• Valgimigli L, Valgimigli M, Gaiani S, Pedulli GF, Bolondi L. Measurement of oxidative stress in human liver by EPR spin-probe technique. Free Radic. Res. 33: 167-178 (2000).

• Valla DC, Benhamou JP. Hepatic granulomas and hepatic sarcoidosis. Clin. Liver Dis. 4: 269-285, ix-x (2000).

• Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J. Hepatol. 32: 865-871 (2000). *

• Van Assche G, Rutgeerts P. Anti-TNF agents in Crohn's disease. Expert Opin. Investig. Drugs 9: 103-111 (2000).

• van Berge Henegouwen GP. Consensus for infliximab treatment of patients with Crohn's disease. Ned. Tijdschr. Geneeskd. 144: 1844-1845 (2000).

• van Blokland SC, van Helden-Meeuwsen CG, Wierenga-Wolf AF, Drexhage HA, Hooijkaas H, van de Merwe JP, Versnel MA. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjogren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis? Lab. Invest. 80: 575-585 (2000).

• van Buuren HR, van Hoogstraten HJE, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J. Hepatol. 33: 543-548 (2000). *

• van Daele PL, Pols HA. Disorders of bone metabolism in gastrointestinal and hepatic diseases. Ned. Tijdschr. Geneeskd. 144: 462-467 (2000).

• Van De Wal Y, Kooy Y, Van Veelen P, Vader W, Koning F, Peña S. Coeliac disease: it takes three to tango! Gut 46: 734-737 (2000). *

• van den Hazel SJ, Wolfhagen EH, van Buuren HR, van de Meeberg PC, Van Leeuwen DJ. Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group. Endoscopy 32: 779-782 (2000).

• van der Kallen CJ, Cantor RM, van Greevenbroek MM, Geurts JM, Bouwman FG, Aouizerat BE, Allayee H, Buurman WA, Lusis AJ, Rotter JI, de Bruin TW. Genome scan for adiposity in Dutch dyslipidemic families reveals novel quantitative trait loci for leptin, body mass index and soluble tumor necrosis factor receptor superfamily 1A. Int. J. Obes. Relat. Metab. Disord. 24: 1381-1391 (2000).

• van der Linden S, van der Heijde D. Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis. Curr. Opin. Rheumatol. 12: 263-268 (2000).

• van Deuren M. Immunology in the medical practice. XXVII. Mannose-binding lectin, an important link for nonspecific or hereditary immune reaction. Ned. Tijdschr. Geneeskd. 144: 1214-1219 (2000).

• van Heel DA, Satsangi J, Carey AH, Jewell DP. Inflammatory bowel disease: progress toward a gene. Can. J. Gastroenterol. 14: 207-218 (2000). *

• van Hoogstraten HJ, Vleggaar FP, Boland GJ, van Steenbergen W, Griffioen P, Hop WC, van Hattum J, van Berge Henegouwen GP, Schalm SW, van Buuren HR. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. Am. J. Gastroenterol. 95: 2015-2022 (2000). *

• Van Kruiningen HJ, Mayo DR, Vanopdenbosch E, Gower-Rousseau C, Cortot A, Colombel JF. Virus serology in familial Crohn disease. Scand. J. Gastroenterol. 35: 403-407 (2000). *

• van Meeteren ME, Meijssen MA, Zijlstra FJ. The effect of dexamethasone treatment on murine colitis. Scand. J. Gastroenterol. 35: 517-521 (2000). *

• van Venrooij WJ, Pruijn GJ. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2: 249-251 (2000). *

• Vandenbroeck K, Fiten P, Ronsse I, Goris A, Porru I, Melis C, Rolesu M, Billiau A, Marrosu MG, Opdenakker G. High-resolution analysis of IL-6 minisatellite polymorphism in Sardinian multiple sclerosis: effect on course and onset of disease. Genes Immun. 1: 460-463 (2000). *

• Vandenbroeck K, Hardt C, Louage J, Fiten P, Jackel S, Ronsse I, Epplen JT, Grimaldi LM, Olsson T, Marrosu MG, Billiau A, Opdenakker G. Lack of association between the interferon regulatory factor-1 (IRF1) locus at 5q31.1 and multiple sclerosis in Germany, northern Italy, Sardinia and Sweden. Genes Immun. 1: 290-292 (2000). *

• Vantelon JM, Godeau B, Andre C, Bierling P. Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset. Thromb. Haemost. 83: 42-45 (2000).

• Vargas-Alarcon G, Granados J, Martinez-Laso J, Gomez-Casado E, Zuniga J, Salgado N, Hernandez-Pacheco G, Hesiquio R, Rodriguez-Reyna TS, Gamboa R, Alcocer-Varela J, Arnaiz-Villena A. Lack of association between the polymorphism at the heat-shock protein (HSP70-2) gene and systemic lupus erythematosus (SLE) in the Mexican Mestizo population. Genes Immun. 1: 367-370 (2000). *

• Varilek GW. Budesonide: not for the long haul. Inflamm. Bowel Dis. 6: 154-155 (2000). *

• Vary CP, Li V, Raouf A, Kitching R, Kola I, Franceschi C, Venanzoni M, Seth A. Involvement of Ets transcription factors and targets in osteoblast differentiation and matrix mineralization. Exp. Cell Res. 257: 213-222 (2000). *

• Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 47: 487-496 (2000). *

• Vasku V, Vasku A, Izakovicova Holla L, Tschoplova S, Kankova K, Benakova N, Semradova V. Polymorphisms in inflammation genes (angiotensinogen, TAP1 and TNF-beta) in psoriasis. Arch. Dermatol. Res. 292: 531-534 (2000). *

• Vecchi M, Sacchi E, Saibeni S, Meucci G, Tagliabue L, Duca F, De Franchis R. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig. Dis. Sci. 45: 1465-1469 (2000). *

• Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20: 1868-1876 (2000). *

• Vejbaesya S, Luangtrakool P, Luangtrakool K, Sermduangprateep C, Parivisutt L. Analysis of TAP and HLA-DM polymorphism in thai rheumatoid arthritis. Hum. Immunol. 61: 309-313 (2000).

• Velasquez JN, Carnevale, Bessaso H, Bramajo J, Kuo L, Fainboim H. Identification of Enterocytozoon bieneusi in a patient with sclerosing cholangitis and AIDS. Acta Gastroenterol. Latinoam. 30: 47-51 (2000).

• Venegas E, Soto A, Cozar MV, Pereira JL, Romero H, Garcia-Luna PP. Oral nutritional supplements. Are they useful? Nutr. Hosp. 15 Suppl. 1: 49-57 (2000).

• Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, Christman JW, Blackwell TS. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 23: 396-403 (2000). *

• Venkateswaran A, Repa JJ, Lobaccaro JM, Bronson A, Mangelsdorf DJ, Edwards PA. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 275: 14700-14707 (2000). *

• Venkatraman A, Ramakrishna BS, Pulimood AB, Patra S, Murthy S. Increased permeability in dextran sulphate colitis in rats: time course of development and effect of butyrate. Scand. J. Gastroenterol. 35: 1053-1059 (2000). *

• Verborgt O, Gibson GJ, Schaffler MB. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J. Bone Miner. Res. 15: 60-67 (2000).

• Verbruggen LA, Dumarey N, Van de Velde H, Rebmann V, Flament J, Van Wayenberge C, Grosse-Wilde H, Demanet C. Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes. Tissue Antigens 56: 436-440 (2000). *

• Verburg M, Renes IB, Meijer HP, Taminiau JA, Buller HA, Einerhand AW, Dekker J. Selective sparing of goblet cells and Paneth cells in the intestine of methotrexate-treated rats. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G1037-G1047 (2000). *

• Verheyen J, Bonig H, Kim YM, Banning U, Mauz-Korholz C, Kramm C, Korholz D. Regulation of interleukin-2 induced interleukin-5 and interleukin-13 production in human peripheral blood mononuclear cells. Scand. J. Immunol. 51: 45-53 (2000). *

• Verity DH, Vaughan RW, Kondeatis E, Madanat W, Zureikat H, Fayyad F, Marr JE, Kanawati CA, Wallace GR, Stanford MR. Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease. Eur. J. Immunogenet. 27: 73-76 (2000).

• Verma S, Brown S, Kirkwood B, Giaffer MH. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am. J. Gastroenterol. 95: 735-739 (2000). *

• Verma S, Kirkwood B, Brown S, Giaffer MH. Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig. Liver Dis. 32: 769-774 (2000).

• Vermeire S, Peeters M, Vlietinck R, Parkes M, Satsangi J, Jewell D, Rutgeerts P. Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity. Inflamm. Bowel Dis. 6: 165-170 (2000). *

• Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 46: 176-181 (2000). *

• Vesy CJ, Kitchens RL, Wolfbauer G, Albers JJ, Munford RS. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from Gram-negative bacterial membranes. Infect. Immun. 68: 2410-2417 (2000). *

• Vigers GP, Dripps DJ, Edwards CK 3rd, Brandhuber BJ. X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1. J. Biol. Chem. 275: 36927-36933 (2000). *

• Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid 10: 791-798 (2000).

• Vionnet N, Hani El-H, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 67: 1470-1480 (2000). *

• Vitellas KM, Keogan MT, Freed KS, Enns RA, Spritzer CE, Baillie JM, Nelson RC. Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. Radiographics 20: 959-975 (2000). *

• Vitellas KM, Keogan MT, Spritzer CE, Nelson RC. MR cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique. Radiographics 20: 939-957 (2000). *

• Vizjak A, Nagode B, Rott T, Koselj M, Rozman B, Kaplan-Pavlovcic S, Kosnik M, Petric V, Ferluga D. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases. Wien. Klin. Wochenschr. 112: 665-670 (2000).

• Vlahcevic ZR, Eggertsen G, Bjorkhem I, Hylemon PB, Redford K, Pandak WM. Regulation of sterol 12alpha-hydroxylase and cholic acid biosynthesis in the rat. Gastroenterology 118: 599-607 (2000). *

• Vleggaar FP, Van Ooteghem NA, Van Buuren HR, Van Berge Henegouwen GP. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders. Scand. J. Gastroenterol. Suppl. 232: 86-92 (2000).

• Vlieger AM, van den Hoogen FH, Brinkman DM, van Laar JM, Schipperus M, Kruize AA, Wulffraat NM. Immunology in the medical practice. XXXII. Transplantation of autologous hematopoietic stem cells for treatment of refractory auto-immune diseases; preliminary favorable results with 35 patients. Ned. Tijdschr. Geneeskd. 144: 1588-1592 (2000).

• Vodoff MV, Gilbert B, Piguet C, Sautereau D, de Lumley L. Acute recurrent pancreatitis and heterozygous mutation of the cystic fibrosis gene: a case report. Arch. Pediatr. 7: 388-390 (2000).

• Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, Blaner WS. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res. 41: 882-893 (2000). *

• Vogelsang H, Suk EK, Janisiw M, Stain C, Mayr WR, Panzer S. Calcaneal ultrasound attenuation and vitamin-D-receptor genotypes in celiac disease. Scand. J. Gastroenterol. 35: 172-176 (2000). *

• Vohl MC, Lepage P, Gaudet D, Brewer CG, Betard C, Perron P, Houde G, Cellier C, Faith JM, Despres JP, Morgan K, Hudson TJ. Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia. J. Lipid Res. 41: 945-952 (2000). *

• Vohra P. Inflammatory bowel disease. Indian J. Pediatr. 67: 747-756 (2000).

• Volker DH, FitzGerald PE, Garg ML. The eicosapentaenoic to docosahexaenoic acid ratio of diets affects the pathogenesis of arthritis in Lew/SSN rats. J. Nutr. 130: 559-565 (2000). *

• von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47: 63-73 (2000). *

• von Lintig J, Vogt K. Filling the gap in vitamin A research. Molecular identification of an enzyme cleaving beta-carotene to retinal. J. Biol. Chem. 275: 11915-11920 (2000). *

• von Schonfeld J, Lange R, Hanrath RD, Erhard J. Adenoma of the biliary tract with dysplasias in a woman with primary sclerosing cholangitis. Med. Klin. 95: 447-449 (2000).

• von Tirpitz C, Klaus J, Bruckel J, Rieber A, Scholer A, Adler G, Bohm BO, Reinshagen M. Increase of bone mineral density with sodium fluoride in patients with Crohn's disease. Eur. J. Gastroenterol. Hepatol. 12: 19-24 (2000).

• Vorechovsky I, Cullen M, Carrington M, Hammarstrom L, Webster AD. Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J. Immunol. 164: 4408-4416 (2000). *

• Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176: 154-170 (2000). *

• Vu MK, Gielkens HA, van Hogezand RA, van Oostayen JA, Lamers CB, Masclee AA. Gallbladder motility in Crohn disease: influence of disease localization and bowel resection. Scand. J. Gastroenterol. 35: 1157-1162 (2000). *

• Wachtershauser A, Loitsch SM, Stein J. PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate. Biochem. Biophys. Res. Commun. 272: 380-385 (2000). *

• Wadleigh DJ, Reddy ST, Kopp E, Ghosh S, Herschman HR. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J. Biol. Chem. 275: 6259-6266 (2000). *

• Wadstrom T. Helicobacter in extragastric intestinal and liver disease. Acta Gastroenterol. Belg. 63: 393-394 (2000).

• Wagner CA, Lukewille U, Kaltenbach S, Moschen I, Broer A, Risler T, Broer S, Lang F. Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. Am. J. Physiol. Renal Physiol. 279: F584-F591 (2000). *

• Wakatsuki T, Miyata M, Shishido S, Suzuki T, Ohira H, Kokubun M, Sato Y, Yamamoto T, Kasukawa R. Sjogren's syndrome with primary biliary cirrhosis, complicated by transverse myelitis and malignant lymphoma. Intern. Med. 39: 260-265 (2000). *

• Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, O'Leary JJ, Berelowitz M, Walker-Smith JA. Enterocolitis in children with developmental disorders. Am. J. Gastroenterol. 95: 2285-2295 (2000). *

• Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: through a glass, darkly. Adverse Drug React. Toxicol. Rev. 19: 265-283 (2000).

• Wakefield AJ, Montgomery SM. Measles virus as a risk for inflammatory bowel disease: an unusually tolerant approach. Am. J. Gastroenterol. 95: 1389-1392 (2000). *

• Walker WA. Role of nutrients and bacterial colonization in the development of intestinal host defense. J. Pediatr. Gastroenterol. Nutr. 30 Suppl. 2: S2-S7 (2000). *

• Wall WJ. Liver transplantation for hepatic and biliary malignancy. Semin. Liver Dis. 20: 425-436 (2000). *

• Walters JR. Bile acids are physiological ligands for a nuclear receptor. Gut 46: 308-309 (2000). *

• Wan YJ, An D, Cai Y, Repa JJ, Hung-Po Chen T, Flores M, Postic C, Magnuson MA, Chen J, Chien KR, French S, Mangelsdorf DJ, Sucov HM. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol. Cell. Biol. 20: 4436-4444 (2000). *

• Wan YJ, Cai Y, Lungo W, Fu P, Locker J, French S, Sucov HM. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice. J. Biol. Chem. 275: 28285-28290 (2000). *

• Wanchu A. Antinuclear antibodies: clinical applications. J. Postgrad. Med. 46: 144-148 (2000). *

• Wandall EP, Damkier P, Moller Pedersen F, Wilson B, Schaffalitzky de Muckadell OB. Survival and incidence of colorectal cancer in patients with ulcerative colitis in Funen county diagnosed between 1973 and 1993. Scand. J. Gastroenterol. 35: 312-317 (2000). *

• Wanders RJ, van Grunsven EG, Jansen GA. Lipid metabolism in peroxisomes: enzymology, functions and dysfunctions of the fatty acid alpha- and beta-oxidation systems in humans. Biochem. Soc. Trans. 28: 141-149 (2000).

• Wang F, Zeltwanger S, Hu S, Hwang TC. Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels. J. Physiol. 524: 637-648 (2000). *

• Wang G, Ge Z, Rasko DA, Taylor DE. Lewis antigens in Helicobacter pylori: biosynthesis and phase variation. Mol. Microbiol. 36: 1187-1196 (2000). *

• Wang J, Jarvis GA, Achtman M, Rosenqvist E, Michaelsen TE, Aase A, Griffiss JM. Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis. Infect. Immun. 68: 1871-1878 (2000). *

• Wang JC, Stafford JM, Scott DK, Sutherland C, Granner DK. The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis. J. Biol. Chem. 275: 14717-14721 (2000). *

• Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J. Cell Sci. 113: 4435-4440 (2000). *

• Wang X, Moylan B, Leopold DA, Kim J, Rubenstein RC, Togias A, Proud D, Zeitlin PL, Cutting GR. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 284: 1814-1819 (2000). *

• Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96: 1703-1708 (2000). *

• Warren KG, Catz I. Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP(85)VVHFFKNIVTP(96)RT in multiple sclerosis patients. Mult. Scler. 6: 300-311 (2000). *

• Wassell J. Haptoglobin: function and polymorphism. Clin. Lab. 46: 547-552 (2000). *

• Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF. Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J. Nutr. 130: 2274-2284 (2000). *

• Wawrzynowicz-Syczewska M, Underhill JA, Clare MA, Boron-Kaczmarska A, McFarlane IG, Donaldson PT. HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland. Liver 20: 234-239 (2000).

• Weetman AP. Graves' disease. N. Engl. J. Med. 343: 1236-1248 (2000). *

• Wehrmann T, Schmitt T, Caspary WF, Seifert H. Local injection of depot corticosteroids in endoscopic therapy of benign bile duct strictures. Z. Gastroenterol. 38: 235-241 (2000).

• Weiss RA. Ancient and modern retroviruses. Acta Microbiol. Immunol. Hung. 47: 403-410 (2000).

• Weiss ST. Parasites and asthma/allergy: what is the relationship? J. Allergy Clin. Immunol. 105: 205-210 (2000).

• Wen L, Wong FS, Tang J, Chen NY, Altieri M, David C, Flavell R, Sherwin R. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J. Exp. Med. 191: 97-104 (2000). *

• Wentworth JM, Agostini M, Love J, Schwabe JW, Chatterjee VK. St John's wort, a herbal antidepressant, activates the steroid X receptor. J. Endocrinol. 166: R11-R16 (2000). *

• Werbajh S, Nojek I, Lanz R, Costas MA. RAC-3 is a NF-kappa B coactivator. FEBS Lett. 485: 195-199 (2000). *

• Wershil BK. Lessons from genetically engineered animal models. IX. Mast cell-deficient mice and intestinal biology. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G343-G348 (2000). *

• Weyand CM, Goronzy JJ. Association of MHC and rheumatoid arthritis. HLA polymorphisms in phenotypic variants of rheumatoid arthritis. Arthritis Res. 2: 212-216 (2000). *

• Wheat VJ, Shumaker H, Burnham C, Shull GE, Yankaskas JR, Soleimani M. CFTR induces the expression of DRA along with Cl(-)/HCO(3)(-) exchange activity in tracheal epithelial cells. Am. J. Physiol. Cell Physiol. 279: C62-C71 (2000). *

• Whitcomb DC. Genetic predispositions to acute and chronic pancreatitis. Med. Clin. North Am. 84: 531-547, vii (2000).

• White JA, Ramshaw H, Taimi M, Stangle W, Zhang A, Everingham S, Creighton S, Tam SP, Jones G, Petkovich M. Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc. Natl. Acad. Sci. U.S.A. 97: 6403-6408 (2000). *

• Whittington RJ, Reddacliff LA, Marsh I, McAllister S, Saunders V. Temporal patterns and quantification of excretion of Mycobacterium avium subsp paratuberculosis in sheep with Johne's disease. Aust. Vet. J. 78: 34-37 (2000).

• Wiendl H, Neuhaus O, Kappos L, Hohlfeld R. Multiple sclerosis. Current review of failed and discontinued clinical trials of drug treatment. Nervenarzt. 71: 597-610 (2000).

• Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Buschenfelde KH, Lohse AW. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355: 1510-1515 (2000). *

• Wiik A. What you should know about PR3-ANCA. An introduction. Arthritis Res. 2: 252-254 (2000). *

• Williams CN, Al-Knawy B, Blanchard W. Bioavailability of four ursodeoxycholic acid preparations. Aliment. Pharmacol. Ther. 14: 1133-1139 (2000). *

• Williams E, Iredale J. Hepatic regeneration and TGF-beta: growing to a prosperous perfection. Gut 46: 593-594 (2000). *

• Williams EJ, Haque S, Banks C, Johnson P, Sarsfield P, Sheron N. Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J. Pathol. 192: 533-539 (2000). *

• Williams HK, Connor R, Edmondson H. Chronic sclerosing sialadenitis of the submandibular and parotid glands: a report of a case and review of the literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 89: 720-723 (2000).

• Williams KM, Bigley EC 3rd, Raybourne RB. Identification of murine B-cell and T-cell epitopes of Escherichia coli outer membrane protein F with synthetic polypeptides. Infect. Immun. 68: 2535-2545 (2000). *

• Williams R, James OF, Warnes TW, Morgan MY. Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre study. Eur. J. Gastroenterol. Hepatol. 12: 203-208 (2000).

• Williams R, Riordan SM. Acute liver failure: established and putative hepatitis viruses and therapeutic implications. J. Gastroenterol. Hepatol. 15: G17-G25 (2000).

• Willis G, Wimperis JZ, Lonsdale R, Fellows IW, Watson MA, Skipper LM, Jennings BA. Incidence of liver disease in people with HFE mutations. Gut 46: 401-404 (2000). *

• Willoughby DA, Moore AR, Colville-Nash PR. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 355: 646-648 (2000). *

• Wilmanns M. Future structural biology applications with a free-electron laser - more than wild dreams? J. Synchrotron Radiat. 7: 41-46 (2000).

• Winqvist O, Rorsman F, Kämpe O. Autoimmune adrenal insufficiency: recognition and management. BioDrugs 13: 107-114 (2000).

• Wirtz S, Neurath MF. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int. J. Colorectal Dis. 15: 144-160 (2000). *

• Wise CA, Barnes R, Gillum J, Herring JA, Bowcock AM, Lovett M. Localization of susceptibility to familial idiopathic scoliosis. Spine 25: 2372-2380 (2000).

• Wise CA, Bennett LB, Pascual V, Gillum JD, Bowcock AM. Localization of a gene for familial recurrent arthritis. Arthritis Rheum. 43: 2041-2045 (2000). *

• Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab. Invest. 80: 617-653 (2000).

• Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J, Polubinska A, Friess H, Gahl GM, Frei U, Jorres A. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 165: 5814-5821 (2000). *

• Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat. Genet. 25: 213-216 (2000). *

• Witte J, Shivananda S, Lennard-Jones JE, Beltrami M, Politi P, Bonanomi A, Tsianos EV, Mouzas I, Schulz TB, Monteiro E, Clofent J, Odes S, Limonard CB, Stockbrugger RW, Russel MG. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand. J. Gastroenterol. 35: 1272-1277 (2000). *

• Wolbrink A. Primary sclerosing cholangitis - a case report. Aviat. Space Environ. Med. 71: 83-84 (2000).

• Wolf DC. IBD highlights from the 1999 American College of Gastroenterology meeting: infliximab and 6-MP. Inflamm. Bowel Dis. 6: 59-60 (2000). *

• Wolf G. The oxidation of 9-cis-retinol: a possible synthesis pathway for 9-cis-retinoic acid. Nutr. Rev. 58: 354-356 (2000).

• Wolf G. Cellular retinoic acid-binding protein II: a coactivator of the transactivation by the retinoic acid receptor complex RAR.RXR. Nutr. Rev. 58: 151-53 (2000).

• Wolfhagen FH, van Buuren HR, Vleggaar FP, Schalm SW. Management of osteoporosis in primary biliary cirrhosis. Best Pract. Res. Clin. Gastroenterol. 14: 629-641 (2000).

• Woltman AM, de Haij S, Boonstra JG, Gobin SJ, Daha MR, van Kooten C. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J. Am. Soc. Nephrol. 11: 2044-2055 (2000). *

• Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9: 589-593 (2000).

• Woo P. Cytokine polymorphisms and inflammation. Clin. Exp. Rheumatol. 18: 767-771 (2000).

• Woodford-Richens K, Bevan S, Churchman M, Dowling B, Jones D, Norbury CG, Hodgson SV, Desai D, Neale K, Phillips RK, Young J, Leggett B, Dunlop M, Rozen P, Eng C, Markie D, Rodriguez-Bigas MA, Sheridan E, Iwama T, Eccles D, Smith GT, Kim JC, Kim KM, et al. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut 46: 656-660 (2000). *

• Worledge KL, Godiska R, Barrett TA, Kink JA. Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats. Dig. Dis. Sci. 45: 2298-2305 (2000). *

• Wu GD. A nuclear receptor to prevent colon cancer. N. Engl. J. Med. 342: 651-653 (2000). *

• Wu H, Zhang G, Minton JE, Ross CR, Blecha F. Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection. Infect. Immun. 68: 5552-5558 (2000). *

• Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J. Gastroenterol. 35: 665-672 (2000). *

• Wu Z, Wang N, Murong S, Lin M. Identification and analysis of mutations of the Wilson disease gene in Chinese population. Chin. Med. J. (Engl.) 113: 40-43 (2000).

• Wulffraat NM, Sanders LA, Kuis W. Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr. Rheumatol. Rep. 2: 316-323 (2000).

• Wuorela M, Raiha I. Acute haemorrhagic colitis possibly caused by Clostridium perfringens. Scand. J. Gastroenterol. 35: 559-560 (2000). *

• Wurbel MA, Philippe JM, Nguyen C, Victorero G, Freeman T, Wooding P, Miazek A, Mattei MG, Malissen M, Jordan BR, Malissen B, Carrier A, Naquet P. The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. Eur. J. Immunol. 30: 262-271 (2000). *

• Wyss A, Wirtz G, Woggon W, Brugger R, Wyss M, Friedlein A, Bachmann H, Hunziker W. Cloning and expression of beta,beta-carotene 15,15'-dioxygenase. Biochem. Biophys. Res. Commun. 271: 334-336 (2000). *

• Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 80: 1107-1213 (2000). *

• Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275: 31335-31339 (2000). *

• Xie Q, Alpers DH. The two isozymes of rat intestinal alkaline phosphatase are products of two distinct genes. Physiol. Genomics 3: 1-8 (2000). *

• Xie W, Barwick JL, Downes M, Blumberg B, Simon CM, Nelson MC, Neuschwander-Tetri BA, Brunt EM, Guzelian PS, Evans RM. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406: 435-439 (2000). *

• Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, Evans RM. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 14: 3014-3023 (2000). *

• Xu BY, Huang D, Pirskanen R, Lefvert AK. beta2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG). Clin. Exp. Immunol. 119: 156-160 (2000). *

• Xu J, Postma DS, Howard TD, Koppelman GH, Zheng SL, Stine OC, Bleecker ER, Meyers DA. Major genes regulating total serum immunoglobulin E levels in families with asthma. Am. J. Hum. Genet. 67: 1163-1173 (2000). *

• Yamada M, Nagatomo J, Setoguchi Y, Kuroki N, Higashi S, Setoguchi T. Circadian rhythms of sterol 12alpha-hydroxylase, cholesterol 7alpha-hydroxylase and DBP involved in rat cholesterol catabolism. Biol. Chem. 381: 1149-1153 (2000).

• Yamada S, Zhu Q, Aihara Y, Onda H, Zhang Z, Yu L, Jin L, Si YJ, Nishigori H, Tomura H, Inoue I, Morikawa A, Yamagata K, Hanafusa T, Matsuzawa Y, Takeda J. Cloning of cDNA and the gene encoding human hepatocyte nuclear factor (HNF)-3 beta and mutation screening in Japanese subjects with maturity-onset diabetes of the young. Diabetologia 43: 121-124 (2000). *

• Yamaguchi H, Osaki T, Kai M, Taguchi H, Kamiya S. Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori. Infect. Immun. 68: 3448-3454 (2000). *

• Yamamoto Y, Zolfaghari R, Ross AC. Regulation of CYP26 (cytochrome P450RAI) mRNA expression and retinoic acid metabolism by retinoids and dietary vitamin A in liver of mice and rats. FASEB J. 14: 2119-2127 (2000). *

• Yamane H, Sugimoto Y, Tanaka S, Ichikawa A. Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem. Biophys. Res. Commun. 278: 224-228 (2000). *

• Yamano T, Higashi T, Nouso K, Nakatsukasa H, Kariyama K, Yumoto E, Kobayashi Y, Yamamoto K, Iwagaki H, Yagi T, Tanimoto T, Kurimoto M, Tanaka N, Tsuji T. Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis. Clin. Exp. Immunol. 122: 227-231 (2000). *

• Yamashita K, Yorioka N, Kyuden Y, Naito T, Tanji C, Ueda C, Usui K, Shigemoto K, Harada S, Yamakido M. A case of CREST syndrome and myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Clin. Nephrol. 53: 296-300 (2000).

• Yanagawa T, Gomi K, Nakao EI, Inada S. CTLA-4 gene polymorphism in Japanese patients with rheumatoid arthritis. J. Rheumatol. 27: 2740-2742 (2000).

• Yang H, Rotter JI. The genetic background of inflammatory bowel disease. Hepatogastroenterology 47: 5-14 (2000).

• Yang JJ, Tuttle RH, Hogan SL, Taylor JG, Phillips BD, Falk RJ, Jennette JC. Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin. Exp. Immunol. 121: 165-172 (2000). *

• Yang P, Tremaine WJ, Meyer RL, Prakash UB. Alpha1-antitrypsin deficiency and inflammatory bowel diseases. Mayo Clin. Proc. 75: 450-455 (2000). *

• Yang W, Rachez C, Freedman LP. Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators. Mol. Cell. Biol. 20: 8008-8017 (2000). *

• Yang XY, Wang LH, Chen T, Hodge DR, Resau JH, DaSilva L, Farrar WL. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J. Biol. Chem. 275: 4541-4544 (2000). *

• Yang YS, Kim SJ, Kim JW, Koh EM. NRAMP1 gene polymorphisms in patients with rheumatoid arthritis in Koreans. J. Korean Med. Sci. 15: 83-87 (2000). *

• Yao K, Yao T, Iwashita A, Matsui T, Kamachi S. Microaggregate of immunostained macrophages in noninflamed gastroduodenal mucosa: a new useful histological marker for differentiating Crohn's colitis from ulcerative colitis. Am. J. Gastroenterol. 95: 1967-1973 (2000). *

• Yarwood JM, Leung DY, Schlievert PM. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol. Lett. 192: 1-7 (2000). *

• Yarze JC, Herlihy KJ, Chase MP, Fritz HP. ERCP experience in a community-based, private-practice setting. Am. J. Gastroenterol. 95: 3006-3007 (2000). *

• Yasoshima M, Tsuneyama K, Harada K, Sasaki M, Gershwin ME, Nakanuma Y. Immunohistochemical analysis of cell-matrix adhesion molecules and their ligands in the portal tracts of primary biliary cirrhosis. J. Pathol. 190: 93-99 (2000). *

• Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18: 143-164 (2000). *

• Yazawa N, Kikuchi K, Ihn H, Fujimoto M, Kubo M, Tamaki T, Tamaki K. Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis. J. Am. Acad. Dermatol. 42: 70-75 (2000).

• Ye MQ, Suriawinata A, Black C, Min AD, Strauchen J, Thung SN. Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a patient with primary biliary cirrhosis. Arch. Pathol. Lab. Med. 124: 604-608 (2000). *

• Yeaman SJ, Kirby JA, Jones DE. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol. Rev. 174: 238-249 (2000). *

• Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun. 1: 386-390 (2000). *

• Yeon HB, Lindor NM, Seidman JG, Seidman CE. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am. J. Hum. Genet. 66: 1443-1448 (2000). *

• Yeum KJ, dos Anjos Ferreira AL, Smith D, Krinsky NI, Russell RM. The effect of alpha-tocopherol on the oxidative cleavage of beta-carotene. Free Radic. Biol. Med. 29: 105-114 (2000).

• Yeung MM, Melgar S, Baranov V, Oberg A, Danielsson A, Hammarstrom S, Hammarstrom ML. Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut 47: 215-227 (2000). *

• Yokohata K, Shirahane K, Yonemasu H, Nabae T, Inoue K, Ohtsuka T, Yamaguchi K, Chijiiwa K, Tanaka M. Focal ductal branch dilatation on magnetic resonance cholangiopancreatography: a hint for early diagnosis of pancreatic carcinoma. Scand. J. Gastroenterol. 35: 1229-1232 (2000). *

• Yonemitsu H, Kimura T, Kagawa K, Iwanami E, Tsuda T. A case of primary sclerosing cholangitis having autoimmune hepatitis-resembling clinical features at the onset of illness. Nippon Shokakibyo Gakkai Zasshi 97: 1506-1510 (2000).

• Yoshida EM, Caron NR, Buczkowski AK, Arbour LT, Scudamore CH, Steinbrecher UP, Erb SR, Chung SW. Indications for liver transplantation in British Columbia's Aboriginal population: a 10-year retrospective analysis. Can. J. Gastroenterol. 14: 775-779 (2000). *

• Young ND. The genetic architecture of resistance. Curr. Opin. Plant Biol. 3: 285-290 (2000). *

• Younossi ZM, Kiwi ML, Boparai N, Price LL, Guyatt G. Cholestatic liver diseases and health-related quality of life. Am. J. Gastroenterol. 95: 497-502 (2000). *

• Yu C, Wang F, Kan M, Jin C, Jones RB, Weinstein M, Deng CX, McKeehan WL. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J. Biol. Chem. 275: 15482-15489 (2000). *

• Yu CR, Peden KW, Zaitseva MB, Golding H, Farber JM. CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand. J. Immunol. 164: 1293-1305 (2000). *

• Yu H, Nasr SZ, Deretic V. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Infect. Immun. 68: 2142-2147 (2000). *

• Yuan CJ, Mandal AK, Zhang Z, Mukherjee AB. Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs. Cancer Res. 60: 1084-1091 (2000). *

• Yuki N. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barre syndrome. Cell. Mol. Life Sci. 57: 527-533 (2000). *

• Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ. Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am. J. Med. Genet. 95: 432-437 (2000).

• Zanelli E, Breedveld FC, de Vries RR. HLA class II association with rheumatoid arthritis: facts and interpretations. Hum. Immunol. 61: 1254-1261 (2000).

• Zapico I, Coto E, Rodriguez A, Alvarez C, Torre JC, Alvarez V. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun. 1: 288-289 (2000). *

• Zebrak J, Skuza B, Pogorzelski A, Ligarska R, Kopytko E, Pawlik J, Rutkiewicz E, Witt M. Partial CFTR genotyping and characterisation of cystic fibrosis patients with myocardial fibrosis and necrosis. Clin. Genet. 57: 56-60 (2000). *

• Zeng H, Liu G, Rea PA, Kruh GD. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 60: 4779-4784 (2000). *

• Zeniya M. Lessons from animal models of primary biliary cirrhosis. J. Gastroenterol. Hepatol. 15: 342-343 (2000). *

• Zeniya M, Toda G. Autoimmune liver disease: current therapy. Intern. Med. 39: 346-347 (2000). *

• Zeuzem S. Gut-liver axis. Int. J. Colorectal Dis. 15: 59-82 (2000). *

• Zhang JS, Feng WG, Li CL, Wang XY, Chang ZL. NF-kappa B regulates the LPS-induced expression of interleukin 12 p40 in murine peritoneal macrophages: roles of PKC, PKA, ERK, p38 MAPK, and proteasome. Cell. Immunol. 204: 38-45 (2000). *

• Zhang QY, Dunbar D, Kaminsky L. Human cytochrome P-450 metabolism of retinals to retinoic acids. Drug Metab. Dispos. 28: 292-297 (2000). *

• Zhang SQ, Kovalenko A, Cantarella G, Wallach D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 12: 301-311 (2000). *

• Zhang WJ, Koltun WA, Tilberg AF, Page MJ, Chorney MJ. Absence of GNAI2 codon 179 oncogene mutations in inflammatory bowel disease. Inflamm. Bowel Dis. 6: 103-106 (2000). *

• Zhang Y, Lee B, Thompson M, Glass R, Cama RI, Figueroa D, Gilman R, Taylor D, Stephenson C. Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and Cryptosporidium. Diarrhea Working Group, Peru. J. Pediatr. Gastroenterol. Nutr. 31: 16-21 (2000). *

• Zhao Q, Chasse SA, Devarakonda S, Sierk ML, Ahvazi B, Rastinejad F. Structural basis of RXR-DNA interactions. J. Mol. Biol. 296: 509-520 (2000). *

• Zheng LY, Yu CQ, Hu BP, Ha Q. Preliminary study on diagnosis of tumor-like Sjogren's syndrome. Shanghai Kou Qiang Yi Xue 9: 138-140 (2000).

• Zhou P, Szot GL, Guo Z, Kim O, He G, Wang J, Grusby MJ, Newell KA, Thistlethwaite JR, Bluestone JA, Alegre ML. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J. Immunol. 165: 5580-5587 (2000). *

• Zhou X, Tan FK, Stivers DN, Arnett FC. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association. Arthritis Rheum. 43: 1068-1073 (2000). *

• Zhu Q, Yamagata K, Yu L, Tomura H, Yamada S, Yang Q, Yoshiuchi I, Sumi S, Miyagawa J, Takeda J, Hanafusa T, Matsuzawa Y. Identification of missense mutations in the hepatocyte nuclear factor-3beta gene in Japanese subjects with late-onset type II diabetes mellitus. Diabetologia 43: 1197-1200 (2000). *

• Ziboh VA, Miller CC, Cho Y. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. Am. J. Clin. Nutr. 71: 361S-366S (2000). *

• Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 67: 117-133 (2000). *

• Zimber A, Chedeville A, Abita JP, Barbu V, Gespach C. Functional interactions between bile acids, all-trans retinoic acid, and 1,25-dihydroxy-vitamin D3 on monocytic differentiation and myeloblastin gene down-regulation in HL60 and THP-1 human leukemia cells. Cancer Res. 60: 672-678 (2000). *

• Zimny M, Fass J, Bares R, Cremerius U, Sabri O, Buechin P, Schumpelick V, Buell U. Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma. Scand. J. Gastroenterol. 35: 883-888 (2000). *

• Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164: 2832-2838 (2000). *

• Zipp F, Windemuth C, Pankow H, Dichgans J, Wienker T, Martin R, Muller C. Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2. Hum. Immunol. 61: 1021-1030 (2000).

• Zolfaghari R, Ross AC. Lecithin:retinol acyltransferase from mouse and rat liver. cDNA cloning and liver-specific regulation by dietary vitamin A and retinoic acid. J. Lipid Res. 41: 2024-2034 (2000). *

• Zoli M, Merkel C, Magalotti D, Gueli C, Grimaldi M, Gatta A, Bernardi M. Natural history of cirrhotic patients with small esophageal varices: a prospective study. Am. J. Gastroenterol. 95: 503-508 (2000). *

• Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, Shapira SK, Farndon PA, Wara DW, Emmal SA, Ferguson BM. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am. J. Hum. Genet. 67: 1555-1562 (2000). *

• Zsembery A, Strazzabosco M, Graf J. Ca2+-activated Cl- channels can substitute for CFTR in stimulation of pancreatic duct bicarbonate secretion. FASEB J. 14: 2345-2356 (2000). *

• Zsembery A, Thalhammer T, Graf J. Bile formation: a concerted action of membrane transporters in hepatocytes and cholangiocytes. News Physiol. Sci. 15: 6-11 (2000). *

• Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Am. J. Gastroenterol. 95: 768-771 (2000). *

• Zuccon L, Corsi B, Levi S, Mattioli M, Fracanzani AL, Corti A, Albertini A, Sampietro M, Fargion S, Arosio P. Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein. Haematologica 85: 346-351 (2000). *

• Zucker-Franklin D. Non-HIV retroviral associations with rheumatic disease. Curr. Rheumatol. Rep. 2: 156-162 (2000).

• Zuklys S, Balciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Hollander GA. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J. Immunol. 165: 1976-1983 (2000). *

Number of references = 2429

www psc-literature.org